
DROP TABLE IF EXISTS `document`;
CREATE TABLE `document` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `document_number` varchar(100) NOT NULL,
  `document_title` varchar(100) NOT NULL,
  `document_owner_id` int(11) NOT NULL,
  `document_category_id` int(11) NOT NULL,
  `document_subcategy_id` int(11) NOT NULL,
  `date_of_1_issue` date NOT NULL,
  `date_of_current_issue` date NOT NULL,
  `live_revision_number` int(11) NOT NULL,
  `status` tinyint(2) NOT NULL COMMENT '1=Live, 2=Obsolete ',
  `location` varchar(100) NOT NULL,
  `no_of_copies` int(11) NOT NULL,
  `interval_months` int(5) NOT NULL,
  `date_of_next_review` date NOT NULL,
  `revised_review_date` date NOT NULL,
  `obsolete_document_owner` varchar(200) NOT NULL,
  `disclaimer` text NOT NULL,
  `content` text NOT NULL,
  `documents` text NOT NULL,
  `footer` varchar(500) NOT NULL,
  `issued_to` int(11) NOT NULL,
  `document_Information` text NOT NULL,
  `images` varchar(100) NOT NULL,
  `is_published` tinyint(2) NOT NULL COMMENT '1 = published',
  `document_status` tinyint(2) NOT NULL DEFAULT 1 COMMENT '1 = active, 0 = inactive',
  `created_by` int(11) NOT NULL,
  `created_at` datetime NOT NULL DEFAULT current_timestamp(),
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=39 DEFAULT CHARSET=utf8mb3;

INSERT INTO `document` (`id`, `document_number`, `document_title`, `document_owner_id`, `document_category_id`, `document_subcategy_id`, `date_of_1_issue`, `date_of_current_issue`, `live_revision_number`, `status`, `location`, `no_of_copies`, `interval_months`, `date_of_next_review`, `revised_review_date`, `obsolete_document_owner`, `disclaimer`, `content`, `documents`, `footer`, `issued_to`, `document_Information`, `images`, `is_published`, `document_status`, `created_by`, `created_at`) VALUES
(1,	'POL-MI-080722',	'FNQH-POL-MI-080722 ',	284,	1,	0,	'2022-08-31',	'2022-08-31',	1,	1,	'Londin',	2,	24,	'2024-08-31',	'2022-08-31',	'Bob',	'<p><strong>Lorem Ipsum</strong>&nbsp;is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry\'s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.</p>',	'<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone, and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone, and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>&nbsp;</p>',	'<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone, and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone, and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>&nbsp;</p>',	'Remaining Essentially unchanged. It was popularised',	1,	'It was popularised in the',	'',	0,	1,	284,	'2022-08-30 06:28:45'),
(2,	'POL-MI-080722',	'FNQH-POL-MI-080722 ',	284,	1,	0,	'2022-08-31',	'2022-08-31',	1,	1,	'Londin',	2,	24,	'2024-08-31',	'2022-08-31',	'Bob',	'<p><strong>Lorem Ipsum</strong>&nbsp;is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry\'s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.</p>',	'<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone, and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone, and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>&nbsp;</p>',	'<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone, and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone, and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY<br>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile and internet use by employees.</p>\r\n<p>Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks, distracts co-workers and colleagues, and can cause significant expense to a<br>business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet use for all employees during their employment with the Company.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes<br>benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. The terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>&nbsp;</p>',	'Remaining Essentially unchanged. It was popularised',	1,	'It was popularised in the',	'',	0,	0,	284,	'2022-09-01 10:34:54'),
(3,	'POL-MI-2022',	'Simply dummy text',	452,	2,	0,	'2022-09-06',	'2021-08-04',	2,	2,	'London',	1,	12,	'2022-08-04',	'2022-09-08',	'Simply Dummy',	'<p><span style=\"font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; text-align: justify; background-color: #ffffff;\">Simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry\'s standard dummy text ever since when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.</span></p>\r\n<p><span style=\"font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; text-align: justify; background-color: #ffffff;\">Simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry\'s standard dummy text ever since when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.</span></p>',	'<h2 style=\"margin: 0px 0px 10px; padding: 0px; font-weight: 400; font-family: DauphinPlain; font-size: 24px; line-height: 24px; background-color: #ffffff;\">Index</h2>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\"><strong style=\"margin: 0px; padding: 0px;\">Lorem Ipsum</strong> is simply dummy............................................. 1&nbsp;</p>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\"><strong style=\"margin: 0px; padding: 0px;\">Lorem Ipsum</strong> is simply dummy............................................. 2&nbsp;</p>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\"><strong style=\"margin: 0px; padding: 0px;\">Lorem Ipsum</strong> is simply dummy............................................. 3</p>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\"><strong style=\"margin: 0px; padding: 0px;\">Lorem Ipsum</strong> is simply dummy............................................. 4&nbsp;</p>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\"><strong style=\"margin: 0px; padding: 0px;\">Lorem Ipsum</strong> is simply dummy............................................. 5&nbsp;</p>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\"><strong style=\"margin: 0px; padding: 0px;\">Lorem Ipsum</strong> is simply dummy............................................. 6&nbsp;</p>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\"><strong style=\"margin: 0px; padding: 0px;\">Lorem Ipsum</strong>&nbsp;is simply dummy............................................. 1&nbsp;</p>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\">&nbsp;</p>',	'<h2 style=\"margin: 0px 0px 10px; padding: 0px; font-weight: 400; font-family: DauphinPlain; font-size: 24px; line-height: 24px; background-color: #ffffff;\">What is Lorem Ipsum?</h2>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\"><strong style=\"margin: 0px; padding: 0px;\">Lorem Ipsum</strong>&nbsp;is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry\'s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.</p>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\">&nbsp;</p>\r\n<h2 style=\"margin: 0px 0px 10px; padding: 0px; font-weight: 400; font-family: DauphinPlain; font-size: 24px; line-height: 24px; background-color: #ffffff;\">What is Lorem Ipsum?</h2>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\"><strong style=\"margin: 0px; padding: 0px;\">Lorem Ipsum</strong>&nbsp;is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry\'s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.</p>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\">&nbsp;</p>\r\n<h2 style=\"margin: 0px 0px 10px; padding: 0px; font-weight: 400; font-family: DauphinPlain; font-size: 24px; line-height: 24px; background-color: #ffffff;\">What is Lorem Ipsum?</h2>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\"><strong style=\"margin: 0px; padding: 0px;\">Lorem Ipsum</strong>&nbsp;is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry\'s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.</p>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\">&nbsp;</p>\r\n<h2 style=\"margin: 0px 0px 10px; padding: 0px; font-weight: 400; font-family: DauphinPlain; font-size: 24px; line-height: 24px; background-color: #ffffff;\">What is Lorem Ipsum?</h2>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\"><strong style=\"margin: 0px; padding: 0px;\">Lorem Ipsum</strong>&nbsp;is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry\'s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.</p>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\">&nbsp;</p>\r\n<h2 style=\"margin: 0px 0px 10px; padding: 0px; font-weight: 400; font-family: DauphinPlain; font-size: 24px; line-height: 24px; background-color: #ffffff;\">What is Lorem Ipsum?</h2>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\"><strong style=\"margin: 0px; padding: 0px;\">Lorem Ipsum</strong>&nbsp;is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry\'s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.</p>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\">&nbsp;</p>\r\n<h2 style=\"margin: 0px 0px 10px; padding: 0px; font-weight: 400; font-family: DauphinPlain; font-size: 24px; line-height: 24px; background-color: #ffffff;\">What is Lorem Ipsum?</h2>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\"><strong style=\"margin: 0px; padding: 0px;\">Lorem Ipsum</strong>&nbsp;is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry\'s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.</p>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\">&nbsp;</p>\r\n<h2 style=\"margin: 0px 0px 10px; padding: 0px; font-weight: 400; font-family: DauphinPlain; font-size: 24px; line-height: 24px; background-color: #ffffff;\">What is Lorem Ipsum?</h2>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\"><strong style=\"margin: 0px; padding: 0px;\">Lorem Ipsum</strong>&nbsp;is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry\'s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.</p>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\">&nbsp;</p>\r\n<h2 style=\"margin: 0px 0px 10px; padding: 0px; font-weight: 400; font-family: DauphinPlain; font-size: 24px; line-height: 24px; background-color: #ffffff;\">What is Lorem Ipsum?</h2>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\"><strong style=\"margin: 0px; padding: 0px;\">Lorem Ipsum</strong>&nbsp;is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry\'s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.</p>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\">&nbsp;</p>\r\n<h2 style=\"margin: 0px 0px 10px; padding: 0px; font-weight: 400; font-family: DauphinPlain; font-size: 24px; line-height: 24px; background-color: #ffffff;\">What is Lorem Ipsum?</h2>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\"><strong style=\"margin: 0px; padding: 0px;\">Lorem Ipsum</strong>&nbsp;is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry\'s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.</p>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\">&nbsp;</p>\r\n<h2 style=\"margin: 0px 0px 10px; padding: 0px; font-weight: 400; font-family: DauphinPlain; font-size: 24px; line-height: 24px; background-color: #ffffff;\">What is Lorem Ipsum?</h2>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\"><strong style=\"margin: 0px; padding: 0px;\">Lorem Ipsum</strong>&nbsp;is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry\'s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.</p>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\">&nbsp;</p>\r\n<h2 style=\"margin: 0px 0px 10px; padding: 0px; font-weight: 400; font-family: DauphinPlain; font-size: 24px; line-height: 24px; background-color: #ffffff;\">What is Lorem Ipsum?</h2>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\"><strong style=\"margin: 0px; padding: 0px;\">Lorem Ipsum</strong>&nbsp;is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry\'s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.</p>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\">&nbsp;</p>\r\n<h2 style=\"margin: 0px 0px 10px; padding: 0px; font-weight: 400; font-family: DauphinPlain; font-size: 24px; line-height: 24px; background-color: #ffffff;\">What is Lorem Ipsum?</h2>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\"><strong style=\"margin: 0px; padding: 0px;\">Lorem Ipsum</strong>&nbsp;is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry\'s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.</p>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\">&nbsp;</p>\r\n<h2 style=\"margin: 0px 0px 10px; padding: 0px; font-weight: 400; font-family: DauphinPlain; font-size: 24px; line-height: 24px; background-color: #ffffff;\">What is Lorem Ipsum?</h2>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\"><strong style=\"margin: 0px; padding: 0px;\">Lorem Ipsum</strong>&nbsp;is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry\'s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.</p>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\">&nbsp;</p>\r\n<h2 style=\"margin: 0px 0px 10px; padding: 0px; font-weight: 400; font-family: DauphinPlain; font-size: 24px; line-height: 24px; background-color: #ffffff;\">What is Lorem Ipsum?</h2>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\"><strong style=\"margin: 0px; padding: 0px;\">Lorem Ipsum</strong>&nbsp;is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry\'s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.</p>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\">&nbsp;</p>\r\n<h2 style=\"margin: 0px 0px 10px; padding: 0px; font-weight: 400; font-family: DauphinPlain; font-size: 24px; line-height: 24px; background-color: #ffffff;\">What is Lorem Ipsum?</h2>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\"><strong style=\"margin: 0px; padding: 0px;\">Lorem Ipsum</strong>&nbsp;is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry\'s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.</p>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\">&nbsp;</p>\r\n<h2 style=\"margin: 0px 0px 10px; padding: 0px; font-weight: 400; font-family: DauphinPlain; font-size: 24px; line-height: 24px; background-color: #ffffff;\">What is Lorem Ipsum?</h2>\r\n<p style=\"margin: 0px 0px 15px; padding: 0px; text-align: justify; font-family: \'Open Sans\', Arial, sans-serif; font-size: 14px; background-color: #ffffff;\"><strong style=\"margin: 0px; padding: 0px;\">Lorem Ipsum</strong> is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry\'s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum. rrrrrr</p>',	'It has survived not only five centuries, but also the leap into electronic typesetting',	1,	'Simply dummy text when an unknown printer',	'',	0,	0,	452,	'2022-09-06 06:32:44'),
(4,	'FNQH-SOP-060522',	'FNQH Document Control SOP [INTERNAL] V1.0',	453,	5,	0,	'2022-09-07',	'2022-07-15',	1,	1,	'INTERNAL',	0,	0,	'1970-01-01',	'2022-07-15',	'Sarah Sharpe',	'<p>This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</p>\r\n<p>Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</p>\r\n<p>&nbsp;</p>',	'<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>DOCUMENT CONTROL&nbsp;</p>\r\n<p>Standard Operating Procedure</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>INTERNAL</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Status:&nbsp; FINAL</p>\r\n<p>Version:&nbsp; 0.1</p>\r\n<p>Issue Date: 06.05.22&nbsp;</p>\r\n<p>Document ID:&nbsp; FNQH-SOP-060522</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</p>\r\n<p>&nbsp;</p>\r\n<p>Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>About This Document</p>\r\n<p>Document Control</p>\r\n<p>Document ID:<span style=\"white-space: pre;\"> </span>FNQH-SOP-060522</p>\r\n<p>Version Number:<span style=\"white-space: pre;\"> </span>V1.0</p>\r\n<p>Date of Version:<span style=\"white-space: pre;\"> </span>5 May 2022</p>\r\n<p>Created by:<span style=\"white-space: pre;\"> </span>Sarah Sharpe</p>\r\n<p>Approved by:<span style=\"white-space: pre;\"> </span></p>\r\n<p>Confidentiality Level:<span style=\"white-space: pre;\"> </span>INTERNAL</p>\r\n<p>Document History</p>\r\n<p>&nbsp;</p>\r\n<p>Date of Edit<span style=\"white-space: pre;\"> </span>Version<span style=\"white-space: pre;\"> </span>Edited by<span style=\"white-space: pre;\"> </span>Description of change&nbsp;</p>\r\n<p>05/06/22<span style=\"white-space: pre;\"> </span>V0.1<span style=\"white-space: pre;\"> </span>Sarah Sharpe<span style=\"white-space: pre;\"> </span>Minor edits</p>\r\n<p>1/07/22<span style=\"white-space: pre;\"> </span>V0.2<span style=\"white-space: pre;\"> </span>Fiona Makowski<span style=\"white-space: pre;\"> </span>Review and edits</p>\r\n<p>03/07/22<span style=\"white-space: pre;\"> </span>V0.3<span style=\"white-space: pre;\"> </span>Sarah Sharpe<span style=\"white-space: pre;\"> </span>Review and accepted edits</p>\r\n<p>15/07/22<span style=\"white-space: pre;\"> </span>V1.0<span style=\"white-space: pre;\"> </span>Fiona Makowski<span style=\"white-space: pre;\"> </span>Review and Approved</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Contents</p>\r\n<p>DOCUMENT CONTROL<span style=\"white-space: pre;\"> </span>1</p>\r\n<p>About This Document<span style=\"white-space: pre;\"> </span>2</p>\r\n<p>Document Control<span style=\"white-space: pre;\"> </span>2</p>\r\n<p>Document History<span style=\"white-space: pre;\"> </span>2</p>\r\n<p>1.<span style=\"white-space: pre;\"> </span>Introduction, Purpose Scope &amp; Users<span style=\"white-space: pre;\"> </span>4</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>Control of Internal Documents<span style=\"white-space: pre;\"> </span>4</p>\r\n<p>4.<span style=\"white-space: pre;\"> </span>Document Control<span style=\"white-space: pre;\"> </span>4</p>\r\n<p>5.<span style=\"white-space: pre;\"> </span>Document Approval<span style=\"white-space: pre;\"> </span>4</p>\r\n<p>6.<span style=\"white-space: pre;\"> </span>Publishing &amp; Distributing Documents; Withdrawal from Use<span style=\"white-space: pre;\"> </span>5</p>\r\n<p>7.<span style=\"white-space: pre;\"> </span>Document Updates<span style=\"white-space: pre;\"> </span>6</p>\r\n<p>8.<span style=\"white-space: pre;\"> </span>Records Control<span style=\"white-space: pre;\"> </span>6</p>\r\n<p>9.<span style=\"white-space: pre;\"> </span>Control of Public Documents<span style=\"white-space: pre;\"> </span>7</p>\r\n<p>10.<span style=\"white-space: pre;\"> </span>Documents of external origin<span style=\"white-space: pre;\"> </span>7</p>\r\n<p>11.<span style=\"white-space: pre;\"> </span>Managing Records kept on the basis of this document<span style=\"white-space: pre;\"> </span>7</p>\r\n<p>12.<span style=\"white-space: pre;\"> </span>Validity and Document Management<span style=\"white-space: pre;\"> </span>7</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&emsp;</p>\r\n<p>1.<span style=\"white-space: pre;\"> </span>Introduction, Purpose Scope &amp; Users</p>\r\n<p>This document is intended to document the standard operating procedures (SOP) at FNQH Pathology for Document Control and details the processes, steps, and detailed instructions so that the relevant (authorised) team member can carry out the task correctly every time.</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>Control of Internal Documents</p>\r\n<p>Internal documents are all documents created inside the organisation.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>Document formatting&nbsp;</p>\r\n<p>The below subheadings are sections that should be used and adhered to in each template for clear composition. Please use this in life document to identify the layout and placement for how a document template should be created and used for each of the sub heading sections and their values outlined below.&nbsp;</p>\r\n<p>4.<span style=\"white-space: pre;\"> </span> Document Control&nbsp;</p>\r\n<p>When creating a document manually the document header must contain the organisation\'s logo and the confidentiality level. The footer contains the document name, current version and date of the document, and number of pages.&nbsp; The Document ID is used to quickly &amp; easily identify documents that are apart of the ISMS. This ID is generated based on the following:&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Company Name: FNQH&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>A category type: Process, Policy, Procedure, Job Description, Evidence (e.g. Proc, Pol, Mins)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Unique reference number: e.g. FNQH-SOP-12345</p>\r\n<p>The Version Number is used to control and understand the adaptation and status of a new or in life document.</p>\r\n<p>Date of Version states the date that the document was last edited/updated.&nbsp;</p>\r\n<p>Created By states the individual person who initiated and drafted the original document.&nbsp;</p>\r\n<p>Approved By states the individual person who authorised the documents initial creation in line with the original Created By documents&rsquo; owner.&nbsp;</p>\r\n<p>Confidentiality Level - Documents that have a higher confidentiality level, for which the distribution needs to be limited, are published by the document owner and stored on restricited access SharePoint page relevant to the distribution list.&nbsp;&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>5.<span style=\"white-space: pre;\"> </span>Document Approval&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>All new and major release documents are to be submitted for approval by the Lead Pathologist, or in the absence of the Lead Pathologist, by the most senior executive.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Some documents may require review before approval by one or more designated reviewers who have an interest in, or competence about, the document content.&nbsp;&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Please reference sub heading Document Control under Document Formatting to understand the differences in Version Numbers and how they are formed/determined.&nbsp;&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Minor Release &ndash; All new minor releases are deemed as pre-approved for immediate release by the author who makes changes to the document. These do not need to go through any additional formal authorisation process so long as the author adheres to the Document Control procedure that keeps the Change History and Version Number up to date across all areas of the document that reflect these values.&nbsp;&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>ALL documents that move through the Document Approval process are NOT permitted to have the final &lsquo;Approved by&rsquo; person the same as the &lsquo;Created by&rsquo; person. The final authorising officer must be different to that of the person who initially created the document coming from an unbiased view.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>6.<span style=\"white-space: pre;\"> </span>Publishing &amp; Distributing Documents; Withdrawal from Use&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Drafts - Any documents that are being drafted and are a current work in progress will remain in the &ldquo;working&rdquo; section or folder in the FNQH Pathology folder whilst the author continues to edit the non-live document.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Ready For Review - Any document that is ready to be reviewed for clearance by an approved member of the FNQH senior management team will be moved and remain sitting in this folder or section until the document has been approved or rejected by the appropriate parties.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Clearance Authorised - Once a document has been authorised as ready for clearance by an appropriate authorised party, they will move the accepted document into production with the old document version (if existent) retired.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Archive - The Archive section or folder is where old versions of documents are moved to once they are retired and moved out of production. Old versions of documents are to remain here as a reference point should they need to be referred back to in future.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>7.<span style=\"white-space: pre;\"> </span>Document Updates&nbsp;&nbsp;</p>\r\n<p>The person listed as document owner has the responsibility for updating the document. Updates are performed in line with the frequency defined for each document, but at least once a year.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>All changes to the document must be described briefly in the \"Change History\" table.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>8.<span style=\"white-space: pre;\"> </span>Records Control&nbsp;</p>\r\n<p>Each internal document must define how records resulting from the use of such a document should be managed; i.e., it must specify the following:&nbsp;&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>(1) record title,&nbsp;&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>(2) storage location,&nbsp;&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>(3) person responsible for storage,&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>(4) controls for record protection, and&nbsp;&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>(5) retention time.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Employees of the organisation may access stored records only after obtaining permission from the person designated as the person responsible for storing individual records. If the sensitivity of certain records is such that permission for access must be obtained from a different person, this must be stated in the concerned internal document in the chapter describing records control. Access and retrieval rights for records are determined by the owners of individual records. Senior Leadership is responsible for destroying all records for which the retention time has expired.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>9.<span style=\"white-space: pre;\"> </span>Control of Public Documents&nbsp;</p>\r\n<p>The format and management of Public Documents are to follow the exact same standards and regulations as all those mentioned above outlined under the key heading &ldquo;Control Of Internal, Confidential &amp; Unclassified Documents&rdquo;. The only exclusions to these procedures and practices are the following:&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>The &ldquo;Document Control&rdquo; section MUST be removed completely from any document that is classified as &ldquo;PUBLIC&rdquo;.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>The &ldquo;Change History&rdquo; section MUST be removed completely from any document that is classified as &ldquo;PUBLIC&rdquo;.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>10.<span style=\"white-space: pre;\"> </span>Documents of external origin&nbsp;</p>\r\n<p>External Document Control&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Each external document that is necessary for the planning and operation must be recorded in the appropriate database e.g. Pathhub, SharePoint, Customer Contracts (if applicable).&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>The person who receives such external documents through regular mail or as courier parcels must forward them to Office manager who must make a record.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>11.<span style=\"white-space: pre;\"> </span> Managing Records kept on the basis of this document</p>\r\n<p>All records supporting this policy shall be kept in the FNQH Pathology document management system in the location, or system based, indicated in the procedure document. Any additional or deleted records shall be kept account of in the FNQH Pathology logging system such that any future enquiry will be able to clearly identify when the changes occurred, who made them, what these changes were and how the changes were approved.</p>\r\n<p>&nbsp;</p>\r\n<p>12.<span style=\"white-space: pre;\"> </span>Validity and Document Management</p>\r\n<p>This document is valid from the date of its approval and will be reviewed on an annual basis. The current working copy will be identified as such, and any superseded documents will be archived and maintained for a period of five years.</p>\r\n<p>&nbsp;</p>\r\n<p>New versions will be identified with a versioning number. Full integers will denote a major document version, and a decimal number will indicate minor amendments or edits.</p>\r\n<p>&nbsp;</p>',	'',	'FNQH - Digital first, better patient outcomes',	0,	'',	'',	0,	0,	453,	'2022-09-07 15:16:17'),
(5,	'FNQH-COM-POL-100622',	'FNQH Pathology Complaints Policy [INTERNAL] V0.1',	453,	5,	0,	'2022-09-07',	'2022-06-10',	0,	1,	'TBC',	0,	0,	'1970-01-01',	'2022-07-22',	'Sarah Sharpe',	'<p>This publication has been prepared and written by FNQH and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</p>\r\n<p>&nbsp;</p>\r\n<p>Note for non-FNQH readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</p>\r\n<p>&nbsp;</p>',	'<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>FNQH Pathology Complaints</p>\r\n<p>Policy</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>INTERNAL</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Status:&nbsp; FINAL</p>\r\n<p>Version:&nbsp; 1.0</p>\r\n<p>Issue Date: 22.07.22</p>\r\n<p>Document ID:&nbsp; FNQH-COM-POL-100622</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>This publication has been prepared and written by FNQH and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</p>\r\n<p>&nbsp;</p>\r\n<p>Note for non-FNQH readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>About This Document</p>\r\n<p>Document Control</p>\r\n<p>Document ID:<span style=\"white-space: pre;\"> </span>FNQH-COM-POL-100622</p>\r\n<p>Version Number:<span style=\"white-space: pre;\"> </span>V1.0</p>\r\n<p>Date of Version:<span style=\"white-space: pre;\"> </span>10 June 2022</p>\r\n<p>Created by:<span style=\"white-space: pre;\"> </span>Sarah Sharpe</p>\r\n<p>Approved by:<span style=\"white-space: pre;\"> </span>Fiona Makowski</p>\r\n<p>Confidentiality Level:<span style=\"white-space: pre;\"> </span>TBC</p>\r\n<p>Document History</p>\r\n<p>Date of Edit<span style=\"white-space: pre;\"> </span>Version<span style=\"white-space: pre;\"> </span>Edited by<span style=\"white-space: pre;\"> </span>Description of change&nbsp;</p>\r\n<p>10/6/22<span style=\"white-space: pre;\"> </span>V0.1<span style=\"white-space: pre;\"> </span>Sarah Sharpe<span style=\"white-space: pre;\"> </span>First draft</p>\r\n<p>1/7/22<span style=\"white-space: pre;\"> </span>V0.2<span style=\"white-space: pre;\"> </span>Fiona Makowski<span style=\"white-space: pre;\"> </span>Review and edit</p>\r\n<p>3/7/22<span style=\"white-space: pre;\"> </span>V0.3<span style=\"white-space: pre;\"> </span>Sarah Sharpe<span style=\"white-space: pre;\"> </span>Review and accept edits</p>\r\n<p>22/07/22<span style=\"white-space: pre;\"> </span>V1.0<span style=\"white-space: pre;\"> </span>Fiona Makowski<span style=\"white-space: pre;\"> </span>Review and Approved</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&emsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Contents</p>\r\n<p>FNQH Pathology Complaints<span style=\"white-space: pre;\"> </span>1</p>\r\n<p>About This Document<span style=\"white-space: pre;\"> </span>2</p>\r\n<p>Document Control<span style=\"white-space: pre;\"> </span>2</p>\r\n<p>Document History<span style=\"white-space: pre;\"> </span>2</p>\r\n<p>Information Access Control SOP Overview<span style=\"white-space: pre;\"> </span>4</p>\r\n<p>1.1.<span style=\"white-space: pre;\"> </span>Introduction, Purpose Scope &amp; Users<span style=\"white-space: pre;\"> </span>4</p>\r\n<p>1.2.<span style=\"white-space: pre;\"> </span>Objectives<span style=\"white-space: pre;\"> </span>4</p>\r\n<p>1.3.<span style=\"white-space: pre;\"> </span>Principles<span style=\"white-space: pre;\"> </span>4</p>\r\n<p>1.4.<span style=\"white-space: pre;\"> </span>Roles and Responsibilities<span style=\"white-space: pre;\"> </span>5</p>\r\n<p>1.5.<span style=\"white-space: pre;\"> </span>Chief Executive is responsible for:<span style=\"white-space: pre;\"> </span>5</p>\r\n<p>1.6.<span style=\"white-space: pre;\"> </span>Director of Clinical Governance is responsible for:<span style=\"white-space: pre;\"> </span>6</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>Managing Records kept on the basis of this document<span style=\"white-space: pre;\"> </span>6</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>Validity and Document Management<span style=\"white-space: pre;\"> </span>6</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&emsp;</p>\r\n<p>Information Access Control SOP Overview</p>\r\n<p>1.1.<span style=\"white-space: pre;\"> </span>Introduction, Purpose Scope &amp; Users</p>\r\n<p>Complaints and compliments provide unique information about the quality of health care from the perspective of consumers and their carers. Management of a complaint provides the opportunity for complainants to have their issues resolved effectively, ensures that any identified risks are managed appropriately, and that action is taken to minimise or eliminate those risks.</p>\r\n<p>&nbsp;</p>\r\n<p>A key component of complaint management is the systematic recording of issues, risks, complaints, and their resolution, which is achieved through the Incident Information Management System (IIMS).</p>\r\n<p>&nbsp;</p>\r\n<p>This policy applies to all complaints about FNQH Pathology services made by members of the public or external organisations.</p>\r\n<p>&nbsp;</p>\r\n<p>1.2.<span style=\"white-space: pre;\"> </span>Objectives&nbsp;</p>\r\n<p>The objectives of the complaints policy are to:</p>\r\n<p>&nbsp;</p>\r\n<p>1.<span style=\"white-space: pre;\"> </span>Assist FNQH Pathology with the timely and effective management of complaints.</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>Establish a standard approach to complaints handling including the establishment of performance indicators to monitor compliance.</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>Ensure that staff are aware of their responsibilities and are empowered to manage complaints.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>1.3.<span style=\"white-space: pre;\"> </span>Principles</p>\r\n<p>The Complaint Management Policy Directive and associated Guidelines are underpinned by the following guiding principles:</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Health services are committed to consumers and quality improvement.</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Consumers and their carers are encouraged and enabled to provide feedback about the service, including complaints.</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>All complaints are acknowledged and responded to promptly and sensitively.</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Complaints are assessed by considering risk factors, the known facts, the wishes of the complainant and accountability of health service staff.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>All complaints are dealt with in a manner that is effective, complete, fair to all parties and provides just outcomes.</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Complaint information is openly communicated while protecting confidentiality and personal privacy.</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>All complaints are recorded to enable review of individual cases, to identify trends and risk and report on aggregated complaint information.</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Complaint management policy, practices, and data are regularly evaluated and the information is used to improve services.</p>\r\n<p>&nbsp;</p>\r\n<p>1.4.<span style=\"white-space: pre;\"> </span>Roles and Responsibilities</p>\r\n<p>Effective complaint management requires a whole-of-organisation approach with clear points of accountability for reporting and feedback.</p>\r\n<p>&nbsp;</p>\r\n<p>1.5.<span style=\"white-space: pre;\"> </span>Senior Management is responsible for:</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Encouraging an environment where complaints are handled seriously and thoroughly.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Ensuring an effective complaint management system is developed and in place for the health service.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Ensuring appropriate resources are available and utilised for effective complaint management.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Reporting to registration boards in accordance with the provisions of the Health Services Act 1997.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Ensuring appropriate actions are implemented to eliminate or minimise similar problems from occurring.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Nominating an executive staff member within the health service who is responsible for:</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Ensuring monitoring and risk rating of all complaints.</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Ensuring local actions are implemented to eliminate or minimise similar problems from occurring.</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Reporting trended complaint data at least every quarter to FNQH Pathology Quality Portfolio and other relevant groups within FNQH pathology.</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Implementing policies and local procedures that support staff, including staff training on complaint management.</p>\r\n<p>&nbsp;</p>\r\n<p>1.6.<span style=\"white-space: pre;\"> </span>Pathlology Site Manager is responsible for:</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Providing a single, publicly recognisable point of contact for the receipt and management of serious complaints from members of the public and staff, regardless of whether those complaints are of a clinical or corporate nature.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Ensuring the proper process for managing complaints is followed by the organisation.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>Managing Records kept on the basis of this document</p>\r\n<p>All records supporting this policy shall be kept in line with FNQH document management. Any additional or deleted records shall be kept account of in line with FNQH document management and recording keeping.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>Validity and Document Management</p>\r\n<p>This document is valid from the date of its approval and will be reviewed on an annual basis. The current working copy will be identified as such, and any superseded documents will be archived and maintained for a period of five years.</p>\r\n<p>&nbsp;</p>\r\n<p>New versions will be identified with a versioning number. Full integers will denote a major document version, and a decimal number will indicate minor amendments or edits.</p>\r\n<p>&nbsp;</p>',	'',	'FNQH - Digital first, better patient outcomes',	0,	'',	'',	0,	0,	453,	'2022-09-07 15:21:31'),
(6,	'FNQH PATHOLOGY-SOP-100622',	'FNQH Pathology Complaints SOP INTERNAL V1.1',	453,	5,	0,	'2022-09-07',	'2022-06-02',	0,	1,	'TBC',	0,	0,	'1970-01-01',	'2022-08-09',	'Sarah Sharpe',	'<p>This publication has been prepared and written by FNQH PATHOLOGY and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</p>\r\n<p>&nbsp;</p>\r\n<p>Note for non-FNQH PATHOLOGY readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH PATHOLOGY does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</p>\r\n<p>&nbsp;</p>',	'<p>FNQH PATHOLOGY&nbsp;</p>\r\n<p>Complaints</p>\r\n<p>Standard Operating Procedure</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>INTERNAL</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Status:&nbsp; FINAL</p>\r\n<p>Version:&nbsp; V1.1</p>\r\n<p>Issue Date: 03.07.22&nbsp;</p>\r\n<p>Document ID:&nbsp; FNQH PATHOLOGY-SOP-100622</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>This publication has been prepared and written by FNQH PATHOLOGY and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</p>\r\n<p>&nbsp;</p>\r\n<p>Note for non-FNQH PATHOLOGY readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH PATHOLOGY does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>About This Document</p>\r\n<p>Document Control</p>\r\n<p>Document ID:<span style=\"white-space: pre;\"> </span>FNQH PATHOLOGY-SOP-100622</p>\r\n<p>Version Number:<span style=\"white-space: pre;\"> </span>V1.0</p>\r\n<p>Date of Version:<span style=\"white-space: pre;\"> </span>2&nbsp; JUNE 2022</p>\r\n<p>Created by:<span style=\"white-space: pre;\"> </span>Larissa McLeod</p>\r\n<p>Approved by:<span style=\"white-space: pre;\"> </span>Fiona Makowski</p>\r\n<p>Confidentiality Level:<span style=\"white-space: pre;\"> </span>TBC</p>\r\n<p>Document History</p>\r\n<p>Date of Edit<span style=\"white-space: pre;\"> </span>Version<span style=\"white-space: pre;\"> </span>Edited by<span style=\"white-space: pre;\"> </span>Description of change&nbsp;</p>\r\n<p>02/06/22<span style=\"white-space: pre;\"> </span>V0.1<span style=\"white-space: pre;\"> </span>Larissa McLeod<span style=\"white-space: pre;\"> </span>Initial Draft</p>\r\n<p>26/06/22<span style=\"white-space: pre;\"> </span>V0.2<span style=\"white-space: pre;\"> </span>Sarah Sharpe<span style=\"white-space: pre;\"> </span>Minor edits</p>\r\n<p>1/07/22<span style=\"white-space: pre;\"> </span>V0.3<span style=\"white-space: pre;\"> </span>Fiona Makowski<span style=\"white-space: pre;\"> </span>Review and edits</p>\r\n<p>03/07/22<span style=\"white-space: pre;\"> </span>V0.4<span style=\"white-space: pre;\"> </span>Sarah Sharpe<span style=\"white-space: pre;\"> </span>Review and accepted edits</p>\r\n<p>22/07/22<span style=\"white-space: pre;\"> </span>V1.0<span style=\"white-space: pre;\"> </span>Fiona Makowski<span style=\"white-space: pre;\"> </span>Review and Approved</p>\r\n<p>09/08/2022<span style=\"white-space: pre;\"> </span>V1.1<span style=\"white-space: pre;\"> </span>Larissa McLeod<span style=\"white-space: pre;\"> </span>Minor Edits</p>\r\n<p>&nbsp;</p>\r\n<p>&emsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Contents</p>\r\n<p>FNQH PATHOLOGY<span style=\"white-space: pre;\"> </span>1</p>\r\n<p>Complaints<span style=\"white-space: pre;\"> </span>1</p>\r\n<p>About This Document<span style=\"white-space: pre;\"> </span>2</p>\r\n<p>Document Control<span style=\"white-space: pre;\"> </span>2</p>\r\n<p>Document History<span style=\"white-space: pre;\"> </span>2</p>\r\n<p>1.<span style=\"white-space: pre;\"> </span>Introduction, Purpose Scope &amp; Users<span style=\"white-space: pre;\"> </span>4</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>Overview - Complaint Standard Operating Procedure<span style=\"white-space: pre;\"> </span>4</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>Procedure<span style=\"white-space: pre;\"> </span>5</p>\r\n<p>4.<span style=\"white-space: pre;\"> </span>The matter cannot be resolved<span style=\"white-space: pre;\"> </span>7</p>\r\n<p>5.<span style=\"white-space: pre;\"> </span>Managing Records kept on the basis of this document<span style=\"white-space: pre;\"> </span>7</p>\r\n<p>6.<span style=\"white-space: pre;\"> </span>Validity and Document Management<span style=\"white-space: pre;\"> </span>8</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&emsp;</p>\r\n<p>1.<span style=\"white-space: pre;\"> </span>Introduction, Purpose Scope &amp; Users</p>\r\n<p>This document is intended to document the policy at FNQH Pathology for complaints and details the processes, steps, and detailed instructions so that the relevant (authorised) team member can carry out the task correctly every time.</p>\r\n<p>&nbsp;</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>Overview - Complaint Standard Operating Procedure</p>\r\n<p>Opportunities are available for patients and other visitors to tell us &ldquo;how we are doing,&rdquo; and we collect systematic patient experience feedback. The practice information sheet provides patients with information on how to provide feedback, including how to make a complaint.&nbsp;&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Patients have a &lsquo;right to complain&rsquo;, and where possible, patients and others are encouraged to raise any concerns directly with the laboratory team, who are all trained to make sure patients of the business feel confident that any feedback or complaints will be handled appropriately. FNQH Pathology are committed to ensuring complaints will be responded to when the patients or other people such as carers, relatives, friends, or other consumers make them known to our team.&nbsp;&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Under national and QLD privacy laws, FNQH Pathology provides and adheres to a complaints process for privacy issues and those related to the Australian Privacy Principles (APPs).</p>\r\n<p>&nbsp;</p>\r\n<p>All members of laboratory team are educated to be prepared to address complaints as they arise. Depending on the nature of the complaint and any advice received from our medical indemnity insurers where required, complaints are recorded and actioned with a copy placed in the patient&rsquo;s health record if related to patient care.</p>\r\n<p>&nbsp;</p>\r\n<p>All clinical and medical staff and administration staff are aware of the professional and legal obligations regarding the mandatory reporting of unprofessional conduct.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>Procedure</p>\r\n<p>Patients and others have opportunities to register their complaints either verbally, in writing (letter), or via our suggestion box. Patients or others are able to complain anonymously if desired. All members of FNQH Pathology are aware of our commitment to address complaints as they arise.&nbsp;&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>When receiving complaints, our practice keeps in mind the following in order to minimise further patient anxiety and hostility:</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Handle all complaints seriously, no matter how trivial they may seem.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Verbal complaints made in person should be addressed in a private area of the business where possible.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Use tactful language when responding to complaints.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Do not blame others; patients may not have all the facts, or they may distort them.&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Address the patient&rsquo;s expectations regarding how they want the matter resolved.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Assure the patient that their complaint will be investigated and the matter not disregarded.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Offer the person an opportunity to complete a formal complaint form (they may accept or decline).</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Document all complaints and other relevant information and place this in the complaint folder so the person designated to manage complaints is informed of the complaint (even if the matter appears to have been resolved).</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Alert the Pathologist or lab manage about disgruntled or hostile patients so they can diffuse the situation immediately - often patients are reluctant to make a complaint directly to a general practitioner.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Always inform the person designated to manage complaints if you become aware of any significant statements made by the patient or significant change in patient attitude.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>FNQH Pathology has appointed Glenn Makowksi and Sarah Sharpe Business Operation with designated responsibility for seeking, collecting, analysing, investigating, resolving and managing all feedback and complaints. Any investigation and resolution of complaints is undertaken using an open disclosure process, incorporating the following:&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Acknowledge the patient&rsquo;s right to complain.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Acknowledge receipt of the complaint as soon as possible but within two (2) working days using the Acknowledgment of Complaint letter template.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Respond to all complaints as soon as reasonably practicable, but within thirty (30) days in an open and constructive manner, including an explanation and, if appropriate, an apology.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>If a resolution of the matter is to take longer than thirty (30) days, an update of the resolution activities will be provided to the patient, with an anticipated revised timeframe for resolution.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Work with the patient to resolve the complaint and communicate the outcome with the patient, including any changes made as a result of the complaint.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Where a complaint is made against a laboratory member, provide the team member with an opportunity to discuss the details in a private setting.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Ensure the complaint does not adversely affect the patient&rsquo;s care.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Record the complaint, investigation and actions in the dedicated complaints file and, if related to patient care, include a copy in the patient&rsquo;s health record.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Ensure, where appropriate, complaints are reviewed at laboratory team meetings; analyse trends and discuss the methods of resolution.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Review other types of patient feedback (i.e. feedback surveys, suggestion box) during laboratory team meetings.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Keep a record of improvement(s) made in response to feedback or complaints.&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Where appropriate, inform the patient about practice improvements made as a result of their input.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>4.<span style=\"white-space: pre;\"> </span>The matter cannot be resolved</p>\r\n<p>If the matter cannot be resolved, the patient is advised about how to contact the external health complaints agency for:</p>\r\n<p>&nbsp;</p>\r\n<p>Queensland</p>\r\n<p>Office of the Health Ombudsman</p>\r\n<p>Telephone: 133 646&nbsp;</p>\r\n<p>Web: www.oho.qld.gov.au&nbsp; &nbsp;&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Complaints that relate to privacy issues or concerns that cannot be resolved internally are to be directed to the Office of the Australian Information Commissioner (OAIC).&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Office of the Australian Information Commissioner&nbsp;</p>\r\n<p>Telephone: 1300 363 992</p>\r\n<p>Postal Address: GPO Box 5218, Sydney NSW 2001</p>\r\n<p>Web: www.oaic.gov.au&nbsp;&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Members of the public may make a notification to the Australian Health Practitioner Regulation Agency (AHPRA) - www.ahpra.gov.au - about the conduct, health or performance of a practitioner or the health of a student. Practitioners, employers and education providers are all mandated by law to report notifiable conduct relating to a registered practitioner or student to AHPRA.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>5.<span style=\"white-space: pre;\"> </span>Managing Records kept on the basis of this document</p>\r\n<p>All records supporting this policy shall be kept in the FNQH Pathology document management system in the location, or system based, indicated in the procedure document. Any additional or deleted records shall be kept account of in the FNQH Pathology logging system such that any future enquiry will be able to clearly identify when the changes occurred, who made them, what these changes were and how the changes were approved.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>6.<span style=\"white-space: pre;\"> </span>Validity and Document Management</p>\r\n<p>This document is valid from the date of its approval and will be reviewed on an annual basis. The current working copy will be identified as such, and any superseded documents will be archived and maintained for a period of five years.</p>\r\n<p>&nbsp;</p>\r\n<p>New versions will be identified with a versioning number. Full integers will denote a major document version, and a decimal number will indicate minor amendments or edits.</p>\r\n<p>&nbsp;</p>',	'',	'FNQH PATHOLOGY - Digital first, better patient outcomes',	0,	'',	'',	0,	0,	453,	'2022-09-07 15:30:16'),
(7,	'FNQH-POL-CA140822 [INTERNAL]',	'FNQH Pathology Corrective and Preventative Action POLICY [INTERNAL] V0.1',	453,	5,	0,	'2022-09-07',	'2022-08-09',	0,	1,	'TBC',	0,	0,	'1970-01-01',	'2022-08-19',	'Sarah Sharpe',	'<p>This publication has been prepared and written by FNQH and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</p>\r\n<p>&nbsp;</p>\r\n<p>Note for non-FNQH readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</p>\r\n<p>&nbsp;</p>',	'<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Corrective and Preventative Action Policy</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>INTERNAL</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Status:&nbsp; DRAFT</p>\r\n<p>Version:&nbsp; 1.0</p>\r\n<p>Issue Date: 19.08.2022&nbsp;</p>\r\n<p>Document ID:&nbsp; FNQH-POL-CA140822&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>This publication has been prepared and written by FNQH and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</p>\r\n<p>&nbsp;</p>\r\n<p>Note for non-FNQH readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>About This Document</p>\r\n<p>Document Control</p>\r\n<p>Document ID:<span style=\"white-space: pre;\"> </span>FNQH-POL-CA140822 [INTERNAL]</p>\r\n<p>Version Number:<span style=\"white-space: pre;\"> </span>V1.0</p>\r\n<p>Date of Version:<span style=\"white-space: pre;\"> </span>19/08/2022</p>\r\n<p>Created by:<span style=\"white-space: pre;\"> </span>Sarah Sharpe</p>\r\n<p>Approved by:<span style=\"white-space: pre;\"> </span>Fiona Makowski</p>\r\n<p>Confidentiality Level:<span style=\"white-space: pre;\"> </span>TBC</p>\r\n<p>Document History</p>\r\n<p>Date of Edit<span style=\"white-space: pre;\"> </span>Version<span style=\"white-space: pre;\"> </span>Edited by<span style=\"white-space: pre;\"> </span>Description of change&nbsp;</p>\r\n<p>14/8/2022<span style=\"white-space: pre;\"> </span>V0.1<span style=\"white-space: pre;\"> </span>Sarah Sharpe<span style=\"white-space: pre;\"> </span>Initial Draft</p>\r\n<p>19/8/2022<span style=\"white-space: pre;\"> </span>V0.2<span style=\"white-space: pre;\"> </span>Larissa McLeaod<span style=\"white-space: pre;\"> </span>Review</p>\r\n<p>19/08/2022<span style=\"white-space: pre;\"> </span>V1.0<span style=\"white-space: pre;\"> </span>Fiona Makowski<span style=\"white-space: pre;\"> </span>Approved</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Contents</p>\r\n<p>Corrective and Preventative Action Policy<span style=\"white-space: pre;\"> </span>1</p>\r\n<p>About This Document<span style=\"white-space: pre;\"> </span>2</p>\r\n<p>Document Control<span style=\"white-space: pre;\"> </span>2</p>\r\n<p>Document History<span style=\"white-space: pre;\"> </span>2</p>\r\n<p>1.1.<span style=\"white-space: pre;\"> </span>Introduction, Purpose Scope &amp; Users<span style=\"white-space: pre;\"> </span>4</p>\r\n<p>1.2.<span style=\"white-space: pre;\"> </span>Corrective and Prevenative Action Policy<span style=\"white-space: pre;\"> </span>4</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>Supporting Documents<span style=\"white-space: pre;\"> </span>5</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>Managing Records kept on the basis of this document<span style=\"white-space: pre;\"> </span>5</p>\r\n<p>4.<span style=\"white-space: pre;\"> </span>Validity and Document Management<span style=\"white-space: pre;\"> </span>5</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&emsp;</p>\r\n<p>1.1.<span style=\"white-space: pre;\"> </span>Introduction, Purpose Scope &amp; Users</p>\r\n<p>This document is intended to document the policy at FNQH Pathology for Corrective and Preventative Action.</p>\r\n<p>&nbsp;</p>\r\n<p>1.2.<span style=\"white-space: pre;\"> </span>Corrective and Prevenative Action Policy&nbsp;</p>\r\n<p>In line with NATA and ISO 15189 requirements, FNQH Pathology will take corrective action to eliminate</p>\r\n<p>the causes of identified nonconformities and ensure the following procedures are adhered to via the following activities &ndash;</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Internal and external reviews</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Quality Assurance&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Continuous Improvement</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Informal and formal feedback&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Reviewing nonconformities;</p>\r\n<p>Determining the root causes of ISO 15189 ASSESSMENT WORKSHEET Self-assessment</p>\r\n<p>&nbsp;</p>\r\n<p>Assigned staff responsible for corrective and preventative actions must -&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Observe&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Document observations</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Evaluating the need for corrective action to ensure that nonconformities do not recur;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Determine and implement corrective action if&nbsp; needed</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Record and review the results of corrective in the corrective action register&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>For the purposes of this policy, preventative actions include but are not limited to the following &ndash;&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Ensure needed improvements and potential sources of nonconformities are identified and action plans developed,</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Implemented and monitored, using control to ensure they are effective and that the documented procedure</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Minimum annual review information to determine potential nonconformities to determine the root cause; and evaluate the need for preventive action</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Implement preventive action and record the result of the outcome and action taken.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>Supporting Documents</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>NATA ISO 15189 ASSESSMENT WORKSHEET Self-assessment.&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>https://nata.com.au/files/2021/05/ISO-15189-Assessment-Worksheet-For-Laboratory-use.pdf</p>\r\n<p>&nbsp;</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>Managing Records kept on the basis of this document</p>\r\n<p>All records supporting this policy shall be kept in the FNQH document management system in the location, or system based, indicated in the procedure document. Any additional or deleted records shall be kept account of in the FNQH logging system such that any future enquiry will be able to clearly identify when the changes occurred, who made them, what these changes were and how the changes were approved.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>4.<span style=\"white-space: pre;\"> </span>Validity and Document Management</p>\r\n<p>This document is valid from the date of its approval and will be reviewed on an annual basis. The current working copy will be identified as such, and any superseded documents will be archived and maintained for a period of five years.</p>\r\n<p>&nbsp;</p>\r\n<p>New versions will be identified with a versioning number. Full integers will denote a major document version, and a decimal number will indicate minor amendments or edits.</p>\r\n<p>&nbsp;</p>',	'',	'FNQH - Digital first, better patient outcomes',	0,	'',	'',	0,	0,	453,	'2022-09-07 15:33:11'),
(8,	'FNQH-SOP-CS-070322',	'FNQH Pathology Coverslipping Protocol [INTERNAL] V1.0',	453,	5,	0,	'2022-09-07',	'2022-07-03',	0,	1,	'TBC',	0,	0,	'1970-01-01',	'2022-07-05',	'Sarah Sharpe',	'<p>This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</p>\r\n<p>&nbsp;</p>\r\n<p>Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</p>\r\n<p>&nbsp;</p>',	'<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>FNQH PATHOLOGY&nbsp;</p>\r\n<p>Coverslipping</p>\r\n<p>Standard Operating Procedure</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>INTERNAL</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Status:&nbsp; FINAL</p>\r\n<p>Version:&nbsp; 1.0</p>\r\n<p>Issue Date: 03.07.22&nbsp;</p>\r\n<p>Document ID:&nbsp; FNQH-SOP-CS-070322</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</p>\r\n<p>&nbsp;</p>\r\n<p>Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>About This Document</p>\r\n<p>Document Control</p>\r\n<p>Document ID:<span style=\"white-space: pre;\"> </span>FNQH-SOP-CS-070322</p>\r\n<p>Version Number:<span style=\"white-space: pre;\"> </span>V1.0</p>\r\n<p>Date of Version:<span style=\"white-space: pre;\"> </span>03.07.22</p>\r\n<p>Created by:<span style=\"white-space: pre;\"> </span>Sarah Sharpe</p>\r\n<p>Approved by:<span style=\"white-space: pre;\"> </span>Fiona Makowski</p>\r\n<p>Confidentiality Level:<span style=\"white-space: pre;\"> </span>TBC</p>\r\n<p>Document History</p>\r\n<p>Date of Edit<span style=\"white-space: pre;\"> </span>Version<span style=\"white-space: pre;\"> </span>Edited by<span style=\"white-space: pre;\"> </span>Description of change&nbsp;</p>\r\n<p>07.03.22<span style=\"white-space: pre;\"> </span>V0.1<span style=\"white-space: pre;\"> </span>Sarah Sharpe<span style=\"white-space: pre;\"> </span>Initial draft</p>\r\n<p>07.03.22<span style=\"white-space: pre;\"> </span>V0.2<span style=\"white-space: pre;\"> </span>Fiona Makowski<span style=\"white-space: pre;\"> </span>Reviewed and suggested edits</p>\r\n<p>07.03.22<span style=\"white-space: pre;\"> </span>V0.3<span style=\"white-space: pre;\"> </span>Sarah Sharpe<span style=\"white-space: pre;\"> </span>Reviewed edits and finalised</p>\r\n<p>15.07.22<span style=\"white-space: pre;\"> </span>V1.0<span style=\"white-space: pre;\"> </span>Fiona Makowski<span style=\"white-space: pre;\"> </span>Approved</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Contents</p>\r\n<p>Cover Slipping<span style=\"white-space: pre;\"> </span>1</p>\r\n<p>About This Document<span style=\"white-space: pre;\"> </span>2</p>\r\n<p>Document Control<span style=\"white-space: pre;\"> </span>2</p>\r\n<p>Document History<span style=\"white-space: pre;\"> </span>2</p>\r\n<p>1.<span style=\"white-space: pre;\"> </span>Introduction, Purpose Scope &amp; Users<span style=\"white-space: pre;\"> </span>4</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>Background<span style=\"white-space: pre;\"> </span>4</p>\r\n<p>2.1.<span style=\"white-space: pre;\"> </span>Coverslipping Process<span style=\"white-space: pre;\"> </span>4</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>Managing Records kept on the basis of this document<span style=\"white-space: pre;\"> </span>5</p>\r\n<p>4.<span style=\"white-space: pre;\"> </span>Validity and Document Management<span style=\"white-space: pre;\"> </span>5</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&emsp;</p>\r\n<p>1.<span style=\"white-space: pre;\"> </span>Introduction, Purpose Scope &amp; Users</p>\r\n<p>This document is intended to document the standard operating procedures (SOP) at FNQH Pathology for the coverslipping protocol, and details the processes, steps, and detailed instructions so that the relevant (authorised) team member can carry out the task correctly every time.</p>\r\n<p>&nbsp;</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>Background</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>The mounting medium permanently binds the coverslip to the section to provide protection from scratching, drying and fading.&nbsp;</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>The mountant must be miscible with the clearing agent.</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>The refractive index of the mounting medium should be close to the average index of tissue (1.530 to 1.540) and the coverslip so that light passes through the section with minimal refraction.</p>\r\n<p>d)<span style=\"white-space: pre;\"> </span>Natural resins such as Canada Balsam are acidic and have gradually been replaced with synthetic resins.</p>\r\n<p>e)<span style=\"white-space: pre;\"> </span>Synthetic resins are neutral and are usually polystyrene based.</p>\r\n<p>f)<span style=\"white-space: pre;\"> </span>Polystyrene mountants have the following advantages:</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>almost colourless</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>do not cause fading of stains</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>dry quickly and completely</p>\r\n<p>&nbsp;</p>\r\n<p>2.1.<span style=\"white-space: pre;\"> </span>Coverslipping Process</p>\r\n<p>Ensure coverslips are clean and free from fingerprints</p>\r\n<p>&nbsp;</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>carefully wipe away unwanted sections from the slide.</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>place a coverslip onto the bench and place a drop of mountant in the middle.</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>lower the slide down onto the coverslip.</p>\r\n<p>d)<span style=\"white-space: pre;\"> </span>turn over the slide and remove any air bubbles by applying pressure onto the coverslip with forceps.</p>\r\n<p>e)<span style=\"white-space: pre;\"> </span>wipe the back of the slide.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>Managing Records kept on the basis of this document</p>\r\n<p>All records supporting this policy shall be kept in the FNQH Pathology document management system in the location, or system based, indicated in the procedure document. Any additional or deleted records shall be kept account of in the FNQH Pathology logging system so that any future enquiry will be able to clearly identify when the changes occurred, who made them, what these changes were and how they were approved.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>4.<span style=\"white-space: pre;\"> </span>Validity and Document Management</p>\r\n<p>This document is valid from the date of its approval and will be reviewed on an annual basis. The current working copy will be identified as such, and any superseded documents will be archived and maintained for a period of five years.</p>\r\n<p>&nbsp;</p>\r\n<p>New versions will be identified with a versioning number. Full integers will denote a major document version, and a decimal number will indicate minor amendments or edits.</p>\r\n<p>&nbsp;</p>',	'',	'FNQH Pathology - Digital first, better patient outcomes',	0,	'',	'',	0,	0,	453,	'2022-09-07 15:36:40'),
(9,	'FNQH-SOP-CS030722',	'FNQH Pathology Cut up Protocol [INTERNAL] V1.0',	453,	5,	0,	'2022-09-07',	'2022-07-03',	0,	1,	'TBC',	0,	0,	'1970-01-01',	'2022-07-22',	'Sarah Sharpe',	'<p>This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</p>\r\n<p>&nbsp;</p>\r\n<p>Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</p>\r\n<p>&nbsp;</p>',	'<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>CUT UP PROTOCOL</p>\r\n<p>Standard Operating Procedure</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>INTERNAL</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Status:&nbsp; FINAL</p>\r\n<p>Version:&nbsp; 1.0</p>\r\n<p>Issue Date: 22.07.22&nbsp;</p>\r\n<p>Document ID:&nbsp; FNQH-SOP-CS030722</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</p>\r\n<p>&nbsp;</p>\r\n<p>Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>About This Document</p>\r\n<p>Document Control</p>\r\n<p>Document ID:<span style=\"white-space: pre;\"> </span>FNQH-SOP-CS030722</p>\r\n<p>Version Number:<span style=\"white-space: pre;\"> </span>V1.0</p>\r\n<p>Date of Version:<span style=\"white-space: pre;\"> </span>03.07.22</p>\r\n<p>Created by:<span style=\"white-space: pre;\"> </span>Sarah Sharpe</p>\r\n<p>Approved by:<span style=\"white-space: pre;\"> </span>Fiona Makowski</p>\r\n<p>Confidentiality Level:<span style=\"white-space: pre;\"> </span>TBC</p>\r\n<p>Document History</p>\r\n<p>Date of Edit<span style=\"white-space: pre;\"> </span>Version<span style=\"white-space: pre;\"> </span>Edited by<span style=\"white-space: pre;\"> </span>Description of change&nbsp;</p>\r\n<p>26/06/22<span style=\"white-space: pre;\"> </span>V0.1<span style=\"white-space: pre;\"> </span>Sarah Sharpe<span style=\"white-space: pre;\"> </span>Initial Draft</p>\r\n<p>1/07/22<span style=\"white-space: pre;\"> </span>V0.2<span style=\"white-space: pre;\"> </span>Fiona Makowski<span style=\"white-space: pre;\"> </span>Review and edits</p>\r\n<p>03/07/22<span style=\"white-space: pre;\"> </span>V0.3<span style=\"white-space: pre;\"> </span>Sarah Sharpe<span style=\"white-space: pre;\"> </span>Review and accepted edits</p>\r\n<p>22/07/22<span style=\"white-space: pre;\"> </span>V1.0<span style=\"white-space: pre;\"> </span>Fiona Makowski<span style=\"white-space: pre;\"> </span>Review and Approved</p>\r\n<p>&nbsp;</p>\r\n<p>&emsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Contents</p>\r\n<p>About This Document<span style=\"white-space: pre;\"> </span>2</p>\r\n<p>Document Control<span style=\"white-space: pre;\"> </span>2</p>\r\n<p>Document History<span style=\"white-space: pre;\"> </span>2</p>\r\n<p>1.<span style=\"white-space: pre;\"> </span>Introduction, Purpose Scope &amp; Users<span style=\"white-space: pre;\"> </span>3</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>External Inspection<span style=\"white-space: pre;\"> </span>3</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>DISSECTION<span style=\"white-space: pre;\"> </span>7</p>\r\n<p>3.1.1.<span style=\"white-space: pre;\"> </span>SMALL SPECIMENS<span style=\"white-space: pre;\"> </span>7</p>\r\n<p>3.1.2.<span style=\"white-space: pre;\"> </span>LIP SPECIMENS<span style=\"white-space: pre;\"> </span>8</p>\r\n<p>3.1.3.<span style=\"white-space: pre;\"> </span>ORIENTATED SPECIMENS<span style=\"white-space: pre;\"> </span>8</p>\r\n<p>3.1.4.<span style=\"white-space: pre;\"> </span>LARGE SPECIMENS<span style=\"white-space: pre;\"> </span>8</p>\r\n<p>3.1.5.<span style=\"white-space: pre;\"> </span>INTERNAL INSPECTION<span style=\"white-space: pre;\"> </span>9</p>\r\n<p>3.1.6.<span style=\"white-space: pre;\"> </span>LYMPH NODES (IF PRESENT)<span style=\"white-space: pre;\"> </span>9</p>\r\n<p>3.1.7.<span style=\"white-space: pre;\"> </span>SPECIMENS &lt;10MM<span style=\"white-space: pre;\"> </span>10</p>\r\n<p>3.1.8.<span style=\"white-space: pre;\"> </span>SPECIMENS&gt;10MM<span style=\"white-space: pre;\"> </span>10</p>\r\n<p>3.1.9.<span style=\"white-space: pre;\"> </span>MELANOCYTIC LESIONS INCLUDING CONGENITAL NAEVI<span style=\"white-space: pre;\"> </span>10</p>\r\n<p>3.1.10.<span style=\"white-space: pre;\"> </span>PIGMENTED LESIONS &gt;100MM<span style=\"white-space: pre;\"> </span>11</p>\r\n<p>3.1.11.<span style=\"white-space: pre;\"> </span>ATYPICAL MELANOCYTIC LESIONS AND MELANOMAS<span style=\"white-space: pre;\"> </span>11</p>\r\n<p>3.1.12.<span style=\"white-space: pre;\"> </span>LYMPH NODES (WHEN PRESENT)<span style=\"white-space: pre;\"> </span>11</p>\r\n<p>4.<span style=\"white-space: pre;\"> </span>REFERENCES<span style=\"white-space: pre;\"> </span>11</p>\r\n<p>5.<span style=\"white-space: pre;\"> </span>Managing Records kept on the basis of this document<span style=\"white-space: pre;\"> </span>12</p>\r\n<p>6.<span style=\"white-space: pre;\"> </span>Validity and Document Management<span style=\"white-space: pre;\"> </span>12</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>1.<span style=\"white-space: pre;\"> </span>Introduction, Purpose Scope &amp; Users</p>\r\n<p>This document is intended to document the standard operating procedures (SOP) at FNQH Pathology for Cut Up Procedures (manual) and details the processes, steps, and detailed instructions so that the relevant (authorised) team member can carry out the task correctly every time. This manual is based on the RCPA Macroscopic Cut Up Manual.</p>\r\n<p>&nbsp;</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>External Inspection&nbsp;&nbsp;</p>\r\n<p>PROCEDURE/SPECIMEN TYPE</p>\r\n<p>&nbsp;</p>\r\n<p>Record as stated by the clinician.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Excision</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Ellipse, with orientation</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Ellipse, without orientation</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Polygonal or irregular</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Wedge</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Punch</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Shave</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Re-excision</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Curette</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Incision</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Other</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Moh\'s specimens</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Scalp biopsies for alopecia</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Nail bed biopsies</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Other, describe</p>\r\n<p>&nbsp;</p>\r\n<p>SPECIMEN ORIENTATION</p>\r\n<p>ORIENTATION MARKERS</p>\r\n<p>Record additional orientation or designation provided by operating clinician:</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Absent</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Present</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Method of orientation (e.g. suture, incision)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Describe orientation of the marker at cut-up (e.g. 12 o\'clock, superior, medial)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Record any coloured inks applied and to which margin</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Describe any dermoscopically identified areas</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>SPECIMEN INTEGRITY</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Intact</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Disrupted/fragmented, describe</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Number of pieces</p>\r\n<p>&nbsp;</p>\r\n<p>ANATOMICAL COMPONENTS PRESENT</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Epidermis</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Dermis</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Subcutis</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Skeletal muscle</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Cartilage</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Bone</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Large vessels</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Large nerves</p>\r\n<p>&nbsp;</p>\r\n<p>SPECIMEN SIZE (MM)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>In three dimensions</p>\r\n<p>&nbsp;</p>\r\n<p>LESION</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Absent</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Present</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Number; if more than one lesion, designate and describe each separately noting the distance between each lesion.</p>\r\n<p>&nbsp;</p>\r\n<p>LESION SIZE (MM)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>In three dimensions</p>\r\n<p>&nbsp;</p>\r\n<p>DISTANCE TO MARGINS (MM)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Distance of lesion to closest margin</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Specify margin if orientated</p>\r\n<p>&nbsp;</p>\r\n<p>LESION DESCRIPTION</p>\r\n<p>PRIMARY LESION&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Macule &ndash; flat, non palpable, &lt;10mm in diameter</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Papule &ndash; elevated lesion, &lt;10mm in diameter</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Vesicle &ndash; small, clear fluid filled blister, &lt;10mm in diameter</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Bullae &ndash; clear fluid filled blister, &gt;10mm in diameter</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Nodule &ndash; firm papule or lesion that extends to dermis or subcutis</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Plaque &ndash; palpable lesion, &gt;10mm in diameter</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Scar</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Ulcer</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Cyst</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Describe contents (eg. soft white material)</p>\r\n<p>&nbsp;</p>\r\n<p>SECONDARY EFFECT</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Keratotic</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Ulcerated/ulceration</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Maximum dimension</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Pigmented, describe colour(s) and variability</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Uniform</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Variegated</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Roughened</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Papillomatous</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Skin-covered</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Telangiectasia</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Haemorrhagic</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Necrotic</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Colour, describe</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Border</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Smooth</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Irregular</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Distinct</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Indistinct</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>DISSECTION</p>\r\n<p>3.1.1.<span style=\"white-space: pre;\"> </span>SMALL SPECIMENS</p>\r\n<p>PUNCH BIOPSY<span style=\"white-space: pre;\"> </span>&nbsp; &nbsp; &nbsp;SHAVE BIOPSY</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>No dissection is required for shave biopsies, curettings and punch biopsies &lt;3mm.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Punch/shave biopsies &gt;3mm should be bisected.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Ellipses of skin can be serially sectioned transversely at 2-4mm intervals, if embedding tips ensure these are clear of the lesion.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>For small lesions, bisect off centre to maximise visualisation of lesion.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>3.1.2.<span style=\"white-space: pre;\"> </span>LIP AND EAR SPECIMENS&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Usually, lip and ear biopsies will be wedge-shaped and can be sectioned at 3mm intervals to include the lateral margins, depending on the anatomic location of the lesion. Alternatively, the specimen can be dissected with longitudinal or shave sections at both lateral margins. Refer to the RCPA manual for further diagrams and videos, or discuss with the Pathologist.&nbsp;&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>3.1.3.<span style=\"white-space: pre;\"> </span>ORIENTATED SPECIMENS</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>The method of orientation (e.g.suture) and what is indicated (e.g. superior margin) should be recorded. Its placement at the time of macroscopy should also be recorded. In many laboratories the suture is generically placed at the 12 o&rsquo;clock position and the specimen is painted along one margin as a minimum. The protocol shown in the illustration below uses three different coloured inks enabling clear identification of the four quadrants. Refer to RCPA.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>PLEASE NOTE - PAINTING PROTOCOLS DIFFER BETWEEN LABORATORIES</p>\r\n<p>3.1.4.<span style=\"white-space: pre;\"> </span>LARGE SPECIMENS</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Large specimens, 50-100mm, will require targeted sectioning guided by visual inspection. The margins of oriented specimens may be painted with ink.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Record colour of inks applied and their corresponding margins.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Section transversely (&ldquo;breadloaf&rdquo;) and lay out slices in sequential order to demonstrate maximum depth of the lesion and its relationship to margins. Photograph and record a block allocation key if required.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>One method for very large specimens, &gt;100mm, is to section radially round the perimeter of the lesion, then bread-loaf as for other specimens. Inspect carefully for multiple/multifocal lesions, lymph nodes, large nerves, blood vessels and attached tissues (e.g. salivary gland, bone and cartilage). Photograph to record a block allocation key.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Record the plane of dissection in orientated specimens or indicate in a diagram or photograph of the dissected specimen. Refer to RCPA</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>3.1.5.<span style=\"white-space: pre;\"> </span>INTERNAL INSPECTION</p>\r\n<p>Describe the cut surface appearance including the following items:</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Tumour extent</p>\r\n<p>&nbsp;</p>\r\n<p>Photograph the dissected specimen if required.</p>\r\n<p>3.1.6.<span style=\"white-space: pre;\"> </span>LYMPH NODES (IF PRESENT)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Sentinel lymph nodes</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Regional lymphadenopathy</p>\r\n<p>&nbsp;</p>\r\n<p>Retrieved from resection specimen</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Describe site(s)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Number retrieved</p>\r\n<p>&nbsp;</p>\r\n<p>Separately submitted</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>For each container, record specimen number and designation</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Collective size of tissue in three dimensions (mm)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Number of grossly identified lymph nodes submitted</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Maximum diameter of each (mm)</p>\r\n<p>&nbsp;</p>\r\n<p>If tumour macroscopically involves any lymph nodes, record:</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Number of macroscopically-involved nodes out of total number of lymph nodes retrieved.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Maximum dimension of largest metastasis.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Note any visible extranodal spread and its proximity to the surgical margin.</p>\r\n<p>&nbsp;</p>\r\n<p>3.1.7.<span style=\"white-space: pre;\"> </span>SPECIMENS &lt;10MM</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Submit all tissue for processing. Biopsy pads or similar may be used to prevent loss of tissue during processing.</p>\r\n<p>&nbsp;</p>\r\n<p>3.1.8.<span style=\"white-space: pre;\"> </span>SPECIMENS&gt;10MM</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Serially section the specimen sequentially to demonstrate maximum depth of the lesion and its relationship to the margins. A photograph of the dissected specimen may be useful and can facilitate block identification.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>It is recommended that most, or all, of the lesion is examined focusing on parameters which may upstage the tumour or affect prognosis.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>The extent of sampling should take into account the following factors of the lesion:</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Maximum thickness</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Any unusual features</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Heterogeneous areas</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Areas of ulceration</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Proximity to the margins (sampling of polar margins is undertaken at the discretion of the laboratory but is recommended if the lesion is within 1-2mm of the margin)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Pay careful attention to the possibility of multiple lesions in large specimens. Each lesion must be sampled as well as the area between lesions to determine if truly separate lesions are present.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>For large lesions with prior biopsies, the earlier report may also indicate a need for greater sampling e.g. where there is perineural spread, lymphovascular invasion etc.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Keratin may need to be trimmed to allow hyperkeratotic lesions to fit in cassettes.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Fat may need to be trimmed if greater than 15mm in thickness and macroscopically normal.</p>\r\n<p>&nbsp;</p>\r\n<p>3.1.9.<span style=\"white-space: pre;\"> </span>&nbsp; &nbsp;MELANOCYTIC LESIONS INCLUDING CONGENITAL NAEVI</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Additional targeted sampling of the following is recommended:</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Darker areas</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Pale possible regressed areas</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Heterogeneous foci</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Crusted foci</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Separate smaller (satellite) lesions</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Ulceration/erosion</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Ink marking can assist in correlating areas of dermatoscopic concern at subsequent microscopic examination.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>3.1.10.<span style=\"white-space: pre;\"> </span>PIGMENTED LESIONS &gt;100MM</p>\r\n<p>One suggested method is to submit all radial sections from the perimeter of the specimen. Submit representative or alternate sections from the remainder of the bread-loafed specimen using the targeted sampling described for large specimens.</p>\r\n<p>&nbsp;</p>\r\n<p>3.1.11.<span style=\"white-space: pre;\"> </span>ATYPICAL MELANOCYTIC LESIONS AND MELANOMAS</p>\r\n<p>Where the specimen is a macroscopically atypical melanocytic lesion or previously diagnosed on biopsy as melanoma, submit all sections of the whole lesion. Where the edge of the lesion is indistinct the whole specimen should be embedded including the poles from the long axis.</p>\r\n<p>&nbsp;</p>\r\n<p>SKIN RE-EXCISIONS FOR MELANOMA</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Sample any macroscopic residual tumour and separate pigmented lesions. More sampling is suggested where there was microscopic perineural invasion, neurotropism, extensive regression, amelanotic tumour, lymphovascular invasion, satellites, angiotropism in the original specimen.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>No clear recommendation exists but in the absence of a previous positive margin and no macroscopic abnormality, the minimum regime is to sample the specimen in its shortest transverse axis, incorporating the area from where the scar appears to the margins. This can generally be achieved in 1-4 cassettes.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Record a diagram of inking and sampling of orientated re-excision specimens.</p>\r\n<p>&nbsp;</p>\r\n<p>3.1.12.<span style=\"white-space: pre;\"> </span>LYMPH NODES (WHEN PRESENT)</p>\r\n<p>No clear recommendation exists. One approach is to submit all lymph nodes &lt;10mm whole. Bisect through longitudinal axis if greater than 3mm. Lymph nodes &gt;10mm may be \"bread-loaf\" sectioned into 3-5mm slices and nodes macroscopically suspicious for metastases sampled.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>4.<span style=\"white-space: pre;\"> </span>REFERENCES&nbsp;</p>\r\n<p>https://www.rcpa.edu.au/manuals/macroscopic-cut-up-manual/skin-soft-tissue-and-bone/skin</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>5.<span style=\"white-space: pre;\"> </span>Managing Records kept on the basis of this document</p>\r\n<p>All records supporting this policy shall be kept in the FNQH Pathology document management system in the location, or system based, indicated in the procedure document. Any additional or deleted records shall be kept account of in the FNQH Pathology logging system such that any future enquiry will be able to clearly identify when the changes occurred, who made them, what these changes were and how the changes were approved.</p>\r\n<p>&nbsp;</p>\r\n<p>6.<span style=\"white-space: pre;\"> </span>Validity and Document Management</p>\r\n<p>This document is valid from the date of its approval and will be reviewed on an annual basis. The current working copy will be identified as such, and any superseded documents will be archived and maintained for a period of five years.</p>\r\n<p>&nbsp;</p>\r\n<p>New versions will be identified with a versioning number. Full integers will denote a major document version, and a decimal number will indicate minor amendments or edits.</p>\r\n<p>&nbsp;</p>',	'',	'FNQH Pathology- Digital first, better patient outcomes',	0,	'',	'',	0,	0,	453,	'2022-09-07 15:38:39'),
(11,	'FNQH-SOP-QM030622',	'FNQH Pathology Quality Manual [INTERNAL] V1.1',	453,	12,	0,	'2022-09-07',	'2022-08-10',	0,	1,	'TBC',	0,	12,	'2023-08-10',	'2022-08-10',	'Sarah Sharpe',	'',	'<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>FNQH Pathology Service</p>\r\n<p>&nbsp;</p>\r\n<p>Quality Manual</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>INTERNAL</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Status: FINAL</p>\r\n<p>Version:&nbsp; 1.1</p>\r\n<p>Issue Date: 10.08.22&nbsp;</p>\r\n<p>Document ID:&nbsp; FNQH0-SOP-QM030622</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>About This Document</p>\r\n<p>Document Control</p>\r\n<p>Document ID:<span style=\"white-space: pre;\"> </span>FNQH-SOP-QM030622</p>\r\n<p>Version Number:<span style=\"white-space: pre;\"> </span>V1.1</p>\r\n<p>Date of Version:<span style=\"white-space: pre;\"> </span>10/08/22</p>\r\n<p>Created by:<span style=\"white-space: pre;\"> </span>Sarah Sharpe</p>\r\n<p>Approved by:<span style=\"white-space: pre;\"> </span>Fiona Makowski</p>\r\n<p>Confidentiality Level:<span style=\"white-space: pre;\"> </span>TBC</p>\r\n<p>Document History</p>\r\n<p>Date of Edit<span style=\"white-space: pre;\"> </span>Version<span style=\"white-space: pre;\"> </span>Edited by<span style=\"white-space: pre;\"> </span>Description of change&nbsp;</p>\r\n<p>03/06/22<span style=\"white-space: pre;\"> </span>V0.1<span style=\"white-space: pre;\"> </span>Sarah Sharpe<span style=\"white-space: pre;\"> </span>Initial draft</p>\r\n<p>01/07/22<span style=\"white-space: pre;\"> </span>V0.2<span style=\"white-space: pre;\"> </span>Fiona Makowski<span style=\"white-space: pre;\"> </span>Review and edit</p>\r\n<p>03/07/22<span style=\"white-space: pre;\"> </span>V0.3<span style=\"white-space: pre;\"> </span>Sarah Sharpe<span style=\"white-space: pre;\"> </span>Review and accept edits</p>\r\n<p>22/07/22<span style=\"white-space: pre;\"> </span>V1.0<span style=\"white-space: pre;\"> </span>Fiona Makowski<span style=\"white-space: pre;\"> </span>Approved</p>\r\n<p>10/08/2022<span style=\"white-space: pre;\"> </span>V1.1<span style=\"white-space: pre;\"> </span>Larissa McLeod<span style=\"white-space: pre;\"> </span>Minor edits by Laboratory Manager</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Contents</p>\r\n<p>About This Document<span style=\"white-space: pre;\"> </span>2</p>\r\n<p>Document Control<span style=\"white-space: pre;\"> </span>2</p>\r\n<p>Document History<span style=\"white-space: pre;\"> </span>2</p>\r\n<p>Overview<span style=\"white-space: pre;\"> </span>6</p>\r\n<p>Quality Policy<span style=\"white-space: pre;\"> </span>6</p>\r\n<p>Quality Objectives<span style=\"white-space: pre;\"> </span>6</p>\r\n<p>Ethics and Behaviour<span style=\"white-space: pre;\"> </span>6</p>\r\n<p>Consent<span style=\"white-space: pre;\"> </span>6</p>\r\n<p>Collection of Information<span style=\"white-space: pre;\"> </span>7</p>\r\n<p>Confidentiality<span style=\"white-space: pre;\"> </span>7</p>\r\n<p>Performance of Tests<span style=\"white-space: pre;\"> </span>7</p>\r\n<p>Freedom of Information<span style=\"white-space: pre;\"> </span>7</p>\r\n<p>Operational Integrity<span style=\"white-space: pre;\"> </span>7</p>\r\n<p>Conflict of Interest<span style=\"white-space: pre;\"> </span>7</p>\r\n<p>Undue Pressure<span style=\"white-space: pre;\"> </span>8</p>\r\n<p>Ethical Treatment of Samples and Tissues<span style=\"white-space: pre;\"> </span>8</p>\r\n<p>Use of Samples for Other Purposes<span style=\"white-space: pre;\"> </span>8</p>\r\n<p>Standards of Behaviour - Dress and Appearance<span style=\"white-space: pre;\"> </span>8</p>\r\n<p>Standards of Behaviour - Courtesy<span style=\"white-space: pre;\"> </span>8</p>\r\n<p>Standards of Behaviour - Office &amp; Reception Area<span style=\"white-space: pre;\"> </span>8</p>\r\n<p>Electronic Communication<span style=\"white-space: pre;\"> </span>9</p>\r\n<p>Courier<span style=\"white-space: pre;\"> </span>9</p>\r\n<p>General Information<span style=\"white-space: pre;\"> </span>9</p>\r\n<p>Scope of Activities<span style=\"white-space: pre;\"> </span>9</p>\r\n<p>Research and Clinical Trials<span style=\"white-space: pre;\"> </span>9</p>\r\n<p>Tertiary service role<span style=\"white-space: pre;\"> </span>9</p>\r\n<p>Laboratory&nbsp; Policies<span style=\"white-space: pre;\"> </span>10</p>\r\n<p>Service to the Client<span style=\"white-space: pre;\"> </span>10</p>\r\n<p>Location<span style=\"white-space: pre;\"> </span>10</p>\r\n<p>Security<span style=\"white-space: pre;\"> </span>10</p>\r\n<p>Cleaning and Waste Disposal<span style=\"white-space: pre;\"> </span>10</p>\r\n<p>Information Technology<span style=\"white-space: pre;\"> </span>11</p>\r\n<p>Validation of Software Changes<span style=\"white-space: pre;\"> </span>11</p>\r\n<p>Communications<span style=\"white-space: pre;\"> </span>11</p>\r\n<p>Clinico-Pathology Meetings<span style=\"white-space: pre;\"> </span>11</p>\r\n<p>Senior Staff Meeting<span style=\"white-space: pre;\"> </span>11</p>\r\n<p>Sectional Staff Meetings<span style=\"white-space: pre;\"> </span>11</p>\r\n<p>General Staff Meetings<span style=\"white-space: pre;\"> </span>12</p>\r\n<p>Memoranda<span style=\"white-space: pre;\"> </span>12</p>\r\n<p>General Communications<span style=\"white-space: pre;\"> </span>12</p>\r\n<p>Lines of responsibility<span style=\"white-space: pre;\"> </span>12</p>\r\n<p>Assignment of Staff<span style=\"white-space: pre;\"> </span>12</p>\r\n<p>Authorisation to Issue Reports or Advice<span style=\"white-space: pre;\"> </span>13</p>\r\n<p>Visitors, University Students on Practicum, Work Experience Students<span style=\"white-space: pre;\"> </span>13</p>\r\n<p>Deputising Arrangements - Periods of Leave<span style=\"white-space: pre;\"> </span>13</p>\r\n<p>Laboratory Manager<span style=\"white-space: pre;\"> </span>13</p>\r\n<p>Senior Staff<span style=\"white-space: pre;\"> </span>13</p>\r\n<p>Quality Officer<span style=\"white-space: pre;\"> </span>13</p>\r\n<p>Education, Training, Performance Review<span style=\"white-space: pre;\"> </span>14</p>\r\n<p>Training and Competency Assessment<span style=\"white-space: pre;\"> </span>14</p>\r\n<p>Performance Review<span style=\"white-space: pre;\"> </span>14</p>\r\n<p>Continuing education and professional development<span style=\"white-space: pre;\"> </span>14</p>\r\n<p>Safety<span style=\"white-space: pre;\"> </span>15</p>\r\n<p>Incidents<span style=\"white-space: pre;\"> </span>15</p>\r\n<p>Samples and Requests<span style=\"white-space: pre;\"> </span>15</p>\r\n<p>General<span style=\"white-space: pre;\"> </span>15</p>\r\n<p>Request Forms<span style=\"white-space: pre;\"> </span>15</p>\r\n<p>The Request as a Contract<span style=\"white-space: pre;\"> </span>15</p>\r\n<p>Transport of Specimens<span style=\"white-space: pre;\"> </span>16</p>\r\n<p>Transport of Referred Tests<span style=\"white-space: pre;\"> </span>16</p>\r\n<p>Specimen Receipt, Storage and Disposal<span style=\"white-space: pre;\"> </span>16</p>\r\n<p>Reporting of Results<span style=\"white-space: pre;\"> </span>16</p>\r\n<p>Urgent Results<span style=\"white-space: pre;\"> </span>16</p>\r\n<p>Critical Results<span style=\"white-space: pre;\"> </span>16</p>\r\n<p>Phoning Results<span style=\"white-space: pre;\"> </span>16</p>\r\n<p>Results Given Directly to Patients<span style=\"white-space: pre;\"> </span>17</p>\r\n<p>Withdrawal of Results/Result Revision<span style=\"white-space: pre;\"> </span>17</p>\r\n<p>Reporting Results<span style=\"white-space: pre;\"> </span>18</p>\r\n<p>Turn Around Times<span style=\"white-space: pre;\"> </span>18</p>\r\n<p>Subcontracting of tests and calibrations<span style=\"white-space: pre;\"> </span>18</p>\r\n<p>Referred Tests<span style=\"white-space: pre;\"> </span>19</p>\r\n<p>Document Control<span style=\"white-space: pre;\"> </span>19</p>\r\n<p>Complaints, Non-conformances and Improvements<span style=\"white-space: pre;\"> </span>19</p>\r\n<p>Complaints<span style=\"white-space: pre;\"> </span>19</p>\r\n<p>Control of Nonconforming testing<span style=\"white-space: pre;\"> </span>19</p>\r\n<p>Corrective Actions<span style=\"white-space: pre;\"> </span>19</p>\r\n<p>Preventative Action and Improvements<span style=\"white-space: pre;\"> </span>20</p>\r\n<p>Control of Records<span style=\"white-space: pre;\"> </span>20</p>\r\n<p>Internal Audits<span style=\"white-space: pre;\"> </span>20</p>\r\n<p>Management Review<span style=\"white-space: pre;\"> </span>20</p>\r\n<p>Methods &amp; Method Validation<span style=\"white-space: pre;\"> </span>20</p>\r\n<p>In-house in vitro devices<span style=\"white-space: pre;\"> </span>21</p>\r\n<p>Equipment<span style=\"white-space: pre;\"> </span>21</p>\r\n<p>Specimen Carry-Over<span style=\"white-space: pre;\"> </span>21</p>\r\n<p>Temporary equipment failure<span style=\"white-space: pre;\"> </span>21</p>\r\n<p>Operator Traceability<span style=\"white-space: pre;\"> </span>21</p>\r\n<p>Assuring the Quality of Test Results<span style=\"white-space: pre;\"> </span>21</p>\r\n<p>Use of expired Materials<span style=\"white-space: pre;\"> </span>22</p>\r\n<p>External Quality Assurance Programs<span style=\"white-space: pre;\"> </span>22</p>\r\n<p>Financial<span style=\"white-space: pre;\"> </span>22</p>\r\n<p>General Revenue<span style=\"white-space: pre;\"> </span>22</p>\r\n<p>Disposal of Equipment<span style=\"white-space: pre;\"> </span>22</p>\r\n<p>Stores<span style=\"white-space: pre;\"> </span>22</p>\r\n<p>NATA&nbsp; Accreditation<span style=\"white-space: pre;\"> </span>23</p>\r\n<p>Authorised Representative<span style=\"white-space: pre;\"> </span>23</p>\r\n<p>NATA Endorsement<span style=\"white-space: pre;\"> </span>23</p>\r\n<p>Scope of Accreditation<span style=\"white-space: pre;\"> </span>23</p>\r\n<p>APA/APL Status<span style=\"white-space: pre;\"> </span>23</p>\r\n<p>References<span style=\"white-space: pre;\"> </span>23</p>\r\n<p>NPAAC Documents<span style=\"white-space: pre;\"> </span>23</p>\r\n<p>Tier 1 - The Principles<span style=\"white-space: pre;\"> </span>23</p>\r\n<p>Tier 2 - Standards and Supervisory Requirements for Pathology Laboratories<span style=\"white-space: pre;\"> </span>23</p>\r\n<p>Tier 3A &ndash; Supervisory Requirements for pathology laboratories<span style=\"white-space: pre;\"> </span>23</p>\r\n<p>Tier 3B &ndash; Technical and specific detailed Requirements for good medical practice in all pathology services<span style=\"white-space: pre;\"> </span>23</p>\r\n<p>Tier 4 &ndash; Technical publications for specific areas of pathology<span style=\"white-space: pre;\"> </span>24</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Overview</p>\r\n<p>This Quality Manual is the basis of FNQH Pathology Quality System and includes policies and procedures to which staff are expected to adhere.</p>\r\n<p>&nbsp;</p>\r\n<p>All Staff must be familiar with and follow the Policies and Procedures contained and referred to in this manual, as well as the Policies of FNQH Pathology.</p>\r\n<p>&nbsp;</p>\r\n<p>The Quality Manager is responsible for the preparation and maintenance of this manual</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Quality Policy</p>\r\n<p>FNQH Pathology provides pathology services to GPs and Skin Cancer Specialists as requested.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>FNQH Pathology meets the requirements customers in an appropriate and timely fashion. We in turn have the same requirements of all parties supplying goods and services to this laboratory.</p>\r\n<p>&nbsp;</p>\r\n<p>The following is in place to ensure the requirements of our clients are met:</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>We have implemented a quality management system based on ISO 15189 and are committed to its use as a minimum requirement in providing products and services to our customers.</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>We aim for continuous quality improvement in all our areas of activity.</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>The concept of continual quality improvement is embraced by all staff. We encourage staff members to contribute to our quality management through regular meetings and feedback. Staff at all levels are encouraged to initiate, participate in and review quality projects and are provided with the appropriate tools and training.</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>We seek feedback from our customers as a means of improving the quality of our service.</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>We participate in external and internal Quality Assurance Programs to continually monitor our performance.</p>\r\n<p>&nbsp;</p>\r\n<p>Quality Objectives</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>To monitor Turnaround Times for a limited set of specific procedures twice yearly and assessed based on National Clinical Indicators</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>To document all laboratory errors via the Quality System, in order to identify systematic approaches to reducing or eliminating errors</p>\r\n<p>&nbsp;</p>\r\n<p>Ethics and Behaviour</p>\r\n<p>Consent</p>\r\n<p>&nbsp;</p>\r\n<p>All procedures carried out on patients must be with their informed consent. For routine procedures written consent may not be required; the patient presenting for the collection procedure infers consent.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Collection of Information</p>\r\n<p>&nbsp;</p>\r\n<p>Personal information is routinely collected from patients. This information includes that required to properly identify the individual and at times, medical history information or other details necessary to provide the service required. Unnecessary information should not be collected. The patient has a right to know the information collected, and the purpose for which it has been collected.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Confidentiality</p>\r\n<p>&nbsp;</p>\r\n<p>All information concerning patients is confidential and must not be disclosed to anyone other than those directly responsible for the patient&rsquo;s care. Staff have a responsibility to ensure that access to records, both written and electronic, is secure. Computer terminals should be logged off when left unattended and password security observed. Any breach of confidentiality, either by commission or omission, will be regarded as serious.</p>\r\n<p>&nbsp;</p>\r\n<p>The regulations concerning confidentiality within FNQH Pathology extend to any information gained as a result of employment. Communication with the media concerning the activities of FNQH Pathology is expressly forbidden without the permission of the Managing Director. Any doubts about the provision of information should be referred in the first instance to the Lead Pathologist or Laboratory Manager.</p>\r\n<p>&nbsp;</p>\r\n<p>Performance of Tests</p>\r\n<p>&nbsp;</p>\r\n<p>Testing shall only be performed in an authorised manner, using approved methods and by personnel trained and authorised to perform the testing. Fabrication of results or use of unapproved methods is not acceptable.</p>\r\n<p>&nbsp;</p>\r\n<p>Freedom of Information</p>\r\n<p>&nbsp;</p>\r\n<p>The Freedom of Information Act guarantees access by members of the public to any information held by the Agency which they are entitled to see. The Agency is required to respond within 30 days of the request.</p>\r\n<p>&nbsp;</p>\r\n<p>If a FOI request is made of this department, it should be forwarded the same day to the Lead Pathologist.</p>\r\n<p>&nbsp;</p>\r\n<p>Operational Integrity</p>\r\n<p>&nbsp;</p>\r\n<p>No staff member is permitted to present for work in a condition which may impair their ability to effectively and safely carry out their duties (e.g., sickness, excessive tiredness, intoxication). All staff who present for work must be capable of carrying out their duties in a safe and professional manner. If they doubt their ability to carry out their assigned duties, they must advise the Senior Scientist or Laboratory Manager immediately.</p>\r\n<p>&nbsp;</p>\r\n<p>If a staff member forms the opinion that another staff member is impaired in their ability to carry out their work the Senior Scientist or Laboratory Manager is to be immediately notified. The Laboratory Management will treat any such information confidentially.</p>\r\n<p>&nbsp;</p>\r\n<p>Conflict of Interest</p>\r\n<p>&nbsp;</p>\r\n<p>Section 79 of the State Services Act details an employee&rsquo;s responsibility to disclose and seek permission to operate a business outside of the State Service. In addition, staff will not accept gifts beyond the agreed organisational limit or other disbursements from suppliers or customers that may cause improper attempts to influence staff.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Undue Pressure</p>\r\n<p>&nbsp;</p>\r\n<p>(Examples: being pressured to release results on an assay when QC is out of limits, and before corrective action is initiated, being pressured to act outside your scope of competency).</p>\r\n<p>&nbsp;</p>\r\n<p>If at any time staff feel that they are being pressured in any way that would interfere with the quality of the test results, or with the quality of the process, the Lead Pathologist is to be immediately informed of the circumstances. It is essential that a log is recorded accurately detailing the nature of the pressure and any action taken to address the issue. A nonconformance is to be raised. The Lead Pathologist will use their professional judgement and will give the appropriate advice and will take any required action. The staff member involved may be offered counselling if required. If the Lead Pathologist is unable to resolve the situation, then the Managing Director will be advised.</p>\r\n<p>&nbsp;</p>\r\n<p>Ethical Treatment of Samples and Tissues</p>\r\n<p>&nbsp;</p>\r\n<p>Samples and tissues are to be treated with respect. Inappropriate or unnecessary comments about the appearance or condition of samples are not tolerated. Samples are to be handled and disposed of in an approved manner.</p>\r\n<p>&nbsp;</p>\r\n<p>Use of Samples for Other Purposes</p>\r\n<p>&nbsp;</p>\r\n<p>An excess of sample may be used for purposes other than that for which it was collected (e.g., to validate a new test procedure) but only if all identification is removed from the specimen.</p>\r\n<p>Identifiable samples may not be used for purposes other than that for which they were collected.</p>\r\n<p>&nbsp;</p>\r\n<p>Standards of Behaviour - Dress and Appearance</p>\r\n<p>&nbsp;</p>\r\n<p>Staff are required to dress in a neat, safe and tidy manner when on duty. No specific dress code is enforced but they should meet general community standards when dressing for work. Waterproof (e.g. leather, rubber) enclosed footwear (closed toe and heel) must be worn, (i.e., no sandals or thongs).&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Jewellery should be kept to a minimum to present a professional approach and must not present an Occupational Health and Safety or infection control risk. Consider personal safety when deciding size and style of earrings, necklaces, bracelets (e.g., diameter of sleeper/hoop style).</p>\r\n<p>&nbsp;</p>\r\n<p>Long hair should be tied back or covered, and beards covered when undertaking aseptic or sterile procedures. Hair accessories must be functional.</p>\r\n<p>&nbsp;</p>\r\n<p>Standards of Behaviour - Courtesy</p>\r\n<p>&nbsp;</p>\r\n<p>Staff are expected to behave in a courteous manner to other staff, patients and visitors at all times, even under provocation. Discourtesy is regarded as a serious breach of discipline. Matters of</p>\r\n<p>dispute that cannot be resolved must be referred to the Laboratory Manager or to a senior staff member.</p>\r\n<p>&nbsp;</p>\r\n<p>Standards of Behaviour - Office &amp; Reception Area</p>\r\n<p>&nbsp;</p>\r\n<p>The Office and Specimen Reception Area are often the first contact with the Laboratory, either in person or by telephone. The staff in these areas must act in a responsible and professional manner at all times. Rudeness, abruptness and general unhelpfulness is not to be displayed at any time. In areas where staff are visible to customers or can be heard, personal matters are not to be discussed. In addition, matters concerning patients are to be carried out in such a fashion as not to breach confidentiality at any time. Discretion is needed when discussing test requirements and receiving specimens.</p>\r\n<p>&nbsp;</p>\r\n<p>Electronic Communication</p>\r\n<p>&nbsp;</p>\r\n<p>Email and Internet activity is governed by specific FNQH Pathology electronic communications policy.</p>\r\n<p>Courier</p>\r\n<p>&nbsp;</p>\r\n<p>The use of FNQH Pathology&rsquo;s car is restricted to staff engaged upon departmental business. Logbooks must be filled out completely after use.</p>\r\n<p>&nbsp;</p>\r\n<p>Staff undertaking courier work for the Laboratory are to maintain appropriate standards of presentation that follow acceptable community norms for persons in this position. They are to facilitate specimen collection and report delivery in such a manner that the needs of the customers are met. They are to obey all relevant State Statutes and Regulations concerning being in control of a motor vehicle. Any fines or other penalties are the total responsibility of the person in charge of the motor vehicle. Logbooks must be clearly and accurately filled out for each journey. Refer to the courier manual for further details.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>General Information</p>\r\n<p>Scope of Activities</p>\r\n<p>&nbsp;</p>\r\n<p>The function of FNQH Pathology is to provide a comprehensive Anatomic Pathology service for General Practitioners and Skin Cancer Clinics in the area. FNQH Pathology provides an appropriate service to the laboratory&rsquo;s client base in terms of range of tests, timeliness, cost effectiveness and access.</p>\r\n<p>The policies and procedures within FNQH Pathology are in accordance with the requirements of the relevant Federal and State Acts and NATA guidelines.</p>\r\n<p>&nbsp;</p>\r\n<p>Normal operation hours are 0800 hours to 1800 hours five days a week. Outside the above hours, an emergency call-back service operates. Pathologists and Senior Staff and are available for consultation when required.</p>\r\n<p>&nbsp;</p>\r\n<p>Pathologists and Senior Scientific Staff provide professional advice and assistance to referrers. Associated with this are regular clinico-pathology correlation meetings.</p>\r\n<p>&nbsp;</p>\r\n<p>Department cars are used to run a specimen collection service to FNQH Skin Cancer Clinics. A courier service is used for General Practitioners using the service.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Reports are delivered by automatic electronic upload to referrers through secure integration with Best Practice or other practice software.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Research and Clinical Trials</p>\r\n<p>&nbsp;</p>\r\n<p>We are involved in providing services for clinical trials and research projects. The research / clinical trial must have appropriate agency ethics approval before any activity is agreed to by the Managing Director. We may elect to provide this service for activities within the scope of our accreditation.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Tertiary service role</p>\r\n<p>&nbsp;</p>\r\n<p>In situations where there is a problem with another laboratory&rsquo;s instrumentation, we are happy to add an occasional sample to our regular batch. Where the procedure is time consuming, resource intensive or exposes the laboratory to additional clinical risk, the Lead Pathologist must be consulted before agreeing to do these tests or procedures. See also section on request forms and contracts later in this manual.</p>\r\n<p>&nbsp;</p>\r\n<p>Laboratory&nbsp; Policies</p>\r\n<p>&nbsp;</p>\r\n<p>The Laboratory is covered by policies and operational arrangements as decided by the FNQH Pathology&nbsp; executive &ndash; refer to FNQH Pathology organisational chart.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Service to the Client</p>\r\n<p>&nbsp;</p>\r\n<p>The clients of the Laboratory are GPs and Skin Cancer Specialists. These customers are the very reason we exist and as such demand the highest standards, both professionally and personally from all the staff associated with the laboratory.</p>\r\n<p>&nbsp;</p>\r\n<p>Client feedback is welcomed and provides a useful guide to areas in which our service could be improved.</p>\r\n<p>&nbsp;</p>\r\n<p>Clients are welcome to access and comment on our testing protocols at any time.</p>\r\n<p>&nbsp;</p>\r\n<p>Location</p>\r\n<p>&nbsp;</p>\r\n<p>The Laboratory is located at 274 Mulgrave Rd, Westcourt QLD 4870 and consists of the following functional areas:</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Specimen Reception</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Pathologist and Laboratory Manager Office</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Laboratory</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Storage Areas</p>\r\n<p>&nbsp;</p>\r\n<p>The laboratory is a modern, air-conditioned, well-lit facility for pathology testing.</p>\r\n<p>&nbsp;</p>\r\n<p>Members of the public must access the laboratory via the reception desk and must not enter the any part of the laboratory unless accompanied by a member of staff.</p>\r\n<p>&nbsp;</p>\r\n<p>Access to FNQH Pathology is via Westcourt Shopping Centre and FNQH Skin Cancer Clinic.</p>\r\n<p>&nbsp;</p>\r\n<p>Security</p>\r\n<p>&nbsp;</p>\r\n<p>The laboratory and offices are secured by locked doors, the public areas are outside the locked zone. Laboratory staff have access to all areas of the laboratory and offices during normal business hours.</p>\r\n<p>&nbsp;</p>\r\n<p>Any unauthorised visitor found in the laboratory should be challenged. The Laboratory Manager should be notified of suspicious behaviour.&nbsp;&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>After core hours, the Laboratory is locked and access is limited to staff with key access.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Cleaning and Waste Disposal</p>\r\n<p>&nbsp;</p>\r\n<p>FNQH Pathology is serviced by a contracted cleaning service. However, staff are responsible for ensuring that work areas are kept clean and tidy throughout the day and that any spillage or excess rubbish is cleared to maintain a safe working environment.</p>\r\n<p>&nbsp;</p>\r\n<p>All areas are to be kept free of rubbish or excess items. In particular emergency exits, corridors and walk areas within FNQH Pathology must be kept clear at all times.</p>\r\n<p>&nbsp;</p>\r\n<p>Non-infective waste is discarded in the DFO shopping centre compactor, then is taken to the City tip. Infected material and histology specimens will be removed by a biohazardous waste removal service and incinerated.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Information Technology</p>\r\n<p>The laboratory information system is PathHub. We have a trained staff member on site for general maintenance and other systems tasks. The application is supported by a service contract with the company and they are responsible for providing comprehensive support and maintenance. FNQH Pathology IT services augment this support as required. Access to the computer system is password protected, and staff have access rights based on need and experience. A system of regular (daily) backup of data is in place and is performed by FNQH Pathology IT services. The laboratory also utilises PathHub as Quality Management Software. The Quality Manager is responsible for overseeing general maintenance, configuration and other system tasks and the application is supported by the parent company Ideagen.</p>\r\n<p>&nbsp;</p>\r\n<p>Appropriate records of test results are kept either on hard disc or as hard copy as per NPAAC and NATA Laboratory accreditation recommendation.</p>\r\n<p>&nbsp;</p>\r\n<p>Validation of Software Changes</p>\r\n<p>&nbsp;</p>\r\n<p>All changes to laboratory information systems or software must be validated prior to introduction. The validation should take account of any potential risk to the integrity of data, and especially of any risk or potential harm to the patient. The rigour of the investigation will depend somewhat on the assessment of risk; this risk assessment is to be documented and is to be carried out by a senior member of staff. The validation is to be clearly documented.</p>\r\n<p>&nbsp;</p>\r\n<p>Communications</p>\r\n<p>Clinico-Pathology Meetings</p>\r\n<p>&nbsp;</p>\r\n<p>These are held on a regular schedule. These meetings are to discuss relevant cases and to provide a forum for direct feedback on the performance of the laboratory to the Lead Pathologist other medical and senior staff attend as required.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Senior Staff Meeting</p>\r\n<p>&nbsp;</p>\r\n<p>The senior staff comprising the senior staff responsible for each section, Laboratory Manager, Office Manager, Quality Manager, Pathologists and other persons as necessary meet on a regular basis to discuss matters of relevance to FNQH Pathology. Minutes are kept of these meetings.</p>\r\n<p>Some matters (e.g., personnel matters) may be excluded from these minutes as the Director or Laboratory Manager sees fit. A quorum is four persons including the Lead Pathologist or Laboratory Manager. Decisions from this meeting are not binding on the Managing Director.</p>\r\n<p>&nbsp;</p>\r\n<p>Sectional Staff Meetings</p>\r\n<p>&nbsp;</p>\r\n<p>Each section holds regular meetings as required to disseminate information. These meetings occur at least quarterly, but generally more often than this. At this meeting, the Senior Staff will give an outline of any matters discussed at the Senior staff meetings and give staff at all levels the chance to raise matters either to be taken to the next meeting or the Lead Pathologist or Laboratory Manger for response. These meetings are also the focus for continuing education and review of quality activities. Short minutes are to be kept of these meetings to allow shift workers, persons on leave and those unable to attend to gain an outline of the contents.</p>\r\n<p>&nbsp;</p>\r\n<p>General Staff Meetings</p>\r\n<p>&nbsp;</p>\r\n<p>These are held as required, usually at about 6 monthly intervals, but more often if specific issues arise. Given the nature of shift work it is acknowledged that some staff will be unable to attend meetings. Presentations, continuing education and general discussion are some of the matters that may be raised.</p>\r\n<p>Memoranda</p>\r\n<p>&nbsp;</p>\r\n<p>Memoranda are issued from time to time where a written directive is required. These are distributed throughout the Laboratory or to individuals as necessary. Authority to issue Memoranda lies with the Lead Pathologist or the Laboratory Manager.</p>\r\n<p>&nbsp;</p>\r\n<p>General Communications</p>\r\n<p>&nbsp;</p>\r\n<p>The Laboratory is committed to providing timely and open communication between all staff. In general, the lines of communication as reflected in the organisation chart should be maintained. This does not preclude direct approach to the Lead Pathologist or the Laboratory Manager if an individual or group so wish. However, many problems will be directed back to FNQH Pathology level for resolution in the first instance.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp; Administration</p>\r\n<p>&nbsp;</p>\r\n<p>The Lead Pathologist is responsible for the Laboratory. The Laboratory Manager and Senior staff are individually responsible for a number of management functions that cross over internal departmental boundaries.</p>\r\n<p>&nbsp;</p>\r\n<p>Education, accreditation, safety, computerisation and special projects are managed on a day-to- day basis by staff assigned to that area. They in turn, rely on other staff to assist and advise them. A regular meeting of senior staff reviews and discusses management matters.</p>\r\n<p>&nbsp;</p>\r\n<p>All Staff are subject to State Acts governing their employment.</p>\r\n<p>&nbsp;</p>\r\n<p>Lines of responsibility</p>\r\n<p>&nbsp;</p>\r\n<p>Staff must determine to whom they are responsible during the shift that they are working. In particular, the responsibility for verification of results must be clearly understood. The sub- departmental head or assigned deputy is responsible for the allocation of duties.</p>\r\n<p>&nbsp;</p>\r\n<p>When working outside normal hours, on-call and shift staff are responsible for the range of work authorised to be done.</p>\r\n<p>&nbsp;</p>\r\n<p>Assignment of Staff</p>\r\n<p>&nbsp;</p>\r\n<p>Staff are assigned to internal departments according to their skills and training needs, and the needs of FNQH Pathology. Senior staff are usually assigned permanently to one section. Other scientific and technical staff may be expected to acquire and maintain skills that allow them to move between sections and perform the routine &ldquo;on-call&rdquo; procedures. Clerical and support staff may also move between sections as necessary.</p>\r\n<p>&nbsp;</p>\r\n<p>Technical management is the responsibility of the Senior Scientist. Technical management of Clerical Services is the direct responsibility of the Laboratory Manager. In the absence of the Supervising Scientist another nominated scientist will deputise in this role</p>\r\n<p>&nbsp;</p>\r\n<p>The Quality Officer has the responsibility for ensuring that all aspects of the Quality System are implemented and updated whenever necessary. In the absence of the Quality Officer the Laboratory Manager will fill this role.</p>\r\n<p>&nbsp;</p>\r\n<p>Whenever the term &ldquo;Manager&rdquo; is used it should be defined as referring to the incumbent or his or her nominee in the absence of the incumbent.</p>\r\n<p>&nbsp;</p>\r\n<p>All staff in the laboratory have a Statement of Duties which is available online and which is updated periodically to reflect any changes in their duties.</p>\r\n<p>&nbsp;</p>\r\n<p>Education, accreditation, safety, computerisation, and special projects are managed on a day-to- day basis by senior staff assigned to that area.</p>\r\n<p>&nbsp;</p>\r\n<p>Authorisation to Issue Reports or Advice</p>\r\n<p>&nbsp;</p>\r\n<p>Professional Staff may give advice on test choice, frequency, and interpretation within the limits of the individuals&rsquo; knowledge and experience, if in any doubt the query must be referred to a more senior scientist or pathologist. Provisional results should only be released by a pathologist.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Visitors, University Students on Practicum, Work Experience Students</p>\r\n<p>&nbsp;</p>\r\n<p>These must be authorised by the Lead Pathologist or Laboratory Manager. When so authorised, generally they will be placed under the direction and responsibility of an appropriate Senior Scientist. They must be advised of our safety procedures and issues relating to confidentiality and appropriate behaviour. They must be under close, constant supervision. Vigilance must be given to any computer access. Identification must be worn at all times. An appropriate dress code must be maintained. Any problems must be reported immediately to the Lead Pathologist or Laboratory manager.</p>\r\n<p>&nbsp;</p>\r\n<p>Deputising Arrangements - Periods of Leave&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Lead Pathologist</p>\r\n<p>&nbsp;</p>\r\n<p>In the absence of the Lead Pathologist, the Laboratory Manager assumes overall responsibility for the Laboratory. For day-to-day clinical decision-making, the Staff Pathologists are employed.</p>\r\n<p>&nbsp;</p>\r\n<p>Laboratory Manager</p>\r\n<p>&nbsp;</p>\r\n<p>In the absence of the Laboratory Manager, one of the Senior Staff will be selected by the Lead Pathologist to act as Laboratory Manager. This person also assumes the role of Fire Warden.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;Senior Staff</p>\r\n<p>&nbsp;</p>\r\n<p>In the absence of Senior Staff, a nominated Scientist with sufficient experience and training will be given responsibility for the day-to-day operations.</p>\r\n<p>&nbsp;</p>\r\n<p>Quality Officer</p>\r\n<p>&nbsp;</p>\r\n<p>In the absence of the Quality Officer the Laboratory Manager or his / her delegate will fill this role.</p>\r\n<p>&nbsp;</p>\r\n<p>Education, Training, Performance Review</p>\r\n<p>&nbsp;</p>\r\n<p>The laboratory has a system of competency assessment to ensure that all staff develop and maintain appropriate skills in all aspects of their work. In addition, staff are expected to attend educational meetings and seminars to maintain and update knowledge.</p>\r\n<p>&nbsp;</p>\r\n<p>Training and Competency Assessment</p>\r\n<p>&nbsp;</p>\r\n<p>The laboratory maintains records to ensure the competence of all staff.</p>\r\n<p>&nbsp;</p>\r\n<p>New staff are given supervision while they work through a documented training program to ensure their level of skill is appropriate for the duties required of them. After this initial training, competency is continually evaluated by senior staff, and additional training provided as required. An annual competency evaluation is completed, this provides a formal opportunity to discuss any issues and offer any further training required.</p>\r\n<p>&nbsp;</p>\r\n<p>NOTE: Training and competency is the responsibility of each individual staff member. It is a staff member&rsquo;s professional duty to ensure that they are demonstrably trained and competent for all tasks performed.</p>\r\n<p>&nbsp;</p>\r\n<p>Performance Review</p>\r\n<p>&nbsp;</p>\r\n<p>New staff are given the opportunity to review their progress with their immediate superior at the end of three months, and at the end of six months when the probationary period ends. This is in addition to the continual process of direction and guidance offered.</p>\r\n<p>&nbsp;</p>\r\n<p>The annual competency assessment evaluation provides the opportunity for senior staff to review progress and development with the staff member. This is an opportunity to set goals for the next year, identify educational and training needs, establish an understanding of what is expected of the staff member and to provide an opportunity for the discussion of work-related problems. Any such training needs are to be documented on the annual competency assessment record.</p>\r\n<p>&nbsp;</p>\r\n<p>Continuing education and professional development</p>\r\n<p>&nbsp;</p>\r\n<p>All scientific and technical staff are expected to maintain a program of self-education.</p>\r\n<p>&nbsp;</p>\r\n<p>A regular program of education is established in the laboratory and all staff are to ensure that they attend and document their attendance. Compliance in relation to continuing education and professional development will be discussed at the annual competency assessment. All staff should also keep a personal record of any continuing education attendance.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Periodic departmental meetings are held to assist in this process and time off to attend courses directly related to work is available where appropriate. In house training courses are available from time to time and staff are encouraged to attend these courses. A log of an individual\'s continuing education is to be maintained in the personnel file. It is the responsibility of each staff member to ensure that self-education is recorded.</p>\r\n<p>&nbsp;</p>\r\n<p>Some funds are available to assist staff to attend conferences and meetings and allocation is at the discretion of the Director and Laboratory Manager. The overriding consideration with regard to the selection of staff to attend conferences and seminars are the needs of FNQH Pathology.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Safety</p>\r\n<p>The safety of staff, patients and the public are of paramount importance to the Laboratory. Staff must be aware of policies and procedures, and these must be followed at all times. Reporting of accidents, incidents and near misses is seen as an important quality assurance exercise to reduce the incidence and possibility of injury.</p>\r\n<p>&nbsp;</p>\r\n<p>Fire Safety Training, including evacuation drills are undertaken annually as part of the Laboratory Fire Safety Program and training in Manual Handling is undertaken Laboratory wide with all staff participation.</p>\r\n<p>&nbsp;</p>\r\n<p>Staff are encouraged to attend additional courses where appropriate, for example First Aid or Warden training.</p>\r\n<p>&nbsp;</p>\r\n<p>Incidents</p>\r\n<p>&nbsp;</p>\r\n<p>The primary means of notification for all health and safety incidents is via the Standard Operating Procedure and lodged with the Laboratory Manager as soon as possible.</p>\r\n<p>&nbsp;</p>\r\n<p>Samples and Requests</p>\r\n<p>General</p>\r\n<p>&nbsp;</p>\r\n<p>Samples are received from GPs and skin cancer clinics at Specimen Reception. Couriers are used to run a specimen collection service to off-site clinics. Taxis are used to augment this service if required. Internally Laboratory Staff are used for the delivery of samples from on-site FNQH Clinics.</p>\r\n<p>&nbsp;</p>\r\n<p>Request Forms</p>\r\n<p>&nbsp;</p>\r\n<p>A completed request form signed by the requesting Medical Officer must accompany each request. The sample must be clearly labelled and matched unequivocally with the request form. For Laboratory policy on unsigned requests and inadequately labelled samples, refer to the Laboratory Manual.</p>\r\n<p>&nbsp;</p>\r\n<p>Under specific circumstances forms signed by a person other than a Medical Officer (e.g. approved health care workers) may be acceptable. The Lead Pathologist, to whom any doubtful cases should be referred, will determine these circumstances. The Health Insurance Commission has determined that a treating medical practitioner may request a pathology service either orally or in writing but oral requests must be confirmed in writing within 14 days from the day when the oral request was made. A facsimile request is taken to have the same status as an original request form.</p>\r\n<p>&nbsp;</p>\r\n<p>For further information please refer to the Laboratory Manual.</p>\r\n<p>&nbsp;</p>\r\n<p>The Request as a Contract</p>\r\n<p>&nbsp;</p>\r\n<p>The receipt of a properly completed request form constitutes a contract between the requesting doctor and the laboratory. The laboratory is at all times obligated to do the utmost to provide the requested service, utilising approved methods and within a reasonable time frame. At times a request may be received which cannot be fulfilled due to reasons, for example, of incorrect sample or unavailability of the test. In these circumstances the requesting doctor is to be notified of the inability to fulfil the contract by phone and/or by written report.</p>\r\n<p>&nbsp;</p>\r\n<p>Where a pattern of non-fulfilment of contract occurs, senior staff are to be involved in review of these. This is to enable discussion with the requesting doctors and resolution of any problems.</p>\r\n<p>&nbsp;</p>\r\n<p>Transport of Specimens</p>\r\n<p>&nbsp;</p>\r\n<p>Couriers are used to run a specimen collection service to off-site clinics. Taxis are used to augment this service if required. Internally Laboratory Staff are used for the delivery of samples from on-site FNQH Clinics.</p>\r\n<p>&nbsp;</p>\r\n<p>Transport of Referred Tests</p>\r\n<p>&nbsp;</p>\r\n<p>The method of transport for referred tests will depend on the sample, the availability of suitable carriers and wishes of the Laboratory to whom the work is referred.</p>\r\n<p>&nbsp;</p>\r\n<p>All specimens that are transported by carriers are to be packed in accordance with IATA regulations and by persons specifically trained to do so.</p>\r\n<p>&nbsp;</p>\r\n<p>Specimen Receipt, Storage and Disposal</p>\r\n<p>&nbsp;</p>\r\n<p>Each sample is given a unique identifying number on receipt in the laboratory and all relevant information about the sample is recorded in the PathHub computer system (refer to the Laboratory Manual).</p>\r\n<p>&nbsp;</p>\r\n<p>All samples are stored in the laboratory in appropriate environmental conditions, which are regularly monitored and recorded.</p>\r\n<p>&nbsp;</p>\r\n<p>Specimens are stored for an appropriate time, using the current NPAAC guidelines as a minimum requirement. Samples are then disposed of in an appropriate manner as described in the Laboratory Manual.</p>\r\n<p>&nbsp;</p>\r\n<p>Reporting of Results</p>\r\n<p>Reports are sent to the requesting doctor and if required, copy doctor(s). Any other doctor requesting a copy of that report can obtain a copy. The onus is on that doctor to have a legitimate requirement for that result, if in doubt refer to the Lead Pathologist.</p>\r\n<p>&nbsp;</p>\r\n<p>Urgent Results</p>\r\n<p>&nbsp;</p>\r\n<p>These tests will be given priority and results phoned, faxed or printed to the location specified on the request form. Care must be taken to protect patient confidentiality when phoning urgent results. The procedure for phoning results, as detailed below, should be followed.</p>\r\n<p>&nbsp;</p>\r\n<p>Critical Results</p>\r\n<p>&nbsp;</p>\r\n<p>Any test result considered urgently required for the immediate management of the patient is to be communicated by phone to the unit concerned or to the requesting doctor. These critical results include but are not limited to malignant melanoma and lymphoma.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Phoning Results</p>\r\n<p>&nbsp;</p>\r\n<p>It is essential that all results issued from the laboratory are correct. Incorrect results or misinterpretation may significantly risk our patient&rsquo;s welfare and compromise staff who issue those results.</p>\r\n<p>&nbsp;</p>\r\n<p>In this light any request for results to be provided over the phone MUST, in the first instance, be queried stating our preference to provide a formal copy, either hard copy or electronic. Remind callers that all patient results originating from a request in Best Practice should be available on that platform. In cases where the requestor persists that call must be directed to the appropriate place.</p>\r\n<p>&nbsp;</p>\r\n<p>All incoming calls must be assessed and directed according to the type of request.</p>\r\n<p>&nbsp;</p>\r\n<p>Before asking any other questions clearly identify the caller and the relationship around the request. If you are unsure or dubious about the need for the caller to have the requested information immediately refer them to your supervisor.</p>\r\n<p>&nbsp;</p>\r\n<p>When you are satisfied the call is bona fide proceed as below:</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Personal calls &ndash; locate the individual and transfer. If unable to locate the person take a message and pass it on.</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Generic pathology logistics related questions &ndash; Office</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>General issue of report related questions such as add copy doctor &ndash; Office</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>General reading of simple, authorised results from PathHub scientist.</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>There must be no interpretation or explanation of result values - these MUST be forwarded to the relevant laboratory.</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>General sample type related questions &ndash; Senior Scientist</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Specific result related questions to the relevant department &ndash; Pathologist</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Detailed result interpretation &ndash; Pathologist.</p>\r\n<p>Only appropriately trained staff are to provide results</p>\r\n<p>&nbsp;</p>\r\n<p>Results Given Directly to Patients</p>\r\n<p>&nbsp;</p>\r\n<p>Results are not given to patients without a specific instruction from the requesting doctor. Should a patient become insistent they are referred to the Lead Pathologist or Managing Director (see also &ldquo;freedom of information&rdquo;).</p>\r\n<p>&nbsp;</p>\r\n<p>Withdrawal of Results/Result Revision</p>\r\n<p>&nbsp;</p>\r\n<p>In cases where a report has been authorised, but it becomes evident that the results are incorrect, the report must be revised immediately. The ISO15189 Standard requires revised reports to be clearly identified as a revision report and the revision report must include the date and time of the revision, the name of the person responsible for the revision and the original report entries must remain in the record after revisions are made, including the exact change.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Immediately upon discovery of the error the revised results are to be phoned or communicated to the appropriate clinical area(s) to ensure they are made aware of any changes to the revised reports. Record the communication.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>To issue a revised report when a report has been already authorised and results have been released use the procedure in the Reporting Errors Procedure document.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Reporting Results</p>\r\n<p>&nbsp;</p>\r\n<p>Reports are sent to the requesting doctor and to any other person or location as directed by the requesting doctor. Any other doctor requesting a copy of that report can obtain a copy. The onus is on that doctor to have a legitimate requirement for that result.</p>\r\n<p>&nbsp;</p>\r\n<p>All confidential paper reports are to be addressed to the requesting doctor in a sealed envelope marked &lsquo;confidential&rsquo;.</p>\r\n<p>&nbsp;</p>\r\n<p>Before any report is issued, the pathologist must check the results for accuracy.</p>\r\n<p>&nbsp;</p>\r\n<p>Reports are checked for the following:</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Patient demographics</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Accuracy and completeness of results</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Tests performed are as requested</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Request form is signed (or re-sent for signing or awaiting signature)</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Report comments are appropriate</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Copy doctors are included</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Compliance with laboratory policy</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Results from other laboratories are annotated accordingly</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Turn Around Times</p>\r\n<p>&nbsp;</p>\r\n<p>Average TATs for most assays are provided for referrers. Where there is likely to be a significant deviation from these times (e.g. by reason of instrument maintenance or breakdown) notification should be provided to the key requesting doctors in those areas where rapid turnaround is normally required. If the delay is likely to be extensive and clinically relevant, the Lead Pathologist shall authorise the use of backup services.</p>\r\n<p>&nbsp;</p>\r\n<p>Subcontracting of tests and calibrations</p>\r\n<p>For tests that cannot be done at this Laboratory under our Terms of Registration or tests that are low in volume or specialised, a referral Laboratory is selected based on Quality (NATA accredited), previous reliable and timely service, and cost.</p>\r\n<p>&nbsp;</p>\r\n<p>The referral laboratory is acknowledged on all reports issued from this laboratory.</p>\r\n<p>&nbsp;</p>\r\n<p>A register of all referral laboratories used by us is kept in the referrals database.</p>\r\n<p>&nbsp;</p>\r\n<p>Overdue tests for our referral laboratories are monitored in PathHub.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Referred Tests</p>\r\n<p>For all specimens that are referred to another Laboratory, records are maintained to allow verification of shipping and return of results. There is also an audit trail to verify that tests have been returned in a clinically relevant time frame. Where tests are not returned in a relevant time frame, then action is taken with the referral laboratory to review the arrangement, correct the problem or find another suitable laboratory.</p>\r\n<p>&nbsp;</p>\r\n<p>Details of specimen requirements for referred tests are kept in the relevant section of the online handbook. All staff packing samples for air transport must have current appropriate IATA certification.</p>\r\n<p>&nbsp;</p>\r\n<p>Document Control</p>\r\n<p>All documents, including this Quality Manual, technical procedures, policies, wall charts and forms are reviewed at least every 2 years by the appropriate manager and updated whenever necessary.</p>\r\n<p>&nbsp;</p>\r\n<p>All master documents are stored on PathHub and are reviewed by FNQH Pathology heads (or their delegate) with final approval by the Pathologist who oversees that section.</p>\r\n<p>&nbsp;</p>\r\n<p>Complaints, Non-conformances and Improvements</p>\r\n<p>Any member of staff who becomes aware of a situation which may require corrective action should notify their Technical Manager as soon as possible. Complaints from clients and suggestions for improvement must also be communicated as soon as possible.</p>\r\n<p>&nbsp;</p>\r\n<p>Complaints</p>\r\n<p>&nbsp;</p>\r\n<p>All complaints are documented and directed to the Director of Pathology or Laboratory Manager as soon as they are received. A CA/PA should be raised in PathHub. Follow up can then be recorded.</p>\r\n<p>&nbsp;</p>\r\n<p>If a Staff member becomes aware that their action or that of others may result in a complaint being made, they should advise the Director of Pathology or Laboratory Manager as soon as possible with all relevant details.</p>\r\n<p>&nbsp;</p>\r\n<p>Control of Nonconforming testing</p>\r\n<p>&nbsp;</p>\r\n<p>The laboratory maintains procedures for dealing with problems arising from any aspect of our testing which for any reason does not conform to the test procedures. All such nonconformances are documented by means of a CA/PA in PathHub, as is the action taken to correct it. The Senior Scientist responsible for the area has the responsibility for evaluating the problem and taking appropriate measures to fix the problem</p>\r\n<p>&nbsp;</p>\r\n<p>When any problems are shown to be of a recurrent of systematic nature, more formal corrective action involving the Quality Manager and Laboratory Manager may be necessary.</p>\r\n<p>&nbsp;</p>\r\n<p>Corrective Actions</p>\r\n<p>&nbsp;</p>\r\n<p>Corrective actions are necessary to correct nonconforming work practices or any departures from policy or procedure that have been identified.</p>\r\n<p>&nbsp;</p>\r\n<p>The procedure for a corrective action begins with investigation to determine the root cause of the problem, followed by implementation of appropriate corrective action and subsequent close monitoring to ensure that the corrective action has been effective.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Preventative Action and Improvements</p>\r\n<p>&nbsp;</p>\r\n<p>Preventative action is a proactive process used to identify improvement opportunities, rather than a reaction to the identification of problems or complaints. Follow up procedures are similar to those used for complaints and nonconformances.</p>\r\n<p>&nbsp;</p>\r\n<p>Control of Records</p>\r\n<p>The laboratory has established procedures for control of technical and quality records as per the NPAAC guidelines. Records kept include:</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>testing and QC reports</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>equipment calibrations</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>internal audits</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>management reviews</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>complaints, corrective, preventative actions</p>\r\n<p>&nbsp;</p>\r\n<p>All records of testing are kept in the PathHub computer system and are accessible to all members of staff with appropriate levels of computer access. All of these records contain full details of tests and results, operator identity and observations or notes and are fully auditable.</p>\r\n<p>&nbsp;</p>\r\n<p>Internal Audits</p>\r\n<p>Internal audits are performed on a regular basis. The audit system is organised and maintained by the Quality Manager.</p>\r\n<p>&nbsp;</p>\r\n<p>The purpose of audits is to monitor the performance of the Quality System and technical procedures, and to determine whether any nonconformance exists or whether improvements can be made and discussed during management meetings (maintain a strong focus on continuous improvement).</p>\r\n<p>&nbsp;</p>\r\n<p>Management Review</p>\r\n<p>A Management Review meeting will occur yearly to review policy and operational issues. The Lead Pathologist, Laboratory Manager and Quality Manager attend; other senior staff may occasionally be required to provide specific items.</p>\r\n<p>&nbsp;</p>\r\n<p>Items examined include Complaints, Corrective Actions, Improvement Opportunities; Internal and External Audits; Document Control; Client feedback (e.g. customer surveys); Suppliers and Referral Labs; Reports from Senior Staff (Incorporating internal and external Quality Control, TATs, changes to volume/type of work).</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Methods &amp; Method Validation</p>\r\n<p>&nbsp;</p>\r\n<p>Procedure manuals are kept for all tests performed in the laboratory. These manuals are part of the document control system and are regularly updated by the Quality Manager and the appropriate Section Manager. Whenever possible the laboratory uses only well documented, standardised methods for testing. Any necessary variations are validated by the appropriate Section Manager prior to use.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>The Laboratory documents the performance and comparability of a new test method before it is used routinely.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>In-house in vitro devices</p>\r\n<p>&nbsp;</p>\r\n<p>In-house in vitro devices (IVD&rsquo;s) are considered therapeutic goods which are regulated under The Therapeutic Goods Act 1989. IVD&rsquo;s are expected to be safe, have a high quality and meet expected standards. All manufacturers of IVD&rsquo;s must certify that their products are safe, perform well for the intended purpose and are manufactured to a high standard of quality.</p>\r\n<p>&nbsp;</p>\r\n<p>Equipment</p>\r\n<p>&nbsp;</p>\r\n<p>All equipment used for testing is permanently on site in the laboratory and is regularly maintained according to a predetermined schedule and procedure by laboratory staff, or by the manufacturer or their agent. All equipment is operated by trained staff following documented procedures. Each item is uniquely identified and logged in the Assets Module in PathHub to enable records of its history to be kept.</p>\r\n<p>&nbsp;</p>\r\n<p>Equipment maintenance records are kept in PathHub. These include calibration and operational checks. Pathology staff perform preventative maintenance on certain items of equipment. Several items of equipment are under Service Contract agreements. Calibration and maintenance procedures and schedules are kept for all relevant equipment.</p>\r\n<p>&nbsp;</p>\r\n<p>Where a piece of equipment is found to be inoperable it is tagged and removed from service until repairs are carried out. A nonconformance should be raised in PathHub against the Asset.</p>\r\n<p>&nbsp;</p>\r\n<p>Specimen Carry-Over</p>\r\n<p>&nbsp;</p>\r\n<p>For all equipment, consideration is to be given as to the potential to report incorrect results due to specimen carry-over. Where this is possible, means shall be put in place to prevent this occurring.</p>\r\n<p>&nbsp;</p>\r\n<p>Temporary equipment failure</p>\r\n<p>&nbsp;</p>\r\n<p>QML Pathology is a NATA accredited Laboratory and, in the event of equipment failure or for any other reason, will provide backup for this Laboratory. In the same manner, we will perform testing for other laboratories as requested.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>The need for such a service would not normally exist for more than a day or two at a time.</p>\r\n<p>&nbsp;</p>\r\n<p>Operator Traceability</p>\r\n<p>&nbsp;</p>\r\n<p>To ensure traceability of the person undertaking the tests, all actions are recorded in PathHub, and any work sheets are annotated with the initials of the person performing the test.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Assuring the Quality of Test Results</p>\r\n<p>Internal and external quality assurance is a vital component in ensuring that the test results and methodologies are of a standard that will not compromise patient care. All quality control results are to be monitored by senior staff and directions for action to be taken are contained in the specific method manuals.</p>\r\n<p>&nbsp;</p>\r\n<p>The laboratory participates in the RCPA and other external Quality Control Programs to provide a comparison of our results with other pathology providers throughout the country.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Use of expired Materials</p>\r\n<p>&nbsp;</p>\r\n<p>All reagents, calibrators and quality control material used must be used within the expiry date of the product. However, it is acknowledged that in exceptional circumstances (for example for reasons of supply or quality of a replacement product) that this may be unavoidable. The use of expired material must only occur after consultation with the Supervising Scientist and under their direction. The test results are only acceptable providing there are no significant shifts or trends in the quality control results. If the quality control results are not acceptable the assay must be suspended until suitable product is available and has been validated. The use of expired material must be reported to the Senior Scientist.</p>\r\n<p>&nbsp;</p>\r\n<p>External Quality Assurance Programs</p>\r\n<p>&nbsp;</p>\r\n<p>All external Quality Control Program results shall be submitted by the due date. External Quality Control Results shall be an agenda item at FNQH Pathology meetings. Actions taken to address unsatisfactory performance shall be discussed and noted in the minutes.</p>\r\n<p>&nbsp;</p>\r\n<p>All external Quality Control results are to be notified to the Lead Pathologist. Remedial actions taken on results with unsatisfactory performance shall be documented on the External Quality Assurance program cycle summary and shall be reviewed by the Lead Pathologist. Where necessary after consultation with the Senior Scientist in charge of the sub-section, the Lead Pathologist shall direct changes to be made in methodologies, procedures or instrumentation or if necessary direct the tests to be done at another laboratory until the problem can be resolved.</p>\r\n<p>&nbsp;</p>\r\n<p>The Laboratory is enrolled in the following External Quality assurance Programs.</p>\r\n<p>PROGRAM<span style=\"white-space: pre;\"> </span>EXAMINATIONS/TESTS</p>\r\n<p>RCPA Anatomical Pathology<span style=\"white-space: pre;\"> </span>Dermatopathology, Technical</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Financial</p>\r\n<p>General Revenue</p>\r\n<p>&nbsp;</p>\r\n<p>Laboratory purchases are made through FNQH Pathology. The Laboratory Manager has authority to purchase all reagents and materials necessary for the day to day operation of the lab. Small items of equipment, (under $5,000) can be purchased in this way although it is wise to clear items such as furniture, refrigerators, and non-scientific equipment with the Managing Director. Computer equipment should be cleared through the CTO.</p>\r\n<p>Disposal of Equipment</p>\r\n<p>&nbsp;</p>\r\n<p>Do not dispose of any equipment without specific authorisation from the Managing Director via the Lead Pathologist or Laboratory Manager.</p>\r\n<p>Stores</p>\r\n<p>&nbsp;</p>\r\n<p>Storage of consumables, specimen containers etc. is limited to a small storage area in FNQH Pathology. Other storage exists within FNQH Skin Cancer Clinic.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>NATA&nbsp; Accreditation</p>\r\n<p>Authorised Representative</p>\r\n<p>&nbsp;</p>\r\n<p>Dr. Fiona Makowski is the NATA Authorised Representative for FNQH Pathology.</p>\r\n<p>&nbsp;</p>\r\n<p>NATA Endorsement</p>\r\n<p>&nbsp;</p>\r\n<p>Reports that are issued on tests done under the Scope of Accreditation may carry the NATA endorsement.</p>\r\n<p>&nbsp;</p>\r\n<p>Scope of Accreditation</p>\r\n<p>&nbsp;</p>\r\n<p>For the current Scope of Accreditation refer to the NATA website. The Quality Manager holds a current copy of this document if required.</p>\r\n<p>&nbsp;</p>\r\n<p>APA/APL Status</p>\r\n<p>&nbsp;</p>\r\n<p>Application has to be made when required to the Federal agencies for APA and APL status together with the fees. The documents are on file for previous years and should be completed promptly. Non approval means no money from Medicare for private patient work.</p>\r\n<p>&nbsp;</p>\r\n<p>References</p>\r\n<p>This quality manual has been prepared with consideration given to the requirements outlined in the following documents:</p>\r\n<p>AS ISO 15189:2012 Medical Laboratories-Requirements for quality and competence</p>\r\n<p>AS 4633 (ISO15189) Application Document, Supplementary requirements for accreditation in the field of medical testing July 2009</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>NPAAC Documents</p>\r\n<p>&nbsp;</p>\r\n<p>Tier 1 - The Principles</p>\r\n<p>&nbsp;</p>\r\n<p>Health Insurance (Accredited Pathology Laboratories - Approval) Principles 2017</p>\r\n<p>&nbsp;</p>\r\n<p>Tier 2 - Standards and Supervisory Requirements for Pathology Laboratories</p>\r\n<p>Requirements for Medical Pathology Service (Third Edition 2018)</p>\r\n<p>Tier 3A &ndash; Supervisory Requirements for pathology laboratories</p>\r\n<p>&nbsp;</p>\r\n<p>Requirements for Supervision in Clinical Governance of Medical Pathology Laboratories (Sixth Edition 2021)</p>\r\n<p>&nbsp;</p>\r\n<p>Requirements for the Communication of High Risk Pathology Results (First Edition 2020)</p>\r\n<p>&nbsp;</p>\r\n<p>Tier 3B &ndash; Technical and specific detailed Requirements for good medical practice in all pathology services</p>\r\n<p>&nbsp;</p>\r\n<p>Requirements for the Estimation',	'',	'FNQH Pathology - Digital first, better patient outcomes',	4,	'',	'',	1,	0,	453,	'2022-09-07 15:42:32'),
(12,	'FNQH-SOP-RE030722',	'FNQH Pathology Reporting Errors Protocol [INTERNAL] V1.0',	453,	12,	0,	'2022-09-07',	'2022-07-22',	0,	1,	'TBC',	0,	12,	'2023-07-22',	'2022-07-22',	'Sarah Sharpe',	'',	'<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>REPORTING ERRORS</p>\r\n<p>Standard Operating Procedure (Protocol)</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>INTERNAL</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Status: FINAL</p>\r\n<p>Version:&nbsp; 1.0</p>\r\n<p>Issue Date: 22.07.22&nbsp;</p>\r\n<p>Document ID:&nbsp; FNQH-SOP-RE030722</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>This publication has been prepared and written by FNQH and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</p>\r\n<p>&nbsp;</p>\r\n<p>Note for non-FNQH readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>About This Document</p>\r\n<p>Document Control</p>\r\n<p>Document ID:<span style=\"white-space: pre;\"> </span>FNQH-SOP-RE030722</p>\r\n<p>Version Number:<span style=\"white-space: pre;\"> </span>V1.0</p>\r\n<p>Date of Version:<span style=\"white-space: pre;\"> </span>22/7/2022</p>\r\n<p>Created by:<span style=\"white-space: pre;\"> </span>Sarah Sharpe</p>\r\n<p>Approved by:<span style=\"white-space: pre;\"> </span>Fiona Makowski</p>\r\n<p>Confidentiality Level:<span style=\"white-space: pre;\"> </span>TBC</p>\r\n<p><span style=\"white-space: pre;\"> </span></p>\r\n<p>Document History</p>\r\n<p>Date of Edit<span style=\"white-space: pre;\"> </span>Version<span style=\"white-space: pre;\"> </span>Edited by<span style=\"white-space: pre;\"> </span>Description of change&nbsp;</p>\r\n<p>26/06/22<span style=\"white-space: pre;\"> </span>V0.1<span style=\"white-space: pre;\"> </span>Sarah Sharpe<span style=\"white-space: pre;\"> </span>Initial Draft</p>\r\n<p>1/07/22<span style=\"white-space: pre;\"> </span>V0.2<span style=\"white-space: pre;\"> </span>Fiona Makowski<span style=\"white-space: pre;\"> </span>Review and edits</p>\r\n<p>03/07/22<span style=\"white-space: pre;\"> </span>V0.3<span style=\"white-space: pre;\"> </span>Sarah Sharpe<span style=\"white-space: pre;\"> </span>Review and accepted edits</p>\r\n<p>22/07/22<span style=\"white-space: pre;\"> </span>V1.0<span style=\"white-space: pre;\"> </span>Fiona Makowski<span style=\"white-space: pre;\"> </span>Approved</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Contents</p>\r\n<p>REPORTING ERRORS<span style=\"white-space: pre;\"> </span>1</p>\r\n<p>About This Document<span style=\"white-space: pre;\"> </span>2</p>\r\n<p>Document Control<span style=\"white-space: pre;\"> </span>2</p>\r\n<p>Document History<span style=\"white-space: pre;\"> </span>2</p>\r\n<p>1.<span style=\"white-space: pre;\"> </span>Introduction, Purpose Scope &amp; Users<span style=\"white-space: pre;\"> </span>4</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>DEFINITIONS<span style=\"white-space: pre;\"> </span>4</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>REFERENCES<span style=\"white-space: pre;\"> </span>5</p>\r\n<p>4.<span style=\"white-space: pre;\"> </span>NOTES<span style=\"white-space: pre;\"> </span>5</p>\r\n<p>5.<span style=\"white-space: pre;\"> </span>Managing Records kept on the basis of this document<span style=\"white-space: pre;\"> </span>6</p>\r\n<p>6.<span style=\"white-space: pre;\"> </span>Validity and Document Management<span style=\"white-space: pre;\"> </span>6</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&emsp;</p>\r\n<p>1.<span style=\"white-space: pre;\"> </span>Introduction, Purpose Scope &amp; Users</p>\r\n<p>This document is intended to document the Standard Operating Procedures (protocol) at FNQH Pathology for reporting errors and details the processes, steps, and detailed instructions so that the relevant (authorised) team member can carry out the task correctly every time.</p>\r\n<p>&nbsp;</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>DEFINITIONS&nbsp;</p>\r\n<p>Supplementary Reports: These include instances where further information or refinement of diagnosis or further ancillary test results are expected at the time of issuing of the original report and the fact that such information will be available in future is mentioned in the body of the original report on the case. Thus any person reading the original report knows to expect another report (&ldquo;supplementary report&rdquo;) to exist or expect it to be created in time.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Amended Reports: These include instances where &ldquo;significant&rdquo; information in the original report is deemed to be incorrect (in error) and which is identified at a date later than issuing of the original report. Such incorrect information may relate to patient demographics, specimen details or significant alteration of diagnosis or important prognostic parameters.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>In respect of Supplementary Reports:&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>1. The subsequent report issued should be titled SUPPLEMENTARY REPORT.</p>\r\n<p>2. Such title be added to the original report at the top of the 1st page of the report.</p>\r\n<p>3. The original report be altered in no way.</p>\r\n<p>3. The additional information be added to an appropriate location of the report with other relevant details such as date, time, and reason for addition.</p>\r\n<p>2. The report should be authorized as per the usual protocols.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>In respect of Amended Reports:&nbsp;</p>\r\n<p>1. The subsequent report be titled AMENDED REPORT&nbsp;</p>\r\n<p>2. Such title be added to the template of the original report at the top of the 1st page of the report with any other relevant details such as date and time of addition and reason for the amendment or the addition as is deemed prudent;&nbsp;</p>\r\n<p>3. The additional information be added in detail in an appropriate location of the report so as to ensure that all aspects of the additional information be readily apparent to the recipients (for example bolded or italicized)&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>4. The original report be altered in no way with the additional and/or altered information or assessment be an addition without altering the previous report;&nbsp;</p>\r\n<p>5. Any known additional clinicians or locations involved in the management of the patient since the original report was transmitted be added to the distribution list of the amended report as is deemed prudent;&nbsp;</p>\r\n<p>6. In addition the relevant amended information should be verbally transmitted to the clinician primarily involved in the current management of the patient or to multiple clinicians where a definite primary clinician cannot be identified to make the clinicians aware of the existence of the amended report.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>REFERENCES</p>\r\n<p>https://www.rcpa.edu.au/getattachment/51f90738-97a2-415c-a21c-f264f15362c6/Supplementary-Amended-Reports-Anatomical-Pathology.aspx</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>4.<span style=\"white-space: pre;\"> </span>NOTES</p>\r\n<p>When a report is issued in Anatomical Pathology the clinicians may access the information in one of three ways:&nbsp;</p>\r\n<p>1. Electronically&nbsp;</p>\r\n<p>2. Printed paper copy&nbsp;</p>\r\n<p>3. Orally from the Pathologist&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>In case of a supplementary report further information is expected to be relayed at a later date and this would be taken in to consideration when management decisions are made for the patient. In case of amended reports there is an unexpected correction of the error in the information contained in the original reports &ndash; this correction requires to be communicated by all of the three ways mentioned above. It is possible that in the meantime management decisions may have been made on the basis of &ldquo;erroneous information contained in the original report&rdquo; hence for medicolegal purposes the content of the original report should not be altered in any way except by way of addition that details the additional information or the error correction clearly.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>5.<span style=\"white-space: pre;\"> </span>Managing Records kept on the basis of this document</p>\r\n<p>All records supporting this policy shall be kept in the FNQH Pathology document management system in the location, or system based, indicated in the procedure document. Any additional or deleted records shall be kept account of in the FNQH Pathology logging system so that any future enquiry will be able to clearly identify when the changes occurred, who made them, what these changes were and how they were were approved.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>6.<span style=\"white-space: pre;\"> </span>Validity and Document Management</p>\r\n<p>This document is valid from the date of its approval and will be reviewed on an annual basis. The current working copy will be identified as such, and any superseded documents will be archived and maintained for a period of five years.</p>\r\n<p>&nbsp;</p>\r\n<p>New versions will be identified with a versioning number. Full integers will denote a major document version, and a decimal number will indicate minor amendments or edits.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>',	'',	'FNQH - Digital first, better patient outcomes',	4,	'',	'',	1,	0,	453,	'2022-09-07 15:44:16'),
(13,	'RFNQH-SOP-A030622',	'FNQH Pathology Risk Management and Assessment SOP [INTERNAL] V1.0',	453,	12,	0,	'2022-09-07',	'2022-07-27',	1,	1,	'TBC',	0,	12,	'2023-07-27',	'2022-07-27',	'Sarah Sharpe',	'',	'<div class=\"WordSection1\">\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<h1 style=\"text-align: right;\" align=\"right\"><a name=\"_Toc108792078\"></a><span lang=\"EN-AU\">Risk Management and Assessment</span></h1>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">Standard Operating Procedure</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">INTERNAL</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">Status: FINAL</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">Version:<span style=\"mso-spacerun: yes;\">&nbsp; </span>1.0</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">Issue Date: 27.07.22 </span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">Document ID:</span><span lang=\"EN-AU\" style=\"font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; layout-grid-mode: line;\"> </span><span lang=\"EN-US\" style=\"font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; layout-grid-mode: line;\">RFNQH-SOP-A030622</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<table class=\"MsoNormalTable\" style=\"border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt;\" border=\"1\" cellspacing=\"0\" cellpadding=\"0\">\r\n<tbody>\r\n<tr style=\"mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes;\">\r\n<td style=\"width: 459.0pt; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"566\">\r\n<p class=\"Copyright\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"Copyright\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</span></p>\r\n<p class=\"Copyright\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"Copyright\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology <span style=\"mso-spacerun: yes;\">&nbsp;</span>does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</span></p>\r\n<p class=\"Copyright\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<h1><a name=\"_Toc108792079\"></a><a name=\"_Toc43193944\"></a><a name=\"_Toc71611337\"></a><a name=\"_Toc71222248\"></a><span style=\"mso-bookmark: _Toc71611337;\"><span style=\"mso-bookmark: _Toc43193944;\"><span style=\"mso-bookmark: _Toc108792079;\"><span lang=\"EN-AU\">About This Document</span></span></span></span></h1>\r\n<p class=\"NoNumberH2\"><a name=\"_Toc523115044\"></a><a name=\"_Toc523114837\"></a><a name=\"_Toc522698780\"></a><a name=\"_Toc522695162\"></a><a name=\"_Toc71222256\"></a><a name=\"_Toc41806967\"></a><a name=\"_Toc523115040\"></a><a name=\"_Toc523114833\"></a><a name=\"_Toc522698776\"></a><a name=\"_Toc522695158\"></a><a name=\"_Toc108792080\"></a><a name=\"_Toc43193945\"></a><span style=\"mso-bookmark: _Toc108792080;\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: Arial; font-style: normal; mso-bidi-font-style: italic;\">Document Control</span></span></span></span></span></span></span></span></span></span></span></span></p>\r\n<table class=\"MsoNormalTable\" style=\"border-collapse: collapse; border: none; mso-border-top-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-border-insideh: .5pt solid black; mso-border-insidev: .5pt solid black;\" border=\"1\" cellspacing=\"0\" cellpadding=\"0\">\r\n<tbody>\r\n<tr style=\"mso-yfti-irow: 0; mso-yfti-firstrow: yes;\">\r\n<td style=\"width: 118.8pt; border: solid black 1.0pt; border-left: none; mso-border-top-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; mso-border-right-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"152\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Document ID:</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 345.6pt; border-top: solid black 1.0pt; border-left: none; border-bottom: solid black 1.0pt; border-right: none; mso-border-left-alt: solid black .5pt; mso-border-top-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"415\">\r\n<p class=\"FirstPage1\" style=\"text-align: left;\" align=\"left\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; layout-grid-mode: line;\">RFNQH-SOP-A030622</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 1;\">\r\n<td style=\"width: 118.8pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; mso-border-right-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"152\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Version Number:</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 345.6pt; border: none; border-bottom: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"415\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">V1.0</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 2;\">\r\n<td style=\"width: 118.8pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; mso-border-right-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"152\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Date of Version:</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 345.6pt; border: none; border-bottom: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"415\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">27.07.22</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 3;\">\r\n<td style=\"width: 118.8pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; mso-border-right-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"152\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Created by:</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 345.6pt; border: none; border-bottom: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"415\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Sarah Sharpe</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 4;\">\r\n<td style=\"width: 118.8pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; mso-border-right-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"152\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Approved by:</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 345.6pt; border: none; border-bottom: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"415\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Fiona Makowski</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 5; mso-yfti-lastrow: yes;\">\r\n<td style=\"width: 118.8pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; mso-border-right-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"152\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Confidentiality Level:</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 345.6pt; border: none; border-bottom: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"415\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">TBC</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<p class=\"NoNumberH2\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><a name=\"_Toc108792081\"></a><a name=\"_Toc43193946\"></a><span style=\"mso-bookmark: _Toc108792081;\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: Arial; font-style: normal; mso-bidi-font-style: italic;\">Document History</span></span></span></span></span></span></span></span></span></span></span></span></p>\r\n<table class=\"MsoNormalTable\" style=\"border-collapse: collapse; border: none; mso-border-alt: solid black .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-border-insideh: .5pt solid black; mso-border-insidev: .5pt solid black;\" border=\"1\" cellspacing=\"0\" cellpadding=\"0\">\r\n<tbody>\r\n<tr style=\"mso-yfti-irow: 0; mso-yfti-firstrow: yes;\">\r\n<td style=\"width: 63.4pt; border: solid black 1.0pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"84\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Date of Edit</span></strong></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 65.85pt; border: solid black 1.0pt; border-left: none; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"87\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Version</span></strong></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 90.05pt; border: solid black 1.0pt; border-left: none; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"118\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Edited by</span></strong></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 212.65pt; border: solid black 1.0pt; border-left: none; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"276\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Description of change </span></strong></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 1;\">\r\n<td style=\"width: 63.4pt; border: solid black 1.0pt; border-top: none; mso-border-top-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"84\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">03/06/22</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 65.85pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"87\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">V0.1</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 90.05pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"118\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Sarah Sharpe</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 212.65pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"276\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">First Draft</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 2;\">\r\n<td style=\"width: 63.4pt; border: solid black 1.0pt; border-top: none; mso-border-top-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"84\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">30/06/22</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 65.85pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"87\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">V0.2</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 90.05pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"118\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Fiona Makowski</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 212.65pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"276\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Review and Edits</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 3;\">\r\n<td style=\"width: 63.4pt; border: solid black 1.0pt; border-top: none; mso-border-top-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"84\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">03/07/22</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 65.85pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"87\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">V0.3</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 90.05pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"118\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Sarah Sharpe</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 212.65pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"276\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Review and accept edits</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 4; mso-yfti-lastrow: yes;\">\r\n<td style=\"width: 63.4pt; border: solid black 1.0pt; border-top: none; mso-border-top-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"84\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">27/07/22</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 65.85pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"87\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">V1.0</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 90.05pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"118\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Fiona Makoswki</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 212.65pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"276\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Review and Approve</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\" style=\"text-align: left;\" align=\"left\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"MsoTocHeading\"><span lang=\"EN-US\">Contents</span></p>\r\n<p class=\"MsoToc1\"><!-- [if supportFields]><span lang=EN-AU><span\r\n style=\'mso-element:field-begin\'></span><span\r\n style=\'mso-spacerun:yes\'></span>TOC \\o \"1-3\" \\h \\z \\u <span\r\n style=\'mso-element:field-separator\'></span></span><![endif]--><span lang=\"EN-AU\"><a href=\"file://ukfd-fsclstr-02/HomeDrives$/3040.3/Downloads/FNQH%20QM%20docs/FNQH%20Pathology%20Risk%20Management%20and%20Assessment%20SOP%20%5bINTERNAL%5d%20V1.0.docx#_Toc108792078\"><span style=\"mso-no-proof: yes;\">Risk Management and Assessment</span><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1 dotted;\"> </span></span><!-- [if supportFields]><span\r\n style=\'color:windowtext;display:none;mso-hide:screen;mso-no-proof:yes;\r\n text-decoration:none;text-underline:none\'><span style=\'mso-element:field-begin\'></span>\r\n PAGEREF _Toc108792078 \\h <span style=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\">1<!-- [if gte mso 9]><xml>\r\n  <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300038003700390032003000370038000000</w:data>\r\n </xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\n display:none;mso-hide:screen;mso-no-proof:yes;text-decoration:none;text-underline:\r\n none\'><span style=\'mso-element:field-end\'></span></span><![endif]--></a></span></p>\r\n<p class=\"MsoToc1\"><span lang=\"EN-AU\"><a href=\"file://ukfd-fsclstr-02/HomeDrives$/3040.3/Downloads/FNQH%20QM%20docs/FNQH%20Pathology%20Risk%20Management%20and%20Assessment%20SOP%20%5bINTERNAL%5d%20V1.0.docx#_Toc108792079\"><span style=\"mso-no-proof: yes;\">About This Document</span><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1 dotted;\"> </span></span><!-- [if supportFields]><span\r\n style=\'color:windowtext;display:none;mso-hide:screen;mso-no-proof:yes;\r\n text-decoration:none;text-underline:none\'><span style=\'mso-element:field-begin\'></span>\r\n PAGEREF _Toc108792079 \\h <span style=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\">2<!-- [if gte mso 9]><xml>\r\n  <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300038003700390032003000370039000000</w:data>\r\n </xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\n display:none;mso-hide:screen;mso-no-proof:yes;text-decoration:none;text-underline:\r\n none\'><span style=\'mso-element:field-end\'></span></span><![endif]--></a></span></p>\r\n<p class=\"MsoToc2\"><span lang=\"EN-AU\"><a href=\"file://ukfd-fsclstr-02/HomeDrives$/3040.3/Downloads/FNQH%20QM%20docs/FNQH%20Pathology%20Risk%20Management%20and%20Assessment%20SOP%20%5bINTERNAL%5d%20V1.0.docx#_Toc108792080\"><span style=\"mso-bidi-font-style: italic; mso-no-proof: yes;\">Document Control</span><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1 dotted;\"> </span></span><!-- [if supportFields]><span\r\n style=\'color:windowtext;display:none;mso-hide:screen;mso-no-proof:yes;\r\n text-decoration:none;text-underline:none\'><span style=\'mso-element:field-begin\'></span>\r\n PAGEREF _Toc108792080 \\h <span style=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\">2<!-- [if gte mso 9]><xml>\r\n  <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300038003700390032003000380030000000</w:data>\r\n </xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\n display:none;mso-hide:screen;mso-no-proof:yes;text-decoration:none;text-underline:\r\n none\'><span style=\'mso-element:field-end\'></span></span><![endif]--></a></span></p>\r\n<p class=\"MsoToc2\"><span lang=\"EN-AU\"><a href=\"file://ukfd-fsclstr-02/HomeDrives$/3040.3/Downloads/FNQH%20QM%20docs/FNQH%20Pathology%20Risk%20Management%20and%20Assessment%20SOP%20%5bINTERNAL%5d%20V1.0.docx#_Toc108792081\"><span style=\"mso-bidi-font-style: italic; mso-no-proof: yes;\">Document History</span><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1 dotted;\">. </span></span><!-- [if supportFields]><span\r\n style=\'color:windowtext;display:none;mso-hide:screen;mso-no-proof:yes;\r\n text-decoration:none;text-underline:none\'><span style=\'mso-element:field-begin\'></span>\r\n PAGEREF _Toc108792081 \\h <span style=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\">2<!-- [if gte mso 9]><xml>\r\n  <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300038003700390032003000380031000000</w:data>\r\n </xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\n display:none;mso-hide:screen;mso-no-proof:yes;text-decoration:none;text-underline:\r\n none\'><span style=\'mso-element:field-end\'></span></span><![endif]--></a></span></p>\r\n<p class=\"MsoToc2\" style=\"tab-stops: 44.0pt right dotted 453.35pt;\"><span lang=\"EN-AU\"><a href=\"file://ukfd-fsclstr-02/HomeDrives$/3040.3/Downloads/FNQH%20QM%20docs/FNQH%20Pathology%20Risk%20Management%20and%20Assessment%20SOP%20%5bINTERNAL%5d%20V1.0.docx#_Toc108792082\"><span style=\"mso-no-proof: yes;\">1.</span><span style=\"mso-bidi-font-size: 11.0pt; font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: \'Times New Roman\'; mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Times New Roman\'; mso-bidi-theme-font: minor-bidi; color: windowtext; mso-fareast-language: EN-AU; mso-bidi-font-weight: normal; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style=\"mso-no-proof: yes;\">Introduction, Purpose Scope, &amp; Users</span><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1 dotted;\">. </span></span><!-- [if supportFields]><span\r\n style=\'color:windowtext;display:none;mso-hide:screen;mso-no-proof:yes;\r\n text-decoration:none;text-underline:none\'><span style=\'mso-element:field-begin\'></span>\r\n PAGEREF _Toc108792082 \\h <span style=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\">4<!-- [if gte mso 9]><xml>\r\n  <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300038003700390032003000380032000000</w:data>\r\n </xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\n display:none;mso-hide:screen;mso-no-proof:yes;text-decoration:none;text-underline:\r\n none\'><span style=\'mso-element:field-end\'></span></span><![endif]--></a></span></p>\r\n<p class=\"MsoToc2\" style=\"tab-stops: 44.0pt right dotted 453.35pt;\"><span lang=\"EN-AU\"><a href=\"file://ukfd-fsclstr-02/HomeDrives$/3040.3/Downloads/FNQH%20QM%20docs/FNQH%20Pathology%20Risk%20Management%20and%20Assessment%20SOP%20%5bINTERNAL%5d%20V1.0.docx#_Toc108792083\"><span style=\"mso-no-proof: yes;\">2.</span><span style=\"mso-bidi-font-size: 11.0pt; font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: \'Times New Roman\'; mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Times New Roman\'; mso-bidi-theme-font: minor-bidi; color: windowtext; mso-fareast-language: EN-AU; mso-bidi-font-weight: normal; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style=\"mso-no-proof: yes;\">Risk Management</span><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1 dotted;\"> </span></span><!-- [if supportFields]><span\r\n style=\'color:windowtext;display:none;mso-hide:screen;mso-no-proof:yes;\r\n text-decoration:none;text-underline:none\'><span style=\'mso-element:field-begin\'></span>\r\n PAGEREF _Toc108792083 \\h <span style=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\">4<!-- [if gte mso 9]><xml>\r\n  <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300038003700390032003000380033000000</w:data>\r\n </xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\n display:none;mso-hide:screen;mso-no-proof:yes;text-decoration:none;text-underline:\r\n none\'><span style=\'mso-element:field-end\'></span></span><![endif]--></a></span></p>\r\n<p class=\"MsoToc2\" style=\"tab-stops: 44.0pt right dotted 453.35pt;\"><span lang=\"EN-AU\"><a href=\"file://ukfd-fsclstr-02/HomeDrives$/3040.3/Downloads/FNQH%20QM%20docs/FNQH%20Pathology%20Risk%20Management%20and%20Assessment%20SOP%20%5bINTERNAL%5d%20V1.0.docx#_Toc108792084\"><span style=\"mso-no-proof: yes;\">3.</span><span style=\"mso-bidi-font-size: 11.0pt; font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: \'Times New Roman\'; mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Times New Roman\'; mso-bidi-theme-font: minor-bidi; color: windowtext; mso-fareast-language: EN-AU; mso-bidi-font-weight: normal; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style=\"mso-no-proof: yes;\">Preventive action</span><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1 dotted;\">. </span></span><!-- [if supportFields]><span\r\n style=\'color:windowtext;display:none;mso-hide:screen;mso-no-proof:yes;\r\n text-decoration:none;text-underline:none\'><span style=\'mso-element:field-begin\'></span>\r\n PAGEREF _Toc108792084 \\h <span style=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\">5<!-- [if gte mso 9]><xml>\r\n  <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300038003700390032003000380034000000</w:data>\r\n </xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\n display:none;mso-hide:screen;mso-no-proof:yes;text-decoration:none;text-underline:\r\n none\'><span style=\'mso-element:field-end\'></span></span><![endif]--></a></span></p>\r\n<p class=\"MsoToc2\" style=\"tab-stops: 44.0pt right dotted 453.35pt;\"><span lang=\"EN-AU\"><a href=\"file://ukfd-fsclstr-02/HomeDrives$/3040.3/Downloads/FNQH%20QM%20docs/FNQH%20Pathology%20Risk%20Management%20and%20Assessment%20SOP%20%5bINTERNAL%5d%20V1.0.docx#_Toc108792085\"><span style=\"mso-no-proof: yes;\">4.</span><span style=\"mso-bidi-font-size: 11.0pt; font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: \'Times New Roman\'; mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Times New Roman\'; mso-bidi-theme-font: minor-bidi; color: windowtext; mso-fareast-language: EN-AU; mso-bidi-font-weight: normal; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style=\"mso-no-proof: yes;\">Continual improvement</span><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1 dotted;\"> </span></span><!-- [if supportFields]><span\r\n style=\'color:windowtext;display:none;mso-hide:screen;mso-no-proof:yes;\r\n text-decoration:none;text-underline:none\'><span style=\'mso-element:field-begin\'></span>\r\n PAGEREF _Toc108792085 \\h <span style=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\">5<!-- [if gte mso 9]><xml>\r\n  <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300038003700390032003000380035000000</w:data>\r\n </xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\n display:none;mso-hide:screen;mso-no-proof:yes;text-decoration:none;text-underline:\r\n none\'><span style=\'mso-element:field-end\'></span></span><![endif]--></a></span></p>\r\n<p class=\"MsoToc2\" style=\"tab-stops: 44.0pt right dotted 453.35pt;\"><span lang=\"EN-AU\"><a href=\"file://ukfd-fsclstr-02/HomeDrives$/3040.3/Downloads/FNQH%20QM%20docs/FNQH%20Pathology%20Risk%20Management%20and%20Assessment%20SOP%20%5bINTERNAL%5d%20V1.0.docx#_Toc108792086\"><span style=\"mso-no-proof: yes;\">5.</span><span style=\"mso-bidi-font-size: 11.0pt; font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: \'Times New Roman\'; mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Times New Roman\'; mso-bidi-theme-font: minor-bidi; color: windowtext; mso-fareast-language: EN-AU; mso-bidi-font-weight: normal; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style=\"mso-no-proof: yes;\">References</span><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1 dotted;\">. </span></span><!-- [if supportFields]><span\r\n style=\'color:windowtext;display:none;mso-hide:screen;mso-no-proof:yes;\r\n text-decoration:none;text-underline:none\'><span style=\'mso-element:field-begin\'></span>\r\n PAGEREF _Toc108792086 \\h <span style=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\">6<!-- [if gte mso 9]><xml>\r\n  <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300038003700390032003000380036000000</w:data>\r\n </xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\n display:none;mso-hide:screen;mso-no-proof:yes;text-decoration:none;text-underline:\r\n none\'><span style=\'mso-element:field-end\'></span></span><![endif]--></a></span></p>\r\n<p class=\"MsoToc2\" style=\"tab-stops: 44.0pt right dotted 453.35pt;\"><span lang=\"EN-AU\"><a href=\"file://ukfd-fsclstr-02/HomeDrives$/3040.3/Downloads/FNQH%20QM%20docs/FNQH%20Pathology%20Risk%20Management%20and%20Assessment%20SOP%20%5bINTERNAL%5d%20V1.0.docx#_Toc108792087\"><span style=\"mso-no-proof: yes;\">6.</span><span style=\"mso-bidi-font-size: 11.0pt; font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: \'Times New Roman\'; mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Times New Roman\'; mso-bidi-theme-font: minor-bidi; color: windowtext; mso-fareast-language: EN-AU; mso-bidi-font-weight: normal; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style=\"mso-no-proof: yes;\">Managing Records kept on the basis of this document</span><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1 dotted;\"> </span></span><!-- [if supportFields]><span\r\n style=\'color:windowtext;display:none;mso-hide:screen;mso-no-proof:yes;\r\n text-decoration:none;text-underline:none\'><span style=\'mso-element:field-begin\'></span>\r\n PAGEREF _Toc108792087 \\h <span style=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\">6<!-- [if gte mso 9]><xml>\r\n  <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300038003700390032003000380037000000</w:data>\r\n </xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\n display:none;mso-hide:screen;mso-no-proof:yes;text-decoration:none;text-und				--></a',	'',	'FNQH Pathology- Digital first, better patient outcomes',	4,	'',	'',	1,	0,	453,	'2022-09-07 15:47:07'),
(14,	'FNQH-SOP-030622',	'FNQH Pathology Temperature Monitoring SOP [INTERNAL] V1.1',	453,	12,	0,	'2022-09-07',	'2022-06-03',	1,	1,	'TBC',	0,	12,	'2023-06-03',	'2022-08-09',	'Sarah Sharpe',	'<p><span style=\"color: #1f1f1f; font-size: 16px; background-color: #f5f5f5;\">Disclaimer</span></p>',	'<p><span style=\"color: #1f1f1f; font-size: 16px; background-color: #f5f5f5;\">Content</span></p>',	'<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span><span style=\"background-color: #f5f5f5; color: #1f1f1f; font-size: 16px;\">Information</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-size: 16.0pt; mso-bidi-font-size: 10.0pt; font-family: \'Century Gothic\',sans-serif; mso-bidi-font-family: Arial;\">Temperature Monitoring </span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-size: 16.0pt; mso-bidi-font-size: 10.0pt; font-family: \'Century Gothic\',sans-serif; mso-bidi-font-family: Arial;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">Standard Operating Procedure</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">INTERNAL</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">Status:<span style=\"mso-spacerun: yes;\">&nbsp; </span>FINAL</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">Version:<span style=\"mso-spacerun: yes;\">&nbsp; </span>1.01</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">Issue Date: 03.06.22 </span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">Document ID:<span style=\"mso-spacerun: yes;\">&nbsp; </span>FNQH-SOP-TM030622</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<table class=\"MsoNormalTable\" style=\"border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt;\" border=\"1\" cellspacing=\"0\" cellpadding=\"0\">\r\n<tbody>\r\n<tr style=\"mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes;\">\r\n<td style=\"width: 459.0pt; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"566\">\r\n<p class=\"Copyright\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"Copyright\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</span></p>\r\n<p class=\"Copyright\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"Copyright\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</span></p>\r\n<p class=\"Copyright\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<h1><a name=\"_Toc107744027\"></a><a name=\"_Toc43193944\"></a><a name=\"_Toc71611337\"></a><a name=\"_Toc71222248\"></a><span style=\"mso-bookmark: _Toc71611337;\"><span style=\"mso-bookmark: _Toc43193944;\"><span style=\"mso-bookmark: _Toc107744027;\"><span lang=\"EN-AU\">About This Document</span></span></span></span></h1>\r\n<p class=\"NoNumberH2\"><a name=\"_Toc523115044\"></a><a name=\"_Toc523114837\"></a><a name=\"_Toc522698780\"></a><a name=\"_Toc522695162\"></a><a name=\"_Toc71222256\"></a><a name=\"_Toc41806967\"></a><a name=\"_Toc523115040\"></a><a name=\"_Toc523114833\"></a><a name=\"_Toc522698776\"></a><a name=\"_Toc522695158\"></a><a name=\"_Toc107744028\"></a><a name=\"_Toc43193945\"></a><span style=\"mso-bookmark: _Toc107744028;\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: Arial; font-style: normal; mso-bidi-font-style: italic;\">Document Control</span></span></span></span></span></span></span></span></span></span></span></span></p>\r\n<table class=\"MsoNormalTable\" style=\"border-collapse: collapse; border: none; mso-border-top-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-border-insideh: .5pt solid black; mso-border-insidev: .5pt solid black;\" border=\"1\" cellspacing=\"0\" cellpadding=\"0\">\r\n<tbody>\r\n<tr style=\"mso-yfti-irow: 0; mso-yfti-firstrow: yes;\">\r\n<td style=\"width: 118.8pt; border: solid black 1.0pt; border-left: none; mso-border-top-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; mso-border-right-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"152\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Document ID:</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 345.6pt; border-top: solid black 1.0pt; border-left: none; border-bottom: solid black 1.0pt; border-right: none; mso-border-left-alt: solid black .5pt; mso-border-top-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"415\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">FNQH-SOP-030622</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 1;\">\r\n<td style=\"width: 118.8pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; mso-border-right-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"152\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Version Number:</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 345.6pt; border: none; border-bottom: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"415\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">V1.0</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 2;\">\r\n<td style=\"width: 118.8pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; mso-border-right-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"152\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Date of Version:</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 345.6pt; border: none; border-bottom: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"415\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">3 June 2022</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 3;\">\r\n<td style=\"width: 118.8pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; mso-border-right-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"152\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Created by:</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 345.6pt; border: none; border-bottom: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"415\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Sarah Sharpe</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 4;\">\r\n<td style=\"width: 118.8pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; mso-border-right-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"152\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Approved by:</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 345.6pt; border: none; border-bottom: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"415\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Fiona Makowski</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 5; mso-yfti-lastrow: yes;\">\r\n<td style=\"width: 118.8pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; mso-border-right-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"152\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Confidentiality Level:</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n<td style=\"width: 345.6pt; border: none; border-bottom: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"415\">\r\n<p class=\"MsoNormal\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">TBC</span></span></span></span></span></span></span></span></span></span></span></p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<p class=\"NoNumberH2\"><span style=\"mso-bookmark: _Toc522695158;\"><span style=\"mso-bookmark: _Toc522698776;\"><span style=\"mso-bookmark: _Toc523114833;\"><span style=\"mso-bookmark: _Toc523115040;\"><span style=\"mso-bookmark: _Toc41806967;\"><span style=\"mso-bookmark: _Toc71222256;\"><span style=\"mso-bookmark: _Toc522695162;\"><span style=\"mso-bookmark: _Toc522698780;\"><span style=\"mso-bookmark: _Toc523114837;\"><span style=\"mso-bookmark: _Toc523115044;\"><a name=\"_Toc107744029\"></a><a name=\"_Toc43193946\"></a><span style=\"mso-bookmark: _Toc107744029;\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: Arial; font-style: normal; mso-bidi-font-style: italic;\">Document History</span></span></span></span></span></span></span></span></span></span></span></span></p>\r\n<table class=\"MsoNormalTable\" style=\"border-collapse: collapse; border: none; mso-border-alt: solid black .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-border-insideh: .5pt solid black; mso-border-insidev: .5pt solid black;\" border=\"1\" cellspacing=\"0\" cellpadding=\"0\">\r\n<tbody>\r\n<tr style=\"mso-yfti-irow: 0; mso-yfti-firstrow: yes;\">\r\n<td style=\"width: 63.4pt; border: solid black 1.0pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"85\">\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Date of Edit</span></strong></p>\r\n</td>\r\n<td style=\"width: 65.85pt; border: solid black 1.0pt; border-left: none; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"87\">\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Version</span></strong></p>\r\n</td>\r\n<td style=\"width: 90.05pt; border: solid black 1.0pt; border-left: none; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"118\">\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Edited by</span></strong></p>\r\n</td>\r\n<td style=\"width: 212.65pt; border: solid black 1.0pt; border-left: none; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"276\">\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Description of change </span></strong></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 1;\">\r\n<td style=\"width: 63.4pt; border: solid black 1.0pt; border-top: none; mso-border-top-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"85\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">03/06/22</span></p>\r\n</td>\r\n<td style=\"width: 65.85pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"87\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">V0.1</span></p>\r\n</td>\r\n<td style=\"width: 90.05pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"118\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Sarah Sharpe</span></p>\r\n</td>\r\n<td style=\"width: 212.65pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"276\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Initial Draft</span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 2;\">\r\n<td style=\"width: 63.4pt; border: solid black 1.0pt; border-top: none; mso-border-top-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"85\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">01/07/22</span></p>\r\n</td>\r\n<td style=\"width: 65.85pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"87\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">V0.2</span></p>\r\n</td>\r\n<td style=\"width: 90.05pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"118\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Fiona Makowski</span></p>\r\n</td>\r\n<td style=\"width: 212.65pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"276\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Review and edits</span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 3;\">\r\n<td style=\"width: 63.4pt; border: solid black 1.0pt; border-top: none; mso-border-top-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"85\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">03/07/22</span></p>\r\n</td>\r\n<td style=\"width: 65.85pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"87\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">V0.3</span></p>\r\n</td>\r\n<td style=\"width: 90.05pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"118\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Sarah Sharpe</span></p>\r\n</td>\r\n<td style=\"width: 212.65pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"276\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Review and accepted edits</span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 4;\">\r\n<td style=\"width: 63.4pt; border: solid black 1.0pt; border-top: none; mso-border-top-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"85\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">15/07/22</span></p>\r\n</td>\r\n<td style=\"width: 65.85pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"87\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">V1.0</span></p>\r\n</td>\r\n<td style=\"width: 90.05pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"118\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Fiona Makowski</span></p>\r\n</td>\r\n<td style=\"width: 212.65pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"276\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Review and Approved</span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 5; mso-yfti-lastrow: yes;\">\r\n<td style=\"width: 63.4pt; border: solid black 1.0pt; border-top: none; mso-border-top-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"85\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">09/08/2022</span></p>\r\n</td>\r\n<td style=\"width: 65.85pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"87\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">V1.1</span></p>\r\n</td>\r\n<td style=\"width: 90.05pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"118\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Larissa McLeod</span></p>\r\n</td>\r\n<td style=\"width: 212.65pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"276\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">Minor edits</span></p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">&nbsp;</span></p>\r\n<p><span lang=\"EN-US\" style=\"font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: \'Times New Roman\'; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; layout-grid-mode: line;\">&nbsp;</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\" style=\"mso-ansi-language: EN-US;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\" style=\"text-align: left;\" align=\"left\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"FirstPage1\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"MsoTocHeading\"><span lang=\"EN-US\">Contents</span></p>\r\n<p class=\"MsoToc1\"><!-- [if supportFields]><span lang=EN-AU><span\r\n style=\'mso-element:field-begin\'></span><span\r\n style=\'mso-spacerun:yes\'></span>TOC \\o \"1-3\" \\h \\z \\u <span\r\n style=\'mso-element:field-separator\'></span></span><![endif]--><span lang=\"EN-AU\"><a href=\"file://ukfd-fsclstr-02/HomeDrives$/3040.3/Downloads/FNQH%20QM%20docs/FNQH%20Pathology%20Temperature%20Monitoring%20SOP%20%5bINTERNAL%5d%20V1.1.docx#_Toc107744027\"><span style=\"mso-no-proof: yes;\">About This Document</span><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1 dotted;\"> </span></span><!-- [if supportFields]><span\r\n style=\'color:windowtext;display:none;mso-hide:screen;mso-no-proof:yes;\r\n text-decoration:none;text-underline:none\'><span style=\'mso-element:field-begin\'></span>\r\n PAGEREF _Toc107744027 \\h <span style=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\">2<!-- [if gte mso 9]><xml>\r\n  <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300037003700340034003000320037000000</w:data>\r\n </xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\n display:none;mso-hide:screen;mso-no-proof:yes;text-decoration:none;text-underline:\r\n none\'><span style=\'mso-element:field-end\'></span></span><![endif]--></a></span></p>\r\n<p class=\"MsoToc2\"><span lang=\"EN-AU\"><a href=\"file://ukfd-fsclstr-02/HomeDrives$/3040.3/Downloads/FNQH%20QM%20docs/FNQH%20Pathology%20Temperature%20Monitoring%20SOP%20%5bINTERNAL%5d%20V1.1.docx#_Toc107744028\"><span style=\"mso-bidi-font-style: italic; mso-no-proof: yes;\">Document Control</span><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1 dotted;\"> </span></span><!-- [if supportFields]><span\r\n style=\'color:windowtext;display:none;mso-hide:screen;mso-no-proof:yes;\r\n text-decoration:none;text-underline:none\'><span style=\'mso-element:field-begin\'></span>\r\n PAGEREF _Toc107744028 \\h <span style=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\">2<!-- [if gte mso 9]><xml>\r\n  <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300037003700340034003000320038000000</w:data>\r\n </xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\n display:none;mso-hide:screen;mso-no-proof:yes;text-decoration:none;text-underline:\r\n none\'><span style=\'mso-element:field-end\'></span></span><![endif]--></a></span></p>\r\n<p class=\"MsoToc2\"><span lang=\"EN-AU\"><a href=\"file://ukfd-fsclstr-02/HomeDrives$/3040.3/Downloads/FNQH%20QM%20docs/FNQH%20Pathology%20Temperature%20Monitoring%20SOP%20%5bINTERNAL%5d%20V1.1.docx#_Toc107744029\"><span style=\"mso-bidi-font-style: italic; mso-no-proof: yes;\">Document History</span><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1 dotted;\">. </span></span><!-- [if supportFields]><span\r\n style=\'color:windowtext;display:none;mso-hide:screen;mso-no-proof:yes;\r\n text-decoration:none;text-underline:none\'><span style=\'mso-element:field-begin\'></span>\r\n PAGEREF _Toc107744029 \\h <span style=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\">2<!-- [if gte mso 9]><xml>\r\n  <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300037003700340034003000320039000000</w:data>\r\n </xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\n display:none;mso-hide:screen;mso-no-proof:yes;text-decoration:none;text-underline:\r\n none\'><span style=\'mso-element:field-end\'></span></span><![endif]--></a></span></p>\r\n<p class=\"MsoToc2\" style=\"tab-stops: 44.0pt right dotted 453.35pt;\"><span lang=\"EN-AU\"><a href=\"file://ukfd-fsclstr-02/HomeDrives$/3040.3/Downloads/FNQH%20QM%20docs/FNQH%20Pathology%20Temperature%20Monitoring%20SOP%20%5bINTERNAL%5d%20V1.1.docx#_Toc107744030\"><span style=\"mso-no-proof: yes;\">1.</span><span lang=\"EN-GB\" style=\"mso-bidi-font-size: 11.0pt; font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: \'Times New Roman\'; mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Times New Roman\'; mso-bidi-theme-font: minor-bidi; color: windowtext; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-font-weight: normal; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style=\"mso-no-proof: yes;\">Temperature Monitoring Policy</span><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1 dotted;\">. </span></span><!-- [if supportFields]><span\r\n style=\'color:windowtext;display:none;mso-hide:screen;mso-no-proof:yes;\r\n text-decoration:none;text-underline:none\'><span style=\'mso-element:field-begin\'></span>\r\n PAGEREF _Toc107744030 \\h <span style=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\">4<!-- [if gte mso 9]><xml>\r\n  <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300037003700340034003000330030000000</w:data>\r\n </xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\n display:none;mso-hide:screen;mso-no-proof:yes;text-decoration:none;text-underline:\r\n none\'><span style=\'mso-element:field-end\'></span></span><![endif]--></a></span></p>\r\n<p class=\"MsoToc2\" style=\"tab-stops: 44.0pt right dotted 453.35pt;\"><span lang=\"EN-AU\"><a href=\"file://ukfd-fsclstr-02/HomeDrives$/3040.3/Downloads/FNQH%20QM%20docs/FNQH%20Pathology%20Temperature%20Monitoring%20SOP%20%5bINTERNAL%5d%20V1.1.docx#_Toc107744031\"><span style=\"mso-no-proof: yes;\">2.</span><span lang=\"EN-GB\" style=\"mso-bidi-font-size: 11.0pt; font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: \'Times New Roman\'; mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Times New Roman\'; mso-bidi-theme-font: minor-bidi; color: windowtext; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-font-weight: normal; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style=\"mso-no-proof: yes;\">Temperature Monitoring Procedure</span><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1 dotted;\">. </span></span><!-- [if supportFields]><span\r\n style=\'color:windowtext;display:none;mso-hide:screen;mso-no-proof:yes;\r\n text-decoration:none;text-underline:none\'><span style=\'mso-element:field-begin\'></span>\r\n PAGEREF _Toc107744031 \\h <span style=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\">4<!-- [if gte mso 9]><xml>\r\n  <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300037003700340034003000330031000000</w:data>\r\n </xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\n display:none;mso-hide:screen;mso-no-proof:yes;text-decoration:none;text-underline:\r\n none\'><span style=\'mso-element:field-end\'></span></span><![endif]--></a></span></p>\r\n<p class=\"MsoToc2\" style=\"tab-stops: 44.0pt right dotted 453.35pt;\"><span lang=\"EN-AU\"><a href=\"file://ukfd-fsclstr-02/HomeDrives$/3040.3/Downloads/FNQH%20QM%20docs/FNQH%20Pathology%20Temperature%20Monitoring%20SOP%20%5bINTERNAL%5d%20V1.1.docx#_Toc107744032\"><span style=\"mso-no-proof: yes;\">3.</span><span lang=\"EN-GB\" style=\"mso-bidi-font-size: 11.0pt; font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: \'Times New Roman\'; mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Times New Roman\'; mso-bidi-theme-font: minor-bidi; color: windowtext; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-font-weight: normal; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style=\"mso-no-proof: yes;\">Managing Records kept on the basis of this document</span><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1 dotted;\"> </span></span><!-- [if supportFields]><span\r\n style=\'color:windowtext;display:none;mso-hide:screen;mso-no-proof:yes;\r\n text-decoration:none;text-underline:none\'><span style=\'mso-element:field-begin\'></span>\r\n PAGEREF _Toc107744032 \\h <span style=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\">5<!-- [if gte mso 9]><xml>\r\n  <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300037003700340034003000330032000000</w:data>\r\n </xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\n display:none;mso-hide:screen;mso-no-proof:yes;text-decoration:none;text-underline:\r\n none\'><span style=\'mso-element:field-end\'></span></span><![endif]--></a></span></p>\r\n<p class=\"MsoToc2\" style=\"tab-stops: 44.0pt right dotted 453.35pt;\"><span lang=\"EN-AU\"><a href=\"file://ukfd-fsclstr-02/HomeDrives$/3040.3/Downloads/FNQH%20QM%20docs/FNQH%20Pathology%20Temperature%20Monitoring%20SOP%20%5bINTERNAL%5d%20V1.1.docx#_Toc107744033\"><span style=\"mso-no-proof: yes;\">4.</span><span lang=\"EN-GB\" style=\"mso-bidi-font-size: 11.0pt; font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: \'Times New Roman\'; mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Times New Roman\'; mso-bidi-theme-font: minor-bidi; color: windowtext; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-font-weight: normal; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style=\"mso-no-proof: yes;\">Validity and Document Management</span><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1 dotted;\"> </span></span><!-- [if supportFields]><span\r\n style=\'color:windowtext;display:none;mso-hide:screen;mso-no-proof:yes;\r\n text-decoration:none;text-underline:none\'><span style=\'mso-element:field-begin\'></span>\r\n PAGEREF _Toc107744033 \\h <span style=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; mso-hide: screen; mso-no-proof: yes; text-decoration: none; text-underline: none;\">5<!-- [if gte mso 9]><xml>\r\n  <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300037003700340034003000330033000000</w:data>\r\n </xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\n display:none;mso-hide:screen;mso-no-proof:yes;text-decoration:none;text-underline:\r\n none\'><span style=\'mso-element:field-end\'></span></span><![endif]--></a></span></p>\r\n<p class=\"MsoNormal\"><!-- [if supportFields]><b><span lang=EN-AU\r\n style=\'mso-no-proof:yes\'><span style=\'mso-element:field-end\'></span></span></b><![endif]--><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<h1><span lang=\"EN-AU\" style=\"font-size: 11.0pt; font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">&nbsp;</span></h1>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<p><span lang=\"EN-AU\" style=\"font-size: 11.0pt; mso-bidi-font-size: 10.0pt; line-height: 107%; font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: \'Times New Roman\'; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-AU; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; layout-grid-mode: line;\">&nbsp;</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%; mso-pagination: widow-orphan;\"><span lang=\"EN-AU\" style=\"font-size: 16.0pt; mso-bidi-font-size: 10.0pt; line-height: 107%; font-family: \'Century Gothic\',sans-serif; mso-bidi-font-family: Arial; layout-grid-mode: both;\">&nbsp;</span></p>\r\n<h2 style=\"margin-left: 18.0pt; text-indent: -18.0pt; mso-list: l2 level1 lfo1;\"><a name=\"_Toc107744030\"></a><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"mso-fareast-font-family: \'Century Gothic\'; mso-bidi-font-family: \'Century Gothic\';\"><span style=\"mso-list: Ignore;\">1.<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\">Temperature Monitoring Policy</span></h2>\r\n<p class=\"MsoNormal\" style=\"line-height: 115%;\"><span lang=\"EN-AU\">This document is intended to document the Policy and Operating Procedures at FNQH Pathology for Temperature Monitoring and details the process steps and detailed instructions so that the relevant (authorised) team member can carry out the task correctly every time.</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: 115%;\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: 115%;\"><span lang=\"EN-AU\">This purpose of this document is to ensure the proper functioning of temperature dependent equipment and environments, such as refrigerators, freezers, heating blocks, water baths, incubators, and test-dependent ambient temperature, the temperatures will be taken daily, recorded, and acted upon in the event of failure. In the laboratories that are not operational every day, minimum and maximum temperatures will be recorded using a device designated for monitoring temperature over a period of days.</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<h2 style=\"margin-left: 18.0pt; text-indent: -18.0pt; mso-list: l2 level1 lfo1;\"><a name=\"_Toc107744031\"></a><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"mso-fareast-font-family: \'Century Gothic\'; mso-bidi-font-family: \'Century Gothic\';\"><span style=\"mso-list: Ignore;\">2.<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\">Temperature Monitoring Procedure</span></h2>\r\n<p class=\"MsoListParagraphCxSpFirst\" style=\"margin-left: 18.0pt; mso-add-space: auto; text-indent: -18.0pt; line-height: 115%; mso-list: l1 level1 lfo2;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: \'Calibri Light\'; mso-fareast-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\"><span style=\"mso-list: Ignore;\">1.<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">The temperature of each refrigerator, freezer, any walk-in refrigerator/freezer, or ambient/room temperature that affects testing should be taken daily, recorded, and initialed on an appropriate temperature log. The temperatures of heating blocks, water baths, and incubators, or ovens (when temperature control is necessary for a procedure) should be taken and recorded on each day of use. Record temperature readings on appropriate form. Acceptable ranges must be defined for all temperature dependent equipment or environments, in accordance with the manufacturer instructions.</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-left: 18.0pt; mso-add-space: auto; line-height: 115%;\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"margin-left: 18.0pt; mso-add-space: auto; text-indent: -18.0pt; line-height: 115%; mso-list: l1 level1 lfo2;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: \'Calibri Light\'; mso-fareast-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\"><span style=\"mso-list: Ignore;\">2.<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Minimum/maximum thermometers may be used in areas that do not provide testing each day.</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: 115%;\"><span lang=\"EN-AU\">Refrigerators, freezers, incubators; there must be evidence of corrective action taken if unacceptable temperatures are obtained on any piece of temperature dependent equipment.</span></p>\r\n<p class=\"MsoListParagraphCxSpFirst\" style=\"text-indent: -18.0pt; line-height: 115%; mso-list: l0 level1 lfo3;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: \'Calibri Light\'; mso-fareast-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\"><span style=\"mso-list: Ignore;\">A.<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">In areas where room temperature tests are performed or reagents are affected by temperature or humidity, the monitor must be recorded each day of testing. Record temperature or humidity of approved form. Document any corrective action.</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18.0pt; line-height: 115%; mso-list: l0 level1 lfo3;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: \'Calibri Light\'; mso-fareast-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\"><span style=\"mso-list: Ignore;\">B.<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Heating blocks or water baths: If unacceptable temperatures are obtained, do not use the equipment for testing,</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-left: 18.0pt; mso-add-space: auto; line-height: 115%;\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-left: 18.0pt; mso-add-space: auto; text-indent: -18.0pt; line-height: 115%; mso-list: l1 level1 lfo2;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: \'Calibri Light\'; mso-fareast-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\"><span style=\"mso-list: Ignore;\">3.<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Lab Administration is responsible for setting temperature limits for each device based on contents and regulatory standards.</span></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"margin-left: 18.0pt; mso-add-space: auto; line-height: 115%;\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">&nbsp;</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: 115%;\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<table class=\"MsoNormalTable\" style=\"margin-left: 5.85pt; border-collapse: collapse; mso-table-layout-alt: fixed; border: none; mso-border-alt: solid black .5pt; mso-yfti-tbllook: 480; mso-padding-alt: 0cm 0cm 0cm 0cm; mso-border-insideh: .5pt solid black; mso-border-insidev: .5pt solid black;\" border=\"1\" cellspacing=\"0\" cellpadding=\"0\">\r\n<tbody>\r\n<tr style=\"mso-yfti-irow: 0; mso-yfti-firstrow: yes; height: 11.4pt;\">\r\n<td style=\"width: 159.6pt; border: solid black 1.0pt; mso-border-alt: solid black .5pt; padding: 0cm 0cm 0cm 0cm; height: 11.4pt;\" valign=\"top\" width=\"213\">\r\n<p class=\"TableParagraph\" style=\"line-height: 10.45pt; mso-line-height-rule: exactly;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"font-size: 10.0pt; mso-bidi-font-size: 11.0pt;\">Asset<span style=\"letter-spacing: -.2pt;\"> type</span></span></strong></p>\r\n</td>\r\n<td style=\"width: 159.6pt; border: solid black 1.0pt; border-left: none; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 0cm 0cm 0cm; height: 11.4pt;\" valign=\"top\" width=\"213\">\r\n<p class=\"TableParagraph\" style=\"line-height: 10.45pt; mso-line-height-rule: exactly;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"font-size: 10.0pt; mso-bidi-font-size: 11.0pt;\">Temperature<span style=\"letter-spacing: -.55pt;\"> </span><span style=\"letter-spacing: -.1pt;\">Range</span></span></strong></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 1; height: 11.5pt;\">\r\n<td style=\"width: 159.6pt; border: solid black 1.0pt; border-top: none; mso-border-top-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 0cm 0cm 0cm; height: 11.5pt;\" valign=\"top\" width=\"213\">\r\n<p class=\"TableParagraph\" style=\"line-height: 10.5pt; mso-line-height-rule: exactly;\"><span style=\"font-size: 10.0pt; mso-bidi-font-size: 11.0pt;\">Laboratory<span style=\"letter-spacing: -.4pt;\"> </span><span style=\"letter-spacing: -.1pt;\">Refrigerator</span></span></p>\r\n</td>\r\n<td style=\"width: 159.6pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 0cm 0cm 0cm; height: 11.5pt;\" valign=\"top\" width=\"213\">\r\n<p class=\"TableParagraph\" style=\"line-height: 10.5pt; mso-line-height-rule: exactly;\"><span style=\"font-size: 10.0pt; mso-bidi-font-size: 11.0pt;\">2C<span style=\"letter-spacing: -.1pt;\"> </span>&ndash;<span style=\"letter-spacing: -.05pt;\"> </span><span style=\"letter-spacing: -.25pt;\">8C</span></span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 2; height: 11.5pt;\">\r\n<td style=\"width: 159.6pt; border: solid black 1.0pt; border-top: none; mso-border-top-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 0cm 0cm 0cm; height: 11.5pt;\" valign=\"top\" width=\"213\">\r\n<p class=\"TableParagraph\" style=\"line-height: 10.5pt; mso-line-height-rule: exactly;\"><span style=\"font-size: 10.0pt; mso-bidi-font-size: 11.0pt;\">Laboratory<span style=\"letter-spacing: -.4pt;\"> </span><span style=\"letter-spacing: -.1pt;\">Freezer</span></span></p>\r\n</td>\r\n<td style=\"width: 159.6pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 0cm 0cm 0cm; height: 11.5pt;\" valign=\"top\" width=\"213\">\r\n<p class=\"TableParagraph\" style=\"line-height: 10.5pt; mso-line-height-rule: exactly;\"><span style=\"font-size: 10.0pt; mso-bidi-font-size: 11.0pt;\">-30C<span style=\"letter-spacing: -.1pt;\"> </span>-<span style=\"letter-spacing: -.05pt;\"> </span>-<span style=\"letter-spacing: -.25pt;\">10C</span></span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 3; height: 11.5pt;\">\r\n<td style=\"width: 159.6pt; border: solid black 1.0pt; border-top: none; mso-border-top-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 0cm 0cm 0cm; height: 11.5pt;\" valign=\"top\" width=\"213\">\r\n<p class=\"TableParagraph\" style=\"line-height: 10.5pt; mso-line-height-rule: exactly;\"><span style=\"font-size: 10.0pt; mso-bidi-font-size: 11.0pt;\">Laboratory<span style=\"letter-spacing: -.5pt;\"> </span><span style=\"letter-spacing: -.1pt;\">Incubator</span></span></p>\r\n</td>\r\n<td style=\"width: 159.6pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 0cm 0cm 0cm; height: 11.5pt;\" valign=\"top\" width=\"213\">\r\n<p class=\"TableParagraph\" style=\"line-height: 10.5pt; mso-line-height-rule: exactly;\"><span style=\"font-size: 10.0pt; mso-bidi-font-size: 11.0pt;\">28C<span style=\"letter-spacing: -.1pt;\"> </span>&ndash;<span style=\"letter-spacing: -.05pt;\"> </span><span style=\"letter-spacing: -.25pt;\">38C</span></span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 4; mso-yfti-lastrow: yes; height: 11.5pt;\">\r\n<td style=\"width: 159.6pt; border: solid black 1.0pt; border-top: none; mso-border-top-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 0cm 0cm 0cm; height: 11.5pt;\" valign=\"top\" width=\"213\">\r\n<p class=\"TableParagraph\" style=\"line-height: 10.5pt; mso-line-height-rule: exactly;\"><span style=\"font-size: 10.0pt; mso-bidi-font-size: 11.0pt;\">Blood<span style=\"letter-spacing: -.15pt;\"> </span>Bank<span style=\"letter-spacing: -.1pt;\"> Refrigerator</span></span></p>\r\n</td>\r\n<td style=\"width: 159.6pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 0cm 0cm 0cm; height: 11.5pt;\" valign=\"top\" width=\"213\">\r\n<p class=\"TableParagraph\" style=\"line-height: 10.5pt; mso-line-height-rule: exactly;\"><span style=\"font-size: 10.0pt; mso-bidi-font-size: 11.0pt;\">1C<span style=\"letter-spacing: -.1pt;\"> </span>&ndash;<span style=\"letter-spacing: -.05pt;\"> </span><span style=\"letter-spacing: -.25pt;\">6C</span></span></p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"mso-bidi-font-size: 11.0pt; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; layout-grid-mode: both;\">&nbsp;</span></p>\r\n<p class=\"MsoListParagraph\" style=\"mso-add-space: auto; text-align: justify; text-indent: -18.0pt; mso-list: l1 level1 lfo2; tab-stops: 83.0pt; text-autospace: none; margin: 4.5pt 32.75pt 8.0pt 18.0pt;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: \'Calibri Light\'; mso-fareast-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\"><span style=\"mso-list: Ignore;\">4.<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!---				--></p>',	'FNQH Pathology - Digital first, better patient outcomes',	4,	'',	'',	1,	0,	453,	'2022-09-07 15:48:55'),
(16,	'FNQH-POL-AD080722',	'ALCOHOL AND DRUG POLICY',	453,	12,	0,	'2022-08-19',	'2022-09-15',	0,	1,	'TCB',	0,	12,	'2023-09-15',	'2022-09-15',	'Sarah Sharpe',	'<p class=\"MsoNormal\"><span style=\"font-size: 13.5pt; line-height: 107%; font-family: Arial, sans-serif;\">This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</span></p>\r\n<p class=\"MsoNormal\"><span style=\"font-size: 13.5pt; line-height: 107%; font-family: Arial, sans-serif;\">&nbsp;</span></p>\r\n<p>&nbsp;</p>\r\n<p class=\"MsoNormal\"><span style=\"font-size: 13.5pt; line-height: 107%; font-family: Arial, sans-serif;\">Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</span></p>',	'<p>1.1. ALCOHOL &amp; DRUGS POLICY</p>\r\n<p>FNQH Pathology (\"the Company\") provides a work environment which aims to ensure the health, safety,&nbsp;respect and productivity of all employees. The Company acknowledges that the use of drugs and alcohol&nbsp;may impair an individual\'s capacity to perform their job safely, efficiently and with respect for work&nbsp;colleagues and customers.</p>\r\n<p>The use of such substances may result in the risk of injury or a threat to the wellbeing of the impaired&nbsp;employee, other employees, and customers as well as members of the public.</p>\r\n<p>The Company has an obligation under work health and safety legislation to provide a safe work&nbsp;environment.</p>\r\n<p>The purpose of this policy is to maintain a work environment that is free from the negative effects of drug&nbsp;and alcohol use.</p>\r\n<p>The Company policy is that employees must not be under the influence of alcohol or drugs when&nbsp;performing any work duties for the Company, at the workplace or otherwise, including (but not limited&nbsp;to) the circumstances set out below. Employees must not commence work or return to work whilst under&nbsp;the influence of alcohol or drugs.</p>\r\n<p>The consequences of breaching this policy will include disciplinary action up to and including termination&nbsp;of employment.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and&nbsp;do not give rise to any contractual rights. To the extent that this policy describes benefits and&nbsp;entitlements for employees, they are discretionary in nature and are also not intended to be contractual.</p>\r\n<p>The terms and conditions of employment that are intended to be contractual are set out in your written&nbsp;employment contract.&nbsp;The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>',	'',	'FNQH-POL-AD080722 [INTERNAL]',	4,	'',	'',	0,	0,	453,	'2022-09-15 20:52:08'),
(17,	'FNQH-POL-CC080722',	'CODE OF CONDUCT POLICY',	453,	12,	10,	'2022-08-19',	'2022-09-15',	0,	1,	'TCB',	0,	12,	'2023-09-15',	'2022-09-15',	'Sarah Sharpe',	'<p>This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</p>\r\n<p>&nbsp;</p>\r\n<p>Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</p>\r\n<p>&nbsp;</p>',	'<p>1.1. CODE OF CONDUCT POLICY</p>\r\n<p>At FNQH Pathology (\"the Company\") we require that all of our employees conduct themselves according&nbsp;to the highest standards of ethics, integrity, and behaviour when dealing with our clients, colleagues and&nbsp;other stakeholders. This includes, but is not necessarily limited to, full compliance with all legal&nbsp;obligations imposed by statute or any other source of law.</p>\r\n<p>This Code establishes the standards of behaviour that must be met by all employees. Where these&nbsp;standards are not met, appropriate disciplinary action will be taken. In cases where the breach involves&nbsp;serious misconduct, this may result in summary dismissal. In cases where a breach of the policy involves a&nbsp;breach of any law, then the relevant government authorities or the police may be notified.</p>\r\n<p>1.1.1. OPERATION</p>\r\n<p>The purpose of this policy is to make it clear what the Company expects from employees, and employees&nbsp;are required to be familiar with and comply with the terms of this policy at all times. Failure to do so may&nbsp;result in disciplinary action, including potentially termination of employment.&nbsp;In so far as this policy imposes any obligations on the Company, those obligations are not contractual and&nbsp;do not give rise to any contractual rights. To the extent that this policy describes benefits and&nbsp;entitlements for employees, they are discretionary in nature and are also not intended to be contractual.</p>\r\n<p>The terms and conditions of employment that are intended to be contractual out in an employee&rsquo;s&nbsp;written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1.2. STANDARDS OF CONDUCT</p>\r\n<p>The standards expected of employees include:</p>\r\n<p>1. Compliance with all Company and workplace policies, procedures, rules, regulations and&nbsp;contracts.</p>\r\n<p>2. Compliance with all laws;</p>\r\n<p>3. Compliance with all reasonable and lawful instructions given by or on behalf of the Company;</p>\r\n<p>4. Devotion of the employee&rsquo;s entire time, attention and skill during normal working hours and at&nbsp;other times as reasonably necessary for the employee to perform their duties;</p>',	'',	'FNQH-POL-CC080722',	4,	'',	'',	0,	1,	453,	'2022-09-15 20:59:04'),
(18,	'FNQH-POL-DT-080722 ',	'DISCIPLINE AND TERMINATION POLICY',	453,	14,	0,	'2022-08-19',	'2022-09-15',	0,	1,	'TCB',	0,	12,	'2023-09-15',	'2022-09-15',	'Sarah Sharpe',	'<p class=\"MsoNormal\"><span style=\"font-size: 13.5pt; line-height: 107%; font-family: Arial, sans-serif;\">This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</span></p>\r\n<p class=\"MsoNormal\"><span style=\"font-size: 13.5pt; line-height: 107%; font-family: Arial, sans-serif;\">&nbsp;</span></p>\r\n<p>&nbsp;</p>\r\n<p class=\"MsoNormal\"><span style=\"font-size: 13.5pt; line-height: 107%; font-family: Arial, sans-serif;\">Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</span></p>',	'<p>1.1. DISCIPLINE &amp; TERMINATION POLICY</p>\r\n<p>This policy contains guidance on performance and conduct management, and the discipline and&nbsp;termination consequences that may follow. It is strictly for general guidance purposes only and aims to&nbsp;provide employees and management with an understanding of the procedures that may be followed in&nbsp;certain circumstances.&nbsp;In so far as this policy imposes any obligations on the Company, those obligations are not contractual and&nbsp;do not give rise to any contractual rights. To the extent that this policy describes benefits and&nbsp;entitlements for employees, they are discretionary in nature and are also not intended to be contractual.</p>\r\n<p>The terms and conditions of employment that are intended to be contractual are set out in an&nbsp;employee&rsquo;s written employment contract.&nbsp;The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.1.1. WHAT CONSTITUTES POOR PERFORMANCE?</p>\r\n<p>An employee&rsquo;s performance will be considered poor or unsatisfactory if the employee is repeatedly not&nbsp;meeting the requirements of their role (as set out in the employee&rsquo;s position description, contract of&nbsp;employment, key performance indicators, Company policies, or as communicated to the employee&nbsp;otherwise). Poor performance may be observed by the employee&rsquo;s manager or other relevant person and&nbsp;may or may not be the result of a formal performance evaluation.</p>\r\n<p>1.1.2. WHAT CONSTITUTES MISCONDUCT?</p>\r\n<p>Misconduct includes, but is not limited to:</p>\r\n<p>Unauthorised absenteeism;</p>\r\n<p>Unacceptable behaviour towards managers/supervisors/employees/clients/customers of the&nbsp;Company;</p>\r\n<p>Inappropriate or dishonest behaviour in the workplace;</p>\r\n<p>Any instances of harassment and/or bullying;</p>\r\n<p>Non-compliance with Company policies, procedures or practices;</p>\r\n<p>Failure to follow lawful and reasonable direction from the Company or an authorised representative of the Company.</p>\r\n<p>Depending on the nature of the poor performance or misconduct, a number of disciplinary steps may be&nbsp;taken. The action taken will depend on the nature and severity of the employee&rsquo;s conduct. The steps&nbsp;below are listed in order of seriousness of the poor performance and/or misconduct, however, they do&nbsp;not need to be followed in sequential order and how any matter is dealt with is always at the complete&nbsp;discretion of the Company.</p>\r\n<p>1.1.3. INFORMAL COUNSELLING</p>\r\n<p>The Company may informally counsel an employee in order to assist the employee to better understand&nbsp;workplace practices, the required level of conduct and/or performance or any other matter the Company&nbsp;feels it appropriate to raise with the employee for their development. If the employee continues to&nbsp;engage in the conduct and/or poor performance which has been subject of informal counselling, the&nbsp;employee may be subject to any of the disciplinary procedures set out below up to and including&nbsp;termination of employment.</p>\r\n<p>1.1.4. FORMAL DISCIPLINARY PROCESS</p>\r\n<p>If the employee&rsquo;s performance or conduct does not improve following informal counselling, the Company&nbsp;may decide to commence a formal disciplinary process. This process may also be followed without prior&nbsp;informal counselling, where the seriousness of the performance or conduct issues mean it is appropriate&nbsp;to move straight to this stage.&nbsp;The employee will usually be given written notification to attend a meeting in relation to the employee&rsquo;s&nbsp;performance or conduct. Generally, the employee will be given at least 24 notice of the meeting. The&nbsp;letter will set out the performance or conduct issues to be discussed and warn the employee of the&nbsp;potential outcomes of the disciplinary process.</p>\r\n<p>The Company will offer the employee an opportunity to have a support person present during the&nbsp;meeting. The support person is not entitled to play an active role in the meeting and is not entitled to&nbsp;speak on behalf of the employee, but may provide support, guidance and advice to the employee (in&nbsp;private if they so wish).</p>\r\n<p>Generally, the following process will be followed in the disciplinary meeting:</p>\r\n<p>The Company will explain to the employee why the employee\'s performance is not meeting the&nbsp;expected standards (by reference to the employee&rsquo;s job description, contract of employment, key&nbsp;performance indicators, etc) or elaborate on any allegations of misconduct;</p>\r\n<p>The employee will be provided with an opportunity to respond to all such issues;</p>\r\n<p>The Company will explain the potential outcomes of the meeting and the employee will be given&nbsp;an opportunity to respond to this (for example, if termination is being considered, the employee&nbsp;should be given an opportunity to say while they feel this is inappropriate).</p>\r\n<p>Possible outcomes of the meeting include (but are not limited to): no action being taken, the need for further investigation, a verbal warning, a performance improvement plan, a written warning, termination of employment (with notice / payment in lieu of notice) and termination of&nbsp;employment without notice (only in cases of serious misconduct). These are discussed further&nbsp;below.</p>\r\n<p>1.1.5. NO ACTION TAKEN</p>\r\n<p>In certain circumstances the Company will decide that no action will be taken against the employee&nbsp;(because, for example, the allegations of misconduct are found to be unsubstantiated). In this situation&nbsp;the Company will generally confirm the outcome of the disciplinary meeting (and that no action is to be&nbsp;taken) in writing.</p>\r\n<p>1.1.6. FURTHER INVESTIGATION</p>\r\n<p>In some circumstances the Company will need to undertake further investigation following the&nbsp;disciplinary meeting in order to decide on the appropriate action to take. This may occur when, for&nbsp;example, there are conflicting versions of events and the Company is not in a position to make a finding&nbsp;on the issues/allegations.</p>\r\n<p>1.1.7. VERBAL WARNINGS</p>\r\n<p>A verbal warning will generally be appropriate where the employee&rsquo;s performance or conduct has not&nbsp;improved following informal counselling, or in relation to an incident that is not serious enough to&nbsp;warrant a written warning. A verbal warning will involve warning the employee that if their performance&nbsp;or conduct does not improve, they may be subject to more serious disciplinary action.&nbsp;A written record of the verbal warning should be kept.</p>\r\n<p>1.1.8. PERFORMANCE IMPROVEMENT PLAN (PIP)</p>\r\n<p>A performance improvement plan (or &ldquo;PIP&rdquo;) is generally used where issues have been identified in an&nbsp;employee&rsquo;s performance that need to be improved. A PIP will set clear goals or targets that the employee&nbsp;is expected to meet by certain dates. The Company will review the employee&rsquo;s performance during the&nbsp;period of the PIP and assist the employee in trying to improve their performance. If the employee&rsquo;s&nbsp;performance does not improve the employee may be required to attend a disciplinary meeting and may&nbsp;be issued a written warning. If the employee&rsquo;s performance does not improve after being issued one or&nbsp;more warnings, they may be required to attend a disciplinary meeting and (if no reasonable excuse can&nbsp;be given for the failure to improve) their employment may be terminated.</p>\r\n<p>1.1.9. WRITTEN WARNINGS</p>\r\n<p>In the event that the Company has serious concerns about an employee&rsquo;s performance or conduct, a written warning may be issued to the employee. This may (but will not necessarily) occur following&nbsp;continued or repeated behaviour raised in earlier informal counselling or in a verbal warning. There may&nbsp;be instances where a written warning may be issued in the first instance, based on the seriousness of the&nbsp;poor performance or conduct.</p>\r\n<p>A written warning will generally inform the employee:</p>\r\n<p>Of the employees\' performance or conduct issues that have been found to be an issue;</p>\r\n<p>Why the Company did not find the employee&rsquo;s response to such issues in the disciplinary meeting&nbsp;to be acceptable;</p>\r\n<p>Of a reasonable timeframe within which the employee must remedy their poor performance&nbsp;and/or conduct;</p>\r\n<p>That if the employee continues to under-perform or engage in misconduct, other disciplinary&nbsp;action may be taken, up to and including termination of employment.</p>\r\n<p>1.2. TERMINATION OF EMPLOYMENT (WITH NOTICE OR&nbsp;PAYMENT IN LIEU OF NOTICE)</p>\r\n<p>Poor performance or misconduct may lead to the termination of an employee&rsquo;s employment (either with&nbsp;notice or payment in lieu of notice).</p>\r\n<p>The number of warnings provided to an employee prior to termination of their employment may vary depending on the circumstances. For example, it may in some circumstances be appropriate for the&nbsp;Company to provide the employee with a number of warnings in relation to the same poor performance&nbsp;or conduct where such poor performance or conduct is of a relatively minor nature, before terminating&nbsp;the employee&rsquo;s employment. Similarly, the Company may provide an employee with a number of&nbsp;warnings where an employee engages in misconduct or poor performance which is separate to that&nbsp;which was the subject of an earlier warning, or which was not reasonably proximate in time to an earlier&nbsp;warning.</p>\r\n<p>In extreme cases of poor performance or misconduct it may be appropriate to terminate employment&nbsp;without any previous warnings having been given.&nbsp;At the disciplinary meeting, the employee will be given an opportunity to explain why they consider&nbsp;termination of employment is not appropriate prior to the Company taking a final decision.</p>\r\n<p>1.3. TERMINATION OF EMPLOYMENT WITHOUT NOTICE&nbsp;(&ldquo;SUMMARY DISMISSAL&rdquo;) IN CASES OF SERIOUS&nbsp;MISCONDUCT&nbsp;</p>\r\n<p>Serious misconduct is wilful and/or deliberate behaviour by an employee that is inconsistent with the&nbsp;continuation of employment, including but not limited to:</p>\r\n<p>A material breach of the employee\'s employment contract;&nbsp;</p>\r\n<p>Serious failure in the performance of duties or improper or inappropriate use of the employee&rsquo;s&nbsp;position;</p>\r\n<p>Wilful violation of any law or rule of a regulatory body;</p>\r\n<p>Deliberately diverting customers or business away from the Company;</p>\r\n<p>Accepting bribes or secret commissions;</p>\r\n<p>Any conduct that in the reasonable opinion of the Company constitutes a serious or potentially&nbsp;serious conflict of interest, including working for a competitor during the term of the employee&rsquo;s&nbsp;employment;</p>\r\n<p>Refusal to comply with a lawful and reasonable direction given by management or any other&nbsp;person duly allowed by the Company;</p>\r\n<p>Dishonest behaviour and/or acting in a way that is inconsistent with the best interests of the&nbsp;Company;</p>\r\n<p>Deliberately providing false or misleading information to the Company or any of the Company\'s&nbsp;customers or suppliers;</p>\r\n<p>Being convicted of a criminal offence which, in the reasonable opinion of the Company, may have&nbsp;the effect of bringing the Company into serious disrepute or affecting the ability of the employee&nbsp;to meet obligations under the employee&rsquo;s employment contract;</p>\r\n<p>Theft or misappropriation of Company property;</p>\r\n<p>Being under the influence of alcohol and/or illegal drugs whilst at work or on Company property;</p>\r\n<p>Acting in a way which in the reasonable opinion of the Company may injure or be likely to injure&nbsp;the business or reputation of the Company;</p>\r\n<p>Acts of bullying, harassment or discrimination;</p>\r\n<p>Threatening, violent, or offensive behaviour;</p>\r\n<p>Conduct that causes imminent, and serious risk to the health, or safety, of a person or the reputation,&nbsp;viability or profitability of the Company.</p>\r\n<p>At the disciplinary meeting, the employee will be given an opportunity to explain why they consider&nbsp;termination of employment without notice is not appropriate prior to the Company making a final&nbsp;decision.</p>\r\n<p>1.4. RECORD KEEPING</p>\r\n<p>Records of verbal warnings and any written warnings will be placed in an employee&rsquo;s personnel file.</p>\r\n<p>1.5. OTHER POLICIES</p>\r\n<p>Employees are encouraged to read this policy in conjunction with other relevant Company policies,</p>\r\n<p>including:</p>\r\n<p>Workplace Anti-Bullying and Anti-Harassment Policy;</p>\r\n<p>Equal Employment Opportunity and Anti-Discrimination Policy;</p>\r\n<p>Code of Conduct;</p>\r\n<p>Grievance Handling Policy.</p>\r\n<p>2. Managing Records kept on the basis of this document</p>\r\n<p>All records supporting this policy shall be kept in the FNQH Pathology document management system in&nbsp;the location, or system based, indicated in the procedure document. Any additional or deleted records&nbsp;shall be kept account of in the FNQH Pathology logging system such that any future inquiry will be able&nbsp;to clearly identify when the changes occurred, who made them, what these changes were and how the&nbsp;changes were approved.</p>\r\n<p>3. Validity and Document Management</p>\r\n<p>This document is valid from the date of its approval and will be reviewed on an annual basis. The current&nbsp;working copy will be identified as such, and any superseded documents will be archived and maintained&nbsp;for a period of five years.&nbsp;New versions will be identified with a versioning number. Full integers will denote a major document&nbsp;version, and a decimal number will indicate minor amendments or edits</p>',	'',	'FNQH-POL-DT-080722 ',	4,	'',	'',	0,	1,	453,	'2022-09-15 21:10:45'),
(19,	'FNQH-POL-EE-080722',	'Equal Employment Opportunity & Discrimination Policy',	453,	14,	0,	'2022-08-19',	'2022-09-15',	0,	1,	'TCB',	0,	12,	'2023-09-15',	'2022-09-15',	'Sarah Sharpe',	'<p class=\"MsoNormal\"><span style=\"line-height: 107%; font-family: Arial, sans-serif;\">This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</span></p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%; font-family: Arial, sans-serif;\">Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</span></p>',	'<p>1.1. EQUAL EMPLOYMENT OPPORTUNITY &amp; ANTIDISCRIMINATION POLICY</p>\r\n<p>1.1.1. AIMS</p>\r\n<p>FNQH Pathology (&ldquo;the Company&rdquo;) is committed to providing a safe, flexible and respectful environment&nbsp;for staff and clients free from all forms of discrimination, bullying and sexual harassment.&nbsp;All staff are required to treat others with dignity, courtesy and respect.&nbsp;By effectively implementing our Equal Employment Opportunity &amp; Anti-Discrimination Policy we will&nbsp;attract and retain talented staff and create a positive working environment for staff.</p>\r\n<p>1.1.2. SCOPE</p>\r\n<p>This policy applies to:</p>\r\n<p>1. Board members</p>\r\n<p>2. All staff, including: managers and supervisors; full-time, part-time or casual, temporary or&nbsp;permanent staff; job candidates; student placements, apprentices, contractors, sub-contractors&nbsp;and volunteers;</p>\r\n<p>3. How the Company provides services to clients and how it interacts with other members of the&nbsp;public;</p>\r\n<p>4. All aspects of employment, recruitment and selection; conditions and benefits; training and&nbsp;promotion; task allocation; shifts; hours; leave arrangements; workload; equipment and&nbsp;transport;</p>\r\n<p>5. On-site, off-site or after-hours work; work-related social functions; conferences &ndash; wherever and&nbsp;whenever staff may be as a result of their duties;</p>\r\n<p>6. Staff treatment of other staff, of clients, and of other members of the public encountered in the&nbsp;course of their duties.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and&nbsp;do not give rise to any contractual rights. To the extent that this policy describes benefits and&nbsp;entitlements for employees, they are discretionary in nature and are also not intended to be contractual.&nbsp;The terms and conditions of employment that are intended to be contractual are set out in an&nbsp;employee&rsquo;s written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.2. STAFF RIGHTS AND RESPONSIBILITIES</p>\r\n<p>All staff are entitled to:</p>\r\n<p>1. Recruitment and selection decisions based on merit and not affected by irrelevant personal&nbsp;characteristics;</p>\r\n<p>2. Work free from discrimination, bullying and sexual harassment;</p>\r\n<p>3. The right to raise issues or to make an enquiry or complaint in a reasonable and respectful&nbsp;manner without being victimised;</p>\r\n<p>4. Reasonable flexibility in working arrangements, especially where needed to accommodate their&nbsp;family responsibilities, disability, religious beliefs or culture.</p>\r\n<p>All staff must:</p>\r\n<p>1. Follow the standards of behaviour outlined in this policy;</p>\r\n<p>2. Offer support to people who experience discrimination, bullying or sexual harassment, including&nbsp;providing information about how to make a complaint;</p>\r\n<p>3. Avoid gossip and respect the confidentiality of complaint resolution procedures;</p>\r\n<p>4. Treat everyone with dignity, courtesy and respect.</p>\r\n<p>1.2.1. ADDITIONAL RESPONSIBILITIES OF MANAGERS AND SUPERVISORS</p>\r\n<p>Managers and supervisors must also:</p>\r\n<p>1. Model appropriate standards of behaviour;</p>\r\n<p>2. Take steps to educate and make staff aware of their obligations under this policy and the law;</p>\r\n<p>3. Intervene quickly and appropriately when they become aware of inappropriate behaviour;</p>\r\n<p>4. Act fairly to resolve issues and enforce workplace behavioural standards, making sure relevant&nbsp;parties are heard;</p>\r\n<p>5. Help staff resolve complaints informally;</p>\r\n<p>6. Refer formal complaints about breaches of this policy to the appropriate complaint handling&nbsp;officer for investigation;</p>\r\n<p>7. Ensure staff who raise an issue or make a complaint are not victimised;</p>\r\n<p>8. Ensure that recruitment decisions are based on merit and that no discriminatory requests for&nbsp;information are made;</p>\r\n<p>9. Seriously consider requests for flexible work arrangements.</p>\r\n<p>1.3. UNACCEPTABLE WORKPLACE CONDUCT</p>\r\n<p>Discrimination, bullying and sexual harassment are unacceptable at the Company and are unlawful under&nbsp;legislation including:</p>\r\n<p>&bull; Sex Discrimination Act 1984 (Cth);</p>\r\n<p>&bull; Racial Discrimination Act 1975 (Cth);</p>\r\n<p>&bull; Disability Discrimination Act 1992 (Cth);</p>\r\n<p>&bull; Age Discrimination Act 2004 (Cth);</p>\r\n<p>&bull; Australian Human Rights Commission Act 1986 (Cth).</p>\r\n<p>Staff (including managers) found to have engaged in such conduct might be counselled, warned or&nbsp;disciplined. Severe or repeated breaches can lead to formal discipline up to and including termination of&nbsp;employment.</p>\r\n<p>Under the law staff can be held personally liable for certain breaches of discrimination law, and the&nbsp;Company can also be vicariously liable for staff members&rsquo; conduct.&nbsp;</p>\r\n<p>1.4. DISCRIMINATION</p>\r\n<p>Discrimination is treating, or proposing to treat, someone unfavourably because of a personal&nbsp;characteristic protected by the law, such as sex, age, race or disability.</p>\r\n<p>Discrimination can occur:</p>\r\n<p>Directly, when a person or group is treated less favourably than another person or group in a similar&nbsp;situation because of a personal characteristic protected by law (see list below).&nbsp;For example, a worker is harassed and humiliated because of their race</p>\r\n<p>or</p>\r\n<p>A worker is refused promotion because they are &lsquo;too old&rsquo;</p>\r\n<p>Indirectly, when an unreasonable requirement, condition or practice is imposed that has, or is likely to&nbsp;have, the effect of disadvantaging people with a personal characteristic protected by law (see list below).&nbsp;For example, redundancy is decided based on people who have had a worker&rsquo;s compensation claim&nbsp;rather than on merit.</p>\r\n<p>Protected personal characteristics under Federal discrimination law include:</p>\r\n<p>1. A disability, disease or injury, including work-related injury;</p>\r\n<p>2. Parental status or status as a carer, for example, because they are responsible for caring for&nbsp;children or other family members;</p>\r\n<p>3. Race, colour, descent, national origin, or ethnic background;</p>\r\n<p>4. Age, whether young or old, or because of age in general;</p>\r\n<p>5. Sex;</p>\r\n<p>6. Industrial activity, including being a member of an industrial organisation like a trade union or&nbsp;taking part in industrial activity, or deciding not to join a union;</p>\r\n<p>7. Religion;</p>\r\n<p>8. Pregnancy and breastfeeding;</p>\r\n<p>9. Sexual orientation, intersex status or gender identity, including gay, lesbian, bisexual, transsexual,&nbsp;transgender, queer and heterosexual;</p>\r\n<p>10. Marital status, whether married, divorced, unmarried or in a de facto relationship or same sex&nbsp;relationship;</p>\r\n<p>11. Political opinion;</p>\r\n<p>12. Social origin;</p>\r\n<p>13. Medical record;</p>\r\n<p>14. An association with someone who has, or is assumed to have, one of these characteristics, such&nbsp;as being the parent of a child with a disability.</p>\r\n<p>15. It is also against the law to treat someone unfavourably because you assume they have a&nbsp;personal characteristic or may have it at some time in the future.</p>\r\n<p>1.5. DISABILITY DISCRIMINATION</p>\r\n<p>Employers are also required in some circumstances to make &ldquo;reasonable adjustments&rdquo; to facilitate&nbsp;employees with disabilities to perform the &ldquo;inherent requirements&rdquo; of the particular role they perform.&nbsp;An employer will be deemed to have discriminated against an employee if they fail to make these&nbsp;adjustments.</p>\r\n<p>The &ldquo;inherent requirements&rdquo; of a position are the essential activities that must be carried out to fulfil the&nbsp;purpose of the position.</p>\r\n<p>An adjustment is not reasonable if it will impose &ldquo;unjustifiable hardship&rdquo; on the employer. In assessing&nbsp;unjustifiable hardship factors to be considered include:</p>\r\n<p>1. The nature of the benefit or detriment to be imposed on any person concerned, including the&nbsp;community;</p>\r\n<p>2. The effect of the employee\'s disability;</p>\r\n<p>3. The financial circumstances and the estimated amount of expenditure required to be made by&nbsp;the employer;</p>\r\n<p>4. The availability of financial and other assistance to the employer.</p>\r\n<p>Examples of adjustments that may in some circumstances be reasonable for an employer to make&nbsp;include:</p>\r\n<p>1. Changing recruitment and selection procedures. For example, providing a sign language&nbsp;interpreter for a Deaf person or ensuring the medical assessor is familiar with a person&rsquo;s&nbsp;particular disability and how it relates to the job requirements.</p>\r\n<p>2. Modifying work premises. For example, making ramps, modifying toilets or providing flashing&nbsp;lights to alert people with a hearing loss.</p>\r\n<p>3. Changes to job design, work schedules or other work practices. For example, swapping some&nbsp;duties among staff or providing regular meal breaks for a person with diabetes.</p>\r\n<p>4. Modifying equipment. For example, lowering a workbench or providing an enlarged computer&nbsp;screen.</p>\r\n<p>5. Providing training or other assistance. For example, running induction programs for staff with a&nbsp;disability and their co-workers, providing a mentor or support person for a person with an&nbsp;intellectual disability, and including staff with a disability in all mainstream training.</p>\r\n<p>6. It is not unlawful to discriminate against a person because of their disability where:</p>\r\n<p>7. They cannot meet the inherent requirements of the job, even when the employer has made any&nbsp;reasonable adjustments; or&nbsp;Providing the person with reasonable adjustments to facilitate their disability imposes an&nbsp;unjustifiable hardship on the employer.</p>\r\n<p>1.6. BULLYING</p>\r\n<p>If someone is being bullied because of a personal characteristic protected by equal opportunity law, it is a&nbsp;form of discrimination.&nbsp;Bullying can take many forms, including jokes, teasing, nicknames, emails, pictures, text messages, social&nbsp;isolation or ignoring people, or unfair work practices.</p>\r\n<p>Under Federal law, this behaviour does not have to be repeated to be discrimination &ndash; it may be a one-off&nbsp;event.</p>\r\n<p>1. Behaviours that may constitute bullying include;</p>\r\n<p>2. Sarcasm and other forms of demeaning language;</p>\r\n<p>3. Threats, abuse or shouting;</p>\r\n<p>4. Coercion;</p>\r\n<p>5. Isolation;</p>\r\n<p>6. Inappropriate blaming;</p>\r\n<p>7. Ganging up;</p>\r\n<p>8. Constant unconstructive criticism;</p>\r\n<p>9. Deliberately withholding information or equipment that a person needs to do their job or access&nbsp;their entitlements;</p>\r\n<p>10. Unreasonable refusal of requests for leave, training or other workplace benefits.</p>\r\n<p>Any form of bullying is unacceptable in the Company and may also be against workplace health and safety&nbsp;law. The Company has a separate Workplace Anti-Bullying and Anti-Harassment Policy which employees&nbsp;must read and abide by, this deals with bullying and harassment that is not a form of discrimination (ie&nbsp;where not based on a protected personal characteristic).</p>\r\n<p>1.7. SEXUAL HARASSMENT</p>\r\n<p>Sexual harassment is a specific and serious form of harassment. It is unwelcome sexual behaviour, which&nbsp;could be expected to make a person feel offended, humiliated or intimidated. Sexual harassment can be&nbsp;physical, spoken or written. It can include:</p>\r\n<p>1. Comments about a person&rsquo;s private life or the way they look;</p>\r\n<p>2. Sexually suggestive behaviour, such as leering or staring;</p>\r\n<p>3. Brushing up against someone, touching, fondling or hugging;</p>\r\n<p>4. Sexually suggestive comments or jokes;</p>\r\n<p>5. Displaying offensive screen savers, photos, calendars or objects;</p>\r\n<p>6. Repeated unwanted requests to go out;</p>\r\n<p>7. Requests for sex;</p>\r\n<p>8. Sexually explicit posts on social networking sites;</p>\r\n<p>9. Insults or taunts of a sexual nature;</p>\r\n<p>10. Intrusive questions or statements about a person&rsquo;s private life;</p>\r\n<p>11. Sending sexually explicit emails or text messages;</p>\r\n<p>12. Inappropriate advances on social networking sites;</p>\r\n<p>13. Accessing sexually explicit internet sites;</p>\r\n<p>14. Behaviour that may also be considered to be an offence under criminal law, such as physical&nbsp;assault, indecent exposure, sexual assault, stalking or obscene communications.</p>\r\n<p>Just because someone does not object to inappropriate behaviour in the workplace at the time, it does&nbsp;not mean that they are consenting to the behaviour.&nbsp;Sexual harassment occurs in the workplace when it happens at work, at work-related events, between&nbsp;people sharing the same workplace, or between colleagues outside of work.</p>\r\n<p>All staff and volunteers have the same rights and responsibilities in relation to sexual harassment.&nbsp;A single incident is enough to constitute sexual harassment &ndash; it doesn&rsquo;t have to be repeated.&nbsp;All incidents of sexual harassment &ndash; no matter how large or small or who is involved &ndash; require employers&nbsp;and managers to respond quickly and appropriately.</p>\r\n<p>The Company recognises that comments and behaviour that do not offend one person can offend&nbsp;another. This policy requires all staff and volunteers to respect other people&rsquo;s limits.&nbsp;The Company will not tolerate or accept any form of sexual harassment, in the workplace or in any workrelated context such as conferences, work functions and business trips. All staff members are responsible&nbsp;for their own behaviour, and under the law may be held personally liable if they engage in sexual&nbsp;harassment. The Company may also be vicariously liable for staff members found to have engaged in any&nbsp;form of sexual harassment.&nbsp;</p>\r\n<p>1.8. VICTIMISATION</p>\r\n<p>Victimisation is subjecting or threatening to subject someone to a detriment because they have asserted&nbsp;their rights under equal opportunity law, made a complaint, helped someone else make a complaint, or&nbsp;refused to do something because it would be discrimination, sexual harassment or victimisation.&nbsp;Victimisation is against the law.&nbsp;It is also victimisation to threaten someone (such as a witness) who may be involved in investigating an&nbsp;equal opportunity concern or complaint.</p>\r\n<p>Victimisation is a very serious breach of this policy and is likely (depending on the severity and&nbsp;circumstances) to result in formal discipline against the perpetrator.&nbsp;The Company has a zero-tolerance approach to victimisation.&nbsp;</p>\r\n<p>1.9. VILIFICATION</p>\r\n<p>Vilification is where a person commits a public act which is reasonably likely to offend, insult, humiliate or&nbsp;intimidate another person because of their race, sex, religion, sexuality or sexual identity. Hatred or&nbsp;vilification due to an attribute protected under equal opportunity laws is unlawful.&nbsp;The Company will not tolerate or accept any form of hatred or vilification due to a protected attribute of&nbsp;another person.</p>\r\n<p>Any conduct that can possibly be observed by the public or any sort of communication either verbal or in&nbsp;writing to the public can be considered a public act. Workplaces can be public places.&nbsp;The Company may be vicariously liable for staff members found to have engaged in any form of unlawful&nbsp;hatred or vilification. Staff may also be sued personally or prosecuted criminally under Commonwealth or&nbsp;State criminal laws.&nbsp;Conduct that may constitute vilification can include verbal or written statements, or even be the&nbsp;reproduction or distribution of already published information. Examples include:</p>\r\n<p>1. Offensive material on the internet, including e-forums, blogs, social networking sites and video&nbsp;sharing sites;</p>\r\n<p>2. Offensive comments or images published in a publication such as a leaflet, flyer, internal message&nbsp;board or workplace intranet;</p>\r\n<p>3. Offensive speeches at public events, work functions or in the workplace;</p>\r\n<p>4. Abusive comments in any public place, such the workplace, or any other place attended in&nbsp;connection with employment; or</p>\r\n<p>5. In some instances, the reproduction or distribution of already published information around the&nbsp;workplace</p>\r\n<p>1.10. CONFIDENTIALITY</p>\r\n<p>It is unacceptable for staff at the Company to talk with other staff members, clients or suppliers about&nbsp;any complaint of discrimination or harassment without the Company&rsquo;s express permission.&nbsp;Breaching the confidentiality of a formal complaint investigation or inappropriately disclosing personal&nbsp;information obtained in a professional role (for example, as a manager) is a serious breach of this policy&nbsp;and may lead to formal discipline</p>\r\n<p>1.11. DECISIONS TO BE BASED ON MERIT</p>\r\n<p>All recruitment and job selection decisions at the Company will be based on merit &ndash; the skills and abilities&nbsp;of the candidate as measured against the inherent requirements of the position &ndash; regardless of personal&nbsp;characteristics.</p>\r\n<p>It is unacceptable and may be against the law to ask job candidates questions, or to in any other way seek&nbsp;information, about their personal characteristics, unless this can be shown to be directly relevant to a&nbsp;genuine requirement of the position.</p>\r\n<p>1.12. RESOLVING ISSUES</p>\r\n<p>The Company strongly encourages any staff member who believes they have been discriminated against,&nbsp;bullied, sexually harassed, vilified or victimised to take appropriate action by making a complaint in&nbsp;accordance with the Grievance Handling Policy.</p>\r\n<p>Any staff member who has witnessed any discrimination, bullying, sexual harassment, vilification or&nbsp;victimisation should report this to their manager or other responsible person in the Company, or can raise&nbsp;a complaint in accordance with the Grievance Handling Policy</p>\r\n<p>1.13. OTHER POLICIES</p>\r\n<p>Employees are encouraged to read this policy in conjunction with other relevant Company policies,&nbsp;including:</p>\r\n<p>1. Workplace Anti-Harassment and Anti-Bullying Policy;</p>\r\n<p>2. Code of Conduct;</p>\r\n<p>3. Grievance Handling Policy.</p>\r\n<p>2. Managing Records kept on the basis of this document</p>\r\n<p>All records supporting this policy shall be kept in the FNQH Pathology document management system in&nbsp;the location, or system based, indicated in the procedure document. Any additional or deleted records&nbsp;shall be kept account of in the FNQH Pathology logging system such that any future inquiry will be able&nbsp;to clearly identify when the changes occurred, who made them, what these changes were and how the&nbsp;changes were approved.</p>\r\n<p>3. Validity and Document Management</p>\r\n<p>This document is valid from the date of its approval and will be reviewed on an annual basis. The current&nbsp;working copy will be identified as such, and any superseded documents will be archived and maintained&nbsp;for a period of five years.&nbsp;New versions will be identified with a versioning number. Full integers will denote a major document&nbsp;version, and a decimal number will indicate minor amendments or edits.</p>',	'',	'FNQH-POL-EE-080722',	4,	'',	'',	0,	1,	453,	'2022-09-15 21:56:10'),
(20,	'FNQH-POL-FW-080722',	'FLEXIBLE WORKING POLICY',	453,	14,	0,	'2022-08-19',	'2022-09-15',	0,	1,	'TCB',	0,	12,	'2023-09-15',	'2022-09-15',	'Sarah Sharpe',	'<p>This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</p>\r\n<p>&nbsp;</p>\r\n<p>Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</p>\r\n<p>&nbsp;</p>',	'<p>1.1. FLEXIBLE WORKING POLICY</p>\r\n<p>1.1.1. OVERVIEW</p>\r\n<p>FNQH Pathology&rsquo;s (&ldquo;the Company&rdquo;) Flexible Working Policy recognizes the importance of achieving a fair&nbsp;balance between work and other responsibilities (such as family responsibilities and care-giving). The&nbsp;Company recognises the benefits of implementing flexible working arrangements such as improved&nbsp;productivity, retention of skilled staff and improved employee satisfaction.</p>\r\n<p>1.2. OPERATION</p>\r\n<p>The Fair Work Act 2009 (Cth) provides that certain employees (referred to in this policy as &ldquo;eligible&nbsp;employees&rdquo;) are entitled to make a written request for flexible working. Eligible employees may make a&nbsp;request to change their working arrangements, such as working part-time, compressed hours, flexible&nbsp;hours, job sharing, working from home, split-shifts and work re-design. The Company will consider such&nbsp;requests and provide a written response.</p>\r\n<p>This policy exists to assist the Company and its employees with the handling of such flexible working&nbsp;requests in accordance with the law. To the extent that there are inconsistencies between this policy and&nbsp;the Fair Work Act 2009 (Cth), the Fair Work Act 2009 (Cth) will prevail.</p>\r\n<p>Where an employee who is not an &ldquo;eligible employee&rdquo; within the meaning of the Fair Work Act 2009&nbsp;(Cth) makes a request for flexible working, the Company will consider such a request at its own discretion,&nbsp;but the terms of this policy will not apply to that request.&nbsp;In so far as this policy imposes any obligations on the Company (i.e. additional to those set out under&nbsp;legislation), those obligations are not contractual and do not give rise to any contractual rights. To the&nbsp;extent that this policy describes benefits and entitlements for employees (ie those additional to those set&nbsp;out under legislation), they are discretionary in nature and are also not intended to be contractual. The&nbsp;terms and conditions of employment that are intended to be contractual are set out in an employee&rsquo;s&nbsp;written employment contract.</p>\r\n<p>The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.3. ELIGIBILITY</p>\r\n<p>The Company will consider an eligible employee&rsquo;s request for flexible working and respond in writing to&nbsp;inform the employee whether their request is granted, partially granted or refused.&nbsp;Employees must satisfy the following before making a request for flexible working under the Fair Work&nbsp;Act 2009 (Cth):</p>\r\n<p>- Full-time and part-time employees: Must have been continuously employed by the Company for&nbsp;at least 12 months before making their request;</p>\r\n<p>- Casual employees: Must have been employed by the Company on a regular and systematic basis&nbsp;for at least 12 months before making their request AND must have a reasonable expectation of&nbsp;continuing employment with the Company on a regular and systematic basis moving forward.</p>\r\n<p>- In addition to the minimum service requirements set out above, to be an &ldquo;eligible employee&rdquo;&nbsp;under this policy, the employee must satisfy at least one of the following circumstances, and the&nbsp;request for flexible working must be because of those circumstances:</p>\r\n<p>- The employee is the parent, or has responsibility for the care, of a child who is of school&nbsp;age or younger (i.e. the age at which the child is required by the applicable State or&nbsp;Territory law to start attending school); or</p>\r\n<p>- The employee is a carer within the meaning of the Carer Recognition Act 2010;</p>\r\n<p>- The employee has a disability;</p>\r\n<p>- The employee is 55 years of age or older;</p>\r\n<p>- The employee is experiencing family or domestic violence; or</p>\r\n<p>- The employee provides care or support to a member of the employee&rsquo;s immediate&nbsp;family, or a member of the employee&rsquo;s household, who requires care or support because&nbsp;of family or domestic violence.</p>\r\n<p>1.4. DOCUMENTATION REQUIREMENTS</p>\r\n<p>An employee who believes they are eligible to make a request for flexible working and considers that a&nbsp;change to their working arrangements would have a positive impact upon their ability to balance their&nbsp;work and other responsibilities should set out their request in writing to their manager. In order for the&nbsp;Company to properly consider the employee&rsquo;s request, it will be helpful if as much detail as possible is&nbsp;included in the employee&rsquo;s request. For example, the employee&rsquo;s request should include the following:</p>\r\n<p>The type of flexible working arrangement that is requested, or different options of flexible working;</p>\r\n<p>- How a new working arrangement would benefit the employee in their day-to-day life;</p>\r\n<p>- A proposed start date and if relevant, an end date;</p>\r\n<p>- Suggestions as to how the employee&rsquo;s proposed flexible working arrangement could impact their&nbsp;fellow employees and how this could be overcome;</p>\r\n<p>- If it may be unclear to the Company why the employee is eligible to apply, then provide details as to&nbsp;why the employee believes they meet the eligibility requirements;</p>\r\n<p>- Any other relevant information.</p>\r\n<p>1.5. PROCEDURE</p>\r\n<p>Once the Company receives the employee&rsquo;s written request to change their working arrangements, it will&nbsp;consider the request, taking into account the employee&rsquo;s proposals and their impact upon the Company&rsquo;s&nbsp;ability to continue to meet its business objectives.&nbsp;If an employee is covered by a modern award, the Company will first discuss the request with the&nbsp;employee to try to reach an agreement about changes to the employee&rsquo;s working conditions, taking into&nbsp;consideration:</p>\r\n<p>- The needs of the employee;</p>\r\n<p>- Consequences for the employee if changes in working arrangements aren&rsquo;t made;</p>\r\n<p>- Any reasonable business grounds for refusing the employee&rsquo;s request.</p>\r\n<p>A written response will be provided to the employee within 21 days of the Company receiving the&nbsp;request. The response will set out whether the employee&rsquo;s request is granted, partially granted (for&nbsp;instance, it may be granted with conditions or for a fixed period of time) or refused.&nbsp;</p>\r\n<p>1.6. AGREEMENT OR REFUSAL</p>\r\n<p>If the employee&rsquo;s request for flexible working is agreed in full, then the start date of the new&nbsp;arrangement will need to be agreed, a review date decided and the relevant change to the employee&rsquo;s&nbsp;terms and conditions will be documented in a Flexible Working Arrangement Record. It is possible also that the employee will be asked to execute a new employment contract to reflect the changes (though&nbsp;this will depend on the nature of the changes).</p>\r\n<p>If the employee&rsquo;s request for flexible working is partially agreed, further discussion will then take place&nbsp;between the employee and the Company to come to a mutually convenient arrangement.&nbsp;The Company can only refuse a request on &ldquo;reasonable business grounds&rdquo; (see below). If a request is&nbsp;refused the written response must include the reasons for the refusal.&nbsp;Modern awards contain specific information on what needs to be included in the written response if the&nbsp;request is refused or if a different change in working arrangements is agreed.&nbsp;The Fair Work Act 2009 (Cth) lists the following as examples of reasonable business grounds for refusing a&nbsp;request (the list is not exhaustive)</p>\r\n<p>- That the new working arrangements requested by the employee would be too costly for the&nbsp;Company;</p>\r\n<p>- That there is no capacity to change the working arrangements of other employees to&nbsp;accommodate the new working arrangements requested by the employee;</p>\r\n<p>- That it would be impractical to change the working arrangements of other employees, or recruit&nbsp;new employees, to accommodate the new working arrangements requested by the employee;</p>\r\n<p>- That the new working arrangements requested by the employee would be likely to result in a&nbsp;significant loss in efficiency or productivity;</p>\r\n<p>- That the new working arrangements requested by the employee would be likely to have a&nbsp;significant negative impact on customer service.</p>\r\n<p>1.7. INTERACTION WITH STATE ENTITLEMENTS</p>\r\n<p>Any State or Territory laws applicable to the location in which the employee is employed that provide&nbsp;employee entitlements in relation to flexible working arrangements, such as carers provisions under antidiscrimination laws, continue to apply to the extent that they are more beneficial to employees.</p>\r\n<p>2. Managing Records kept on the basis of this document</p>\r\n<p>All records supporting this policy shall be kept in the FNQH Pathology document management system in&nbsp;the location, or system based, indicated in the procedure document. Any additional or deleted records&nbsp;shall be kept account of in the FNQH Pathology logging system such that any future inquiry will be able&nbsp;to clearly identify when the changes occurred, who made them, what these changes were and how the&nbsp;changes were approved.</p>\r\n<p>3. Validity and Document Management</p>\r\n<p>This document is valid from the date of its approval and will be reviewed on an annual basis. The current&nbsp;working copy will be identified as such, and any superseded documents will be archived and maintained&nbsp;for a period of five years.&nbsp;New versions will be identified with a versioning number. Full integers will denote a major document&nbsp;version, and a decimal number will indicate minor amendments or edits.</p>',	'',	'FNQH-POL-FW-080722',	4,	'',	'',	0,	1,	453,	'2022-09-15 22:05:01'),
(21,	'FNQH-POL-GH-080722',	'Grievance Handling Policy',	453,	14,	0,	'2022-08-19',	'2022-09-15',	0,	1,	'TCB',	0,	12,	'2023-09-15',	'2022-09-15',	'Sarah Sharpe',	'<p class=\"MsoNormal\"><span style=\"line-height: 107%; font-family: Arial, sans-serif;\">This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</span></p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%; font-family: Arial, sans-serif;\">&nbsp;</span></p>\r\n<p>&nbsp;</p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%; font-family: Arial, sans-serif;\">Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</span></p>',	'<p>GRIEVANCE HANDLING POLICY</p>\r\n<p>1.1.1. OVERVIEW</p>\r\n<p>At FNQH Pathology (&ldquo;the Company&rdquo;) we aim to foster good relations amongst employees and between&nbsp;employees and management. We acknowledge that the enjoyment you experience in your job is&nbsp;reflected in how well you work and how well you relate to your colleagues and customers.We also acknowledge that problems can arise at work that may sometimes cause you to feel aggrieved.&nbsp;These problems can sometimes arise from the behaviour or decisions of management or other&nbsp;employees.</p>\r\n<p>The purpose of this policy is to allow you to have such problems, referred to as grievances, addressed</p>\r\n<p>internally in a timely and confidential manner.</p>\r\n<p>A grievance can be about anything done, or not done, by management or another employee or&nbsp;employees, which you feel affects you unfairly or unjustly. A grievance can also be about discrimination,&nbsp;harassment, bullying or any other employment related decision or behaviour that you think is unfair,&nbsp;unjust or upsetting.&nbsp;This Grievance Handling Policy outlines the procedures you should follow to try to resolve a grievance and&nbsp;also outlines the steps the Company will take to resolve your grievance if you make a formal complaint.</p>\r\n<p>In so far as this policy imposes any obligations on the Company, those obligations are not contractual and&nbsp;do not give rise to any contractual rights. To the extent that this policy describes benefits and&nbsp;entitlements for employees, they are discretionary in nature and are also not intended to be contractual.&nbsp;The terms and conditions of employment that are intended to be contractual are set out in an&nbsp;employee&rsquo;s written employment contract.&nbsp;The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.2. WHAT ARE YOUR OPTIONS IF YOU HAVE A&nbsp;GRIEVANCE?</p>\r\n<p>In general there are three options to consider if you have a grievance, being:</p>\r\n<p>- Deal with the matter informally. A grievance can be dealt with informally by approaching the&nbsp;involved in your grievance, if you feel comfortable in doing so. You can tell them that their&nbsp;behaviour, decision, actions, etc. was unfair, offensive, discriminatory etc., and why you believe&nbsp;this to be so. The person may have been totally unaware of the affect of their behaviour or&nbsp;decision on you. By telling them you will give them a chance to redress the situation. This may not&nbsp;be appropriate in some cases, particularly if you do not feel comfortable speaking to the person.</p>\r\n<p>- Speak to your manager or other senior person. If you do not want to speak to the person directly,&nbsp;you can tell your manager about your grievance. They should be able to tell you what your&nbsp;options are. They may approach the person complained about and talk to them informally about&nbsp;your grievance. They may decide to take more formal action. Generally, they will seek your&nbsp;approval before doing anything &ndash; although sometimes they may decide that taking action will be&nbsp;necessary even if you do not wish them to do so (for example where failure to do so poses a&nbsp;health and safety risk). If your grievance is about your manager, you may wish to speak to&nbsp;another senior person. Alternatively, you may decide to make a formal complaint.</p>\r\n<p>- Make a formal complaint. If you do decide to make a formal complaint, this can be done by&nbsp;putting the complaint in writing and reporting it to your manager (or other senior person). The&nbsp;written complaint should contain a description of the incident(s), decision, behaviour in question,&nbsp;the time and date of the incident(s), the names of any witnesses, your signature and date of the&nbsp;complaint.</p>\r\n<p>1.2.1. IF YOU MAKE A FORMAL COMPLAINT HOW WILL YOUR GRIEVANCE&nbsp;BE HANDLED?</p>\r\n<p>Grievances will be handled in accordance with the following guidelines:</p>\r\n<p>- Grievances will be treated with the utmost confidentiality (except where the Company deems it is&nbsp;necessary to disclose the complaint for the purpose of dealing with it effectively; disclosure will&nbsp;be no wider than is strictly necessary). It is important that you also maintain confidentiality and&nbsp;do not discuss your complaint with others, unless the Company gives you permission to do so;&nbsp;</p>\r\n<p>- Any grievance will be taken seriously, handled impartially, and any steps taken will be in&nbsp;accordance with the principles of procedural fairness;</p>\r\n<p>- Employees who raise grievances are protected from victimisation;</p>\r\n<p>- Grievances will be dealt with promptly, taking into account all the circumstances; and</p>\r\n<p>- Generally, you may have a support person with you at any stage of the process.</p>\r\n<p>1.3. THE INVESTIGATION</p>\r\n<p>Where a grievance cannot be resolved informally, and the company deems an investigation is required,&nbsp;the matter will be investigated by such appropriate person as the Company deems appropriate. This may&nbsp;be an external investigation.&nbsp;How the investigation is to be conducted is at the complete discretion of the Company. The following are&nbsp;general guidelines only.&nbsp;During the investigation, you will generally be interviewed first, following which any witnesses, the person&nbsp;against whom the complaint is made, and any other relevant people will be independently interviewed.&nbsp;</p>\r\n<p>Both you and the person against whom the complaint is made will generally be allowed to have a support&nbsp;person present when the interview is being conducted.</p>\r\n<p>- If the complaint is substantiated, appropriate action will be taken (see below);</p>\r\n<p>- If the complaint is unsubstantiated, you will generally be given an explanation as to why that&nbsp;finding was made;</p>\r\n<p>- If the complaint is found to have been fabricated or vexatious, appropriate disciplinary action&nbsp;may be taken against you up to and including termination of employment.</p>\r\n<p>1.4. WHAT ARE THE POSSIBLE OUTCOMES?</p>\r\n<p>If the investigation reveals that your complaint is valid, a number of actions may be taken, depending on&nbsp;the nature of the complaint. The person against whom the complaint is made may be asked to give you a&nbsp;written apology, he/she may be given a written warning, counselling, transfer, demotion, or may be&nbsp;subjected to disciplinary action up to and including termination of employment.</p>\r\n<p>If the investigation is inconclusive, i.e. the complaint cannot be proved due to lack of evidence or the&nbsp;conduct is not sufficiently serious to justify disciplinary action, the Company may nevertheless take a&nbsp;number of actions. These may include training and/or monitoring of relevant staff.&nbsp;If the complaint is found to have been completely fabricated or raised vexatiously, appropriate action&nbsp;may be taken against you in accordance with the Disciplinary and Termination Policy including&nbsp;counselling, an official formal warning, transfer, demotion, or disciplinary action up to and including&nbsp;termination of employment, depending on the seriousness of the circumstances.</p>\r\n<p>1.5. WHAT IF YOU ARE NOT SATISFIED WITH THE&nbsp;OUTCOME</p>\r\n<p>If you are not satisfied with the way in which your grievance was handled, you may have the option of&nbsp;raising your complaint with an outside agency, such as the Australian Human Rights Commission the Fair&nbsp;Work Ombudsman or the relevant State Anti-Discrimination Board and other bodies. You may also wish&nbsp;to consider making a claim in the Fair Work Commission or the court. In appropriate circumstances you&nbsp;may wish to seek advice from a union or lawyer.</p>\r\n<p>1.6. OTHER POLICIES</p>\r\n<p>Employees and are encouraged to read this policy in conjunction with other relevant Company policies,</p>\r\n<p>including:</p>\r\n<p>- Code of Conduct;</p>\r\n<p>- Workplace Anti-Bullying &amp; Anti-Harassment Policy;</p>\r\n<p>- Equal Employment Opportunity and Anti-Discrimination Policy.</p>\r\n<p>2. Managing Records kept on the basis of this document</p>\r\n<p>All records supporting this policy shall be kept in the FNQH Pathology document management system in&nbsp;the location, or system based, indicated in the procedure document. Any additional or deleted records&nbsp;shall be kept account of in the FNQH Pathology logging system such that any future enquiry will be able&nbsp;to clearly identify when the changes occurred, who made them, what these changes were and how the&nbsp;changes were approved.</p>\r\n<p>3. Validity and Document Management</p>\r\n<p>This document is valid from the date of its approval and will be reviewed on an annual basis. The current&nbsp;working copy will be identified as such, and any superseded documents will be archived and maintained&nbsp;for a period of five years.</p>\r\n<p>New versions will be identified with a versioning number. Full integers will denote a major document&nbsp;version, and a decimal number will indicate minor amendments or edits.</p>',	'',	'FNQH-POL-GH-080722',	4,	'',	'',	0,	1,	453,	'2022-09-15 22:16:17'),
(22,	'FNQH-POL-SM-080722',	'SOCIAL MEDIA POLICY',	453,	14,	0,	'2022-08-19',	'2022-09-15',	0,	1,	'TCB',	0,	12,	'2023-09-15',	'2022-09-15',	'Sarah Sharpe',	'<p class=\"MsoNormal\"><span style=\"line-height: 107%; font-family: Arial, sans-serif;\">This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</span></p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%; font-family: Arial, sans-serif;\">&nbsp;</span></p>\r\n<p>&nbsp;</p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%; font-family: Arial, sans-serif;\">Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</span></p>',	'<p>1.1. SOCIAL MEDIA POLICY</p>\r\n<p>At FNQH Pathology (&ldquo;the Company&rdquo;) we understand that social media networks (such as Facebook,&nbsp;Twitter, LinkedIn, Instagram etc.) play an important part in today\'s society and that the majority of our&nbsp;employees may use social media in some personal capacity.&nbsp;It is important for all employees of the Company to be aware that much of the information exchanged&nbsp;within social media networks online or otherwise falls within the public domain, and the line drawn&nbsp;between what is considered to be personal and public is not always clear. It is also important to&nbsp;remember that information posted on social network sites can be easily traced and can generally be&nbsp;accessed at any time.</p>\r\n<p>The purpose of this policy is to outline minimum standards regarding social media use and participation&nbsp;for all employees during their employment with the Company.&nbsp;&nbsp;In so far as this policy imposes any obligations on the Company, those obligations are not contractual and&nbsp;do not give rise to any contractual rights. To the extent that this policy describes benefits and&nbsp;entitlements for employees, they are discretionary in nature and are also not intended to be contractual.</p>\r\n<p>The terms and conditions of employment that are intended to be contractual are set out in an&nbsp;employee&rsquo;s written employment contract.&nbsp;The Company may unilaterally introduce, vary, remove or replace this policy at any time.&nbsp;The following rules should be followed by all employees of the Company in relation to social media&nbsp;networks. These rules apply whether employees are using social media either during or outside of work&nbsp;hours:</p>\r\n<p>- Employees should not post anything on social media networks that refers to their employment,&nbsp;the Company or any persons associated with the Company (eg other employees, directors,&nbsp;customers, clients, suppliers, etc) without the Company&rsquo;s express permission;</p>\r\n<p>- Employees should not identify themselves on social media networks as an employee of the&nbsp;Company. Employees should not, for example, post pictures of themselves in any work uniform;&nbsp;</p>\r\n<p>- When participating in social media networks, employees of the Company should ensure that&nbsp;personal comments do not bring the Company or any of its directors or its employees into&nbsp;disrepute;</p>\r\n<p>- It is unacceptable to disparage the Company, or any persons associated with the Company (eg&nbsp;other employees, directors, customers, clients, suppliers, etc) in any way when participating in&nbsp;social media networks;</p>\r\n<p>- Employees of the Company should not participate in social media networks in such a way that&nbsp;negatively impacts upon their effectiveness and productivity at work;</p>\r\n<p>- Employees are not to access social media sites during working hours unless the use is directly related to the performance of duties required in the course of their employment;</p>\r\n<p>- When participating in social media networks, employees of the Company should not imply that&nbsp;any personal comments are endorsed in any way by the Company;</p>\r\n<p>- When participating in social media networks, employees must not disclose confidential&nbsp;information belonging to the Company or any other information the employee is required to&nbsp;keep confidential;</p>\r\n<p>- Employees are prohibited from posting pictures, images or other items of their work, place of&nbsp;work or whilst taken when performing their work duties without the Company&rsquo;s express&nbsp;permission;</p>\r\n<p>- Employees of the Company should not participate in social media networks in such a way that&nbsp;harasses, discriminates or treats unfairly or inappropriately any other employee, customer or&nbsp;client of the Company.</p>\r\n<p>Any breach of this policy may result in disciplinary action, up to and including termination of employment.</p>\r\n<p>1.2. OTHER POLICIES</p>\r\n<p>Employees are encouraged to read this policy in conjunction with other relevant Company policies,&nbsp;including:</p>\r\n<p>- Code of Conduct;</p>\r\n<p>- Telephone, Mobile &amp; Internet Policy;</p>\r\n<p>- Workplace Anti-Bullying &amp; Anti-Harassment Policy;</p>\r\n<p>- Equal Employment Opportunity and Anti-Discrimination Policy.</p>\r\n<p>2. Managing Records kept on the basis of this document</p>\r\n<p>All records supporting this policy shall be kept in the FNQH Pathology document management system in&nbsp;the location, or system based, indicated in the procedure document. Any additional or deleted records&nbsp;shall be kept account of in the FNQH Pathology logging system such that any future enquiry will be able&nbsp;to clearly identify when the changes occurred, who made them, what these changes were and how the&nbsp;changes were approved.</p>\r\n<p>3. Validity and Document Management</p>\r\n<p>This document is valid from the date of its approval and will be reviewed on an annual basis. The current&nbsp;working copy will be identified as such, and any superseded documents will be archived and maintained&nbsp;for a period of five years.</p>\r\n<p>New versions will be identified with a versioning number. Full integers will denote a major document&nbsp;version, and a decimal number will indicate minor amendments or edits.</p>',	'',	'FNQH-POL-SM-080722',	4,	'',	'',	0,	1,	453,	'2022-09-15 22:21:12'),
(23,	'FNQH-TV-220722',	'TEAM VALUES',	453,	14,	0,	'2022-08-19',	'2022-09-15',	0,	1,	'TCB',	0,	12,	'2023-09-15',	'2022-09-15',	'Sarah Sharpe',	'<p class=\"MsoNormal\"><span style=\"line-height: 107%; font-family: Arial, sans-serif;\">This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</span></p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%; font-family: Arial, sans-serif;\">&nbsp;</span></p>\r\n<p>&nbsp;</p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%; font-family: Arial, sans-serif;\">Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</span></p>',	'<p>1.1. FNQH PATHOLOGY TEAM VALUES</p>\r\n<p>Team Work - We are one team&nbsp;</p>\r\n<p>We value teamwork. At FNQH Pathology, we recognise that it takes all of us, to work together at 100% to&nbsp;achieve our vision. We know that the strongest teams foster diverse personalities, talents and skills, and&nbsp;we believe in using our experience to help others achieve their best.</p>\r\n<p>Quality - We are bold and ambitious</p>\r\n<p>We want to inspire. We act with ambition and aspire to continuously learn, grow and strive for&nbsp;excellence. We set ambitious goals and throw everything into achieving them. We celebrate all our wins&nbsp;and recognise that we all contribute to the business so we can share in the value we create.</p>\r\n<p>Integrity - We work with integrity</p>\r\n<p>We treat others as we expect to be treated. We believe in serving our customers to the very best of our&nbsp;abilities. Our clients are at the centre of everything we do, and we are constantly putting ourselves in our&nbsp;customer\'s shoes. In fact, we are our own customers, so this is never too difficult!</p>\r\n<p>Learning and Inventing</p>\r\n<p>We\'re always looking for a better way to get the job done. We challenge prevailing assumptions and&nbsp;suggest better approaches. We don\'t get stopped by roadblocks rather, we shift it and invent practical&nbsp;solutions. It\'s all about constant learning and expanding our knowledge to gain new skills and expertise.&nbsp;FNQH Pathology continuous learning is about encouraging employees to learn and providing them with&nbsp;the tools that facilitate this learning.</p>',	'',	'FNQH-TV-220722',	4,	'',	'',	0,	1,	453,	'2022-09-15 22:23:33'),
(24,	'FNQH-POL-MI-080722',	'Telephone, Mobile and Internet Policy',	453,	14,	0,	'2022-08-19',	'2022-09-15',	0,	1,	'TCB',	0,	12,	'2023-09-15',	'2022-09-15',	'Sarah Sharpe',	'<p class=\"MsoNormal\"><span style=\"line-height: 107%; font-family: Arial, sans-serif;\">This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</span></p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%; font-family: Arial, sans-serif;\">&nbsp;</span></p>\r\n<p>&nbsp;</p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%; font-family: Arial, sans-serif;\">Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</span></p>',	'<p>1.1. TELEPHONE, MOBILE &amp; INTERNET POLICY</p>\r\n<p>FNQH Pathology (\"the company\") provides this policy to set out guidance relating to telephone, mobile&nbsp;and internet use by employees.&nbsp;Inappropriate use of mobile, telephone and internet at work decreases productivity, causes security risks,&nbsp;distracts co-workers and colleagues, and can cause significant expense to a business.</p>\r\n<p>This policy is designed to set down minimum standards regarding mobile phone, telephone and internet&nbsp;use for all employees during their employment with the Company.&nbsp;In so far as this policy imposes any obligations on the Company, those obligations are not contractual and&nbsp;do not give rise to any contractual rights. To the extent that this policy describes benefits and&nbsp;entitlements for employees, they are discretionary in nature and are also not intended to be contractual.</p>\r\n<p>The terms and conditions of employment that are intended to be contractual are set out in an&nbsp;employee&rsquo;s written employment contract.&nbsp;The Company may unilaterally introduce, vary, remove or replace this policy at any time.</p>\r\n<p>1.2. TELEPHONE &amp; MOBILE PHONE USE</p>\r\n<p>The Company appreciates that staff may have a need to make and receive some personal telephone calls&nbsp;during work hours. However, unless in the case of an emergency, telephone and mobile phone use&nbsp;should never interfere with employees&rsquo; work duties, including but not limited to the service of customers.</p>\r\n<p>The following guidelines govern the use of telephones and mobile phones and the making and/or&nbsp;receiving of personal calls during work time:</p>\r\n<p>- Personal calls should never take precedence over the service of customers and clients. Unless&nbsp;there is an emergency, all personal phone calls should be restricted to legitimate work breaks (for&nbsp;example, your meal break) or before or after the commencement of your shift;</p>\r\n<p>- Any workplace telephones are provided for the conduct of the Company\'s business. Such&nbsp;telephones should not be used for personal calls except in the case of emergency, or where you&nbsp;have permission to make or receive personal calls by your manager. Any use of Company&nbsp;telephones for the conduct of any other business or for the financial gain of any other party is&nbsp;expressly prohibited;</p>\r\n<p>- All personal calls during the performance of your work duties, should be kept as short as possible&nbsp;in the interests of minimising disruption to work;&nbsp;Employees must not use Company telephones (including mobile phones) in any way that offends&nbsp;the law or as a device for delivery of offensive or objectionable communications. Offences of this&nbsp;nature may result in disciplinary action up to an including termination of employment;</p>\r\n<p>- Where you are provided with a Company mobile phone it is provided solely for the performance of your work duties unless the Company informs you otherwise. The Company will only pay for legitimate work calls and you may be required to pay for personal phone usage (unless you are&nbsp;informed otherwise).</p>\r\n<p>1.3. USE OF THE INTERNET AND EMAILS AT WORK</p>\r\n<p>The Company acknowledges that employees may need to access and use the internet to carry out their&nbsp;duties and to send and receive emails. In order to provide employees with clear expectations as to what is&nbsp;and what is not an appropriate use of the internet and email at work, the following guidelines have been&nbsp;developed.</p>\r\n<p>This policy applies to the use of the Company&rsquo;s internet and email services whilst employees are at work,&nbsp;and when employees access such services outside of work hours (for example when they take a Company&nbsp;laptop home or on a business trip or client visit).&nbsp;This policy also applies to the use of personal equipment (eg mobile phones and personal computers)&nbsp;that are used to access Company systems or emails.</p>\r\n<p>Please remember that your work emails are property of the Company, as are all programs and files used&nbsp;on the Company&rsquo;s internet and computer systems. You should therefore use all such systems and&nbsp;materials appropriately in accordance with your work duties and follow any directions given to you by the&nbsp;Company regarding their use.</p>\r\n<p>On request you must provide all password and login details used in connection with your work duties to&nbsp;the Company. You must also return all Company equipment and materials (eg laptops, USB drives,&nbsp;Company data saved in other locations, etc) on request and upon termination of your employment.&nbsp;As far as is reasonably possible, the Company will respect the privacy of individuals in the application and&nbsp;enforcement of this policy.</p>\r\n<p>- Only use the internet and email for legitimate business purposes related to your job;</p>\r\n<p>- Permission from your manager may be sought to use the Company internet in non-work time for&nbsp;study, research or other reasonable purposes;</p>\r\n<p>- Do not use the Company internet or email for personal use. In particular, you should not access&nbsp;personal emails, or social media unless specific permission of your manager has been obtained;</p>\r\n<p>- Do not use the Company internet or email for personal gain or the benefits of persons other than&nbsp;the Company;</p>\r\n<p>- Do not use the Company internet or email to send defamatory, threatening, sexually explicit,&nbsp;offensive or obscene messages or images to other employees or to anyone outside the Company;</p>\r\n<p>- Do not use the Company internet or email to send messages or images that are discriminatory&nbsp;(such as those which are racist or involve sexual harassment) to other employees or to anyone&nbsp;outside the Company;</p>\r\n<p>- Do not use the Company internet or email in any way which involves sending or accessing&nbsp;material that is unlawful or illegal;</p>\r\n<p>- Do not use the Company internet or email to download, upload, retrieve or send a sexually&nbsp;explicit, racist or otherwise discriminatory, illegal or unlawful, offensive or obscene material while&nbsp;you are on work premises (even if using your personal equipment), or while using Company computers or systems inside or outside of work premises;</p>\r\n<p>- Do not access without permission (hack) any computer, whether owned by the Company or by&nbsp;any other organisation;</p>\r\n<p>- When you send emails or use the Company internet, do not disclose confidential information,&nbsp;unless this is necessary for the performance of your work duties;</p>\r\n<p>- Do not delete information belonging to the Company from its computer systems without its&nbsp;permission;</p>\r\n<p>- Do not use the Company internet or email for the creation of legal or contractual obligations that&nbsp;bind the Company unless specifically authorised to do so by your manager;</p>\r\n<p>- Do not use the Company\'s systems, internet or wi-fi to connect to personal services (such as&nbsp;personal email services) during working hours using Company or personal equipment;</p>\r\n<p>- Do not use another employee\'s computer or email to carry out any of the activities prohibited&nbsp;above.</p>\r\n<p>- A breach of this policy may result in disciplinary action up to and including termination of&nbsp;employment. In addition, unlawful or illegal use of the Company&rsquo;s internet or email systems may&nbsp;constitute a civil or criminal offence for which you could be personally liable.</p>\r\n<p>1.4. OTHER POLICIES</p>\r\n<p>Employees are encouraged to read this policy in conjunction with other relevant Company policies,&nbsp;including:</p>\r\n<p>- Code of Conduct;</p>\r\n<p>- Social Media Policy;</p>\r\n<p>- Workplace Anti-Bullying &amp; Anti-Harassment Policy;</p>\r\n<p>- Equal Employment Opportunity and Anti-Discrimination Policy.</p>\r\n<p>2. Managing Records kept on the basis of this document</p>\r\n<p>All records supporting this policy shall be kept in the FNQH Pathology document management system in&nbsp;the location, or system based, indicated in the procedure document. Any additional or deleted records&nbsp;shall be kept account of in the FNQH Pathology logging system such that any future enquiry will be able&nbsp;to clearly identify when the changes occurred, who made them, what these changes were and how the&nbsp;changes were approved.</p>\r\n<p>3. Validity and Document Management</p>\r\n<p>This document is valid from the date of its approval and will be reviewed on an annual basis. The current&nbsp;working copy will be identified as such, and any superseded documents will be archived and maintained&nbsp;for a period of five years.</p>\r\n<p>New versions will be identified with a versioning number. Full integers will denote a major document&nbsp;version, and a decimal number will indicate minor amendments or edits.&nbsp;</p>',	'',	'FNQH-POL-MI-080722',	4,	'',	'',	0,	1,	453,	'2022-09-15 22:31:35'),
(25,	'FNQH-SOP-060522',	'DOCUMENT CONTROL ',	453,	12,	0,	'2022-09-05',	'2022-09-12',	0,	1,	'TCB',	0,	12,	'2023-09-12',	'2022-12-16',	'Sarah Sharpe',	'<p class=\"Copyright\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</span></p>\r\n<p class=\"Copyright\"><span style=\"font-family: Calibri, sans-serif;\">Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</span></p>',	'<p>1.<span style=\"white-space: pre;\"> </span>Introduction, Purpose Scope &amp; Users</p>\r\n<p>This document is intended to document the standard operating procedures (SOP) at FNQH Pathology for Document Control and details the processes, steps, and detailed instructions so that the relevant (authorised) team member can carry out the task correctly every time.</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>Control of Internal Documents</p>\r\n<p>Internal documents are all documents created inside the organisation.&nbsp;</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>Document formatting&nbsp;</p>\r\n<p>The below subheadings are sections that should be used and adhered to in each template for clear composition. Please use this in-life document to identify the layout and placement for how a document template should be created and used for each of the subheading sections and their values outlined below.&nbsp;</p>\r\n<p>4.<span style=\"white-space: pre;\"> </span> Document Control&nbsp;</p>\r\n<p>When creating a document manually the document header must contain the organization\'s logo and the confidentiality level. The footer contains the document name, the current version and date of the document, and the number of pages.&nbsp; The Document ID is used to quickly &amp; easily identify documents that are a part of the ISMS. This ID is generated based on the following:&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Company Name: FNQH Pathology</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>A category type: Process, Policy, Procedure, Job Description, Evidence (e.g. Proc, Pol, Mins)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Unique reference number: e.g. FNQH-SOP-12345</p>\r\n<p>The Version Number is used to control and understand the adaptation and status of a new or in life document.</p>\r\n<p>Date of Version states the date that the document was last edited/updated.&nbsp;</p>\r\n<p>Created By states the individual person who initiated and drafted the original document.&nbsp;</p>\r\n<p>Approved By states the individual person who authorised the documents initial creation in line with the original Created By documents&rsquo; owner.&nbsp;</p>\r\n<p>Confidentiality Level - Documents that have a higher confidentiality level, for which the distribution needs to be limited, are published by the document owner and stored on restricted access SharePoint page relevant to the distribution list.&nbsp;&nbsp;</p>\r\n<p>5.<span style=\"white-space: pre;\"> </span>Document Approval&nbsp;</p>\r\n<p><span style=\"white-space: pre;\">- </span>All new and major release documents are to be submitted for approval by the Lead Pathologist, or in the absence of the Lead Pathologist, by the most senior executive.</p>\r\n<p>- Some documents may require review before approval by one or more designated reviewers who have an interest in, or competence about, the document content.&nbsp;&nbsp;</p>\r\n<p><span style=\"white-space: pre;\">- </span>Please reference sub heading Document Control under Document Formatting to understand the differences in Version Numbers and how they are formed/determined.&nbsp;&nbsp;</p>\r\n<p><span style=\"white-space: pre;\">- </span>Minor Release &ndash; All new minor releases are deemed as pre-approved for immediate release by the author who makes changes to the document. These do not need to go through any additional formal authorisation process so long as the author adheres to the Document Control procedure that keeps the Change History and Version Number up to date across all areas of the document that reflect these values.&nbsp;&nbsp;</p>\r\n<p><span style=\"white-space: pre;\">- </span>ALL documents that move through the Document Approval process are NOT permitted to have the final &lsquo;Approved by&rsquo; person the same as the &lsquo;Created by&rsquo; person. The final authorising officer must be different to that of the person who initially created the document coming from an unbiased view.&nbsp;</p>\r\n<p>6.<span style=\"white-space: pre;\"> </span>Publishing &amp; Distributing Documents; Withdrawal from Use&nbsp;</p>\r\n<p>Drafts - Any documents that are being drafted and are a current work in progress will remain in the &ldquo;working&rdquo; section or folder in the FNQH Pathology folder whilst the author continues to edit the non-live document.&nbsp;</p>\r\n<p>Ready For Review - Any document that is ready to be reviewed for clearance by an approved member of the FNQH Pathology senior management team will be moved and remain sitting in this folder or section until the document has been approved or rejected by the appropriate parties.&nbsp;</p>\r\n<p>Clearance Authorised - Once a document has been authorised as ready for clearance by an appropriate authorised party, they will move the accepted document into production with the old document version (if existent) retired.&nbsp;</p>\r\n<p>Archive - The Archive section or folder is where old versions of documents are moved to once they are retired and moved out of production. Old versions of documents are to remain here as a reference point should they need to be referred back to in the future.&nbsp;</p>\r\n<p>7.<span style=\"white-space: pre;\"> </span>Document Updates&nbsp;&nbsp;</p>\r\n<p>The person listed as document owner has the responsibility for updating the document. Updates are performed in line with the frequency defined for each document, but at least once a year.&nbsp;</p>\r\n<p>All changes to the document must be described briefly in the \"Change History\" table.&nbsp;</p>\r\n<p>8.<span style=\"white-space: pre;\"> </span>Records Control&nbsp;</p>\r\n<p>Each internal document must define how records resulting from the use of such a document should be managed; i.e., it must specify the following:&nbsp;&nbsp;</p>\r\n<p>(1) record title,&nbsp;&nbsp;</p>\r\n<p>(2) storage location,&nbsp;&nbsp;</p>\r\n<p>(3) person responsible for storage,&nbsp;</p>\r\n<p>(4) controls for record protection, and&nbsp;&nbsp;</p>\r\n<p>(5) retention time.&nbsp;</p>\r\n<p>Employees of the organisation may access stored records only after obtaining permission from the person designated as the person responsible for storing individual records. If the sensitivity of certain records is such that permission for access must be obtained from a different person, this must be stated in the concerned internal document in the chapter describing records control. Access and retrieval rights for records are determined by the owners of individual records. Senior Leadership is responsible for destroying all records for which the retention time has expired.&nbsp;</p>\r\n<p>9.<span style=\"white-space: pre;\"> </span>Control of Public Documents&nbsp;</p>\r\n<p>The format and management of Public Documents are to follow the exact same standards and regulations as all those mentioned above outlined under the key heading &ldquo;Control Of Internal, Confidential &amp; Unclassified Documents&rdquo;. The only exclusions to these procedures and practices are the following:&nbsp;</p>\r\n<p>The &ldquo;Document Control&rdquo; section MUST be removed completely from any document that is classified as &ldquo;PUBLIC&rdquo;.&nbsp;</p>\r\n<p>The &ldquo;Change History&rdquo; section MUST be removed completely from any document that is classified as &ldquo;PUBLIC&rdquo;.&nbsp;</p>\r\n<p>10.<span style=\"white-space: pre;\"> </span>Documents of external origin&nbsp;</p>\r\n<p>External Document Control&nbsp;</p>\r\n<p>Each external document that is necessary for the planning and operation must be recorded in the appropriate database e.g. PathHub, SharePoint, Customer Contracts (if applicable).&nbsp;</p>\r\n<p>The person who receives such external documents through regular mail or as courier parcels must forward them to the Office Manager who must make a record.&nbsp;</p>\r\n<p>11.<span style=\"white-space: pre;\"> </span> Managing Records kept on the basis of this document</p>\r\n<p>All records supporting this policy shall be kept in the FNQH Pathology document management system in the location, or system based, indicated in the procedure document. Any additional or deleted records shall be kept account of in the FNQH Pathology logging system such that any future enquiry will be able to clearly identify when the changes occurred, who made them, what these changes were and how the changes were approved.</p>\r\n<p>12.<span style=\"white-space: pre;\"> </span>Validity and Document Management</p>\r\n<p>This document is valid from the date of its approval and will be reviewed on an annual basis. The current working copy will be identified as such, and any superseded documents will be archived and maintained for a period of five years.</p>\r\n<p>New versions will be identified with a versioning number. Full integers will denote a major document version, and a decimal number will indicate minor amendments or edits.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>',	'',	'FNQH-SOP-060522',	4,	'',	'',	0,	1,	453,	'2022-09-16 11:09:27'),
(26,	'FNQH-SOP-CM160922',	'COLLECTION MANUAL',	453,	12,	0,	'2022-09-05',	'2022-09-12',	0,	1,	'TCB',	0,	12,	'2023-09-12',	'2022-09-16',	'Sarah Sharpe',	'<p>This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording, or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</p>\r\n<p>Note for non-FNQH Pathology readers: The contents of this publication are subject to the incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</p>\r\n<p>&nbsp;</p>',	'<p>1.<span style=\"white-space: pre;\"> </span>Introduction, Purpose Scope &amp; Users</p>\r\n<p>This document is intended to document the standard operating procedures (SOP) at FNQH Pathology for Collection Procedures (manual) and details the processes, steps, and detailed instructions so that the relevant (authorised) team member can carry out the task correctly every time.&nbsp;</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>Facilities Required at the Clinic</p>\r\n<p><span style=\"white-space: pre;\">- </span>Storage area for shipping boxes and supplies.</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>Specimen Collection Laboratory Supplies to be provided by FNQH Pathology&nbsp;</p>\r\n<p><span style=\"white-space: pre;\">- </span>To be supplied by FNQH Pathology upon the request of the clinic:</p>\r\n<p><span style=\"white-space: pre;\">- </span>Items required to collect and store specimens.</p>\r\n<p>4.<span style=\"white-space: pre;\"> </span>Biopsy Procedure</p>\r\n<p><span style=\"white-space: pre;\">- </span>Please collect all specimens according to the procedures set forth in your organisation.</p>\r\n<p><span style=\"white-space: pre;\">- </span>For the routine processing of specimens, please submerge the specimen in pre-filled formalin containers (for ideal fixation, the ratio of 10% buffered formalin to tissue should be 10:1).</p>\r\n<p><span style=\"white-space: pre;\">- </span>For advice on sampling methods for particular scenarios please contact the laboratory.</p>\r\n<p><span style=\"white-space: pre;\">- </span>FNQHP accepts skin specimens only.&nbsp;</p>\r\n<p><span style=\"white-space: pre;\">- </span>FNQHP is not able to offer immunofluorescence studies.</p>\r\n<p>Specimen Collection and Labelling</p>\r\n<p><span style=\"white-space: pre;\">- </span>Please complete a specimen request form for each patient including at least:</p>\r\n<p><span style=\"white-space: pre;\">- </span>First name and surname</p>\r\n<p><span style=\"white-space: pre;\">- </span>Date of birth</p>\r\n<p><span style=\"white-space: pre;\">- </span>Address</p>\r\n<p><span style=\"white-space: pre;\">- </span>Type and number of specimens</p>\r\n<p><span style=\"white-space: pre;\">- </span>Relevant clinical information</p>\r\n<p><span style=\"white-space: pre;\">- </span>If the specimen is urgent, indicate time and date the report is required.</p>\r\n<p><span style=\"white-space: pre;\">- </span>For the specimen jar, please check a specimen is in the jar and label it with:</p>\r\n<p><span style=\"white-space: pre;\">- </span>First name and surname, and</p>\r\n<p><span style=\"white-space: pre;\">- </span>Specimen site and/or number (corresponding with the request form).</p>\r\n<p><span style=\"white-space: pre;\">- </span>Each patient should have a separate biohazard bag with specimens and request forms separated in the bag.</p>\r\n<p><span style=\"white-space: pre;\">- </span>A list of the specimens should be enclosed with each batch so that the specimens can be checked off and any discrepancies can be resolved quickly.</p>\r\n<p>5.<span style=\"white-space: pre;\"> </span>Storage</p>\r\n<p><span style=\"white-space: pre;\">- </span>Samples must be stored in an adequate volume of formalin.&nbsp;</p>\r\n<p><span style=\"white-space: pre;\">- </span>Storage should be at room temperature.</p>\r\n<p>6.<span style=\"white-space: pre;\"> </span>Packaging</p>\r\n<p><span style=\"white-space: pre;\">- </span>Triple packaging is recommended for the surface transport of all specimens.</p>\r\n<p><span style=\"white-space: pre;\">- </span>Packaging should consist of three components (triple packed) and must be packaged as follows:&nbsp;</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>The primary receptacle(s) should be leakproof (i.e. the specimen pot).</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>The primary receptacle(s) should be placed into leakproof secondary packaging with sufficient absorbent material to absorb any likely spill. Multiple fragile primary receptacles must be packed with suitable cushioning material in such a way that any release of liquid substance will not compromise the integrity of the cushioning material&nbsp;</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>The secondary packaging/s should be placed into an outer packaging of adequate strength for its capacity, mass and intended use and with a secure closure to prevent loss of contents.</p>\r\n<p>For example:</p>\r\n<p><span style=\"white-space: pre;\">- </span>Place each patient&rsquo;s specimen pot inside a sealable plastic bag.</p>\r\n<p><span style=\"white-space: pre;\">- </span>Place all the samples for the batch inside a large sealable plastic bag or crate containing absorbent material (e.g. combine dressing).</p>\r\n<p><span style=\"white-space: pre;\">- </span>Place the large bag or crate containing all the samples inside a shipping crate or Esky.</p>\r\n<p>Clearly label the outside of the shipping crate with the name and address of origin and the laboratory address:</p>\r\n<p><span style=\"white-space: pre;\">- </span>FNQH Pathology, 274 Mulgrave Rd, Westcourt QLD 4870</p>\r\n<p>Shipping</p>\r\n<p><span style=\"white-space: pre;\">- </span>Samples should be shipped to the laboratory on the day of biopsy.</p>\r\n<p><span style=\"white-space: pre;\">- </span>The laboratory should be notified of shipments using the electronic ordering system.</p>\r\n<p>7.<span style=\"white-space: pre;\"> </span>Managing Records kept on the basis of this document</p>\r\n<p>All records supporting this policy shall be kept in the FNQH Pathology document management system in the location, or system based, indicated in the procedure document. Any additional or deleted records shall be kept account of in the FNQH Pathology logging system such that any future enquiry will be able to clearly identify when the changes occurred, who made them, what these changes were and how the changes were approved.</p>\r\n<p>8.<span style=\"white-space: pre;\"> </span>Validity and Document Management</p>\r\n<p>This document is valid from the date of its approval and will be reviewed on an annual basis. The current working copy will be identified as such, and any superseded documents will be archived and maintained for a period of five years.</p>\r\n<p>New versions will be identified with a versioning number. Full integers will denote a major document version, and a decimal number</p>',	'',	'FNQH-SOP-CM160922',	4,	'',	'',	0,	1,	453,	'2022-09-16 11:20:24'),
(27,	'FNQH PATHOLOGY-SOP-100622 ',	'Complaints',	453,	12,	0,	'2022-09-06',	'2022-09-16',	0,	1,	'TCB',	0,	12,	'2023-09-16',	'2022-09-16',	'Sarah Sharpe',	'<p class=\"Copyright\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">This publication has been prepared and written by FNQH PATHOLOGY and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</span></p>\r\n<p class=\"Copyright\"><span style=\"font-family: Calibri, sans-serif;\">Note for non-FNQH PATHOLOGY readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH PATHOLOGY does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</span></p>',	'<p>1.<span style=\"white-space: pre;\"> </span>Introduction, Purpose Scope &amp; Users</p>\r\n<p>This document is intended to document the policy at FNQH Pathology for complaints and details the processes, steps, and detailed instructions so that the relevant (authorised) team member can carry out the task correctly every time.</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>Overview - Complaint Standard Operating Procedure</p>\r\n<p>Opportunities are available for patients and other visitors to tell us &ldquo;how we are doing,&rdquo; and we collect systematic patient experience feedback. The practice information sheet provides patients with information on how to provide feedback, including how to make a complaint.&nbsp;&nbsp;</p>\r\n<p>Patients have a &lsquo;right to complain&rsquo;, and where possible, patients and others are encouraged to raise any concerns directly with the laboratory team, who are all trained to make sure patients of the business feel confident that any feedback or complaints will be handled appropriately. FNQH Pathology are committed to ensuring complaints will be responded to when the patients or other people such as carers, relatives, friends, or other consumers make them known to our team.&nbsp;&nbsp;</p>\r\n<p>Under national and QLD privacy laws, FNQH Pathology provides and adheres to a complaints process for privacy issues and those related to the Australian Privacy Principles (APPs).</p>\r\n<p>All members of the laboratory team are educated to be prepared to address complaints as they arise. Depending on the nature of the complaint and any advice received from our medical indemnity insurers where required, complaints are recorded and actioned with a copy placed in the patient&rsquo;s health record if related to patient care.</p>\r\n<p>All clinical, medical, and administration staff are aware of the professional and legal obligations regarding the mandatory reporting of unprofessional conduct.</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>Procedure</p>\r\n<p>Patients and others have opportunities to register their complaints either verbally, in writing (letter), or via our suggestion box. Patients or others are able to complain anonymously if desired. All members of FNQH Pathology are aware of our commitment to address complaints as they arise.&nbsp;&nbsp;</p>\r\n<p>When receiving complaints, our practice keeps in mind the following in order to minimise further patient anxiety and hostility:</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Handle all complaints seriously, no matter how trivial they may seem.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Verbal complaints made in person should be addressed in a private area of the business where possible.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Use tactful language when responding to complaints.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Do not blame others; patients may not have all the facts, or they may distort them.&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Address the patient&rsquo;s expectations regarding how they want the matter resolved.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Assure the patient that their complaint will be investigated and the matter not disregarded.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Offer the person an opportunity to complete a formal complaint form (they may accept or decline).</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Document all complaints and other relevant information and place this in the complaint folder so the person designated to manage complaints is informed of the complaint (even if the matter appears to have been resolved).</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Alert the Lead Pathologist or Laboratory Manager about disgruntled or hostile patients so they can diffuse the situation immediately - often patients are reluctant to make a complaint directly to a general practitioner.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Always inform the person designated to manage complaints if you become aware of any significant statements made by the patient or significant change in patient attitude.&nbsp;</p>\r\n<p>NQH Pathology has appointed to the Chief Technology Officer and Business Operations Manager with designated responsibility for seeking, collecting, analysing, investigating, resolving and managing all feedback and complaints. Any investigation and resolution of complaints is undertaken using an open disclosure process, incorporating the following:&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Acknowledge the patient&rsquo;s right to complain.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Acknowledge receipt of the complaint as soon as possible but within two (2) working days using the Acknowledgment of Complaint letter template.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Respond to all complaints as soon as reasonably practicable, but within thirty (30) days in an open and constructive manner, including an explanation and, if appropriate, an apology.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>If a resolution of the matter is to take longer than thirty (30) days, an update of the resolution activities will be provided to the patient, with an anticipated revised timeframe for resolution.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Work with the patient to resolve the complaint and communicate the outcome with the patient, including any changes made as a result of the complaint.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Where a complaint is made against a laboratory member, provide the team member with an opportunity to discuss the details in a private setting.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Ensure the complaint does not adversely affect the patient&rsquo;s care.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Record the complaint, investigation and actions in the dedicated complaints file and, if related to patient care, include a copy in the patient&rsquo;s health record.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Ensure, where appropriate, complaints are reviewed at laboratory team meetings; analyse trends and discuss the methods of resolution.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Review other types of patient feedback (i.e. feedback surveys, suggestion box) during laboratory team meetings.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Keep a record of improvement(s) made in response to feedback or complaints.&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Where appropriate, inform the patient about practice improvements made as a result of their input.&nbsp;</p>\r\n<p>4.<span style=\"white-space: pre;\"> </span>The matter cannot be resolved</p>\r\n<p>If the matter cannot be resolved, the patient is advised about how to contact the external health complaints agency for:</p>\r\n<p>Queensland</p>\r\n<p>Office of the Health Ombudsman</p>\r\n<p>Telephone: 133 646&nbsp;</p>\r\n<p>Web: www.oho.qld.gov.au&nbsp; &nbsp;&nbsp;</p>\r\n<p>Complaints that relate to privacy issues or concerns that cannot be resolved internally are to be directed to the Office of the Australian Information Commissioner (OAIC).&nbsp;</p>\r\n<p>Office of the Australian Information Commissioner&nbsp;</p>\r\n<p>Telephone: 1300 363 992</p>\r\n<p>Postal Address: GPO Box 5218, Sydney NSW 2001</p>\r\n<p>Web: www.oaic.gov.au&nbsp;&nbsp;</p>\r\n<p>Members of the public may make a notification to the Australian Health Practitioner Regulation Agency (AHPRA) - www.ahpra.gov.au - about the conduct, health or performance of a practitioner or the health of a student. Practitioners, employers, and education providers are all mandated by law to report notifiable conduct relating to a registered practitioner or student to AHPRA.&nbsp;</p>\r\n<p>5.<span style=\"white-space: pre;\"> </span>Managing Records kept on the basis of this document</p>\r\n<p>All records supporting this policy shall be kept in the FNQH Pathology document management system in the location, or system based, indicated in the procedure document. Any additional or deleted records shall be kept account of in the FNQH Pathology logging system such that any future enquiry will be able to clearly identify when the changes occurred, who made them, what these changes were and how the changes were approved.</p>\r\n<p>6.<span style=\"white-space: pre;\"> </span>Validity and Document Management</p>\r\n<p>This document is valid from the date of its approval and will be reviewed on an annual basis. The current working copy will be identified as such, and any superseded documents will be archived and maintained for a period of five years.</p>\r\n<p>New versions will be identified with a versioning number. Full integers will denote a major document version, and a decimal number will indicate minor amendments or edits.</p>\r\n<p>&nbsp;</p>',	'',	'FNQH PATHOLOGY-SOP-100622 ',	4,	'',	'',	0,	1,	453,	'2022-09-16 11:29:38'),
(28,	' FNQH-SOP-CS030722 ',	'Cut up Protocols',	453,	12,	0,	'2022-09-05',	'2022-09-16',	0,	1,	'TCB',	0,	12,	'2023-09-16',	'2022-09-16',	'Sarah Sharpe',	'<p>This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</p>\r\n<p>&nbsp;</p>\r\n<p>Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</p>\r\n<p>&nbsp;</p>',	'<p>1.<span style=\"white-space: pre;\"> </span>Introduction, Purpose, Scope, &amp; Users</p>\r\n<p>This document is intended to document the standard operating procedures (SOP) at FNQH Pathology for Cut Up Procedures (manual) and details the processes, steps, and detailed instructions so that the relevant (authorised) team member can carry out the task correctly every time. This manual is based on the RCPA Macroscopic Cut Up Manual.</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>External Inspection&nbsp;&nbsp;</p>\r\n<p>PROCEDURE/SPECIMEN TYPE</p>\r\n<p>Record as stated by the clinician.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Excision</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Ellipse, with orientation</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Ellipse, without orientation</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Polygonal or irregular</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Wedge</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Punch</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Shave</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Re-excision</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Curette</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Incision</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Other</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Moh\'s specimens</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Scalp biopsies for alopecia</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Nail bed biopsies</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Other, describe</p>\r\n<p>SPECIMEN ORIENTATION</p>\r\n<p>ORIENTATION MARKERS</p>\r\n<p>Record additional orientation or designation provided by operating clinician:</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Absent</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Present</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Method of orientation (e.g. suture, incision)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Describe orientation of the marker at cut-up (e.g. 12 o\'clock, superior, medial)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Record any coloured inks applied and to which margin</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Describe any dermoscopically identified areas</p>\r\n<p>SPECIMEN INTEGRITY</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Intact</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Disrupted/fragmented, describe</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Number of pieces</p>\r\n<p>ANATOMICAL COMPONENTS PRESENT</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Epidermis</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Dermis</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Subcutis</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Skeletal muscle</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Cartilage</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Bone</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Large vessels</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Large nerves</p>\r\n<p>SPECIMEN SIZE (MM)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>In three dimensions</p>\r\n<p>LESION</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Absent</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Present</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Number; if more than one lesion, designate and describe each separately noting the distance between each lesion.</p>\r\n<p>LESION SIZE (MM)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>In three dimensions</p>\r\n<p>DISTANCE TO MARGINS (MM)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Distance of lesion to closest margin</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Specify margin if orientated</p>\r\n<p>LESION DESCRIPTION</p>\r\n<p>PRIMARY LESION&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Macule &ndash; flat, non palpable, &lt;10mm in diameter</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Papule &ndash; elevated lesion, &lt;10mm in diameter</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Vesicle &ndash; small, clear fluid filled blister, &lt;10mm in diameter</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Bullae &ndash; clear fluid filled blister, &gt;10mm in diameter</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Nodule &ndash; firm papule or lesion that extends to dermis or subcutis</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Plaque &ndash; palpable lesion, &gt;10mm in diameter</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Scar</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Ulcer</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Cyst</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Describe contents (eg. soft white material)</p>\r\n<p>SECONDARY EFFECT</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Keratotic</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Ulcerated/ulceration</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Maximum dimension</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Pigmented, describe colour(s) and variability</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Uniform</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Variegated</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Roughened</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Papillomatous</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Skin-covered</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Telangiectasia</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Haemorrhagic</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Necrotic</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Colour, describe</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Border</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Smooth</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Irregular</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Distinct</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Indistinct</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>DISSECTION</p>\r\n<p>3.1.1.<span style=\"white-space: pre;\"> </span>CASSETTE COLOURS</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Standard = White</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Levels required = Blue</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Urgent = Yellow</p>\r\n<p>3.1.2.<span style=\"white-space: pre;\"> </span>SMALL SPECIMENS</p>\r\n<p>PUNCH BIOPSY<span style=\"white-space: pre;\"> </span>&nbsp; &nbsp; &nbsp;SHAVE BIOPSY</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>No dissection is required for shave biopsies, curettings and punch biopsies &lt;3mm.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Punch/shave biopsies &gt;3mm should be bisected.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Ellipses of skin can be serially sectioned transversely at 2-4mm intervals, if embedding tips ensure these are clear of the lesion.&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>For small lesions, bisect off centre to maximise visualisation of lesion.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>3.1.3.<span style=\"white-space: pre;\"> </span>LIP AND EAR SPECIMENS&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Usually, lip and ear biopsies will be wedge-shaped and can be sectioned at 3mm intervals to include the lateral margins, depending on the anatomic location of the lesion. Alternatively, the specimen can be dissected with longitudinal or shave sections at both lateral margins. Refer to the RCPA manual for further diagrams and videos, or discuss with the Pathologist.&nbsp;&nbsp;</p>\r\n<p>3.1.4.<span style=\"white-space: pre;\"> </span>ORIENTATED SPECIMENS</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>The method of orientation (e.g.suture) and what is indicated (e.g. superior margin) should be recorded. Its placement at the time of macroscopy should also be recorded. In many laboratories the suture is generically placed at the 12 o&rsquo;clock position and the specimen is painted along one margin as a minimum. The protocol shown in the illustration below uses three different coloured inks enabling clear identification of the four quadrants. Refer to RCPA Cut up manual for further information (see references).</p>\r\n<p>PLEASE NOTE - PAINTING PROTOCOLS DIFFER BETWEEN LABORATORIES</p>\r\n<p>3.1.5.<span style=\"white-space: pre;\"> </span>LARGE SPECIMENS</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Large specimens, 50-100mm, will require targeted sectioning guided by visual inspection. The margins of oriented specimens may be painted with ink.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Record colour of inks applied and their corresponding margins.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Section transversely (&ldquo;breadloaf&rdquo;) and lay out slices in sequential order to demonstrate maximum depth of the lesion and its relationship to margins. Photograph and record a block allocation key if required.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>One method for very large specimens, &gt;100mm, is to section radially round the perimeter of the lesion, then bread-loaf as for other specimens. Inspect carefully for multiple/multifocal lesions, lymph nodes, large nerves, blood vessels and attached tissues (e.g. salivary gland, bone and cartilage). Photograph to record a block allocation key.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Record the plane of dissection in orientated specimens or indicate in a diagram or photograph of the dissected specimen. Refer to RCPA Cut up manual for further information (see references).</p>\r\n<p>&nbsp;</p>\r\n<p>3.1.6.<span style=\"white-space: pre;\"> </span>INTERNAL INSPECTION</p>\r\n<p>Describe any relevant cut surface appearance such as:</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Tumour extent</p>\r\n<p>&nbsp;</p>\r\n<p>Photograph the dissected specimen if required.</p>\r\n<p>3.1.7.<span style=\"white-space: pre;\"> </span>LYMPH NODES (IF PRESENT)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Sentinel lymph nodes</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Regional lymphadenopathy</p>\r\n<p>&nbsp;</p>\r\n<p>Retrieved from resection specimen</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Describe site(s)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Number retrieved</p>\r\n<p>Separately submitted</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>For each container, record specimen number and designation</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Collective size of tissue in three dimensions (mm)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Number of grossly identified lymph nodes submitted</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Maximum diameter of each (mm)</p>\r\n<p>If tumour macroscopically involves any lymph nodes, record:</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Number of macroscopically-involved nodes out of total number of lymph nodes retrieved.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Maximum dimension of largest metastasis.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Note any visible extranodal spread and its proximity to the surgical margin.</p>\r\n<p>3.1.8.<span style=\"white-space: pre;\"> </span>SPECIMENS &lt;10MM</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Submit all tissue for processing. Biopsy pads or similar may be used to prevent loss of tissue during processing.</p>\r\n<p>3.1.9.<span style=\"white-space: pre;\"> </span>SPECIMENS&gt;10MM</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Serially section the specimen sequentially to demonstrate maximum depth of the lesion and its relationship to the margins. A photograph of the dissected specimen may be useful and can facilitate block identification.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>It is recommended that most, or all, of the lesion is examined focusing on parameters which may upstage the tumour or affect prognosis.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>The extent of sampling should take into account the following factors of the lesion:</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Maximum thickness</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Any unusual features</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Heterogeneous areas</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Areas of ulceration</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Proximity to the margins (sampling of polar margins is undertaken at the discretion of the laboratory but is recommended if the lesion is within 1-2mm of the margin)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Pay careful attention to the possibility of multiple lesions in large specimens. Each lesion must be sampled as well as the area between lesions to determine if truly separate lesions are present.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>For large lesions with prior biopsies, the earlier report may also indicate a need for greater sampling e.g. where there is perineural spread, lymphovascular invasion etc.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Keratin may need to be trimmed to allow hyperkeratotic lesions to fit in cassettes.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Fat may need to be trimmed if greater than 15mm in thickness and macroscopically normal.</p>\r\n<p>3.1.10.<span style=\"white-space: pre;\"> </span>&nbsp; &nbsp;MELANOCYTIC LESIONS INCLUDING CONGENITAL NAEVI</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Additional targeted sampling of the following is recommended:</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Darker areas</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Pale possible regressed areas</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Heterogeneous foci</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Crusted foci</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Separate smaller (satellite) lesions</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Ulceration/erosion</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Ink marking can assist in correlating areas of dermatoscopic concern at subsequent microscopic examination.</p>\r\n<p>3.1.11.<span style=\"white-space: pre;\"> </span>PIGMENTED LESIONS &gt;100MM</p>\r\n<p>One suggested method is to submit all radial sections from the perimeter of the specimen. Submit representative or alternate sections from the remainder of the bread-loafed specimen using the targeted sampling described for large specimens.</p>\r\n<p>3.1.12.<span style=\"white-space: pre;\"> </span>ATYPICAL MELANOCYTIC LESIONS AND MELANOMAS</p>\r\n<p>Where the specimen is a macroscopically atypical melanocytic lesion or previously diagnosed on biopsy as melanoma, submit all sections of the whole lesion. Where the edge of the lesion is indistinct the whole specimen should be embedded including the poles from the long axis.</p>\r\n<p>SKIN RE-EXCISIONS FOR MELANOMA</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Sample any macroscopic residual tumour and separate pigmented lesions. More sampling is suggested where there was microscopic perineural invasion, neurotropism, extensive regression, amelanotic tumour, lymphovascular invasion, satellites, angiotropism in the original specimen.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>No clear recommendation exists but in the absence of a previous positive margin and no macroscopic abnormality, the minimum regime is to sample the specimen in its shortest transverse axis, incorporating the area from where the scar appears to the margins. This can generally be achieved in 1-4 cassettes.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Record a diagram of inking and sampling of orientated re-excision specimens.</p>\r\n<p>3.1.13.<span style=\"white-space: pre;\"> </span>LYMPH NODES (WHEN PRESENT)</p>\r\n<p>No clear recommendation exists. One approach is to submit all lymph nodes &lt;10mm whole. Bisect through longitudinal axis if greater than 3mm. Lymph nodes &gt;10mm may be \"bread-loaf\" sectioned into 3-5mm slices and nodes macroscopically suspicious for metastases sampled.</p>\r\n<p>4.<span style=\"white-space: pre;\"> </span>REFERENCES&nbsp;</p>\r\n<p>https://www.rcpa.edu.au/manuals/macroscopic-cut-up-manual/skin-soft-tissue-and-bone/skin</p>\r\n<p>5.<span style=\"white-space: pre;\"> </span>Managing Records kept on the basis of this document</p>\r\n<p>All records supporting this policy shall be kept in the FNQH Pathology document management system in the location, or system based, indicated in the procedure document. Any additional or deleted records shall be kept account of in the FNQH Pathology logging system such that any future enquiry will be able to clearly identify when the changes occurred, who made them, what these changes were and how the changes were approved.</p>\r\n<p>6.<span style=\"white-space: pre;\"> </span>Validity and Document Management</p>\r\n<p>This document is valid from the date of its approval and will be reviewed on an annual basis. The current working copy will be identified as such, and any superseded documents will be archived and maintained for a period of five years.</p>\r\n<p>&nbsp;</p>\r\n<p>New versions will be identified with a versioning number. Full integers will denote a major document version, and a decimal number will indicate minor amendments or edits.</p>\r\n<p>&nbsp;</p>',	'',	' FNQH-SOP-CS030722 ',	4,	'',	'',	0,	1,	453,	'2022-09-16 11:37:16'),
(29,	'FNQH-SOP-RE030722 ',	'Issuing Amended and Supplementary Reports',	453,	12,	0,	'2022-09-05',	'2022-09-16',	0,	1,	'TCB',	0,	12,	'2023-09-16',	'2022-09-16',	'Sarah Sharpe',	'<p>&nbsp;</p>\r\n<p>This publication has been prepared and written by FNQH and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</p>\r\n<p>&nbsp;</p>\r\n<p>Note for non-FNQH readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</p>\r\n<p>&nbsp;</p>',	'<p>1.<span style=\"white-space: pre;\"> </span>Introduction, Purpose Scope &amp; Users</p>\r\n<p>This document is intended to document the Standard Operating Procedures (protocol) at FNQH Pathology for issuing amended and supplementary reports and details the processes, steps, and detailed instructions so that the relevant (authorised) team member can carry out the task correctly every time.</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>DEFINITIONS&nbsp;</p>\r\n<p>Supplementary Reports: These include instances where further information or refinement of diagnosis or further ancillary test results are expected at the time of issuing of the original report and the fact that such information will be available in future is mentioned in the body of the original report on the case. Thus any person reading the original report knows to expect another report (&ldquo;supplementary report&rdquo;) to exist or expect it to be created in time.&nbsp;</p>\r\n<p>Amended Reports: These include instances where &ldquo;significant&rdquo; information in the original report is deemed to be incorrect (in error) and which is identified at a date later than issuing of the original report. Such incorrect information may relate to patient demographics, specimen details or significant alteration of diagnosis or important prognostic parameters.&nbsp;</p>\r\n<p>In respect of Supplementary Reports:&nbsp;</p>\r\n<p>1. The subsequent report issued should be titled SUPPLEMENTARY REPORT.</p>\r\n<p>2. Such title be added to the original report at the top of the 1st page of the report, with the date, and &ldquo;see end of report&rdquo; (ie. SUPPLEMENTARY REPORT ADDED 01/07/22, SEE END OF REPORT).</p>\r\n<p>3. The original report be altered in no way.</p>\r\n<p>4. The additional information be added to the end of the report with other relevant details such as date, time, and reason for addition.</p>\r\n<p>5. The report should be authorized as per the usual protocols.&nbsp;</p>\r\n<p>In respect of Amended Reports:&nbsp;</p>\r\n<p>1. The subsequent report be titled AMENDED REPORT&nbsp;</p>\r\n<p>2. Such title be added to the template of the original report at the top of the 1st page of the report with any other relevant details such as date and time of addition, location of amendment, and reason for the amendment or the addition as is deemed prudent.</p>\r\n<p>3. The additional information be added in detail in an appropriate location of the report so as to ensure that all aspects of the additional information be readily apparent to the recipients (for example bolded or italicized)&nbsp;</p>\r\n<p>4. The original report be altered in no way with the additional and/or altered information or assessment be an addition without altering the previous report.&nbsp;</p>\r\n<p>5. Any known additional clinicians or locations involved in the management of the patient since the original report was transmitted be added to the distribution list of the amended report as is deemed prudent.</p>\r\n<p>6. In addition the relevant amended information should be verbally transmitted to the clinician primarily involved in the current management of the patient or to multiple clinicians where a definite primary clinician cannot be identified to make the clinicians aware of the existence of the amended report.</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>REFERENCES</p>\r\n<p>https://www.rcpa.edu.au/getattachment/51f90738-97a2-415c-a21c-f264f15362c6/Supplementary-Amended-Reports-Anatomical-Pathology.aspx</p>\r\n<p>4.<span style=\"white-space: pre;\"> </span>NOTES</p>\r\n<p>When a report is issued in Anatomical Pathology the clinicians may access the information in one of several ways:&nbsp;</p>\r\n<p>1.<span style=\"white-space: pre;\"> </span>Electronically via practice software</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>Electronically via email</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>Printed paper copy</p>\r\n<p>4.<span style=\"white-space: pre;\"> </span>Verbally from the pathologist</p>\r\n<p>In the case of a supplementary report, further information is expected to be relayed at a later date and this would be taken into consideration when management decisions are made for the patient.&nbsp;</p>\r\n<p>In the case of amended reports there is an unexpected correction of the error in the information contained in the original reports &ndash; this correction requires to be communicated at least one of ways mentioned above, and receipt should be acknowledged. It is possible that in the meantime management decisions may have been made on the basis of &ldquo;erroneous information contained in the original report&rdquo; hence for medicolegal purposes the content of the original report should not be altered in any way except by way of addition that details the additional information or the error correction clearly.</p>\r\n<p>5.<span style=\"white-space: pre;\"> </span>Managing Records kept on the basis of this document</p>\r\n<p>All records supporting this policy shall be kept in the FNQH Pathology document management system in the location, or system based, indicated in the procedure document. Any additional or deleted records shall be kept account of in the FNQH Pathology logging system so that any future enquiry will be able to clearly identify when the changes occurred, who made them, what these changes were and how they were were approved.</p>\r\n<p>6.<span style=\"white-space: pre;\"> </span>Validity and Document Management</p>\r\n<p>This document is valid from the date of its approval and will be reviewed on an annual basis. The current working copy will be identified as such, and any superseded documents will be archived and maintained for a period of five years.</p>\r\n<p>New versions will be identified with a versioning number. Full integers will denote a major document version, and a decimal number will indicate minor amendments or edits.</p>',	'',	'FNQH-SOP-RE030722 ',	4,	'',	'',	0,	1,	453,	'2022-09-16 11:42:26'),
(30,	'FNQH-COM-POL-100622',	'FNQH Pathology Complaints',	453,	14,	0,	'2022-09-05',	'2022-09-12',	0,	1,	'TCB',	0,	12,	'2023-09-12',	'2022-09-16',	'Sarah Sharpe',	'<p>This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</p>\r\n<p>Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</p>\r\n<p>&nbsp;</p>',	'<p>Information Access Control SOP Overview</p>\r\n<p>1.1.<span style=\"white-space: pre;\"> </span>Introduction, Purpose Scope &amp; Users</p>\r\n<p>Complaints and compliments provide unique information about the quality of health care from the perspective of consumers and their carers. Management of a complaint provides the opportunity for complainants to have their issues resolved effectively, ensures that any identified risks are managed appropriately, and that action is taken to minimise or eliminate those risks.</p>\r\n<p>A key component of complaint management is the systematic recording of issues, risks, complaints, and their resolution, which is achieved through the Incident Information Management System (IIMS).</p>\r\n<p>This policy applies to all complaints about FNQH Pathology services made by members of the public or external organisations.</p>\r\n<p>1.2.<span style=\"white-space: pre;\"> </span>Objectives&nbsp;</p>\r\n<p>The objectives of the complaints policy are to:</p>\r\n<p>1.<span style=\"white-space: pre;\"> </span>Assist FNQH Pathology with the timely and effective management of complaints.</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>Establish a standard approach to complaints handling including the establishment of performance indicators to monitor compliance.</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>Ensure that staff are aware of their responsibilities and are empowered to manage complaints.&nbsp;</p>\r\n<p>1.3.<span style=\"white-space: pre;\"> </span>Principles</p>\r\n<p>The Complaint Management Policy Directive and associated Guidelines are underpinned by the following guiding principles:</p>\r\n<p><span style=\"white-space: pre;\">- </span>Health services are committed to consumers and quality improvement.</p>\r\n<p><span style=\"white-space: pre;\">- </span>Consumers and their carers are encouraged and enabled to provide feedback about the service, including complaints.</p>\r\n<p>- All complaints are acknowledged and responded to promptly and sensitively.</p>\r\n<p><span style=\"white-space: pre;\">- </span>Complaints are assessed by considering risk factors, the known facts, the wishes of the complainant and accountability of health service staff.</p>\r\n<p>- All complaints are dealt with in a manner that is effective, complete, fair to all parties and provides just outcomes.</p>\r\n<p><span style=\"white-space: pre;\">- </span>Complaint information is openly communicated while protecting confidentiality and personal privacy.</p>\r\n<p><span style=\"white-space: pre;\">- </span>All complaints are recorded to enable review of individual cases, to identify trends and risk and report on aggregated complaint information.</p>\r\n<p><span style=\"white-space: pre;\">- </span>Complaint management policy, practices, and data are regularly evaluated and the information is used to improve services.</p>\r\n<p>1.4.<span style=\"white-space: pre;\"> </span>Roles and Responsibilities</p>\r\n<p>Effective complaint management requires a whole-of-organisation approach with clear points of accountability for reporting and feedback.</p>\r\n<p>1.5.<span style=\"white-space: pre;\"> </span>Senior Management is responsible for:</p>\r\n<p><span style=\"white-space: pre;\">- </span>Encouraging an environment where complaints are handled seriously and thoroughly.</p>\r\n<p><span style=\"white-space: pre;\">- </span>Ensuring an effective complaint management system is developed and in place for the health service.</p>\r\n<p><span style=\"white-space: pre;\">- </span>Ensuring appropriate resources are available and utilised for effective complaint management.</p>\r\n<p><span style=\"white-space: pre;\">- </span>Reporting to registration boards in accordance with the provisions of the Health Services Act 1997.</p>\r\n<p><span style=\"white-space: pre;\">- </span>Ensuring appropriate actions are implemented to eliminate or minimise similar problems from occurring.</p>\r\n<p><span style=\"white-space: pre;\">- </span>Nominating an executive staff member within the health service who is responsible for:</p>\r\n<p><span style=\"white-space: pre;\">- </span>Ensuring monitoring and risk rating of all complaints.</p>\r\n<p><span style=\"white-space: pre;\">- </span>Ensuring local actions are implemented to eliminate or minimise similar problems from occurring.</p>\r\n<p>- Reporting trended complaint data to relevant groups within FNQH Pathology.</p>\r\n<p><span style=\"white-space: pre;\">- </span>Implementing policies and local procedures that support staff, including staff training on complaint management.</p>\r\n<p>1.6.<span style=\"white-space: pre;\"> </span>Pathlology Site Manager is responsible for:</p>\r\n<p><span style=\"white-space: pre;\">- </span>Providing a single, publicly recognisable point of contact for the receipt and management of serious complaints from members of the public and staff, regardless of whether those complaints are of a clinical or corporate nature.</p>\r\n<p><span style=\"white-space: pre;\">- </span>Ensuring the proper process for managing complaints is followed by the organisation.</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>Managing Records kept on the basis of this document</p>\r\n<p>All records supporting this policy shall be kept in line with FNQH Pathology document management. Any additional or deleted records shall be kept account of in line with FNQH Pathology document management and recording keeping.&nbsp;</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>Validity and Document Management</p>\r\n<p>This document is valid from the date of its approval and will be reviewed on an annual basis. The current working copy will be identified as such, and any superseded documents will be archived and maintained for a period of five years.</p>\r\n<p>New versions will be identified with a versioning number. Full integers will denote a major document version, and a decimal number will indicate minor amendments or edits.</p>',	'',	'FNQH-COM-POL-100622',	4,	'',	'',	0,	1,	453,	'2022-09-16 12:08:34'),
(31,	'FNQH-POL-CA140822',	'Corrective and Preventative Action Policy',	453,	14,	0,	'2022-09-05',	'2022-09-12',	0,	1,	'TCB',	0,	12,	'2023-09-12',	'2022-09-16',	'Sarah Sharpe',	'<p>This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</p>\r\n<p>Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH&nbsp; Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</p>\r\n<p>&nbsp;</p>',	'<p>1.1.<span style=\"white-space: pre;\"> </span>Introduction, Purpose Scope &amp; Users</p>\r\n<p>This document is intended to document the policy at FNQH Pathology for Corrective and Preventative Action.</p>\r\n<p>1.2.<span style=\"white-space: pre;\"> </span>Corrective and Prevenative Action Policy&nbsp;</p>\r\n<p>In line with NATA and ISO 15189 requirements, FNQH Pathology will take corrective action to eliminate</p>\r\n<p>the causes of identified nonconformities and ensure the following procedures are adhered to via the following activities &ndash;</p>\r\n<p><span style=\"white-space: pre;\">- </span>Internal and external reviews</p>\r\n<p><span style=\"white-space: pre;\">- </span>Quality Assurance&nbsp;</p>\r\n<p><span style=\"white-space: pre;\">- </span>Continuous Improvement</p>\r\n<p><span style=\"white-space: pre;\">- </span>Informal and formal feedback&nbsp;</p>\r\n<p>Reviewing nonconformities by determining the root causes (It is recommended when reviewing noncomformities individuals use the ISO 15189 ASSESSMENT WORKSHEET Self-assessment).</p>\r\n<p>Assigned staff responsible for corrective and preventative actions must -&nbsp;</p>\r\n<p>- Observe&nbsp;</p>\r\n<p><span style=\"white-space: pre;\">- </span>Document observations</p>\r\n<p><span style=\"white-space: pre;\">- </span>Evaluating the need for corrective action to ensure that nonconformities do not recur;</p>\r\n<p><span style=\"white-space: pre;\">- </span>Determine and implement corrective action if&nbsp; needed</p>\r\n<p><span style=\"white-space: pre;\">- </span>Record and review the results of corrective action in the corrective action register&nbsp;</p>\r\n<p>For the purposes of this policy, preventative actions include but are not limited to the following &ndash;&nbsp;</p>\r\n<p><span style=\"white-space: pre;\">- </span>Ensure needed improvements and potential sources of nonconformities are identified and action plans developed,</p>\r\n<p><span style=\"white-space: pre;\">- </span>Ensure improvements implemented and recorded appropriately (document control)</p>\r\n<p><span style=\"white-space: pre;\">- </span>Ensure a review has been set (at a minimum 12 months)</p>\r\n<p><span style=\"white-space: pre;\">- </span>Implement preventive action and record the result of the outcome and action taken.&nbsp;</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>Supporting Documents</p>\r\n<p><span style=\"white-space: pre;\">- </span>NATA ISO 15189 ASSESSMENT WORKSHEET Self-assessment</p>\r\n<p><span style=\"white-space: pre;\">- </span>https://nata.com.au/files/2021/05/ISO-15189-Assessment-Worksheet-For-Laboratory-use.pdf</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>Managing Records kept on the basis of this document</p>\r\n<p>All records supporting this policy shall be kept in the FNQH Pathology document management system in the location, or system based, indicated in the procedure document. Any additional or deleted records shall be kept account of in the FNQH Pathology logging system such that any future enquiry will be able to clearly identify when the changes occurred, who made them, what these changes were and how the changes were approved.</p>\r\n<p>4.<span style=\"white-space: pre;\"> </span>Validity and Document Management</p>\r\n<p>This document is valid from the date of its approval and will be reviewed on an annual basis. The current working copy will be identified as such, and any superseded documents will be archived and maintained for a period of five years.</p>\r\n<p>New versions will be identified with a versioning number. Full integers will denote a major document version, and a decimal number will indicate minor amendments or edits.</p>',	'',	'FNQH-POL-CA140822',	4,	'',	'',	0,	1,	453,	'2022-09-16 12:16:09'),
(32,	'FNQH-POL-SA260822',	'Services Agreement Policy',	453,	14,	0,	'2022-09-05',	'2022-09-12',	0,	1,	'TCB',	0,	12,	'2023-09-12',	'2022-09-16',	'Sarah Sharpe',	'<p>This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</p>\r\n<p>Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</p>\r\n<p>&nbsp;</p>',	'<p>1.1.<span style=\"white-space: pre;\"> </span>Introduction, Purpose Scope &amp; Users</p>\r\n<p>This document is intended to document the Services Agreement Policy for FNQH Pathology.</p>\r\n<p>1.2.<span style=\"white-space: pre;\"> </span>FNQH Pathology Service Agreement Policy&nbsp;&nbsp;</p>\r\n<p>FNQH Pathology shall have documented procedures for the establishment and review of agreements for providing FNQH Pathology services. Each request accepted by the laboratory for the examination(s) shall be considered an agreement.&nbsp;</p>\r\n<p>Agreements to provide FNQH Pathology services shall consider the request, the examination and the report. The agreement shall specify the information needed on the request to ensure appropriate examination and result interpretation.&nbsp;</p>\r\n<p>The following conditions shall be met when the laboratory enters into an agreement to provided medical laboratory services.&nbsp;</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>The requirement to the customers and users, and of the providers of the laboratory services, including the examination processes to be used, shall be defined, document and understood.</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>The laboratory shall have the capability and resources to meet the requirements.&nbsp;</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>FNQH Pathology personnel shall have the skills and expertise necessary for the performance of the intended examinations.</p>\r\n<p>d)<span style=\"white-space: pre;\"> </span>Examination procedures selected shall be appropriate and able to meet the customer\'s needs.</p>\r\n<p>e)<span style=\"white-space: pre;\"> </span>Customers and users shall be informed of deviations from the agreement that impact upon the examination results.</p>\r\n<p>f)<span style=\"white-space: pre;\"> </span>Reference shall be made to any work referred by the laboratory to the referral laboratory or consultant.&nbsp;</p>\r\n<p><span style=\"white-space: pre;\">- </span>Customers and users may include clinicians, health care organisations, third-party payment organisations or agencies, pharmaceutical companies, and patients.&nbsp;</p>\r\n<p><span style=\"white-space: pre;\">- </span>Where patients are customers (e.g. when patients have the ability to directly request examinations), changes in service should be reflected in explanatory information and laboratory reports.&nbsp;</p>\r\n<p><span style=\"white-space: pre;\">- </span>Laboratories should not enter into financial arrangements with referring practitioners or funding agencies where those arrangements act as an inducement for the referral of examinations or patients or interfere with practitioners\' independent assessment of what is best for the patient.&nbsp;</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>Reviews of Service Agreements</p>\r\n<p><span style=\"white-space: pre;\">- </span>Reviews of an agreement to provide medical laboratory services shall include all aspects of the agreement.&nbsp;</p>\r\n<p><span style=\"white-space: pre;\">- </span>Records of these reviews shall include any changes to the agreement and any pertinent discussions.</p>\r\n<p>- When an agreement needs to be amended after laboratory services have commenced, the same agreement review process shall be repeated, and any amendments shall be communicated to all affected parties.&nbsp;</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>Managing Records kept on the basis of this document</p>\r\n<p>All records supporting this policy shall be kept in the FNQH Pathology document management system in the location, or system based, indicated in the procedure document. Any additional or deleted records shall be kept account of in the FNQH Pathology logging system such that any future enquiry will be able to clearly identify when the changes occurred, who made them, what these changes were and how the changes were approved.</p>\r\n<p>4.<span style=\"white-space: pre;\"> </span>Validity and Document Management</p>\r\n<p>This document is valid from the date of its approval and will be reviewed on an annual basis. The current working copy will be identified as such, and any superseded documents will be archived and maintained for a period of five years.</p>\r\n<p>New versions will be identified with a versioning number. Full integers will denote a major document version, and a decimal number will indicate minor amendments or edits.</p>',	'',	'FNQH-POL-SA260822',	4,	'',	'',	0,	1,	453,	'2022-09-16 12:20:33'),
(33,	'FNQHM-020622 ',	'FNQH PATHOLOGY LABORATORY MANUAL',	453,	12,	0,	'2022-09-05',	'2022-09-16',	0,	1,	'TCB',	0,	12,	'2023-09-16',	'2022-09-16',	'Sarah Sharpe',	'<p>This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</p>\r\n<p>&nbsp;</p>\r\n<p>Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</p>\r\n<p>&nbsp;</p>',	'<p>INTRODUCTION, PURPOSE, SCOPE, &amp; USERS</p>\r\n<p>This manual is intended to document the standard operating procedures (SOP) at FNQH Pathology for all activities and items listed in the contents page. The manual details the processes, steps, and detailed instructions so that the relevant (authorised) team member can carry out the task correctly every time.</p>\r\n<p>DAILY WORK SCHEDULE</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Turn on the cold plates and fill water baths.&nbsp;</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Drain wax from the processor retort, let cool and transfer blocks to the embedding centre.</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>Start clean cycle on the processor.</p>\r\n<p>d)<span style=\"white-space: pre;\"> </span>Embed specimens, clean up and refill embedding centre with wax.</p>\r\n<p>e)<span style=\"white-space: pre;\"> </span>Remove excess wax from blocks and trim to reveal a full face.</p>\r\n<p>f)<span style=\"white-space: pre;\"> </span>Cut sections, stain, and coverslip.</p>\r\n<p>g)<span style=\"white-space: pre;\"> </span>Cut extra slides, deeper levels and special stains as requested.&nbsp;</p>\r\n<p>h)<span style=\"white-space: pre;\"> </span>Clean up microtomes and waterbaths.</p>\r\n<p>i)<span style=\"white-space: pre;\"> </span>Change reagents on the stainer as required.</p>\r\n<p>j)<span style=\"white-space: pre;\"> </span>File blocks and dried slides.</p>\r\n<p>k)<span style=\"white-space: pre;\"> </span>Send out slides / specimens for referral or request as required.</p>\r\n<p>l)<span style=\"white-space: pre;\"> </span>Book in new specimens and perform cut-up.</p>\r\n<p>m)<span style=\"white-space: pre;\"> </span> Place specimens in processor and start processor.</p>\r\n<p>n)<span style=\"white-space: pre;\"> </span> Clean cut-up bench and sink, soak instruments, and disinfect cut up board.</p>\r\n<p>o)<span style=\"white-space: pre;\"> </span>Check processor&rsquo;s time is counting down for the overnight cycle before leaving.</p>\r\n<p>MAINTENANCE</p>\r\n<p>Maintenance Sheets</p>\r\n<p>C\\My Documents\\Maintenance Sheets</p>\r\n<p>Leica Tissue Stainer</p>\r\n<p>Monday</p>\r\n<p>Fill stainer with new reagents</p>\r\n<p>Daily</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Check solution levels</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Clean haematoxylin as required.</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>Rotate alcohol and xylene as required.</p>\r\n<p>Friday</p>\r\n<p>Empty and clean all containers</p>\r\n<p>Bi-Annually</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Preventative maintenance by Leica.</p>\r\n<p>Leica Tissue Processor&nbsp;</p>\r\n<p>Daily</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Check solution levels and oven temperature.</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Run clean cycle.</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>Clean retort.</p>\r\n<p>Monday or as needed</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Change and rotate first wax.</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Change formalin.</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>Change diluted alcohols.</p>\r\n<p>d)<span style=\"white-space: pre;\"> </span>Change and rotate first absolute alcohol.</p>\r\n<p>e)<span style=\"white-space: pre;\"> </span>Change and rotate first xylene.</p>\r\n<p>Monthly</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span> Warm water flush</p>\r\n<p>Bi-Annually</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Preventative maintenance by Leica.</p>\r\n<p>Leica Embedding Centre</p>\r\n<p>Daily</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Clean and refill wax</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Clean out any tissue debris that may have accumulated in the bottom of the heating block.</p>\r\n<p>Weekly</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Remove solidified wax and debris from surface and between grooves; empty overflow tray.</p>\r\n<p>Annually</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Preventative maintenance by Leica.</p>\r\n<p>Microm Microtome</p>\r\n<p>Daily</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Clean</p>\r\n<p>Annually</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Preventative Maintenance by Leica.</p>\r\n<p>Leica Floatation Bath</p>\r\n<p>Daily</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Every working day, tip out contents of water bath, rinse in hot water and wipe clean.</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Each morning add 40 ml of chrome alum-gelatin adhesive and top up to the lip with de-ionized or tap water.</p>\r\n<p>Gelatin-Chrome Alum Recipe</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>To 10g gelatin, add 150ml water and allow to stand for a short period until gelatin becomes soft.&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Add 850 mls boiling water and continue to heat until gelatin completely dissolved.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Add 1g of Chrome Alum to the solution and mix well. Add thymol and use.</p>\r\n<p>RISK - CAUTION - Chrome Alum (Chromium potassium sulphate) - Harmful if swallowed. Irritating to eyes.&nbsp;</p>\r\n<p>CAUTION - Thymol - Harmful if swallowed. Causes burns. When using, do not eat, drink or smoke. Do not breathe dust. .Avoid contact with skin and eyes.</p>\r\n<p>Ref: Histologic Technical Bulletin for Histotechnology Vol VIII, No 3-July, 1978</p>\r\n<p>Olympus and Leitz Microscopes</p>\r\n<p>Daily</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Clean lenses and wipe over whole microscope to remove dust, and</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Wipe stage to remove residue</p>\r\n<p>Annually</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Preventative maintenance by ALM.&nbsp;&nbsp;</p>\r\n<p>SPECIMEN RECEPTION</p>\r\n<p>COLLECTION OF SPECIMENS</p>\r\n<p>Doctors are provided with instruction regarding the collection of specimens. (See FNQH Pathology Collection Manual).</p>\r\n<p>TRANSPORT OF SPECIMENS</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>FNQH Pathology couriers are used for routine pick-up and deliveries.</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>The couriers are made aware of the nature of the specimens transported.</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>Shipping instructions are provided to the doctors and clinics sending the specimens. (See FNQH Pathology Collection Manual).</p>\r\n<p>LABORATORY ETHICS</p>\r\n<p>There are both legal and ethical issues relating to confidentiality. These relate to specimen handling and to written, verbal and electronic transfer of information relating to specimens. The confidentiality of medical conditions must be respected, likewise, human samples must be treated with due respect.</p>\r\n<p>ACCEPTABLE REQUESTS</p>\r\n<p>Acceptable request forms and specimens</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Ideally, the form must contain the patient&rsquo;s name, date of birth, address, Medicare number, the doctor&rsquo;s name, address, provider number and signature if applicable. The specimen and request forms must have at least two forms of identification (usually name and date of birth).</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>The name on the specimen(s) must be the same as the name on the request form.</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>The correct specimen(s) for the tests requested are received.</p>\r\n<p>d)<span style=\"white-space: pre;\"> </span>The specimen(s) are not leaking or affected by transportation or storage conditions.</p>\r\n<p>This description is of an ideal specimen. During a single run, a number of the specimens may not fulfil all of the above criteria.&nbsp; This does not mean that they are rejected completely as they may still fulfil the minimum requirements below.</p>\r\n<p>Minimum labelling requirements of specimens</p>\r\n<p>The minimum labelling requirement for acceptance as per NATA requirement for at least two forms of ID e.g. patient&rsquo;s surname and date of birth.</p>\r\n<p>When not to accept a specimen</p>\r\n<p>If no form is received with the specimen, or more than one unlabelled specimen is received from a single practice please consult the pathologist.</p>\r\n<p>What to do with unlabelled specimens and request forms</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>If the container or request form is received unlabelled, or there is any discrepancy between the request form and the container label as to the patient&rsquo;s name, the doctor is contacted to verify the contents.&nbsp;</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>The problem is recorded in the Specimen Reception Problem Log and on the back of the request form along with the corrective action taken.</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>If the sample is ultimately processed, a comment detailing the procedures followed should be included in the final report.</p>\r\n<p>REFERRED SPECIMENS</p>\r\n<p>Specimens that cannot be processed by FNQH Pathology are referred to other pathology laboratories (See Referred Cases).</p>\r\n<p>LOGGING IN SPECIMENS</p>\r\n<p>Checking Patient Details</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Check that the patient details on the specimen container match the patient details on the request form, and match to the specimen location on the container.&nbsp;</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Do not log in consecutive patients with the same surname if possible &ndash; separate them with other patients.</p>\r\n<p>Labelling</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Assign each case an accession number from PathHub and place the applicable numbered laboratory stickers on the top left-hand corner of the request form, and the lid and side of the pot(s).</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Each specimen within a particular case is sub-labelled with a sequential number (ie. 1, 2, 3). If there is only one specimen it is not given a number.&nbsp;</p>\r\n<p>Urgent Specimens Protocol</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Specimens that are marked urgent are &ldquo;prioritised&rdquo;.</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>If possible (e.g. a punch biopsy), the specimen is processed preferentially (e.g. a short processing cycle).</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>The specimen is embedded in a yellow cassette, cut and stained first.</p>\r\n<p>d)<span style=\"white-space: pre;\"> </span>The results are e-mailed or faxed to the referring practitioner as soon as they become available.</p>\r\n<p>Printing Blocks and Slides</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Print one cassette for each specimen. The accession number is printed on the front of the cassette and the surname on the left side.</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Printe a slide for each specimen. First the accession number, then the surname.</p>\r\n<p>03-1768</p>\r\n<p>SMITH</p>\r\n<p>CUT-UP</p>\r\n<p>See Cut-Up Manual.</p>\r\n<p>PROCESSING</p>\r\n<p>PRINCIPLES</p>\r\n<p>As water (contained in tissue and fixative) and paraffin (end of processing cycle) are not miscible, tissues which have been fixed in aqueous fixatives such as formalin, must be transferred through solutions which are miscible with each other until they can be infiltrated with paraffin.&nbsp;</p>\r\n<p>Fixation&nbsp;</p>\r\n<p>- Before processing can begin, tissues must be adequately fixed.&nbsp;</p>\r\n<p>- Fixation for small biopsies i.e. 2 - 3mm in diameter will be completed in 2 - 3 hours.&nbsp; Larger specimens will need at least overnight if not longer. Ensure the specimen is fully covered in sufficient formalin before leaving to fix overnight, a ratio of at least 10:1 formalin to specimen is recommended for adequate fixation.</p>\r\n<p>Dehydration</p>\r\n<p><span style=\"white-space: pre;\">- </span>This stage replaces water with alcohol. Gradually increasing concentrations of alcohol are used so that the tissues are not damaged when the water and alcohol are mixed. Lower concentrations of alcohol tend to macerate the tissues when left for a considerable period of time. Absolute alcohol removes the last traces of water but can shrink and harden tissue, so the minimum required time should be used.</p>\r\n<p><span style=\"white-space: pre;\">- </span>A typical dehydration sequence for specimens not more than 4mm thick would be:</p>\r\n<p><span style=\"white-space: pre;\">- </span>70% ethanol&nbsp; &nbsp; &nbsp; 15 min</p>\r\n<p><span style=\"white-space: pre;\">- </span>90% ethanol&nbsp; &nbsp; &nbsp; 15 min</p>\r\n<p><span style=\"white-space: pre;\">- </span>100% ethanol&nbsp; &nbsp; 15 min</p>\r\n<p><span style=\"white-space: pre;\">- </span>100% ethanol&nbsp; &nbsp; 15 min</p>\r\n<p><span style=\"white-space: pre;\">- </span>100% ethanol&nbsp; &nbsp; 30 min</p>\r\n<p><span style=\"white-space: pre;\">- </span>100% ethanol&nbsp; &nbsp; 45 mi</p>\r\n<p>Clearing</p>\r\n<p><span style=\"white-space: pre;\">- </span>This removes the alcohol from the tissues before paraffin infiltration. As paraffin and alcohol are not miscible, an interposing antemedium agent is used. Xylene is used because it is quickly evaporated from the tissue during paraffin infiltration. Minimum times should be used as tissues can shrink and harden in xylene.</p>\r\n<p><span style=\"white-space: pre;\">- </span>A typical clearing sequence for specimens not more than 4mm thick would be:</p>\r\n<p><span style=\"white-space: pre;\">- </span>Xylene&nbsp; &nbsp;20 min</p>\r\n<p><span style=\"white-space: pre;\">- </span>Xylene&nbsp; &nbsp;20 min&nbsp;</p>\r\n<p><span style=\"white-space: pre;\">- </span>Xylene&nbsp; &nbsp;45 min</p>\r\n<p>Paraffin infiltration&nbsp;</p>\r\n<p><span style=\"white-space: pre;\">- </span>This replaces xylene with molten paraffin to fill out cavities in the tissues to support structures contained within them, thus reproducing them in their natural state. Paraffin infiltration should be at approximately 56 - 58oC with the processor temperature held at 62oC. Hard tissues are best processed by longer times in paraffin to allow sufficient impregnation.</p>\r\n<p><span style=\"white-space: pre;\">- </span>A typical infiltration sequence for specimens not more than 4mm thick would be:</p>\r\n<p><span style=\"white-space: pre;\">- </span>Wax&nbsp; &nbsp; &nbsp; 30 min</p>\r\n<p>- Wax&nbsp; &nbsp; &nbsp; 30 min</p>\r\n<p><span style=\"white-space: pre;\">- </span>Wax&nbsp; &nbsp; &nbsp; 45 min</p>\r\n<p>REFERENCES</p>\r\n<p>KARSON, F.L., MARTIN, J.H., LYNN, J.A. (1972) \'Formalin Fixation for Electronmicroscopy; A re-evaluation\' American Journal of Clinical Pathology.&nbsp; March 1983, pp. 265 - 375.</p>\r\n<p>KARSON, F.L. &amp; MARTIN, J.H. \'Formaldehyde as a Fixative for Light and Electronmicroscopy\'</p>\r\n<p>Journal of Histotechnology.&nbsp; Vol. 2, No. 2, June 1979, pp. 58 - 60.</p>\r\n<p><span style=\"white-space: pre;\"> </span></p>\r\n<p>&nbsp;</p>\r\n<p><span style=\"white-space: pre;\"> </span></p>\r\n<p>SPECIFICATIONS AND OPERATION OF PROCESSOR</p>\r\n<p>See Leica Tissue Processor Operating Manual.</p>\r\n<p>PROCESSOR SOLUTIONS AND PROGRAMMES &ndash; need to edit</p>\r\n<p>PROCESSING&nbsp;Fatty tissue</p>\r\n<p>Provided the processing schedule was uninterrupted, tissue which is not processed sufficiently is usually fatty and can be identified by the translucent, yellow colour and the slippery feel of the tissue at the end of the processing cycle and the subsequent inability to section. The usual cause of &ldquo;bad processing&rdquo; is the thickness of the segment of tissue taken during cut up. If left to section to the following day, the block may have &ldquo;sunk&rdquo; i.e. have a concave surface due to dehydration of the tissue.&nbsp;</p>\r\n<p>The sections may be reprocessed by firstly reverse processing as follows:</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Melt the wax away from the tissue in the front chamber of the thermal console of the embedding chamber, being careful to keep each segment with its cassette.</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Place the tissue into the cassette and put a lid on it.</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>Place the cassettes into a large beaker of xylene, cover and leave for 2 changes of 45 min each.</p>\r\n<p>d)<span style=\"white-space: pre;\"> </span>Empty the xylene into a contaminated waste drum, and fill with 100% alcohol. If there is a white waxy precipitate, empty and refill with 100% alcohol. If the precipitate appears again, replace with xylene for a further 45 mins.&nbsp;</p>\r\n<p>e)<span style=\"white-space: pre;\"> </span>Empty the xylene into a contaminated waste drum and replace with 100% alcohol for 3 changes of 45 mins each.</p>\r\n<p>f)<span style=\"white-space: pre;\"> </span>Replace the 100% alcohol with 70% alcohol for 45 mins.</p>\r\n<p>g)<span style=\"white-space: pre;\"> </span>Empty the alcohol and fill with 10% formalin.&nbsp;</p>\r\n<p>h)<span style=\"white-space: pre;\"> </span>At this stage the tissue can process on the usual cycle.</p>\r\n<p>Interrupted cycle</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Provided the tissues have not been left without a solution covering them, or left for a prolonged period in 100% alcohol or xylene, there should not be any significant problems with cutting.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Prolonged exposure to dehydrating (alcohol) and clearing (xylene) will affect smaller tissue segments to a greater extent than those with large amounts of fat by excessive drying and shrinking, thereby making cutting more difficult.&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>If tissues segments have been left without a solution covering them for a prolonged period of time, it is possible to rehydrate them to give a reasonable staining quality.&nbsp;</p>\r\n<p>Rehydrating solution<span style=\"white-space: pre;\"> </span></p>\r\n<p><span style=\"white-space: pre;\">- </span>70% Ethanol<span style=\"white-space: pre;\"> </span> 70 ml</p>\r\n<p><span style=\"white-space: pre;\">- </span>Glycerol<span style=\"white-space: pre;\"> </span> 30 ml</p>\r\n<p><span style=\"white-space: pre;\">- </span>Dithionite<span style=\"white-space: pre;\"> </span> 1.0 gm</p>\r\n<p><span style=\"white-space: pre;\">- </span>Tissues remain in the solution for several hours, usually overnight, after which processing is commenced at the dehydrating stage in the usual manner. In sectioning such damaged tissues the use of a section adhesive is recommended.</p>\r\n<p><span style=\"white-space: pre;\">- </span>Dehydrate small biopsies according to the following method. For larger specimens add 10-15 min to the process.</p>\r\n<p><span style=\"white-space: pre;\">- </span>50% alcohol<span style=\"white-space: pre;\"> </span>15 mins</p>\r\n<p><span style=\"white-space: pre;\">- </span>60% alcohol<span style=\"white-space: pre;\"> </span>15 mins</p>\r\n<p><span style=\"white-space: pre;\">- </span>80% alcohol<span style=\"white-space: pre;\"> </span>15 mins</p>\r\n<p><span style=\"white-space: pre;\">- </span>95% alcohol<span style=\"white-space: pre;\"> </span>15 mins</p>\r\n<p><span style=\"white-space: pre;\">- </span>95% alcohol<span style=\"white-space: pre;\"> </span>15 mins</p>\r\n<p><span style=\"white-space: pre;\">- </span>absolute alcohol<span style=\"white-space: pre;\"> </span>15 mins</p>\r\n<p><span style=\"white-space: pre;\">- </span>absolute alcohol<span style=\"white-space: pre;\"> </span>15 mins</p>\r\n<p><span style=\"white-space: pre;\">- </span>xylene<span style=\"white-space: pre;\"> </span>15 mins</p>\r\n<p><span style=\"white-space: pre;\">- </span>xylene<span style=\"white-space: pre;\"> </span>15 mins</p>\r\n<p><span style=\"white-space: pre;\">- </span>wax<span style=\"white-space: pre;\"> </span>30 mins</p>\r\n<p><span style=\"white-space: pre;\">- </span>wax<span style=\"white-space: pre;\"> </span>30 mins</p>\r\n<p><span style=\"white-space: pre;\">- </span>wax<span style=\"white-space: pre;\"> </span>30 mins</p>\r\n<p>EMBEDDING&nbsp;SPECIFICATIONS AND OPERATION OF EMBEDDING CENTRE</p>\r\n<p>See Leica EG 1140H Instruction Manual.</p>\r\n<p>PROCEDURE</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Turn on the magnifying light and light of the console.</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Place the cassettes from the processor into the cassette warmer of the embedding centre.</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>Select the first cassette and place onto the heated work area. Remove the lid from the cassette and select an appropriately sized base mould from the mould warmer. Ensure that there will be sufficient wax surrounding the tissue on all sides of the block (approx. 3 - 5 mm) to allow ease of sectioning and ribboning.</p>\r\n<p>d)<span style=\"white-space: pre;\"> </span>Fill the deep portion of the mould with molten wax from the dispenser by pressing the dispenser lever. Place the mould onto the work area beneath the spout or directly onto the refrigerated spot at the front of the dispenser spout.</p>\r\n<p>e)<span style=\"white-space: pre;\"> </span>Place the tissue into the mould and orientate it correctly. If necessary, the base of the mould can be re-heated by placing it onto the work area. When oriented correctly, press the tissue gently onto the base mould surface with forceps to ensure the surface of the tissue is as flat as possible.&nbsp;</p>\r\n<p>f)<span style=\"white-space: pre;\"> </span>Place the cassette on top of the base mould and fill the cassette/mould unit with molten wax. Do not wait too long to fill the cassette or the wax will not adhere to the wax in the base mould and the cassette and block will not bond sufficiently to ensure stability during cutting.</p>\r\n<p>g)<span style=\"white-space: pre;\"> </span>Place the complete cassette/mould unit onto the cold plate.</p>\r\n<p>h)<span style=\"white-space: pre;\"> </span>When sufficiently cooled, the embedded specimen block can be removed from the mould easily. Do not force removal. Smaller blocks will take longer to cool.&nbsp;</p>\r\n<p>i)<span style=\"white-space: pre;\"> </span>When all blocks have been removed from the moulds, place the moulds&nbsp; into the mould warmer. Please note: Moulds should be cleaned first with water and detergent, allowed to dry, then put back in the mould warmer to prevent build up of wax residue.</p>\r\n<p>j)<span style=\"white-space: pre;\"> </span>Remove excess wax from the sides of the block.</p>\r\n<p>k)<span style=\"white-space: pre;\"> </span>Never open more than one block at a time.</p>\r\n<p>l)<span style=\"white-space: pre;\"> </span>Forceps are kept hot in the embedding centre heating block.&nbsp; Forceps are wiped with tissue paper after removal from heating block to prevent cross-contamination.</p>\r\n<p>ORIENTATION</p>\r\n<p>Tissue is orientated in such a way that the resistance that the tissue can offer the knife proceeds from the lesser amount to the greater amount as the block is sectioned.</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Segments of skin should be placed in the mould horizontally so that the epidermis (surface) of the skin is cut last. The epidermis is usually the hardest part of the skin and can damage the knife; cutting the epidermis last eliminates the problem of it folding up, therefore can&rsquo;t be floated out properly.</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Ensure that all tissue is embedded flat.</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>Ensure that the cut surface is down or as advised by the Pathologist. If in doubt, consult the Pathologist for direction.&nbsp;</p>\r\n<p>d)<span style=\"white-space: pre;\"> </span>If possible, place all segments side by side across the mould. If there are too many sections place them in rows with space between each (brick laying fashion) so there is least overlap (Diagram 1).</p>\r\n<p>e)<span style=\"white-space: pre;\"> </span>Ensure there is space between each segment and that segments do not touch or overlap. If the end pieces of the ellipse of skin are included in the cassette embed them at either end of the mould or on a separate row. Segments should not be touching, but should still be close.</p>\r\n<p>- Diagram 1)<span style=\"white-space: pre;\"> </span></p>\r\n<p>- Epidermis&nbsp; &nbsp;&nbsp;</p>\r\n<p>f)<span style=\"white-space: pre;\"> </span>Embed nails, skins with very hard keratin layers and plantar warts vertically so that the blade cuts along the hard ridge rather than across it (Diagram 2).</p>\r\n<p>- Diagram 2)</p>\r\n<p>- Epidermis</p>\r\n<p>MICROTOMY&nbsp;SPECIFICATIONS AND OPERATION OF MICROTOMES</p>\r\n<p>See Microm Microtome Operating Manual.</p>\r\n<p>WATER BATH</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Ensure dish is clean (all wax removed with hot water and washed with 70% alcohol or scrub wax off with hot water and detergent). Preferably wash the previous day to prevent air bubbles settling on the bottom of the dish.</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Fill the dish with warm water.</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>The temperature of the water bath will be approx. 43oC (or 10oC below the melting point of the wax).</p>\r\n<p>d)<span style=\"white-space: pre;\"> </span>Before cutting begins remove all traces of floating material from the surface of the water with tissue.</p>\r\n<p>CUTTING BLOCKS - GENERAL</p>\r\n<p>When you sit at the microtome, before placing in a blade or block, check:</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>that all screws in the block holder, which control the angle, are tight.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>that the blade holder is set at the right angle.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>that the blade holder is secure.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>that the water bath and cold plate are at the right temperature.</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Keep all blocks in lab number order as they are cut to eliminate errors.</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Lock the hand wheel and place a block into the block clamp on the microtome horizontally with the name upper most and the lab number on the right hand side for consistency, so the angle will not have to be altered in the event of deeper cuts being required.</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>Insert a blade into the knife holder and clamp.</p>\r\n<p>d)<span style=\"white-space: pre;\"> </span>Move the specimen to the rear limit using the course feed then approach the knife holder on the knife holder base to the specimen as close as possible.</p>\r\n<p>e)<span style=\"white-space: pre;\"> </span>Unlock the hand wheel and trim the block to a full face, being careful with small tissue segments and single segments which usually require levels</p>\r\n<p>f)<span style=\"white-space: pre;\"> </span>Rotate the right hand wheel so that block is above the blade, then move the locking lever to the back and remove the block from the clamp.</p>\r\n<p>g)<span style=\"white-space: pre;\"> </span>Place block on the freezer plate. Trim a batch of blocks before beginning cutting.</p>\r\n<p>h)<span style=\"white-space: pre;\"> </span>Select the appropriate section thickness, lock the hand wheel and place a trimmed block in the block clamp. Unlock the hand wheel and cut a section by rotating the hand wheel at a uniform speed.</p>\r\n<p>a.<span style=\"white-space: pre;\"> </span>For routine sectioning, section thickness will be 3 microns.</p>\r\n<p>b.<span style=\"white-space: pre;\"> </span>For cutting routine levels, trim up to 10 turns of the microtome per level, depending on the size of the tissue. (3&micro;m turns, thus 30&micro;m in total in between each level. For example, when cutting 3 levels, take the first level from the face of the block, then trim in 30&micro;m (as described above) before taking the second level and repeat for the third level.&nbsp;</p>\r\n<p>c.<span style=\"white-space: pre;\"> </span>If unsure please consult with the pathologist or senior scientist.</p>\r\n<p>i)<span style=\"white-space: pre;\"> </span>Float the section onto the water bath and remove all wrinkles.</p>\r\n<p>j)<span style=\"white-space: pre;\"> </span>Never put more than one patient&rsquo;s sections in the water bath at one time. Clean the water bath as required.</p>\r\n<p>k)<span style=\"white-space: pre;\"> </span>Lock the block in a position above the blade and remove it from the clamp.</p>\r\n<p>l)<span style=\"white-space: pre;\"> </span>Pick up the section onto the centre of the slide and leave it to dry in a slide rack before transfer to the staining machine.</p>\r\n<p>03-1768</p>\r\n<p>SMITH</p>\r\n<p>L 1&nbsp;</p>\r\n<p>Punch biopsies&nbsp;</p>\r\n<p>Three levels on one slide, one central ribbon.</p>\r\n<p>Shaves and Curettes</p>\r\n<p>Three levels on one slide for non-dissected specimens, one central ribbon.</p>\r\n<p>Two levels on one slide for dissected specimens, one central ribbon.</p>\r\n<p>Excision specimens&nbsp;</p>\r\n<p>One level on a slide.</p>\r\n<p>Deeper levels</p>\r\n<p>Cut deeper levels as requested.&nbsp;</p>\r\n<p>If special stains are also requested, cut levels for special stains before deeper levels unless specifically requested otherwise.</p>\r\n<p>If a &lsquo;level through&rsquo; is requested, cut levels as normal until the entire specimen has been cut through. This may take a number of slides.</p>\r\n<p>If &lsquo;serial sections&rsquo; are requested, take the number of sections asked for without any trimming.</p>\r\n<p>Note on the request form the deeper levels cut.</p>\r\n<p>Special stains</p>\r\n<p>Cut one slide without further trimming for each stain requested.</p>\r\n<p>Immunoperoxidase</p>\r\n<p>All immunoperoxidase sections must be placed on poly-l-lysine coated slides.&nbsp;Cut one section per slide for each antibody requested.&nbsp;</p>\r\n<p>Difficult blocks</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Poly-l-lysine coated slides are used to adhere sections more securely to the slide.</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Hard tissue - warm the surface of the block by immersing in the water bath, then cool on the freezer plate. Cut sections but do not trim, as the warm water does not penetrate very far into the tissue. Use a new section of blade if still not cutting evenly. Sections of some skins with hard keratin layers and plantar warts should be placed on poly-l-lysine coated slides.</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>Nail - after trimming float the block in the water bath for about 10 mins, and then cool on the freezer plate. Cut sections but do not trim, as the warm water does not penetrate very far into the tissue. Place sections on poly-l-lysine coated slide</p>\r\n<p>d)<span style=\"white-space: pre;\"> </span>Bone - after trimming, if the block does not section well float in the water bath for a few minutes, cool slightly on the freezer plate. Cut sections but do not trim, as the warm water does not penetrate very far into the tissue. Place sections on poly-l-lysine coated slide</p>\r\n<p>e)<span style=\"white-space: pre;\"> </span>Fatty, not well processed tissue - increase the index of the cutting thickness to between 5 and 7m; the block should be as cold as possible.</p>\r\n<p>f)<span style=\"white-space: pre;\"> </span>Cysts - the contents of cysts do not often cut well or at all. Place as much of the section as possible onto the slide.</p>\r\n<p>g)<span style=\"white-space: pre;\"> </span>Shattered blocks and tissue lifted out of blocks - retrieve all pieces of tissue and place into a mould together with the cassette. When the wax has melted re-embed all pieces of tissue as closely as possible to their original positions. If possible, trim and cut the block at a right angle to the line of break along the tissue.</p>\r\n<p>PROBLEMS WITH SECTIONING AND POSSIBLE CAUSES</p>\r\n<p>Split ribbons or lengthwise scratches</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Dirt or other undesirable material on the knife-edge.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Calcium, foreign bodies (sutures, staples or crystals in the specimen).</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Grit or dirt in the paraffin.</p>\r\n<p>Thick and thin sections</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Block too large for microtome.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Loose set screws.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Block or tissue too hard to section without soaking.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Angle of knife insufficient to clear block.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Knife holder or disposable blade holder rusted.</p>\r\n<p>Compressions and wrinkles</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Knife and/or block warm.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Knife too vertical.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Sections too thin.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Loose microtome set screws.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Dull blade.</p>\r\n<p>Scratches, lines, or splits in part of section</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Dirt or foreign bodies in paraffin.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Calcium or foreign bodies in tissue.</p>\r\n<p>Unequal section size</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Block not adequately trimmed or aligned with knife.</p>\r\n<p>Uneven or Crooked Ribbons</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Irregular knife-edge.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Knife and block not parallel.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Block not square or rectangle.</p>\r\n<p>Holes or thick and thin portions in sections</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Tissue not processed completely.</p>\r\n<p>Dry, torn, incomplete sections</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Incomplete processing or infiltration.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Paraffin too hot at infiltration or embedding stages.</p>\r\n<p>Ribbon will not form</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Dull knife.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Block too warm.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Incorrect knife angle.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Loose microtome mechanism.</p>\r\n<p>STAINING&nbsp;PRINCIPLES</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>The tissue is impregnated with wax and consequently it is essential to remove all traces of the wax since no dye can permeate wax. Heating the slides and then immersing them in a solvent such as xylene removes wax.</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Dyes are either water- or low-grade alcohol-based. Since xylene is not miscible with either, the slides are transferred to absolute alcohol, which is miscible with xylene.&nbsp;</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>Slides are then transferred to lower grade alcohol before being immersed in water to prevent possible destruction of tissue elements by diffusion currents. As not all staining solutions are water based it is not always necessary to wash slides with water as the final step before staining.</p>\r\n<p>d)<span style=\"white-space: pre;\"> </span>After staining is complete the slides are usually dehydrated with absolute alcohol, cleared in xylene and mounted with mounting medium.</p>\r\n<p>SPECIFICATIONS AND OPERATION OF STAINER</p>\r\n<p>See Leica Tissue Stainer Instruction Manual.</p>\r\n<p>Record any control slides along with their corresponding accession numbers on the Internal Quality Control Log.</p>\r\n<p>STAINER CONFIGURATION&nbsp;MOUNTING</p>\r\n<p>Media</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>The mounting medium permanently binds the coverslip to the section to provide protection from scratching, drying, and fading.&nbsp;</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>The mountant must be miscible with the clearing agent.</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>The refractive index of the mounting medium should be close to the average index of tissue (1.530 to 1.540) and the coverslip so that light passes through the section with minimal refraction.</p>\r\n<p>Coverslips</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Ensure coverslips are clean and free from fingerprints.</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Carefully wipe away unwanted sections from the slide.</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>Place a coverslip onto the bench and place a drop of mountant in the middle.</p>\r\n<p>d)<span style=\"white-space: pre;\"> </span>Lower the slide down onto the coverslip .</p>\r\n<p>e)<span style=\"white-space: pre;\"> </span>Turn over the slide and remove any air bubbles by applying pressure onto the coverslip with forceps.</p>\r\n<p>f)<span style=\"white-space: pre;\"> </span>Wipe the back of the slide.</p>\r\n<p>HAEMATOXYLIN AND EOSIN</p>\r\n<p>Haematoxylin</p>\r\n<p>Haematoxylin is a natural dye, which was first used about 1863. It has little affinity for tissue used alone but in combination with aluminium, iron, chromium, copper or tungsten salts it is a powerful nuclear stain. It has polychromatic properties, which may be brought out with proper differentiation. The active colouring agent, haematin is formed by the oxidation of haematoxylin. This process is known as &lsquo;ripening&rsquo; and takes several days, or weeks, unless it is hastened by the addition of an oxidising agent such as mercuric oxide, hydrogen peroxide, potassium permanganate, sodium perchlorate, or sodium iodate. These artificial oxidisers only start the process, so the solution can be used immediately, but this oxidisation process continues slowly over a period of time, during which the haematoxylin retains its staining properties. Once the oxidisation is complete the haematoxylin is no longer useful for staining. If the amount of oxidising agent is increased the process is more rapid, but the down side is that the life of the stain is decreased. The amount listed for any particular method should be strictly adhered to. Storage is another factor that may affect oxidisation. When stored in a dark, tightly sealed container the process is slower, but when the staining dish is exposed to light and air it is markedly increased, therefore in a staining set up, the solution should be changed at least once a week for consistent staining.</p>\r\n<p>Employing a haematoxylin solution, which contains an excess of aluminium salts, or acid, thus increasing the selectivity for nuclei accomplishes progressive staining. After staining with haematoxylin, the slides are washed well in water and the secondary stain applied.</p>\r\n<p>Regressive staining, the tissue is over stained in a relatively neutral solution of haematoxylin. The excess stain is removed with an acid alcohol solution, and then the sections are neutralised with an alkaline solution such as a weak ammonium water or lithium carbonate water. In a well-differentiated section, the cytoplasm should be colourless and the nuclear substances (chromatin) should be clearly visible, showing some metachromatic properties.</p>\r\n<p>Eosin</p>\r\n<p>Counterstain for haematoxylin is usually eosin. A counterstain is defined as a stain applied to render the effect of another stain more discernible. This is not the case in the H&amp;E technique, as the eosin plays a definite diagnostic role in the demonstration of inclusion bodies and cytoplasmic changes, thus it should be considered as a secondary stain.</p>\r\n<p>Common problems</p>\r\n<p>A common error encountered is the improper use of alcohols after the eosin has been applied. The primary purpose of the alcohols is dehydration, secondly the removal of excess eosin. If passed too quickly through the alcohols excess eosin will overshadow many diagnostic features, such as pigments and inclusion bodies. The correct differentiation of eosin must be observed.</p>\r\n<p>Groups of tiny dark grey or black granules are due to precipitation of Haematoxylin.&nbsp; These lie on top of the section and appear particularly common in parts that contain mucus.&nbsp; The only way of avoiding this precipitate is to filter the Haematoxylin staining solution about once a week. Skim off oxidised film on Haematoxylin each morning with hand towel, to stop background staining of the control slide.</p>\r\n<p>Dull red or brown staining of nuclei is most likely due to insufficient blueing after differentiation.&nbsp;Nuclei appear as blue rings with colourless centres when the Haematoxylin staining time has been too short.&nbsp;Uniformly weak staining of the nuclear membrane and chromatin is usually due to over differentiation.&nbsp;Sections in which the nuclei are blue and congested without proper chromatin details have not had sufficient differentiation, in very bad cases the cytoplasm is an unpleasant slatey blue colour.</p>\r\n<p>FIXATION<span style=\"white-space: pre;\"> </span>10% Neutral Buffered Formalin</p>\r\n<p>TECHNIQUE<span style=\"white-space: pre;\"> </span>Cut paraffin sections at 3 microns</p>\r\n<p>SOLUTIONS:</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>HARRIS HAEMATOXYLIN (ready to use stain)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>EOSIN (ready to use stain)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>SCOTT&rsquo;S BLUEING SOLUTION (ready to use stain)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>70% ALCOHOL</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Ethanol<span style=\"white-space: pre;\"> </span>1400ml</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Distilled Water<span style=\"white-space: pre;\"> </span>600ml<span style=\"white-space: pre;\"> </span></p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>1% ACID ALCOHOL</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Ethanol<span style=\"white-space: pre;\"> </span>1400ml</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Distilled Water<span style=\"white-space: pre;\"> </span>600ml</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Conc. HCL<span style=\"white-space: pre;\"> </span>20ml</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>0.1% ACID ALCOHOL (Auto-stainer)</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Ethanol<span style=\"white-space: pre;\"> </span>1400ml</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Distilled Water<span style=\"white-space: pre;\"> </span>600ml</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Conc. HCL<span style=\"white-space: pre;\"> </span>2ml</p>\r\n<p>PROCEDURE</p>\r\n<p>1. Xylol<span style=\"white-space: pre;\"> </span>2min</p>\r\n<p>2. Xylol<span style=\"white-space: pre;\"> </span>2min</p>\r\n<p>3. Absolute Alcohol<span style=\"white-space: pre;\"> </span>1min</p>\r\n<p>4. Absolute Alcohol<span style=\"white-space: pre;\"> </span>1min</p>\r\n<p>5. 70% Alcohol<span style=\"white-space: pre;\"> </span>1min</p>\r\n<p>6. Water<span style=\"white-space: pre;\"> </span> <span style=\"white-space: pre;\"> </span>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;1min</p>\r\n<p>7. Haematoxylin<span style=\"white-space: pre;\"> </span>&nbsp; 7min</p>\r\n<p>8. Water<span style=\"white-space: pre;\"> </span>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 1min</p>\r\n<p>9. 0.1% Acid Alcohol<span style=\"white-space: pre;\"> </span>&nbsp; 15 sec</p>\r\n<p>10. Water<span style=\"white-space: pre;\"> </span>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;1min</p>\r\n<p>11. Scott&rsquo;s Blue<span style=\"white-space: pre;\"> </span>&nbsp; &nbsp;2min</p>\r\n<p>12. Water<span style=\"white-space: pre;\"> </span>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;1min</p>\r\n<p>13. 95% Alcohol<span style=\"white-space: pre;\"> </span>&nbsp; &nbsp;1min</p>\r\n<p>14. Eosin<span style=\"white-space: pre;\"> </span>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;2min</p>\r\n<p>15. Absolute Alcohol<span style=\"white-space: pre;\"> </span>&nbsp; &nbsp;1min</p>\r\n<p>16. Absolute Alcohol<span style=\"white-space: pre;\"> </span>&nbsp; &nbsp;1min</p>\r\n<p>17. Absolute Alcohol<span style=\"white-space: pre;\"> </span>&nbsp; &nbsp;1min</p>\r\n<p>18. Xylol<span style=\"white-space: pre;\"> </span>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;1min</p>\r\n<p>19. Xylol<span style=\"white-space: pre;\"> </span>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;1min</p>\r\n<p>Results:<span style=\"white-space: pre;\"> </span></p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Nuclei, calcium deposits, bacteria - blue.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Mucin, cartilage - pale blue-grey.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Red blood cells, eosinophil leucocytes - red.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Cytoplasm of other cells - shades of pink</p>\r\n<p>IRON (GOMORIS&rsquo; METHOD)&nbsp;MEDICAL REVIEW</p>\r\n<p>Iron occurs in many forms in the body, it is present in such enzymes as the cytochromes and the peroxidases, but the largest quantities are present in the red cells as haemoglobin, in muscle as myoglobin, and in the reticulo-endothelial system stores as ferritin and haemosiderin. Iron is normally stored in the ferritin state and combined with B-globulin as ferritin, a compound containing about 23% ferric iron. Ferritin cannot be seen under the light microscope in routine paraffin sections, and does not usually give a Prussian blue reaction.</p>\r\n<p>In this respect it is distinguished from haemosiderin, in which the proportion of iron is considerably higher (about 36%) and the Prussian blue reaction is positive. Haemosiderin appears as brown, insoluble granules that give the Prussian blue reaction. It is found in any situation where excessive quantities of iron are being stored. This may occur as a local phenomenon or else is generalised.</p>\r\n<p>Whenever there is a haemorrhage, the iron from the broken down red cells is found in the nearby macrophages in the form of haemosiderin (and also ferritin). This is seen around organising haematomata, haemorrhagic infarcts, fractures, etc. A brownish discoloration around a brain cyst is therefore good evidence if it&rsquo;s origin from an infarct. The sclerosing haemangioma is often deeply pigmented and can be mistaken both clinically and pathologically for a malignant melanoma unless special stains are used. The epidermis overlying the lesion is frequently acanthotic and deeply pigmented with melanin; this is largely responsible for the pigmentation noted clinically. When the lesion is incised, the deep haemosiderosis is apparent.</p>\r\n<p>PRINCIPLE</p>\r\n<p>The first step in the procedure employs an acidified colloidal solution of ferric hydroxide. Acid mucosubstances and certain acid mucins are the principal substances in a tissue section that absorb the colloidal ferric ions. It is believed the initial linkage is an ionic bond of the ferric ion with the free carboxyl group of the protein. Iron bound to tissue substances is then demonstrated by the Prussian blue reaction. On treatment with potassium ferrocyanide, the ferric ion forms ferric ferrocyanide, or Prussian blue. Positive staining is therefore indicated by a blue colour.</p>\r\n<p>Non-specific staining is reduced by acidified colloidal solution and degree of polymerisation of the acid mucosubstances; however, the colour is usually a deeper shade than that produced by alcian methods. The colloidal iron method does not have the histochemical specificity of some of the alcian blue techniques.</p>\r\n<p>FIXATION.<span style=\"white-space: pre;\"> </span>10% neutral Buffered Formalin</p>\r\n<p>TECHNIQUE.<span style=\"white-space: pre;\"> </span>Cut sections at 3 microns</p>\r\n<p>CONTROL.<span style=\"white-space: pre;\"> </span>Liver containing iron</p>\r\n<p>SOLUTIONS:</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>COMMERCIAL KIT</p>\r\n<p>PROCEDURE</p>\r\n<p>1. Bring sections to water<span style=\"white-space: pre;\"> </span></p>\r\n<p>2. Working Solution<span style=\"white-space: pre;\"> </span>20min</p>\r\n<p>3. Distilled Water<span style=\"white-space: pre;\"> </span>Rinse</p>\r\n<p>4. 1% Alcoholic Eosin<span style=\"white-space: pre;\"> </span>30sec</p>\r\n<p>5. Absolute Alcohol x2<span style=\"white-space: pre;\"> </span>10sec</p>\r\n<p>6. Dehydrate and clear</p>\r\n<p>Results</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Ferric Iron (Haemosiderin)<span style=\"white-space: pre;\"> </span>Blue</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Other Tissue <span style=\"white-space: pre;\"> </span>Pink/Red</p>\r\n<p>REFERENCES</p>\r\n<p>Manual of Histologic Staining Methods, Armed Forces Institute of Pathology, 3rd Edition, McGraw-Hill, 1968.</p>\r\n<p>PERIODIC ACID- SCHIFF&nbsp;MEDICAL REVIEW</p>\r\n<p>The periodic acid-Schiff reaction, or PAS stain, demonstrates the presence of certain polysaccharides, particularly of glycogen and mucoproteins containing neutral mucopolysaccharides, by staining them red. The PAS reaction is of value also in the study of fibrinoid degeneration, since the fibrin deposits in such areas are PAS positive. Furthermore, since the cell wall of fungi are composed of a mixture of cellulose and chitin and thus contain polysaccharides, all fungi stain bright red with PAS reaction.</p>\r\n<p>PRINCIPLE</p>\r\n<p>With PAS reaction, tissue is first oxidised by periodic acid. The oxidative process results in the formation of aldehyde groupings through carbon to carbon bond cleavage. Free hydroxyl groups should be present for oxidation to take place. Periodic acid will not oxidise newly formed aldehyde groups to further breakdown products, oxidation is complete when it reaches the aldehyde stage.</p>\r\n<p>The Schiff reagent detects the newly formed aldehyde groups. The first stage reaction involves the formation of a colourless, unstable dialdehyde addition compound that is then transformed to the coloured final product by the restoration of the quinoid chromophoric grouping.</p>\r\n<p>FIXATION<span style=\"white-space: pre;\"> </span>10% Neutral Buffered Formalin</p>\r\n<p>TECHNIQUE<span style=\"white-space: pre;\"> </span>Cut paraffin sections at 4 microns</p>\r\n<p>CONTROL<span style=\"white-space: pre;\"> </span>Ileum</p>\r\n<p>SOLUTIONS</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>1% PERIODIC ACID</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>59% Periodic Acid<span style=\"white-space: pre;\"> </span>10ml</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Distilled Water<span style=\"white-space: pre;\"> </span>490ml</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>SCHIFF&rsquo;S REAGENT&nbsp; (ready to use stain)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>HAEMATOXYLIN</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>0.1% ACID ALCOHOL (as per H&amp;E stain)</p>\r\n<p>PROCEDURE</p>\r\n<p>1.<span style=\"white-space: pre;\"> </span>Bring sections to water</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>Periodic Acid<span style=\"white-space: pre;\"> </span>5min</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>Running Water<span style=\"white-space: pre;\"> </span>5min</p>\r\n<p>4.<span style=\"white-space: pre;\"> </span>Schiff&rsquo;s Reagent<span style=\"white-space: pre;\"> </span>15min</p>\r\n<p>5.<span style=\"white-space: pre;\"> </span>Running Water<span style=\"white-space: pre;\"> </span>5min</p>\r\n<p>6.<span style=\"white-space: pre;\"> </span>Haematoxylin<span style=\"white-space: pre;\"> </span>3min</p>\r\n<p>7.<span style=\"white-space: pre;\"> </span>Tap Water<span style=\"white-space: pre;\"> </span>1min</p>\r\n<p>8.<span style=\"white-space: pre;\"> </span>0.1% Acid Alcohol<span style=\"white-space: pre;\"> </span>15sec</p>\r\n<p>9.<span style=\"white-space: pre;\"> </span>Tap Water<span style=\"white-space: pre;\"> </span>1min</p>\r\n<p>10.<span style=\"white-space: pre;\"> </span>Scott&rsquo;s Blue<span style=\"white-space: pre;\"> </span>1min</p>\r\n<p>11.<span style=\"white-space: pre;\"> </span>Tap Water<span style=\"white-space: pre;\"> </span>1min</p>\r\n<p>12.<span style=\"white-space: pre;\"> </span>Dehydrate and clear</p>\r\n<p>Results</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Fungi - Red</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Nuclei - Blue</p>\r\n<p>ZIEHL-NEELSON (ACID FAST BACILLI)&nbsp;MEDICAL REVIEW</p>\r\n<p>Acid-fast methods are most frequently used to demonstrate the presence of acid-fast bacteria in tissue sections. Acid-fast bacteria belong to the genus Mycobacterium, of which several species are pathogenic to man, including Mycobacterium tuberculosis, Mycobacterium lepton and various other species that cause mycobacteriosis. Certain fungal species also exhibit acid-fast characteristics as well as certain lipofuchsins and intranuclear inclusion bodies.</p>\r\n<p>PRINCIPLE</p>\r\n<p>Most acid-fast stains involve the application of a phenylmethane (i.e. Carbol Fuchsin) in a phenol solution. Phenol enhances the staining and appears to combine with the fuchsin dye within the acid-fast bacilli. It also functions to dissolve the fuchsin dye. Alcohol is usually added to the carbol fuchsin solution both to enhance the staining and to dissolve the dye. When the carbol fuchsin is applied, all cells, including the normally hard to stain acid-fast varieties, are coloured red.&nbsp;</p>\r\n<p>The next step is the application of acid alcohol decolouriser. More uniform decolourisation is obtained with the use of an alcoholic, rather than an aqueous, solution. At the decolourisation stage, all the tissue elements, except the acid-fast ones, are rendered colourless. This is the classic acid-fast phenomenon. One concept states that acid-fastness is determined by selective permeability of the cell wall, and should the cell be mechanically disrupted, the acid-fast property will be lost. There also seems to be a correlation between the lipid content of the acid-fast bacteria and the ability to stain. Both are probable contributing factors.</p>\r\n<p>FIXATION.<span style=\"white-space: pre;\"> </span>10% Neutral Buffered Formalin</p>\r\n<p>TECHNIQUE.<span style=\"white-space: pre;\"> </span>Cut sections at 4 microns</p>\r\n<p>CONTROL.<span style=\"white-space: pre;\"> </span>AFB Positive Tissue / Leprosy</p>\r\n<p>SOLUTIONS.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>CARBOL&nbsp; FUCHSIN&nbsp; (ready to use stain)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>ACID&nbsp; ALCOHOL</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Hydrochloric Acid<span style=\"white-space: pre;\"> </span>10ml</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>70%&nbsp; Alcohol<span style=\"white-space: pre;\"> </span>1000ml</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>0.5% METHYLENE BLUE (ready to use stain)</p>\r\n<p>PROCEDURE</p>\r\n<p>1. Bring sections to water.</p>\r\n<p>2. Carbol Fuchsin<span style=\"white-space: pre;\"> </span>30min</p>\r\n<p>3. Tap Water<span style=\"white-space: pre;\"> </span>Wash</p>\r\n<p>5. Acid Alcohol<span style=\"white-space: pre;\"> </span>2-5 dips</p>\r\n<p>6. Tap Water<span style=\"white-space: pre;\"> </span>Wash</p>\r\n<p>7. Methylene Blue<span style=\"white-space: pre;\"> </span>2min</p>\r\n<p>8. Tap Water<span style=\"white-space: pre;\"> </span>Wash</p>\r\n<p>9. Dehydrate, Clear and Mount</p>\r\n<p>Results</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Acid-Fast Bacilli<span style=\"white-space: pre;\"> </span>Pink</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Background<span style=\"white-space: pre;\"> </span>Blue</p>\r\n<p>IMMUNOPEROXIDASE</p>\r\n<p>Referred externally.</p>\r\n<p>INTERNAL CHECKING / QUALITY CONTROL:</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Every day run a H&amp;E control slide through the stainer. After completion of the staining and mounting of the slide, check the microscopic appearance of the nuclei, cytoplasm, and surrounding structures for correct staining.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>If in doubt consult the pathologist.&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>The day sheet must be filled in and signed and dated.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Each slide must be checked against the block before leaving the laboratory for the reporting pathologist.&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Check also for adequate clearing of bubbles, stain deposit, fingerprint carry over or other debris.&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Initial the first label of each case to indicate the block has been checked.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Check the label on the slide against the request form.&nbsp;&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Ensure correct patient name and specimen type.&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Check the block number and name against the slide and request form.&nbsp;&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Check the tissue present in the block is identical to the slide. (Some variation will occur when performing levels but the last level, eg L3 must be the same. Any discrepancy is bought in to the pathologist&rsquo;s attention for action.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Providing the patient name, number, specimen and block are all correct; the slides can then be issued to the pathologist for reporting.&nbsp;&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Once the blocks have been checked against the slides, they are filed in numerical order in the block filing boxes.&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Slides are allowed to dry for at least one day prior to filing. Slides are filed in numerical order in the filing boxes.&nbsp;</p>\r\n<p>FILING&nbsp;SLIDES&nbsp;Storage</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Must be stored for 10 years minimum</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Paediatric samples must be kept until the patient turns 25yo.</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>Stored in cardboard boxes</p>\r\n<p>Filing</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Begin with the lowest lab number at the front of the box or drawer and file from front to back&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>do not file slides until they have dried for at least 1 day</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>file in lab numerical order</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>specimen order (1 - 5)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>block order (A - E)</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Leave space for missing slides with a piece of foam or cardboard.</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>Leave space at the end of each row for easy movement of slides.&nbsp;</p>\r\n<p>d)<span style=\"white-space: pre;\"> </span>Label each box with the first and last numbers; number each box sequentially and stack in order.</p>\r\n<p>BLOCKS&nbsp;Storage</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Blocks must be stored for 10 years minimum&nbsp;</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Paediatric samples must be kept until the patient turns 25yo.</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>Stored in cardboard boxes</p>\r\n<p>Filing</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Begin with the lowest lab number at the front of the box</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>file in lab numerical order</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>specimen order (1 - 5)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>block order (A - E)</p>\r\n<p>SPECIMENS</p>\r\n<p>Storage</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Containers with no residual tissue and unblocked tissue must be stored for one month from date of issue of specimen report.</p>\r\n<p>Filing</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>All specimens are stored in the plastic containers. A new container is used each week. After five weeks discard the first bucket.</p>\r\n<p>DISCARDING&nbsp;SLIDES</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Must be stored for 10 years minimum</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Paediatric samples must be kept until the patient turns 25yo.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Place in a sharps container.</p>\r\n<p>BLOCKS</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Must be stored for 10 years minimum</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Paediatric samples must be kept until the patient turns 25yo.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Place in a contaminated waste bag and seal with a plastic tie.</p>\r\n<p>SPECIMENS</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Specimens may be discarded after one month</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Place in a contaminated waste bag and seal with a plastic tie.</p>\r\n<p>REFERENCES</p>\r\n<p>https://www.rcpa.edu.au/Library/Practising-Pathology/DM/Doc/Requirements-for-the-Retention-of-Laboratory-recor.aspx</p>\r\n<p>REFERRED CASES SPECIMENS</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Any specimens that are referred to FNQH Pathology requiring tests other than histology e.g. microbiology, are sent to QML Pathology (11 Riverview Place, Murarrie QLD 4172, Phone: 07 3121 4444).</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Log details of the specimen in the send away folder.</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>Take the specimen to the nearest QML collection room, or ring the QML courier for pick-up.&nbsp;</p>\r\n<p>d)<span style=\"white-space: pre;\"> </span>When a copy of the result is received, record it in the send away folder and add it to the patient file. If a result is not received after one week, follow it upwith QML.</p>\r\n<p>SPECIAL STAINS</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Refer all cases requiring special stains or immunohistochemistry not performed at FNQH Pathology to QML Pathology</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Cut at least 2 sections per slide using coated slides or send blocks.</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>Send 1 slide for each antibody requested and a spare.</p>\r\n<p>d)<span style=\"white-space: pre;\"> </span>Dry in the stainer oven for 10 minutes.</p>\r\n<p>e)<span style=\"white-space: pre;\"> </span>Log all details in the sendaway folder.</p>\r\n<p>f)<span style=\"white-space: pre;\"> </span>Send:</p>\r\n<p>1)<span style=\"white-space: pre;\"> </span>A request form asking for stains required.</p>\r\n<p>2)<span style=\"white-space: pre;\"> </span>A copy of our request form.</p>\r\n<p>3)<span style=\"white-space: pre;\"> </span>Slides in a plastic slide container.</p>\r\n<p>g)<span style=\"white-space: pre;\"> </span>Send carefully packaged by post in a padded envelope.</p>\r\n<p>SLIDES AND BLOCKS</p>\r\n<p>a)<span style=\"white-space: pre;\"> </span>Slides may be requested by a doctor to be sent to another pathologist for a second opinion.&nbsp;</p>\r\n<p>b)<span style=\"white-space: pre;\"> </span>Ask the requesting person to indicate the name of the person requesting the referral, the name and exact address of the person the slides must be sent to, and the patient&rsquo;s details.&nbsp;</p>\r\n<p>c)<span style=\"white-space: pre;\"> </span>Always write a covering note or complete a referral form detailing the above and indicating that the slides/blocks must be returned.</p>\r\n<p>d)<span style=\"white-space: pre;\"> </span>A pathologist must review all slides before they are sent out.</p>\r\n<p>e)<span style=\"white-space: pre;\"> </span>Log in the sendaway folder.</p>\r\n<p>f)<span style=\"white-space: pre;\"> </span>Send carefully packaged by post in a padded envelope.</p>\r\n<p>SUPPLIES INSTRUCTIONS FOR SPECIMEN SHIPPING</p>\r\n<p>Packaging Requirements&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p>\r\n<p>According to NPAAC Guidelines the nature of the specimens received by this laboratory places them under Category C in regards to hazard classification.&nbsp;For any substances categorised as Category C, triple packaging must be used.&nbsp;</p>\r\n<p>The three necessary components are as follows:</p>\r\n<p>1.<span style=\"white-space: pre;\"> </span>The specimen must be put in a primary, leak-proof receptacle, e.g. specimen jar.</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>The primary receptacle must be placed in leak-proof secondary packaging with sufficient absorbent cushioning material to absorb the entire contents, e.g. biohazard bag and combine dressing.</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>The secondary container must be placed into outer packaging of adequate strength for its capacity, mass, and intended use and with a secure closure to prevent loss of contents, e.g. in a large plastic bag inside a plastic storage container with the lid taped shut.</p>\r\n<p>Instructions For Transporting Specimens</p>\r\n<p>1.<span style=\"white-space: pre;\"> </span>Specimens should have 10x the volume of 10% formalin to the volume (size) of the specimen.</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>Each patient should have a separate biohazard bag with specimens and request forms separated in the bag.</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>Containers and the bags should be securely sealed to prevent leaks.</p>\r\n<p>4.<span style=\"white-space: pre;\"> </span>Both the request forms and the specimens should have patient details including full name, DOB and site of specimen for cross-checking purposes.</p>\r\n<p>5.<span style=\"white-space: pre;\"> </span>The specimens should be placed in hard plastic containers which should be clipped shut as well as taped closed.</p>\r\n<p>6.<span style=\"white-space: pre;\"> </span>If no hard plastic shipping containers are available, all the specimens should be placed in a large plastic bag w',	'',	'FNQHM-020622 ',	4,	'',	'',	0,	1,	453,	'2022-09-16 12:32:43'),
(34,	'FNHQ-SOP-QM030622',	'Quality Manual',	453,	12,	0,	'2022-09-05',	'2022-09-16',	0,	1,	'TCB',	0,	12,	'2023-09-16',	'2022-09-16',	'Sarah Sharpe',	'',	'<p>Overview</p>\r\n<p>This Quality Manual is the basis of the FNQH Pathology Quality System and includes policies and procedures to which staff are expected to adhere. All Staff must be familiar with and follow the Policies and Procedures contained and referred to in this manual, as well as the Policies of FNQH Pathology.</p>\r\n<p>The Quality Manager is responsible for the preparation and maintenance of this manual</p>\r\n<p>Quality Policy</p>\r\n<p>FNQH Pathology provides pathology services to GPs and Skin Cancer Specialists as requested.&nbsp;</p>\r\n<p>FNQH Pathology meets the requirements of customers in an appropriate and timely fashion. We in turn have the same requirements of all parties supplying goods and services to this laboratory.</p>\r\n<p>The following is in place to ensure the requirements of our clients are met:</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>We have implemented a quality management system based on ISO 15189 and are committed to its use as a minimum requirement in providing products and services to our customers.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>We aim for continuous quality improvement in all our areas of activity.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>The concept of continual quality improvement is embraced by all staff. We encourage staff members to contribute to our quality management through regular meetings and feedback. Staff at all levels are encouraged to initiate, participate in and review quality projects and are provided with the appropriate tools and training.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>We seek feedback from our customers as a means of improving the quality of our service.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>We participate in external and internal Quality Assurance Programs to continually monitor our performance.</p>\r\n<p>Quality Objectives</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>To monitor Turnaround Times for a limited set of specific procedures twice yearly and assessed based on National Clinical Indicators</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>To document all laboratory errors via the Quality System, in order to identify systematic approaches to reducing or eliminating errors</p>\r\n<p>Ethics and Behaviour&nbsp;</p>\r\n<p>Consent</p>\r\n<p>All procedures carried out on patients must be with their informed consent. For routine procedures written consent may not be required; the patient presenting for the collection procedure infers consent.&nbsp;</p>\r\n<p>&nbsp;Collection of Information</p>\r\n<p>Personal information is routinely collected from patients. This information includes that required to properly identify the individual and at times, medical history information or other details necessary to provide the service required. Unnecessary information should not be collected. The patient has a right to know the information collected, and the purpose for which it has been collected.&nbsp;</p>\r\n<p>Confidentiality</p>\r\n<p>All information concerning patients is confidential and must not be disclosed to anyone other than those directly responsible for the patient&rsquo;s care. Staff have a responsibility to ensure that access to records, both written and electronic, is secure. Computer terminals should be logged off when left unattended and password security observed. Any breach of confidentiality, either by commission or omission, will be regarded as serious.</p>\r\n<p>The regulations concerning confidentiality within FNQH Pathology extend to any information gained as a result of employment. Communication with the media concerning the activities of FNQH Pathology is expressly forbidden without the permission of the Managing Director. Any doubts about the provision of information should be referred in the first instance to the Lead Pathologist or Laboratory Manager.</p>\r\n<p>Performance of Tests</p>\r\n<p>Testing shall only be performed in an authorised manner, using approved methods and by personnel trained and authorised to perform the testing. Fabrication of results or use of unapproved methods is not acceptable.</p>\r\n<p>Freedom of Information</p>\r\n<p>The Freedom of Information Act guarantees access by members of the public to any information held by the Agency which they are entitled to see. The Agency is required to respond within 30 days of the request.</p>\r\n<p>If a FOI request is made of this department, it should be forwarded the same day to the Lead Pathologist.</p>\r\n<p>Operational Integrity</p>\r\n<p>No staff member is permitted to present for work in a condition which may impair their ability to effectively and safely carry out their duties (e.g., sickness, excessive tiredness, intoxication). All staff who present for work must be capable of carrying out their duties in a safe and professional manner. If they doubt their ability to carry out their assigned duties, they must advise the Senior Scientist or Laboratory Manager immediately.</p>\r\n<p>If a staff member forms the opinion that another staff member is impaired in their ability to carry out their work the Senior Scientist or Laboratory Manager is to be immediately notified. The Laboratory Management will treat any such information confidentially.</p>\r\n<p>Conflict of Interest</p>\r\n<p>Section 79 of the State Services Act details an employee&rsquo;s responsibility to disclose and seek permission to operate a business outside of the State Service. In addition, staff will not accept gifts beyond the agreed organisational limit or other disbursements from suppliers or customers that may cause improper attempts to influence staff.</p>\r\n<p>Undue Pressure</p>\r\n<p>(Examples: being pressured to release results on an assay when QC is out of limits, and before corrective action is initiated, being pressured to act outside your scope of competency).</p>\r\n<p>If at any time staff feel that they are being pressured in any way that would interfere with the quality of the test results, or with the quality of the process, the Lead Pathologist is to be immediately informed of the circumstances. It is essential that a log is recorded accurately detailing the nature of the pressure and any action taken to address the issue. A nonconformance is to be raised. The Lead Pathologist will use their professional judgement and will give the appropriate advice and will take any required action. The staff member involved may be offered counselling if required. If the Lead Pathologist is unable to resolve the situation, then the Managing Director will be advised.</p>\r\n<p>Ethical Treatment of Samples and Tissues</p>\r\n<p>Samples and tissues are to be treated with respect. Inappropriate or unnecessary comments about the appearance or condition of samples are not tolerated. Samples are to be handled and disposed of in an approved manner.</p>\r\n<p>Use of Samples for Other Purposes</p>\r\n<p>An excess of sample may be used for purposes other than that for which it was collected (e.g., to validate a new test procedure) but only if all identification is removed from the specimen.</p>\r\n<p>Identifiable samples may not be used for purposes other than that for which they were collected.</p>\r\n<p>Standards of Behaviour - Dress and Appearance</p>\r\n<p>Staff are required to dress in a neat, safe and tidy manner when on duty. No specific dress code is enforced but they should meet general community standards when dressing for work. Waterproof (e.g. leather, rubber) enclosed footwear (closed toe and heel) must be worn, (i.e., no sandals or thongs).&nbsp;</p>\r\n<p>Jewellery should be kept to a minimum to present a professional approach and must not present an Occupational Health and Safety or infection control risk. Consider personal safety when deciding size and style of earrings, necklaces, bracelets (e.g., diameter of sleeper/hoop style).</p>\r\n<p>Long hair should be tied back or covered, and beards covered when undertaking aseptic or sterile procedures. Hair accessories must be functional.</p>\r\n<p>Standards of Behaviour - Courtesy</p>\r\n<p>Staff are expected to behave in a courteous manner to other staff, patients and visitors at all times, even under provocation. Discourtesy is regarded as a serious breach of discipline. Matters of&nbsp;dispute that cannot be resolved must be referred to the Laboratory Manager or to a senior staff member.</p>\r\n<p>Standards of Behaviour - Office &amp; Reception Area</p>\r\n<p>The Office and Specimen Reception Area are often the first contact with the Laboratory, either in person or by telephone. The staff in these areas must act in a responsible and professional manner at all times. Rudeness, abruptness and general unhelpfulness is not to be displayed at any time. In areas where staff are visible to customers or can be heard, personal matters are not to be discussed. In addition, matters concerning patients are to be carried out in such a fashion as not to breach confidentiality at any time. Discretion is needed when discussing test requirements and receiving specimens.</p>\r\n<p>Electronic Communication</p>\r\n<p>Email and Internet activity is governed by specific FNQH Pathology electronic communications policy.</p>\r\n<p>Courier</p>\r\n<p>The use of FNQH Pathology&rsquo;s car is restricted to staff engaged upon departmental business. Logbooks must be filled out completely after use.</p>\r\n<p>Staff undertaking courier work for the Laboratory are to maintain appropriate standards of presentation that follow acceptable community norms for persons in this position. They are to facilitate specimen collection and report delivery in such a manner that the needs of the customers are met. They are to obey all relevant State Statutes and Regulations concerning being in control of a motor vehicle. Any fines or other penalties are the total responsibility of the person in charge of the motor vehicle. Logbooks must be clearly and accurately filled out for each journey. Refer to the courier manual for further details.</p>\r\n<p>General Information</p>\r\n<p>Scope of Activities</p>\r\n<p>The function of FNQH Pathology is to provide a comprehensive Anatomic Pathology service for General Practitioners and Skin Cancer Clinics in the area. FNQH Pathology provides an appropriate service to the laboratory&rsquo;s client base in terms of range of tests, timeliness, cost effectiveness and access.</p>\r\n<p>The policies and procedures within FNQH Pathology are in accordance with the requirements of the relevant Federal and State Acts and NATA guidelines.</p>\r\n<p>Normal operation hours are 0800 hours to 1800 hours five days a week. Outside the above hours, an emergency call-back service operates. Pathologists and Senior Staff and are available for consultation when required.</p>\r\n<p>Pathologists and Senior Scientific Staff provide professional advice and assistance to referrers. Associated with this are regular clinico-pathology correlation meetings.</p>\r\n<p>Department cars are used to run a specimen collection service to FNQH Skin Cancer Clinics. A courier service is used for General Practitioners using the service.&nbsp;</p>\r\n<p>Reports are delivered by automatic electronic upload to referrers through secure integration with Best Practice or other practice software.&nbsp;</p>\r\n<p>Research and Clinical Trials</p>\r\n<p>We are involved in providing services for clinical trials and research projects. The research / clinical trial must have appropriate agency ethics approval before any activity is agreed to by the Managing Director. We may elect to provide this service for activities within the scope of our accreditation.&nbsp;</p>\r\n<p>Tertiary service role</p>\r\n<p>In situations where there is a problem with another laboratory&rsquo;s instrumentation, we are happy to add an occasional sample to our regular batch. Where the procedure is time consuming, resource intensive or exposes the laboratory to additional clinical risk, the Lead Pathologist must be consulted before agreeing to do these tests or procedures. See also section on request forms and contracts later in this manual.</p>\r\n<p>Laboratory&nbsp; Policies</p>\r\n<p>The Laboratory is covered by policies and operational arrangements as decided by the FNQH Pathology&nbsp; Executive &ndash; refer to FNQH Pathology organisational chart.&nbsp;</p>\r\n<p>Service to the Client</p>\r\n<p>The clients of the Laboratory are GPs and Skin Cancer Specialists. These customers are the very reason we exist and as such demand the highest standards, both professionally and personally from all the staff associated with the laboratory.</p>\r\n<p>Client feedback is welcomed and provides a useful guide to areas in which our service could be improved.</p>\r\n<p>Clients are welcome to access and comment on our testing protocols at any time.</p>\r\n<p>Location</p>\r\n<p>The Laboratory is located at 274 Mulgrave Rd, Westcourt QLD 4870 and consists of the following functional areas:</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Specimen Reception</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Pathologist and Laboratory Manager Office</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Laboratory</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Storage Areas</p>\r\n<p>The laboratory is a modern, air-conditioned, well-lit facility for pathology testing.</p>\r\n<p>Members of the public must access the laboratory via the reception desk and must not enter the any part of the laboratory unless accompanied by a member of staff.</p>\r\n<p>Access to FNQH Pathology is via Westcourt Shopping Centre and FNQH Skin Cancer Clinic.</p>\r\n<p>Security</p>\r\n<p>The laboratory and offices are secured by locked doors, the public areas are outside the locked zone. Laboratory staff have access to all areas of the laboratory and offices during normal business hours.</p>\r\n<p>Any unauthorised visitor found in the laboratory should be challenged. The Laboratory Manager should be notified of suspicious behaviour.&nbsp;&nbsp;</p>\r\n<p>After core hours, the Laboratory is locked and access is limited to staff with key access.&nbsp;</p>\r\n<p>Cleaning and Waste Disposal</p>\r\n<p>FNQH Pathology is serviced by a contracted cleaning service. However, staff are responsible for ensuring that work areas are kept clean and tidy throughout the day and that any spillage or excess rubbish is cleared to maintain a safe working environment.</p>\r\n<p>All areas are to be kept free of rubbish or excess items. In particular emergency exits, corridors and walk areas within FNQH Pathology must be kept clear at all times.</p>\r\n<p>Non-infective waste is discarded in the DFO shopping centre compactor, then is taken to the City tip. Infected material and histology specimens will be removed by a biohazardous waste removal service and incinerated.&nbsp;</p>\r\n<p>Information Technology</p>\r\n<p>The laboratory information system is PathHub. We have a trained staff member on site for general maintenance and other systems tasks. The application is supported by a service contract with the company and they are responsible for providing comprehensive support and maintenance. FNQH Pathology IT services augment this support as required. Access to the computer system is password protected, and staff have access rights based on need and experience. A system of regular (daily) backup of data is in place and is performed by FNQH Pathology IT services. The laboratory also utilises PathHub as Quality Management Software. The Quality Manager is responsible for overseeing general maintenance, configuration and other system tasks and the application is supported by the parent company Ideagen.</p>\r\n<p>Appropriate records of test results are kept either on hard disc or as hard copy as per NPAAC and NATA Laboratory accreditation recommendation.</p>\r\n<p>Validation of Software Changes</p>\r\n<p>All changes to laboratory information systems or software must be validated prior to introduction. The validation should take account of any potential risk to the integrity of data, and especially of any risk or potential harm to the patient. The rigour of the investigation will depend somewhat on the assessment of risk; this risk assessment is to be documented and is to be carried out by a senior member of staff. The validation is to be clearly documented.</p>\r\n<p>Communications</p>\r\n<p>Clinico-Pathology Meetings</p>\r\n<p>These are held on a regular schedule. These meetings are to discuss relevant cases and to provide a forum for direct feedback on the performance of the laboratory to the Lead Pathologist. Other medical and senior staff attend as required.&nbsp;</p>\r\n<p>Senior Staff Meeting</p>\r\n<p>The senior staff comprising the senior staff responsible for each section, Laboratory Manager, Office Manager, Quality Manager, Pathologists and other persons as necessary meet on a regular basis to discuss matters of relevance to FNQH Pathology. Minutes are kept of these meetings. Some matters (e.g., personnel matters) may be excluded from these minutes as the Director or Laboratory Manager sees fit. A quorum is four persons including the Lead Pathologist or Laboratory Manager. Decisions from this meeting are not binding on the Managing Director.</p>\r\n<p>Sectional Staff Meetings</p>\r\n<p>Each section holds regular meetings as required to disseminate information. These meetings occur at least quarterly, but generally more often than this. At this meeting, the Senior Staff will give an outline of any matters discussed at the Senior staff meetings and give staff at all levels the chance to raise matters either to be taken to the next meeting or the Lead Pathologist or Laboratory Manger for response. These meetings are also the focus for continuing education and review of quality activities. Short minutes are to be kept of these meetings to allow shift workers, persons on leave and those unable to attend to gain an outline of the contents.</p>\r\n<p>General Staff Meetings</p>\r\n<p>These are held as required, usually at about 6 monthly intervals, but more often if specific issues arise. Given the nature of shift work it is acknowledged that some staff will be unable to attend meetings. Presentations, continuing education and general discussion are some of the matters that may be raised.</p>\r\n<p>Memoranda</p>\r\n<p>Memoranda are issued from time to time where a written directive is required. These are distributed throughout the Laboratory or to individuals as necessary. Authority to issue Memoranda lies with the Lead Pathologist or the Laboratory Manager.</p>\r\n<p>General Communications</p>\r\n<p>The Laboratory is committed to providing timely and open communication between all staff. In general, the lines of communication as reflected in the organisation chart should be maintained. This does not preclude direct approach to the Lead Pathologist or the Laboratory Manager if an individual or group so wish. However, many problems will be directed back to FNQH Pathology level for resolution in the first instance.</p>\r\n<p>Administration</p>\r\n<p>The Lead Pathologist is responsible for the Laboratory. The Laboratory Manager and Senior staff are individually responsible for a number of management functions that cross over internal departmental boundaries.</p>\r\n<p>Education, accreditation, safety, computerisation and special projects are managed on a day-to- day basis by staff assigned to that area. They in turn, rely on other staff to assist and advise them. A regular meeting of senior staff reviews and discusses management matters.</p>\r\n<p>All Staff are subject to State Acts governing their employment.</p>\r\n<p>Lines of responsibility</p>\r\n<p>Staff must determine to whom they are responsible during the shift that they are working. In particular, the responsibility for verification of results must be clearly understood. The sub- departmental head or assigned deputy is responsible for the allocation of duties.</p>\r\n<p>When working outside normal hours, on-call and shift staff are responsible for the range of work authorised to be done.</p>\r\n<p>Assignment of Staff</p>\r\n<p>Staff are assigned to internal departments according to their skills and training needs, and the needs of FNQH Pathology. Senior staff are usually assigned permanently to one section. Other scientific and technical staff may be expected to acquire and maintain skills that allow them to move between sections and perform the routine &ldquo;on-call&rdquo; procedures. Clerical and support staff may also move between sections as necessary.</p>\r\n<p>Technical management is the responsibility of the Senior Scientist. Technical management of Clerical Services is the direct responsibility of the Laboratory Manager. In the absence of the Supervising Scientist another nominated scientist will deputise in this role</p>\r\n<p>The Quality Officer has the responsibility for ensuring that all aspects of the Quality System are implemented and updated whenever necessary. In the absence of the Quality Officer the Laboratory Manager will fill this role. Whenever the term &ldquo;Manager&rdquo; is used it should be defined as referring to the incumbent or his or her nominee in the absence of the incumbent.</p>\r\n<p>All staff in the laboratory have a Statement of Duties which is available online and which is updated periodically to reflect any changes in their duties. Education, accreditation, safety, computerisation, and special projects are managed on a day-to- day basis by senior staff assigned to that area.</p>\r\n<p>Authorisation to Issue Reports or Advice</p>\r\n<p>Professional Staff may give advice on test choice, frequency, and interpretation within the limits of the individuals&rsquo; knowledge and experience, if in any doubt the query must be referred to a more senior scientist or pathologist. Provisional results should only be released by a pathologist.</p>\r\n<p>Visitors, University Students on Practicum, Work Experience Students</p>\r\n<p>These must be authorised by the Lead Pathologist or Laboratory Manager. When so authorised, generally they will be placed under the direction and responsibility of an appropriate Senior Scientist. They must be advised of our safety procedures and issues relating to confidentiality and appropriate behaviour. They must be under close, constant supervision. Vigilance must be given to any computer access. Identification must be worn at all times. An appropriate dress code must be maintained. Any problems must be reported immediately to the Lead Pathologist or Laboratory manager.</p>\r\n<p>Deputising Arrangements - Periods of Leave&nbsp;</p>\r\n<p>Lead Pathologist</p>\r\n<p>In the absence of the Lead Pathologist, the Laboratory Manager assumes overall responsibility for the Laboratory. For day-to-day clinical decision-making, the Staff Pathologists are employed.</p>\r\n<p>Laboratory Manager</p>\r\n<p>In the absence of the Laboratory Manager, one of the Senior Staff will be selected by the Lead Pathologist to act as Laboratory Manager. This person also assumes the role of Fire Warden.</p>\r\n<p>Senior Staff</p>\r\n<p>In the absence of Senior Staff, a nominated Scientist with sufficient experience and training will be given responsibility for the day-to-day operations.</p>\r\n<p>Quality Officer</p>\r\n<p>In the absence of the Quality Officer the Laboratory Manager or his / her delegate will fill this role.</p>\r\n<p>Education, Training, Performance Review</p>\r\n<p>The laboratory has a system of competency assessment to ensure that all staff develop and maintain appropriate skills in all aspects of their work. In addition, staff are expected to attend educational meetings and seminars to maintain and update knowledge.</p>\r\n<p>Training and Competency Assessment</p>\r\n<p>The laboratory maintains records to ensure the competence of all staff.</p>\r\n<p>New staff are given supervision while they work through a documented training program to ensure their level of skill is appropriate for the duties required of them. After this initial training, competency is continually evaluated by senior staff, and additional training provided as required. An annual competency evaluation is completed, this provides a formal opportunity to discuss any issues and offer any further training required.</p>\r\n<p>NOTE: Training and competency is the responsibility of each individual staff member. It is a staff member&rsquo;s professional duty to ensure that they are demonstrably trained and competent for all tasks performed.</p>\r\n<p>Performance Review</p>\r\n<p>New staff are given the opportunity to review their progress with their immediate superior at the end of three months, and at the end of six months when the probationary period ends. This is in addition to the continual process of direction and guidance offered.</p>\r\n<p>The annual competency assessment evaluation provides the opportunity for senior staff to review progress and development with the staff member. This is an opportunity to set goals for the next year, identify educational and training needs, establish an understanding of what is expected of the staff member and to provide an opportunity for the discussion of work-related problems. Any such training needs are to be documented on the annual competency assessment record.</p>\r\n<p>Continuing education and professional development</p>\r\n<p>All scientific and technical staff are expected to maintain a program of self-education.</p>\r\n<p>A regular program of education is established in the laboratory and all staff are to ensure that they attend and document their attendance. Compliance in relation to continuing education and professional development will be discussed at the annual competency assessment. All staff should also keep a personal record of any continuing education attendance.&nbsp;</p>\r\n<p>Periodic departmental meetings are held to assist in this process and time off to attend courses directly related to work is available where appropriate. In house training courses are available from time to time and staff are encouraged to attend these courses. A log of an individual\'s continuing education is to be maintained in the personnel file. It is the responsibility of each staff member to ensure that self-education is recorded.</p>\r\n<p>Some funds are available to assist staff to attend conferences and meetings and allocation is at the discretion of the Director and Laboratory Manager. The overriding consideration with regard to the selection of staff to attend conferences and seminars are the needs of FNQH Pathology.</p>\r\n<p>Safety</p>\r\n<p>The safety of staff, patients and the public are of paramount importance to the Laboratory. Staff must be aware of policies and procedures, and these must be followed at all times. Reporting of accidents, incidents and near misses is seen as an important quality assurance exercise to reduce the incidence and possibility of injury.</p>\r\n<p>Fire Safety Training, including evacuation drills are undertaken annually as part of the Laboratory Fire Safety Program and training in Manual Handling is undertaken Laboratory wide with all staff participation.</p>\r\n<p>Staff are encouraged to attend additional courses where appropriate, for example First Aid or Warden training.</p>\r\n<p>Incidents</p>\r\n<p>The primary means of notification for all health and safety incidents is via the Standard Operating Procedure and lodged with the Laboratory Manager as soon as possible.</p>\r\n<p>Samples and Requests</p>\r\n<p>General</p>\r\n<p>Samples are received from GPs and skin cancer clinics at Specimen Reception. Couriers are used to run a specimen collection service to off-site clinics. Taxis are used to augment this service if required. Internally Laboratory Staff are used for the delivery of samples from on-site FNQH Clinics.</p>\r\n<p>Request Forms</p>\r\n<p>A completed request form signed by the requesting Medical Officer must accompany each request. The sample must be clearly labelled and matched unequivocally with the request form. For Laboratory policy on unsigned requests and inadequately labelled samples, refer to the Laboratory Manual.</p>\r\n<p>Under specific circumstances forms signed by a person other than a Medical Officer (e.g. approved health care workers) may be acceptable. The Lead Pathologist, to whom any doubtful cases should be referred, will determine these circumstances. The Health Insurance Commission has determined that a treating medical practitioner may request a pathology service either orally or in writing but oral requests must be confirmed in writing within 14 days from the day when the oral request was made. A facsimile request is taken to have the same status as an original request form.</p>\r\n<p>For further information please refer to the Laboratory Manual.</p>\r\n<p>The Request as a Contract</p>\r\n<p>The receipt of a properly completed request form constitutes a contract between the requesting doctor and the laboratory. The laboratory is at all times obligated to do the utmost to provide the requested service, utilising approved methods and within a reasonable time frame. At times a request may be received which cannot be fulfilled due to reasons, for example, of incorrect sample or unavailability of the test. In these circumstances the requesting doctor is to be notified of the inability to fulfil the contract by phone and/or by written report.</p>\r\n<p>Where a pattern of non-fulfilment of contract occurs, senior staff are to be involved in review of these. This is to enable discussion with the requesting doctors and resolution of any problems.</p>\r\n<p>Transport of Specimens</p>\r\n<p>Couriers are used to run a specimen collection service to off-site clinics. Taxis are used to augment this service if required. Internally Laboratory Staff are used for the delivery of samples from on-site FNQH Clinics.</p>\r\n<p>Transport of Referred Tests</p>\r\n<p>The method of transport for referred tests will depend on the sample, the availability of suitable carriers and wishes of the Laboratory to whom the work is referred.</p>\r\n<p>All specimens that are transported by carriers are to be packed in accordance with IATA regulations and by persons specifically trained to do so.</p>\r\n<p>Specimen Receipt, Storage and Disposal</p>\r\n<p>Each sample is given a unique identifying number on receipt in the laboratory and all relevant information about the sample is recorded in the PathHub computer system (refer to the Laboratory Manual).</p>\r\n<p>All samples are stored in the laboratory in appropriate environmental conditions, which are regularly monitored and recorded.</p>\r\n<p>Specimens are stored for an appropriate time, using the current NPAAC guidelines as a minimum requirement. Samples are then disposed of in an appropriate manner as described in the Laboratory Manual.</p>\r\n<p>Reporting of Results</p>\r\n<p>Reports are sent to the requesting doctor and if required, copy doctor(s). Any other doctor requesting a copy of that report can obtain a copy. The onus is on that doctor to have a legitimate requirement for that result, if in doubt refer to the Lead Pathologist.</p>\r\n<p>Urgent Results</p>\r\n<p>These tests will be given priority and results phoned, faxed or printed to the location specified on the request form. Care must be taken to protect patient confidentiality when phoning urgent results. The procedure for phoning results, as detailed below, should be followed.</p>\r\n<p>Critical Results</p>\r\n<p>Any test result considered urgently required for the immediate management of the patient is to be communicated by phone to the unit concerned or to the requesting doctor. These critical results include but are not limited to malignant melanoma and lymphoma.&nbsp;</p>\r\n<p>Phoning Results</p>\r\n<p>It is essential that all results issued from the laboratory are correct. Incorrect results or misinterpretation may significantly risk our patient&rsquo;s welfare and compromise staff who issue those results.</p>\r\n<p>In this light any request for results to be provided over the phone MUST, in the first instance, be queried stating our preference to provide a formal copy, either hard copy or electronic. Remind callers that all patient results originating from a request in Best Practice should be available on that platform. In cases where the requestor persists that call must be directed to the appropriate place.</p>\r\n<p>All incoming calls must be assessed and directed according to the type of request.</p>\r\n<p>Before asking any other questions clearly identify the caller and the relationship around the request. If you are unsure or dubious about the need for the caller to have the requested information immediately refer them to your supervisor.</p>\r\n<p>For further information refer to the &ldquo;Communication of Pathology Results SOP&rdquo;. Only appropriately trained staff are to provide results</p>\r\n<p>Results Given Directly to Patients</p>\r\n<p>Results are not given to patients without a specific instruction from the requesting doctor. Should a patient become insistent they are referred to the Lead Pathologist or Managing Director (see also &ldquo;freedom of information&rdquo;).</p>\r\n<p>Withdrawal of Results/Result Revision</p>\r\n<p>In cases where a report has been authorised, but it becomes evident that the results are incorrect, the report must be revised immediately. The ISO15189 Standard requires revised reports to be clearly identified as a revision report and the revision report must include the date and time of the revision, the name of the person responsible for the revision and the original report entries must remain in the record after revisions are made, including the exact change.&nbsp;</p>\r\n<p>Immediately upon discovery of the error the revised results are to be phoned or communicated to the appropriate clinical area(s) to ensure they are made aware of any changes to the revised reports. Record the communication.</p>\r\n<p>To issue a revised report when a report has been already authorised and results have been released use the procedure in the Reporting Errors Procedure document.&nbsp;</p>\r\n<p>Reporting Results</p>\r\n<p>Reports are sent to the requesting doctor and to any other person or location as directed by the requesting doctor. Any other doctor requesting a copy of that report can obtain a copy. The onus is on that doctor to have a legitimate requirement for that result. All confidential paper reports are to be addressed to the requesting doctor in a sealed envelope marked &lsquo;confidential&rsquo;. Before any report is issued, the pathologist must check the results for accuracy.</p>\r\n<p>Reports are checked for the following:</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Patient demographics</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Accuracy and completeness of results</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Tests performed are as requested</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Request form is signed (or re-sent for signing or awaiting signature)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Report comments are appropriate</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Copy doctors are included</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Compliance with laboratory policy</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Results from other laboratories are annotated accordingly</p>\r\n<p>Turn Around Times</p>\r\n<p>Average TATs for most assays are provided for referrers. Where there is likely to be a significant deviation from these times (e.g. by reason of instrument maintenance or breakdown) notification should be provided to the key requesting doctors in those areas where rapid turnaround is normally required. If the delay is likely to be extensive and clinically relevant, the Lead Pathologist shall authorise the use of backup services.</p>\r\n<p>Subcontracting of tests and calibrations</p>\r\n<p>For tests that cannot be done at this Laboratory under our Terms of Registration or tests that are low in volume or specialised, a referral Laboratory is selected based on Quality (NATA accredited), previous reliable and timely service, and cost.</p>\r\n<p>The referral laboratory is acknowledged on all reports issued from this laboratory. A register of all referral laboratories used by us is kept in the referrals database.&nbsp;Overdue tests for our referral laboratories are monitored in PathHub.</p>\r\n<p>Referred Tests</p>\r\n<p>For all specimens that are referred to another Laboratory, records are maintained to allow verification of shipping and return of results. There is also an audit trail to verify that tests have been returned in a clinically relevant time frame. Where tests are not returned in a relevant time frame, then action is taken with the referral laboratory to review the arrangement, correct the problem or find another suitable laboratory.</p>\r\n<p>Details of specimen requirements for referred tests are kept in the relevant section of the online handbook. All staff packing samples for air transport must have current appropriate IATA certification.</p>\r\n<p>Document Control</p>\r\n<p>All documents, including this Quality Manual, technical procedures, policies, wall charts and forms are reviewed at least every 2 years by the appropriate manager and updated whenever necessary. All master documents are stored on PathHub and are reviewed by FNQH Pathology heads (or their delegate) with final approval by the Pathologist who oversees that section.</p>\r\n<p>Complaints, Non-conformances and Improvements</p>\r\n<p>Any member of staff who becomes aware of a situation which may require corrective action should notify their Technical Manager as soon as possible. Complaints from clients and suggestions for improvement must also be communicated as soon as possible.</p>\r\n<p>Complaints</p>\r\n<p>All complaints are documented and directed to the Director of Pathology or Laboratory Manager as soon as they are received. A CA/PA should be raised in PathHub. Follow up can then be recorded. If a Staff member becomes aware that their action or that of others may result in a complaint being made, they should advise the Director of Pathology or Laboratory Manager as soon as possible with all relevant details.</p>\r\n<p>Control of Nonconforming testing</p>\r\n<p>The laboratory maintains procedures for dealing with problems arising from any aspect of our testing which for any reason does not conform to the test procedures. All such nonconformances are documented by means of a CA/PA in PathHub, as is the action taken to correct it. The Senior Scientist responsible for the area has the responsibility for evaluating the problem and taking appropriate measures to fix the problem</p>\r\n<p>When any problems are shown to be of a recurrent of systematic nature, more formal corrective action involving the Quality Manager and Laboratory Manager may be necessary.</p>\r\n<p>Corrective Actions</p>\r\n<p>Corrective actions are necessary to correct nonconforming work practices or any departures from policy or procedure that have been identified. The procedure for a corrective action begins with investigation to determine the root cause of the problem, followed by implementation of appropriate corrective action and subsequent close monitoring to ensure that the corrective action has been effective.&nbsp;</p>\r\n<p>Preventative Action and Improvements</p>\r\n<p>Preventative action is a proactive process used to identify improvement opportunities, rather than a reaction to the identification of problems or complaints. Follow up procedures are similar to those used for complaints and nonconformances.</p>\r\n<p>Control of Records</p>\r\n<p>The laboratory has established procedures for control of technical and quality records as per the NPAAC guidelines. Records kept include:</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>testing and QC reports</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>equipment calibrations</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>internal audits</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>management reviews</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>complaints, corrective, preventative actions</p>\r\n<p>All records of testing are kept in the PathHub computer system and are accessible to all members of staff with appropriate levels of computer access. All of these records contain full details of tests and results, operator identity and observations or notes and are fully auditable.</p>\r\n<p>Internal Audits</p>\r\n<p>Internal audits are performed on a regular basis. The audit system is organised and maintained by the Quality Manager.</p>\r\n<p>The purpose of audits is to monitor the performance of the Quality System and technical procedures, and to determine whether any nonconformance exists or whether improvements can be made and discussed during management meetings (maintain a strong focus on continuous improvement).</p>\r\n<p>Management Review</p>\r\n<p>A Management Review meeting will occur yearly to review policy and operational issues. The Lead Pathologist, Laboratory Manager and Quality Manager attend; other senior staff may occasionally be required to provide specific items.</p>\r\n<p>Items examined include Complaints, Corrective Actions, Improvement Opportunities; Internal and External Audits; Document Control; Client feedback (e.g. customer surveys); Suppliers and Referral Labs; Reports from Senior Staff (Incorporating internal and external Quality Control, TATs, changes to volume/type of work).</p>\r\n<p>Methods &amp; Method Validation</p>\r\n<p>Procedure manuals are kept for all tests performed in the laboratory. These manuals are part of the document control system and are regularly updated by the Quality Manager and the appropriate Section Manager. Whenever possible the laboratory uses only well documented, standardised methods for testing. Any necessary variations are validated by the appropriate Section Manager prior to use.&nbsp;</p>\r\n<p>The Laboratory documents the performance and comparability of a new test method before it is used routinely.&nbsp;</p>\r\n<p>In-house in vitro devices</p>\r\n<p>In-house in vitro devices (IVD&rsquo;s) are considered therapeutic goods which are regulated under The Therapeutic Goods Act 1989. IVD&rsquo;s are expected to be safe, have a high quality and meet expected standards. All manufacturers of IVD&rsquo;s must certify that their products are safe, perform well for the intended purpose and are manufactured to a high standard of quality.</p>\r\n<p>Equipment</p>\r\n<p>All equipment used for testing is permanently on site in the laboratory and is regularly maintained according to a predetermined schedule and procedure by laboratory staff, or by the manufacturer or their agent. All equipment is operated by trained staff following documented procedures. Each item is uniquely identified and logged in the Assets Module in PathHub to enable records of its history to be kept.</p>\r\n<p>Equipment maintenance records are kept in PathHub. These include calibration and operational checks. Pathology staff perform preventative maintenance on certain items of equipment. Several items of equipment are under Service Contract agreements. Calibration and maintenance procedures and schedules are kept for all relevant equipment.</p>\r\n<p>Where a piece of equipment is found to be inoperable it is tagged and removed from service until repairs are carried out. A nonconformance should be raised in PathHub against the Asset.</p>\r\n<p>Specimen Carry-Over</p>\r\n<p>For all equipment, consideration is to be given as to the potential to report incorrect results due to specimen carry-over. Where this is possible, means shall be put in place to prevent this occurring.</p>\r\n<p>Temporary equipment failure</p>\r\n<p>QML Pathology is a NATA accredited Laboratory and, in the event of equipment failure or for any other reason, will provide backup for this Laboratory. In the same manner, we will perform testing for other laboratories as requested.&nbsp;The need for such a service would not normally exist for more than a day or two at a time.</p>\r\n<p>Operator Traceability</p>\r\n<p>To ensure traceability of the person undertaking the tests, all actions are recorded in PathHub, and any work sheets are annotated with the initials of the person performing the test.</p>\r\n<p>Assuring the Quality of Test Results</p>\r\n<p>Internal and external quality assurance is a vital component in ensuring that the test results and methodologies are of a standard that will not compromise patient care. All quality control results are to be monitored by senior staff and directions for action to be taken are contained in the specific method manuals.</p>\r\n<p>The laboratory participates in the RCPA and other external Quality Control Programs to provide a comparison of our results with other pathology providers throughout the country.</p>\r\n<p>Use of expired Materials</p>\r\n<p>All reagents, calibrators and quality control material used must be used within the expiry date of the product. However, it is acknowledged that in exceptional circumstances (for example for reasons of supply or quality of a replacement product) that this may be unavoidable. The use of expired material must only occur after consultation with the Supervising Scientist and under their direction. The test results are only acceptable providing there are no significant shifts or trends in the quality control results. If the quality control results are not acceptable the assay must be suspended until suitable product is available and has been validated. The use of expired material must be reported to the Senior Scientist.</p>\r\n<p>External Quality Assurance Programs</p>\r\n<p>All external Quality Control Program results shall be submitted by the due date. External Quality Control Results shall be an agenda item at FNQH Pathology meetings. Actions taken to address unsatisfactory performance shall be discussed and noted in the minutes.</p>\r\n<p>All external Quality Control results are to be notified to the Lead Pathologist. Remedial actions taken on results with unsatisfactory performance shall be documented on the External Quality Assurance program cycle summary and shall be reviewed by the Lead Pathologist. Where necessary after consultation with the Senior Scientist in charge of the sub-section, the Lead Pathologist shall direct changes to be made in methodologies, procedures or instrumentation or if necessary direct the tests to be done at another laboratory until the problem can be resolved.</p>\r\n<p>The Laboratory is enrolled in the following External Quality assurance Programs.</p>\r\n<p>PROGRAM<span style=\"white-space: pre;\"> </span>EXAMINATIONS/TESTS</p>\r\n<p>RCPA Anatomical Pathology<span style=\"white-space: pre;\"> </span>Dermatopathology, Technical</p>\r\n<p>Financial</p>\r\n<p>General Revenue</p>\r\n<p>Laboratory purchases are made through FNQH Pathology. The Laboratory Manager has authority to purchase all reagents and materials necessary for the day to day operation of the lab. Small items of equipment, (under $5,000) can be purchased in this way although it is wise to clear items such as furniture, refrigerators, and non-scientific equipment with the Managing Director. Computer equipment should be cleared through the CTO.</p>\r\n<p>Disposal of Equipment</p>\r\n<p>Do not dispose of any equipment without specific authorisation from the Managing Director via the Lead Pathologist or Laboratory Manager.</p>\r\n<p>Stores</p>\r\n<p>Storage of consumables, specimen containers etc. is limited to a small storage area in FNQH Pathology. Other storage exists within FNQH Skin Cancer Clinic.&nbsp;</p>\r\n<p>NATA&nbsp; Accreditation</p>\r\n<p>Authorised Representative</p>\r\n<p>Dr. Fiona Makowski is the NATA Authorised Representative for FNQH Pathology.</p>\r\n<p>NATA Endorsement</p>\r\n<p>Reports that are issued on tests done under the Scope of Accreditation may carry the NATA endorsement.</p>\r\n<p>Scope of Accreditation</p>\r\n<p>For the current Scope of Accreditation refer to the NATA website. The Quality Manager holds a current copy of this document if required.</p>\r\n<p>APA/APL Status</p>\r\n<p>Application has to be made when required to the Federal agencies for APA and APL status together with the fees. The documents are on file for previous years and should be completed promptly. Non approval means no money from Medicare for private patient work.</p>\r\n<p>References</p>\r\n<p>This quality manual has been prepared with consideration given to the requirements outlined in the following documents:</p>\r\n<p>AS ISO 15189:2012 Medical Laboratories-Requirements for quality and competence</p>\r\n<p>AS 4633 (ISO15189) Application Document, Supplementary requirements for accreditation in the field of medical testing July 2009</p>\r\n<p>NPAAC Documents</p>\r\n<p>Tier 1 - The Principles</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Health Insurance (Accredited Pathology Laboratories - Approval) Principles 2017</p>\r\n<p>Tier 2 - Standards and Supervisory Requirements for Pathology Laboratories</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Requirements for Medical Pathology Service (Third Edition 2018)</p>\r\n<p>Tier 3A &ndash; Supervisory Requirements for pathology laboratories</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Requirements for Supervision in Clinical Governance of Medical Pathology Laboratories (Sixth Edition 2021)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Requirements for the Communication of High Risk Pathology Results (First Edition 2020)</p>\r\n<p>Tier 3B &ndash; Technical and specific detailed Requirements for good medical practice in all pathology services</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Requirements for the Estimation of Measurement Uncertainty 2007</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Requirements for the Packaging and Transport of Pathology Specimens and Associated Materials (Fourth Edition 2013) (with Amendment)</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Requirements for Quality Control, External Quality Assessment and Method Evaluation (Sixth Edition 2018)</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Requirements for the Retention of Laboratory Records and Diagnostic Material (Eighth Edition 2021)</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Requirements for Information Communication and Reporting (Fourth Edition 2020)</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Requirements for the Development and Use of In-house In Vitro Diagnostic Devices (Fourth Edition 2018)</p>\r\n<p>o<span style=\"white-space: pre;\"> </span>Guidelines for Approved Pathology Collection Centres (Requirements for Medical Pathology Specimen Collection) (Third Edition 2013)</p>\r\n<p>Tier 4 &ndash; Technical publications for specific areas of pathology</p>\r\n<p>Anatomical Pathology</p>\r\n<p>Requirements for the Performance of the Anatomical Pathology Cut-Up (Fourth Edition 2013)</p>\r\n<p>Requirements for the Facilities and Operations of Mortuaries (Third Edition 2013)</p>\r\n<p>Performance Measures for Australian Laboratories Reporting Cervical Cytology (Third Edition 2015)</p>\r\n<p>Requirements for validation of self-collected vaginal swabs for use in the National Cervical Screening Program (First Edition 2019)</p>\r\n<p>Requirements for laboratories reporting tests for the National Cervical Screening Program (Second Edition 2019)</p>\r\n<p>Best Practice Pathology Guidelines</p>\r\n<p>Guidelines for Point of Care Testing (First edition 2015)</p>\r\n<p>&nbsp;</p>',	'',	'FNHQ-SOP-QM030622',	4,	'',	'',	0,	1,	453,	'2022-09-16 13:03:40'),
(35,	'RFNQH-SOP-A030622 ',	'Risk Management and Assessment',	453,	12,	0,	'2022-09-05',	'2022-09-16',	0,	1,	'TCB',	0,	12,	'2023-09-16',	'2022-09-16',	'Sarah Sharpe',	'<p>This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</p>\r\n<p>&nbsp;</p>\r\n<p>Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology&nbsp; does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</p>\r\n<p>&nbsp;</p>',	'<p>1.<span style=\"white-space: pre;\"> </span>Introduction, Purpose, Scope, &amp; Users</p>\r\n<p>This document is intended to document the standard operating procedures (SOP) at FNQH Pathology for a risk assessment and details the processes, steps, and detailed instructions so that the relevant (authorised) team member can carry out the task correctly every time.</p>\r\n<p>2.<span style=\"white-space: pre;\"> </span>Risk Management&nbsp;</p>\r\n<p>FNQH Pathology recognises the importance of a risk-based approach to business management to ensure optimal patient outcomes. In support of patient-centric care the laboratory executive and quality management team engages in regular high-level reviews of the overall business practice in the department and makes determinations, based on assessment of the data, and defines appropriate actions to mitigate any systemic risks identified.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Monthly Report by using the analysis function in PathHub. Looking at:</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Source:&nbsp;</p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>External non conformance</p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>Internal non conformance</p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>Equipment unscheduled maintenance</p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>Customer feedback</p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>Suggestions</p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>Compliments</p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>Suppliers</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Drill down into internal non-conformances looking at:</p>\r\n<p>&nbsp; &nbsp; &nbsp;o<span style=\"white-space: pre;\"> </span>Fault category <span style=\"white-space: pre;\"> </span></p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>Mislabelled Sample</p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>Incorrect Sample Handling</p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>Sample Registration Error</p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>Lost/Discarded Sample<span style=\"white-space: pre;\"> </span></p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>Incorrect Sample Collected<span style=\"white-space: pre;\"> </span></p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>Non-compliance with Procedure<span style=\"white-space: pre;\"> </span></p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>Documentation Error</p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>Reception Error</p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>Incorrect Result Reported</p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>Incorrect Result Not Reported</p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>Delayed Result</p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>Equipment Failure<span style=\"white-space: pre;\"> </span></p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>Equipment Maintenance<span style=\"white-space: pre;\"> </span>&nbsp;</p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>Complaint<span style=\"white-space: pre;\"> </span>&nbsp;</p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>RCPA QAP Issue<span style=\"white-space: pre;\"> </span></p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>Stores / Supply Issue<span style=\"white-space: pre;\"> </span></p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>Work Health and Safety Incident<span style=\"white-space: pre;\"> </span></p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>Computer Failure<span style=\"white-space: pre;\"> </span></p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"white-space: pre;\"> </span>Product Error<span style=\"white-space: pre;\"> </span></p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Forward report to management (Lab manager and Lead Pathologist) for review.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Schedule meeting between Lab Manager and Lead Pathologist to formally assess what have been identified as our major risks (see Appendix A), NPAAC Tier 2 Document Requirements for Medical Pathology Services)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Use risk matrix (Appendix A) and risk assessment form to assess risks, and document proactive approaches to prevention of harm and promotion of better outcomes.</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>Preventive action</p>\r\n<p>The laboratory determines actions to eliminate the causes of potential nonconformities in order to prevent their occurrence. Preventive actions shall be appropriate to the effects of the potential problems.</p>\r\n<p>The laboratory has documented procedures for:</p>\r\n<p>a) reviewing laboratory data and information to determine where potential nonconformities exist;</p>\r\n<p>b) determining the root cause(s) of potential nonconformities;</p>\r\n<p>c) evaluating the need for preventive action to prevent the occurrence of nonconformities;</p>\r\n<p>d) determining and implementing preventive action needed;</p>\r\n<p>e) recording the results of preventive action taken;</p>\r\n<p>f) reviewing the effectiveness of the preventive action taken.</p>\r\n<p>NOTE: Preventive action is a proactive process for identifying opportunities for improvement rather than a reaction to the identification of problems or complaints (i.e. nonconformities). In addition to internal review of the operational procedures, preventive action might involve analysis of data and/or audits, including trend and risk analyses, and quality assessment and assurance.&nbsp;</p>\r\n<p>4.<span style=\"white-space: pre;\"> </span> Continual improvement</p>\r\n<p>The laboratory aims to continually improve the effectiveness of the quality management system, including the pre-examination, examination, and post-examination processes, through the use of management reviews to compare the laboratory&rsquo;s actual performance in its evaluation activities, corrective actions and preventive actions with its intentions, as stated in the quality policy and quality objectives. Improvement activities shall be directed at areas of highest priority based on risk assessments. Action plans for improvement are developed, documented and implemented, as appropriate. The effectiveness of the actions taken are determined through a focused review or audit of the area.</p>\r\n<p>Laboratory management ensures that the laboratory participates in continual improvement activities that encompass relevant areas and outcomes of patient care. When the continual improvement programme identifies opportunities for improvement, laboratory management addresses them regardless of where they occur. Laboratory management communicates to staff improvement plans and related goals.</p>\r\n<p>5.<span style=\"white-space: pre;\"> </span>References</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>NPAAC Tier 2 Document Requirements for Medical Pathology Services (Third Edition 2018)&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>NPAAC Risk Matrix (https://www1.health.gov.au/internet/main/publishing.nsf/Content/npaac-risk-matrix)</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>ISO 15189-2012 Medical laboratories - Requirements for quality and competence&nbsp;</p>\r\n<p>6.<span style=\"white-space: pre;\"> </span>Managing Records kept on the basis of this document</p>\r\n<p>All records supporting this policy shall be kept in the FNQH Pathology document management system in the location, or system based, indicated in the procedure document. Any additional or deleted records shall be kept account of in the FNQH Pathology logging system such that any future enquiry will be able to clearly identify when the changes occurred, who made them, what these changes were and how the changes were approved.</p>\r\n<p>7.<span style=\"white-space: pre;\"> </span>Validity and Document Management</p>\r\n<p>This document is valid from the date of its approval and will be reviewed on an annual basis. The current working copy will be identified as such, and any superseded documents will be archived and maintained for a period of five years.</p>\r\n<p>New versions will be identified with a versioning number. Full integers will denote a major document version, and a decimal number will indicate minor amendments or edits.</p>\r\n<p>Appendix A<span style=\"white-space: pre;\"> </span>Risk Assessment &ndash; Risk Points</p>\r\n<p>The following risk points must be considered as part of a Medical Pathology Service&rsquo;s risk assessment to mitigate potential risks to the delivery of quality pathology services and patient safety.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Governance: Clear governance structures will facilitate prompt corrective action where the accuracy, clinical utility or timeliness of testing has been compromised. They will also promote early notification to the referring doctor about test results or clinically significant events in the management of the patient.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Competency of staff: Demonstrated ability to perform a task successfully and efficiently.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Patient identification: Clear processes to allow unequivocal identification of the patient and promote safe and timely testing.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Specimen integrity: Processes that address common pre analytical issues and promote safe and timely testing.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Specimen traceability: Processes that enable the traceability of samples and promote the safety and timeliness of testing.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Specimen analysis: Processes that address failures of Quality Control and promote safe and timely testing.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Verification, validation, and documentation of methods: Verification is the process of demonstrating the performance criteria to which the method has been validated can be met by the facility, prior to introducing into routine use.&nbsp; Method validation is the process of establishing the performance characteristics and limitations of a method, and the identification of the influences that may change these characteristics, and to what extent.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Quality Assurance: Participation in Quality Assurance Programs, performance reviews and corrective actions where performance is unsatisfactory.&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Reporting results: Unambiguous reports, current best practice reporting, promote the safety of testing by facilitating timely and appropriate clinical interventions.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Turnaround times: Turnaround times that allow timely decision-making promote good patient outcomes from testing.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Communication: Processes that allow the communication of critical (high risk) results to clinicians, the management of confidential results, and privacy, promote the safety of testing.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Send away tests: Risk management processes that address transport, handovers, specimen integrity, the quality of testing in the referral Medical Pathology Service, turnaround times and the delivery of reports to the referring doctor and the referring Medical Pathology Service improve the safety of testing.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Reviews of incidents: Processes that investigate incidents with real or potential adverse outcomes for patients, take corrective actions, monitor the efficacy of these actions, and improve the safety of testing. Processes to identify, track and reduce diagnostic errors.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>IT Algorithms, systems, and interfaces&nbsp;</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Logistics</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Skilled workforce</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Critical results</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Accreditation failure</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Business continuity</p>\r\n<p>Appendix B<span style=\"white-space: pre;\"> </span>Risk Assessment &ndash; Matrices</p>\r\n<p class=\"MsoNormal\"><strong><span lang=\"EN-AU\">Assessment of Liklihood</span></strong></p>\r\n<table class=\"MsoNormalTable\" style=\"width: 327pt;\" border=\"0\" width=\"0\" cellspacing=\"0\" cellpadding=\"0\">\r\n<tbody>\r\n<tr style=\"mso-yfti-irow: 0; mso-yfti-firstrow: yes; height: 14.5pt;\">\r\n<td style=\"width: 48.0pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"64\">&nbsp;</td>\r\n<td style=\"width: 78.0pt; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"104\">\r\n<p class=\"MsoNormal\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Likelihood</span></strong></p>\r\n</td>\r\n<td style=\"width: 141.0pt; border: solid windowtext 1.0pt; border-left: none; mso-border-top-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"188\">\r\n<p class=\"MsoNormal\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Frequency</span></strong></p>\r\n</td>\r\n<td style=\"width: 60.0pt; border: solid windowtext 1.0pt; border-left: none; mso-border-top-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"81\">\r\n<p class=\"MsoNormal\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Probability</span></strong></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 1; height: 14.5pt;\">\r\n<td style=\"width: 48.0pt; border: solid windowtext 1.0pt; border-right: none; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"64\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">&nbsp;</span></p>\r\n</td>\r\n<td style=\"width: 78.0pt; border: solid windowtext 1.0pt; border-top: none; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"104\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Almost certain</span></p>\r\n</td>\r\n<td style=\"width: 141.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"188\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Several times a week</span></p>\r\n</td>\r\n<td style=\"width: 60.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"81\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">&gt;95-100%</span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 2; height: 14.5pt;\">\r\n<td style=\"width: 48.0pt; border-top: none; border-left: solid windowtext 1.0pt; border-bottom: solid windowtext 1.0pt; border-right: none; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"64\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">&nbsp;</span></p>\r\n</td>\r\n<td style=\"width: 78.0pt; border: solid windowtext 1.0pt; border-top: none; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"104\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Likely</span></p>\r\n</td>\r\n<td style=\"width: 141.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"188\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Several times a year</span></p>\r\n</td>\r\n<td style=\"width: 60.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"81\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">&gt;70-95%</span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 3; height: 14.5pt;\">\r\n<td style=\"width: 48.0pt; border-top: none; border-left: solid windowtext 1.0pt; border-bottom: solid windowtext 1.0pt; border-right: none; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"64\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">&nbsp;</span></p>\r\n</td>\r\n<td style=\"width: 78.0pt; border: solid windowtext 1.0pt; border-top: none; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"104\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Possible</span></p>\r\n</td>\r\n<td style=\"width: 141.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"188\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Once every 1-2 years</span></p>\r\n</td>\r\n<td style=\"width: 60.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"81\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">&gt;30-70%</span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 4; height: 14.5pt;\">\r\n<td style=\"width: 48.0pt; border-top: none; border-left: solid windowtext 1.0pt; border-bottom: solid windowtext 1.0pt; border-right: none; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"64\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">&nbsp;</span></p>\r\n</td>\r\n<td style=\"width: 78.0pt; border: solid windowtext 1.0pt; border-top: none; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"104\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Unlikely</span></p>\r\n</td>\r\n<td style=\"width: 141.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"188\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Once every 3-5 years</span></p>\r\n</td>\r\n<td style=\"width: 60.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"81\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">&gt;5-30%</span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 5; mso-yfti-lastrow: yes; height: 14.5pt;\">\r\n<td style=\"width: 48.0pt; border-top: none; border-left: solid windowtext 1.0pt; border-bottom: solid windowtext 1.0pt; border-right: none; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"64\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">&nbsp;</span></p>\r\n</td>\r\n<td style=\"width: 78.0pt; border: solid windowtext 1.0pt; border-top: none; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"104\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Rare</span></p>\r\n</td>\r\n<td style=\"width: 141.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"188\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Less often than every 5 years</span></p>\r\n</td>\r\n<td style=\"width: 60.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"81\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">&lt;5%</span></p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<p class=\"MsoNormal\"><strong><span lang=\"EN-AU\">Assessment of Seriousness</span></strong></p>\r\n<table class=\"MsoNormalTable\" style=\"width: 474.9pt;\" border=\"0\" width=\"0\" cellspacing=\"0\" cellpadding=\"0\">\r\n<tbody>\r\n<tr style=\"mso-yfti-irow: 0; mso-yfti-firstrow: yes; height: 14.5pt;\">\r\n<td style=\"width: 48.0pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"64\">&nbsp;</td>\r\n<td style=\"width: 76.15pt; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"102\">\r\n<p class=\"MsoNormal\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Consequences</span></strong></p>\r\n</td>\r\n<td style=\"width: 350.75pt; border: solid windowtext 1.0pt; border-left: none; mso-border-top-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"468\">\r\n<p class=\"MsoNormal\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Examples</span></strong></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 1; height: 29.0pt;\">\r\n<td style=\"width: 48.0pt; border: solid windowtext 1.0pt; border-right: none; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"64\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">&nbsp;</span></p>\r\n</td>\r\n<td style=\"width: 76.15pt; border: solid windowtext 1.0pt; border-top: none; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"102\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Catastrophic</span></p>\r\n</td>\r\n<td style=\"width: 350.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"bottom\" width=\"468\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Unexpected patient death, prolonged unplanned cessation of critical service, multiple deaths or life-threatening injuries to non-patients</span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 2; height: 29.0pt;\">\r\n<td style=\"width: 48.0pt; border-top: none; border-left: solid windowtext 1.0pt; border-bottom: solid windowtext 1.0pt; border-right: none; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"64\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">&nbsp;</span></p>\r\n</td>\r\n<td style=\"width: 76.15pt; border: solid windowtext 1.0pt; border-top: none; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"102\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Major</span></p>\r\n</td>\r\n<td style=\"width: 350.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"bottom\" width=\"468\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Permanent patient loss of bodily function, unplanned interruption of critical service, death or life-threatening injury to non-patient</span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 3; height: 29.0pt;\">\r\n<td style=\"width: 48.0pt; border-top: none; border-left: solid windowtext 1.0pt; border-bottom: solid windowtext 1.0pt; border-right: none; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"64\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">&nbsp;</span></p>\r\n</td>\r\n<td style=\"width: 76.15pt; border: solid windowtext 1.0pt; border-top: none; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"102\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Moderate</span></p>\r\n</td>\r\n<td style=\"width: 350.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"bottom\" width=\"468\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Temporary patient loss of bodily function, disruption of service, serious harm or injury to non-patient</span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 4; height: 29.0pt;\">\r\n<td style=\"width: 48.0pt; border-top: none; border-left: solid windowtext 1.0pt; border-bottom: solid windowtext 1.0pt; border-right: none; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"64\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">&nbsp;</span></p>\r\n</td>\r\n<td style=\"width: 76.15pt; border: solid windowtext 1.0pt; border-top: none; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"102\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Minor</span></p>\r\n</td>\r\n<td style=\"width: 350.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"bottom\" width=\"468\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Increased patient care level, limited and manageable disruption of service, minor harm or injury to non-patient requiring first-aid</span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 5; mso-yfti-lastrow: yes; height: 29.0pt;\">\r\n<td style=\"width: 48.0pt; border-top: none; border-left: solid windowtext 1.0pt; border-bottom: solid windowtext 1.0pt; border-right: none; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"64\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">&nbsp;</span></p>\r\n</td>\r\n<td style=\"width: 76.15pt; border: solid windowtext 1.0pt; border-top: none; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"102\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Minimal</span></p>\r\n</td>\r\n<td style=\"width: 350.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"bottom\" width=\"468\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Patient requiring first aid, minimal effect on service delivery, minor injury to non-patient not requiring immediate treatment</span></p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<p class=\"MsoNormal\"><strong><span lang=\"EN-AU\">Risk Matrix</span></strong></p>\r\n<table class=\"MsoNormalTable\" style=\"width: 474.9pt;\" border=\"0\" width=\"0\" cellspacing=\"0\" cellpadding=\"0\">\r\n<tbody>\r\n<tr style=\"mso-yfti-irow: 0; mso-yfti-firstrow: yes; height: 15.0pt;\">\r\n<td style=\"width: 24.9pt; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; mso-rotate: 90; height: 15.0pt;\" rowspan=\"6\" nowrap=\"nowrap\" width=\"34\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">LIKELIHOOD</span></strong></p>\r\n</td>\r\n<td style=\"width: 81.2pt; border: solid windowtext 1.0pt; border-left: none; mso-border-top-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; background: #BFBFBF; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"108\">\r\n<p class=\"MsoNormal\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Almost certain</span></strong></p>\r\n</td>\r\n<td style=\"width: 68.8pt; border: solid windowtext 1.0pt; border-left: none; background: red; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" width=\"92\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">25</span></strong></p>\r\n</td>\r\n<td style=\"width: 75.0pt; border: solid windowtext 1.0pt; border-left: none; background: red; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" width=\"100\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">22</span></strong></p>\r\n</td>\r\n<td style=\"width: 75.0pt; border: solid windowtext 1.0pt; border-left: none; background: #FFC000; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" width=\"100\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">16</span></strong></p>\r\n</td>\r\n<td style=\"width: 75.0pt; border: solid windowtext 1.0pt; border-left: none; background: yellow; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" width=\"100\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">10</span></strong></p>\r\n</td>\r\n<td style=\"width: 75.0pt; border: solid windowtext 1.0pt; border-left: none; background: yellow; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" width=\"100\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">7</span></strong></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 1; height: 15.0pt;\">\r\n<td style=\"width: 81.2pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; background: #BFBFBF; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"108\">\r\n<p class=\"MsoNormal\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Likely</span></strong></p>\r\n</td>\r\n<td style=\"width: 68.8pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; background: red; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" width=\"92\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">24</span></strong></p>\r\n</td>\r\n<td style=\"width: 75.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; background: red; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" width=\"100\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">21</span></strong></p>\r\n</td>\r\n<td style=\"width: 75.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; background: #FFC000; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" width=\"100\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">15</span></strong></p>\r\n</td>\r\n<td style=\"width: 75.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; background: yellow; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" width=\"100\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">9</span></strong></p>\r\n</td>\r\n<td style=\"width: 75.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; background: yellow; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" width=\"100\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">6</span></strong></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 2; height: 15.0pt;\">\r\n<td style=\"width: 81.2pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; background: #BFBFBF; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"108\">\r\n<p class=\"MsoNormal\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Possible</span></strong></p>\r\n</td>\r\n<td style=\"width: 68.8pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; background: red; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" width=\"92\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">23</span></strong></p>\r\n</td>\r\n<td style=\"width: 75.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; background: #FFC000; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" width=\"100\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">18</span></strong></p>\r\n</td>\r\n<td style=\"width: 75.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; background: yellow; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" width=\"100\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">13</span></strong></p>\r\n</td>\r\n<td style=\"width: 75.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; background: yellow; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" width=\"100\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">8</span></strong></p>\r\n</td>\r\n<td style=\"width: 75.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; background: #00B050; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" width=\"100\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">3</span></strong></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 3; height: 15.0pt;\">\r\n<td style=\"width: 81.2pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; background: #BFBFBF; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"108\">\r\n<p class=\"MsoNormal\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Unlikely</span></strong></p>\r\n</td>\r\n<td style=\"width: 68.8pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; background: #FFC000; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" width=\"92\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">20</span></strong></p>\r\n</td>\r\n<td style=\"width: 75.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; background: #FFC000; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" width=\"100\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">17</span></strong></p>\r\n</td>\r\n<td style=\"width: 75.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; background: yellow; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" width=\"100\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">12</span></strong></p>\r\n</td>\r\n<td style=\"width: 75.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; background: #00B050; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" width=\"100\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">5</span></strong></p>\r\n</td>\r\n<td style=\"width: 75.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; background: #00B050; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" width=\"100\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">2</span></strong></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 4; height: 15.0pt;\">\r\n<td style=\"width: 81.2pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; background: #BFBFBF; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"108\">\r\n<p class=\"MsoNormal\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Rare</span></strong></p>\r\n</td>\r\n<td style=\"width: 68.8pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; background: #FFC000; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" width=\"92\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">19</span></strong></p>\r\n</td>\r\n<td style=\"width: 75.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; background: yellow; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" width=\"100\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">14</span></strong></p>\r\n</td>\r\n<td style=\"width: 75.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; background: yellow; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" width=\"100\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">11</span></strong></p>\r\n</td>\r\n<td style=\"width: 75.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; background: #00B050; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" width=\"100\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">4</span></strong></p>\r\n</td>\r\n<td style=\"width: 75.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; background: #00B050; padding: 0cm 5.4pt 0cm 5.4pt; height: 15.0pt;\" width=\"100\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">1</span></strong></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 5; height: 14.5pt;\">\r\n<td style=\"width: 81.2pt; border: none; border-right: solid windowtext 1.0pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" width=\"108\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">&nbsp;</span></strong></p>\r\n</td>\r\n<td style=\"width: 68.8pt; border: none; border-right: solid windowtext 1.0pt; background: #BFBFBF; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" width=\"92\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Catastrophic</span></strong></p>\r\n</td>\r\n<td style=\"width: 75.0pt; border: none; border-right: solid windowtext 1.0pt; background: #BFBFBF; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" width=\"100\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Major</span></strong></p>\r\n</td>\r\n<td style=\"width: 75.0pt; border: none; border-right: solid windowtext 1.0pt; background: #BFBFBF; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" width=\"100\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Moderate</span></strong></p>\r\n</td>\r\n<td style=\"width: 75.0pt; border: none; border-right: solid windowtext 1.0pt; background: #BFBFBF; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" width=\"100\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Minor</span></strong></p>\r\n</td>\r\n<td style=\"width: 75.0pt; border: none; border-right: solid windowtext 1.0pt; background: #BFBFBF; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" width=\"100\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Minimal</span></strong></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 6; mso-yfti-lastrow: yes; height: 20.0pt;\">\r\n<td style=\"width: 24.9pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 20.0pt;\" nowrap=\"nowrap\" width=\"34\">&nbsp;</td>\r\n<td style=\"width: 450.0pt; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 20.0pt;\" colspan=\"6\" nowrap=\"nowrap\" width=\"600\">\r\n<p class=\"MsoNormal\" style=\"text-align: center;\" align=\"center\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">CONSEQUENCE</span></strong></p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<p class=\"MsoNormal\"><strong><span lang=\"EN-AU\">&nbsp;</span></strong><strong><span lang=\"EN-AU\">Grade and Action Required</span></strong></p>\r\n<table class=\"MsoNormalTable\" style=\"width: 474.9pt;\" border=\"0\" width=\"0\" cellspacing=\"0\" cellpadding=\"0\">\r\n<tbody>\r\n<tr style=\"mso-yfti-irow: 0; mso-yfti-firstrow: yes; height: 14.5pt;\">\r\n<td style=\"width: 48.0pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"64\">&nbsp;</td>\r\n<td style=\"width: 98.0pt; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"top\" nowrap=\"nowrap\" width=\"131\">\r\n<p class=\"MsoNormal\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Risk Rating</span></strong></p>\r\n</td>\r\n<td style=\"width: 328.9pt; border: solid windowtext 1.0pt; border-left: none; mso-border-top-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 14.5pt;\" valign=\"top\" width=\"439\">\r\n<p class=\"MsoNormal\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Action Required</span></strong></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 1; height: 29.0pt;\">\r\n<td style=\"width: 48.0pt; border: solid windowtext 1.0pt; border-right: none; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"64\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">&nbsp;</span></p>\r\n</td>\r\n<td style=\"width: 98.0pt; border: solid windowtext 1.0pt; border-top: none; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; background: red; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"top\" nowrap=\"nowrap\" width=\"131\">\r\n<p class=\"MsoNormal\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Extreme (21-25)</span></strong></p>\r\n</td>\r\n<td style=\"width: 328.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"top\" width=\"439\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Escalate to Managing Director and implement detailed action plan to reduce risk rating. At least monthly reporting.</span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 2; height: 29.0pt;\">\r\n<td style=\"width: 48.0pt; border-top: none; border-left: solid windowtext 1.0pt; border-bottom: solid windowtext 1.0pt; border-right: none; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"64\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">&nbsp;</span></p>\r\n</td>\r\n<td style=\"width: 98.0pt; border: solid windowtext 1.0pt; border-top: none; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; background: #FFC000; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"top\" nowrap=\"nowrap\" width=\"131\">\r\n<p class=\"MsoNormal\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">High (15-20)</span></strong></p>\r\n</td>\r\n<td style=\"width: 328.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"top\" width=\"439\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Escalate to senior management and implement detailed action plan to reduce risk rating.</span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 3; height: 29.0pt;\">\r\n<td style=\"width: 48.0pt; border-top: none; border-left: solid windowtext 1.0pt; border-bottom: solid windowtext 1.0pt; border-right: none; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"64\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">&nbsp;</span></p>\r\n</td>\r\n<td style=\"width: 98.0pt; border: solid windowtext 1.0pt; border-top: none; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; background: yellow; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"top\" nowrap=\"nowrap\" width=\"131\">\r\n<p class=\"MsoNormal\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Medium (6-14)</span></strong></p>\r\n</td>\r\n<td style=\"width: 328.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"top\" width=\"439\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Specify accountability, monitor trends, implement improvement plan.</span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 4; mso-yfti-lastrow: yes; height: 29.0pt;\">\r\n<td style=\"width: 48.0pt; border-top: none; border-left: solid windowtext 1.0pt; border-bottom: solid windowtext 1.0pt; border-right: none; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"bottom\" nowrap=\"nowrap\" width=\"64\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">&nbsp;</span></p>\r\n</td>\r\n<td style=\"width: 98.0pt; border: solid windowtext 1.0pt; border-top: none; mso-border-left-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; background: #00B050; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"top\" nowrap=\"nowrap\" width=\"131\">\r\n<p class=\"MsoNormal\"><strong><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Low (1-5)</span></strong></p>\r\n</td>\r\n<td style=\"width: 328.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-bottom-alt: solid windowtext .5pt; mso-border-right-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 29.0pt;\" valign=\"top\" width=\"439\">\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">Monitor trends and manage by routine procedures.</span></p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<p class=\"MsoNormal\">&nbsp;</p>',	'',	'RFNQH-SOP-A030622 ',	4,	'',	'',	0,	0,	453,	'2022-09-16 13:14:03'),
(36,	'FNQH-SOP-TM030622 ',	'Temprature Monitoring',	453,	12,	0,	'2022-09-05',	'2022-09-16',	0,	1,	'TCB',	0,	12,	'2023-09-16',	'2022-09-16',	'Sarah Sharpe',	'<p>This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</p>\r\n<p>&nbsp;</p>\r\n<p>Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</p>\r\n<p>&nbsp;</p>',	'<p><strong>1.<span style=\"white-space: pre;\"> </span>Temperature Monitoring Policy</strong></p>\r\n<p>This document is intended to document the Policy and Operating Procedures at FNQH Pathology for Temperature Monitoring and details the process steps and detailed instructions so that the relevant (authorised) team member can carry out the task correctly every time.</p>\r\n<p>This purpose of this document is to ensure the proper functioning of temperature dependent equipment and environments, such as refrigerators, freezers, heating blocks, water baths, incubators, and test-dependent ambient temperature, the temperatures will be taken daily, recorded, and acted upon in the event of failure. In the laboratories that are not operational every day, minimum and maximum temperatures will be recorded using a device designated for monitoring temperature over a period of days.</p>\r\n<p><strong>2.<span style=\"white-space: pre;\"> </span>Temperature Monitoring Procedure</strong></p>\r\n<p>1.<span style=\"white-space: pre;\"> </span>The temperature of each refrigerator, freezer, any walk-in refrigerator/freezer, or ambient/room temperature that affects testing should be taken daily, recorded, and initialed on an appropriate temperature log. The temperatures of heating blocks, water baths, and incubators, or ovens (when temperature control is necessary for a procedure) should be taken and recorded on each day of use. Record temperature readings on the appropriate form. Acceptable ranges must be defined for all temperature dependent equipment or environments, in accordance with the manufacturer instructions.</p>\r\n<p><strong>2.<span style=\"white-space: pre;\"> </span>LOCATION OR EQUIPMENT RELATED GUIDANCE</strong></p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Minimum/maximum thermometers may be used in areas that do not provide testing each day.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Refrigerators, freezers, incubators: there must be evidence of corrective action taken if unacceptable temperatures are obtained on any piece of temperature dependent equipment.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>In areas where room temperature tests are performed or reagents are affected by temperature or humidity, the monitor must be recorded each day of testing. Record temperature or humidity on the approved form and document any corrective action.</p>\r\n<p>&bull;<span style=\"white-space: pre;\"> </span>Heating blocks or water baths: If unacceptable temperatures are obtained, do not use the equipment for testing.</p>\r\n<p>3.<span style=\"white-space: pre;\"> </span>Lab Administration is responsible for setting temperature limits for each device based on contents and regulatory standards.</p>\r\n<table class=\"MsoNormalTable\" style=\"margin-left: 5.85pt; border: none;\" border=\"1\" cellspacing=\"0\" cellpadding=\"0\">\r\n<tbody>\r\n<tr style=\"mso-yfti-irow: 0; mso-yfti-firstrow: yes; height: 11.4pt;\">\r\n<td style=\"width: 159.6pt; border-width: 1pt; border-color: black; border-image: initial; padding: 0cm; height: 11.4pt;\" valign=\"top\" width=\"213\">\r\n<p class=\"TableParagraph\" style=\"line-height: 10.45pt; mso-line-height-rule: exactly;\"><strong><span style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Asset<span style=\"letter-spacing: -.2pt;\"> type</span></span></strong></p>\r\n</td>\r\n<td style=\"width: 159.6pt; border-top-width: 1pt; border-right-width: 1pt; border-bottom-width: 1pt; border-top-color: black; border-right-color: black; border-bottom-color: black; border-image: initial; border-left: none; padding: 0cm; height: 11.4pt;\" valign=\"top\" width=\"213\">\r\n<p class=\"TableParagraph\" style=\"line-height: 10.45pt; mso-line-height-rule: exactly;\"><strong><span style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Temperature<span style=\"letter-spacing: -.55pt;\"> </span><span style=\"letter-spacing: -.1pt;\">Range</span></span></strong></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 1; height: 11.5pt;\">\r\n<td style=\"width: 159.6pt; border-right-width: 1pt; border-bottom-width: 1pt; border-left-width: 1pt; border-right-color: black; border-bottom-color: black; border-left-color: black; border-image: initial; border-top: none; padding: 0cm; height: 11.5pt;\" valign=\"top\" width=\"213\">\r\n<p class=\"TableParagraph\" style=\"line-height: 10.5pt; mso-line-height-rule: exactly;\"><span style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Laboratory<span style=\"letter-spacing: -.4pt;\"> </span><span style=\"letter-spacing: -.1pt;\">Refrigerator</span></span></p>\r\n</td>\r\n<td style=\"width: 159.6pt; border-top: none; border-left: none; border-bottom-width: 1pt; border-bottom-color: black; border-right-width: 1pt; border-right-color: black; padding: 0cm; height: 11.5pt;\" valign=\"top\" width=\"213\">\r\n<p class=\"TableParagraph\" style=\"line-height: 10.5pt; mso-line-height-rule: exactly;\"><span style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">2C<span style=\"letter-spacing: -.1pt;\"> </span>&ndash;<span style=\"letter-spacing: -.05pt;\"> </span><span style=\"letter-spacing: -.25pt;\">8C</span></span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 2; height: 11.5pt;\">\r\n<td style=\"width: 159.6pt; border-right-width: 1pt; border-bottom-width: 1pt; border-left-width: 1pt; border-right-color: black; border-bottom-color: black; border-left-color: black; border-image: initial; border-top: none; padding: 0cm; height: 11.5pt;\" valign=\"top\" width=\"213\">\r\n<p class=\"TableParagraph\" style=\"line-height: 10.5pt; mso-line-height-rule: exactly;\"><span style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Laboratory<span style=\"letter-spacing: -.4pt;\"> </span><span style=\"letter-spacing: -.1pt;\">Freezer</span></span></p>\r\n</td>\r\n<td style=\"width: 159.6pt; border-top: none; border-left: none; border-bottom-width: 1pt; border-bottom-color: black; border-right-width: 1pt; border-right-color: black; padding: 0cm; height: 11.5pt;\" valign=\"top\" width=\"213\">\r\n<p class=\"TableParagraph\" style=\"line-height: 10.5pt; mso-line-height-rule: exactly;\"><span style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">-30C<span style=\"letter-spacing: -.1pt;\"> </span>-<span style=\"letter-spacing: -.05pt;\"> </span>-<span style=\"letter-spacing: -.25pt;\">10C</span></span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 3; height: 11.5pt;\">\r\n<td style=\"width: 159.6pt; border-right-width: 1pt; border-bottom-width: 1pt; border-left-width: 1pt; border-right-color: black; border-bottom-color: black; border-left-color: black; border-image: initial; border-top: none; padding: 0cm; height: 11.5pt;\" valign=\"top\" width=\"213\">\r\n<p class=\"TableParagraph\" style=\"line-height: 10.5pt; mso-line-height-rule: exactly;\"><span style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Laboratory<span style=\"letter-spacing: -.5pt;\"> </span><span style=\"letter-spacing: -.1pt;\">Incubator</span></span></p>\r\n</td>\r\n<td style=\"width: 159.6pt; border-top: none; border-left: none; border-bottom-width: 1pt; border-bottom-color: black; border-right-width: 1pt; border-right-color: black; padding: 0cm; height: 11.5pt;\" valign=\"top\" width=\"213\">\r\n<p class=\"TableParagraph\" style=\"line-height: 10.5pt; mso-line-height-rule: exactly;\"><span style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">28C<span style=\"letter-spacing: -.1pt;\"> </span>&ndash;<span style=\"letter-spacing: -.05pt;\"> </span><span style=\"letter-spacing: -.25pt;\">38C</span></span></p>\r\n</td>\r\n</tr>\r\n<tr style=\"mso-yfti-irow: 4; mso-yfti-lastrow: yes; height: 11.5pt;\">\r\n<td style=\"width: 159.6pt; border-right-width: 1pt; border-bottom-width: 1pt; border-left-width: 1pt; border-right-color: black; border-bottom-color: black; border-left-color: black; border-image: initial; border-top: none; padding: 0cm; height: 11.5pt;\" valign=\"top\" width=\"213\">\r\n<p class=\"TableParagraph\" style=\"line-height: 10.5pt; mso-line-height-rule: exactly;\"><span style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Blood<span style=\"letter-spacing: -.15pt;\"> </span>Bank<span style=\"letter-spacing: -.1pt;\"> Refrigerator</span></span></p>\r\n</td>\r\n<td style=\"width: 159.6pt; border-top: none; border-left: none; border-bottom-width: 1pt; border-bottom-color: black; border-right-width: 1pt; border-right-color: black; padding: 0cm; height: 11.5pt;\" valign=\"top\" width=\"213\">\r\n<p class=\"TableParagraph\" style=\"line-height: 10.5pt; mso-line-height-rule: exactly;\"><span style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">1C<span style=\"letter-spacing: -.1pt;\"> </span>&ndash;<span style=\"letter-spacing: -.05pt;\"> </span><span style=\"letter-spacing: -.25pt;\">6C</span></span></p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<p>4.<span style=\"white-space: pre;\"> </span>Verification of thermometers: An appropriate thermometric standard device of known accuracy, guaranteed to meet NPAAC guidelines must be used or thermometers may be discarded and new ones ordered and placed into service when verification is required.</p>\r\n<p><strong>3.<span style=\"white-space: pre;\"> </span>Managing Records kept on the basis of this document</strong></p>\r\n<p>All records supporting this policy shall be kept in the FNQH document management system in the location, or system based, indicated in the procedure document. Any additional or deleted records shall be kept account of in the FNQH logging system such that any future enquiry will be able to clearly identify when the changes occurred, who made them, what these changes were and how the changes were approved.</p>\r\n<p>&nbsp;</p>\r\n<p><strong>4.<span style=\"white-space: pre;\"> </span>Validity and Document Management</strong></p>\r\n<p>This document is valid from the date of its approval and will be reviewed on an annual basis. The current working copy will be identified as such, and any superseded documents will be archived and maintained for a period of five years.</p>\r\n<p>&nbsp;</p>\r\n<p>New versions will be identified with a versioning number. Full integers will denote a major document version, and a decimal number will indicate minor amendments or edits.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>',	'',	'FNQH-SOP-TM030622 ',	4,	'',	'',	0,	1,	453,	'2022-09-16 13:19:10'),
(37,	'001',	'Code of Conduct',	451,	4,	0,	'2022-09-17',	'2022-09-17',	1,	1,	'Perth',	1,	12,	'2023-09-17',	'2023-09-17',	'Trevor Stanley ',	'<div style=\"text-align: justify;\">\r\n<table cellspacing=\"0\" cellpadding=\"0\" align=\"left\">\r\n<tbody>\r\n<tr>\r\n<td style=\"padding: 0cm 9.0pt 0cm 9.0pt;\" align=\"left\" valign=\"top\">\r\n<p class=\"Copyright\" style=\"mso-element: frame; mso-element-frame-hspace: 9.0pt; mso-element-wrap: around; mso-element-anchor-vertical: paragraph; mso-element-anchor-horizontal: column; mso-element-top: 8.95pt; mso-height-rule: exactly;\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</span></p>\r\n<p class=\"Copyright\" style=\"mso-element: frame; mso-element-frame-hspace: 9.0pt; mso-element-wrap: around; mso-element-anchor-vertical: paragraph; mso-element-anchor-horizontal: column; mso-element-top: 8.95pt; mso-height-rule: exactly;\"><span style=\"font-family: Calibri, sans-serif; text-align: justify;\">Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</span></p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n</div>',	'<h2><a name=\"_Toc108180595\"></a><!-- [if !supportLists]--><span lang=\"EN-AU\">1.1.<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\">CODE OF CONDUCT POLICY</span></h2>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">At FNQH Pathology (\"the Company\") we require that all of our employees conduct themselves according to the highest standards of ethics, integrity, and behaviour when dealing with our clients, colleagues and other stakeholders.&nbsp; This includes, but is not necessarily limited to, full compliance with all legal obligations imposed by statute or any other source of law.</span></p>\r\n<p><span lang=\"EN-AU\" style=\"font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: \'Times New Roman\'; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-AU; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; layout-grid-mode: line;\">This Code establishes the standards of behaviour that must be met by all employees. Where these standards are not met, appropriate disciplinary action will be taken. In cases where the breach involves serious misconduct, this may result in summary dismissal. In cases where a breach of the policy involves a breach of any law, then the relevant government authorities or the police may be notified.</span></p>\r\n<h3 style=\"mso-list: l0 level3 lfo1;\"><a name=\"_Toc108180596\"></a><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"mso-fareast-font-family: \'Century Gothic\'; mso-bidi-font-family: \'Century Gothic\';\"><span style=\"mso-list: Ignore;\">1.1.1.<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\">OPERATION</span></h3>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">The purpose of this policy is to make it clear what the Company expects from employees, and employees are required to be familiar with and comply with the terms of this policy at all times.<span style=\"mso-spacerun: yes;\">&nbsp; </span>Failure to do so may result in disciplinary action, including potentially termination of employment.</span></p>\r\n<p class=\"MsoNormal\"><span style=\"font-size: 11pt;\">In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual.</span></p>\r\n<p class=\"MsoNormal\"><span style=\"font-size: 11pt;\">The terms and conditions of employment that are intended to be contractual out in an employee&rsquo;s written employment contract.</span></p>\r\n<p class=\"MsoNormal\"><span style=\"font-size: 11pt;\">The Company may unilaterally introduce, vary, remove or replace this policy at any time.</span></p>\r\n<h3 style=\"mso-list: l0 level3 lfo1;\"><a name=\"_Toc108180597\"></a><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"mso-fareast-font-family: \'Century Gothic\'; mso-bidi-font-family: \'Century Gothic\';\"><span style=\"mso-list: Ignore;\">1.1.2.<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\">STANDARDS OF CONDUCT</span></h3>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">The standards expected of employees include:</span></p>\r\n<p class=\"MsoListParagraphCxSpFirst\" style=\"text-indent: -18pt; text-align: justify;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Compliance with all Company and workplace policies, procedures, rules, regulations and contracts;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Compliance with all laws;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Compliance with all reasonable and lawful instructions given by or on behalf of the Company;</span></p>\r\n<p style=\"text-align: justify;\"><span lang=\"EN-AU\" style=\"font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: \'Times New Roman\'; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-AU; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; layout-grid-mode: line;\"> </span></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-indent: -18pt; text-align: justify;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Devotion of the employee&rsquo;s entire time, attention and skill during normal working hours and at other times as reasonably necessary for the employee to perform their duties;</span></p>\r\n<p class=\"MsoListParagraphCxSpFirst\" style=\"text-indent: -18pt; text-align: justify;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">&middot;<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To be honest and fair in dealings with customers, clients, co-workers, Company management and the general public, and to treat them with courtesy and respect;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">&middot;<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To be faithful and diligent, and actively pursue the Company&rsquo;s best interests at all times;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">&middot;<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To work in a safe and compliant manner, and to observe all workplace health and safety rules and responsibilities;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">&middot;<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Refraining from any discriminatory, bullying or harassing behaviour toward customers, clients, co-workers, Company management and the general public;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">&middot;<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To not make any statements to the media about the Company&rsquo;s business, unless expressly authorised to do so by the Company;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">&middot;<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To not make any statements about the Company on social media, or any other public platform, that may harm the Company&rsquo;s reputation;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">&middot;<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To not, in connection with the employee&rsquo;s employment, accept any financial or other benefit from any entity other than the Company &ndash; unless acceptance of such benefit is in accordance with the Company&rsquo;s other workplace policies or is otherwise disclosed to the Company and expressly permitted by the Company;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">&middot;<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Dependent on terms of the employment contract to determine if you are permitted to engage in any employment or provide any services, thus seeking verification and/or company consent. </span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">&middot;<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Dependent on terms of employment to not engage in any employment or provide any services to a supplier or competitor of the Company, except with the Company&rsquo;s prior written consent;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">&middot;<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Immediately disclosing any potential, perceived or actual conflict of interest (whether direct or indirect) that may give rise to a conflict with the performance of the employee&rsquo;s obligations to the Company, or the Company&rsquo;s business, confidential information or reputational interests.<span style=\"mso-spacerun: yes;\">&nbsp; </span>The Company may direct employees to take action to eliminate or reduce any such conflict, and employees must comply with such directions;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">&middot;<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To not engage in conduct, whether during or after work hours, that in the opinion of the Company causes damage or potential damage to the Company&rsquo;s property or reputation;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">&middot;<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To not use, or come to work while affected by use of prohibited drugs or alcohol;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">&middot;<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To not discriminate on the basis of personal characteristics including (but not limited to) sex, race, disability, pregnancy, age, marital status or sexual orientation;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">&middot;<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To ensure and maintain punctuality;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">&middot;<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To respect the Company&rsquo;s property;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">&middot;<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To dress in an appropriate manner and to ensure that appearance is presentable, clean, neat and tidy (including but not limited to wearing any uniform that is required of you by the Company);</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">&middot;<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To not use Company internet to access and/or download sexually explicit material or other offensive material;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">&middot;<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To not use Company email to send sexually explicit or<span style=\"mso-spacerun: yes;\">&nbsp; </span>suggestive material, or other offensive or harassing material;</span></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-indent: -18pt; text-align: justify;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">&middot;<span style=\"font: 7.0pt \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To maintain both during employment and after termination of employment with the Company, the confidentiality of any confidential information, records or other materials acquired during the course of employment;</span></p>\r\n<p class=\"MsoListParagraphCxSpFirst\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">At all times, behave in a way that upholds the Company&rsquo;s core values and the integrity and good reputation of the Company;</span></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-indent: -18pt; text-align: justify;\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\"> </span></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Reporting any conduct of other workplace participants which is in breach of any of the above, or potentially in breach of any of the above, without delay</span><span lang=\"EN-AU\">.</span></p>\r\n<h3><a name=\"_Toc108180598\"></a><!-- [if !supportLists]--><span lang=\"EN-AU\">1.1.3.<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\">OTHER POLICIES</span></h3>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">Employees are encouraged to read this policy in conjunction with other relevant Company policies, including:</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Workplace Anti-Bullying &amp; Anti-Harassment Policy;</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\"><span lang=\"EN-AU\" style=\"font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: \'Times New Roman\'; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-AU; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; layout-grid-mode: line;\">&nbsp; Equal Employment Opportunity and Anti-Discrimination Policy</span></span></p>\r\n<h2 style=\"margin-left: 18.0pt; text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><a name=\"_Toc108180599\"></a><a name=\"_Toc43193955\"></a><!-- [if !supportLists]--><span lang=\"EN-AU\">1.<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\">Managing Records kept on the basis of this document</span></h2>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\"><span lang=\"EN-AU\" style=\"font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: \'Times New Roman\'; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-AU; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; layout-grid-mode: line;\"> </span></span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">All records supporting this policy shall be kept in the FNQH Pathology document management system in the location, or system based, indicated in the procedure document. Any additional or deleted records shall be kept account of in the FNQH Pathology logging system such that any future enquiry will be able to clearly identify when the changes occurred, who made them, what these changes were and how the changes were approved.</span></p>\r\n<h2 style=\"margin-left: 18.0pt; text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><a name=\"_Toc108180600\"></a><a name=\"_Toc43193956\"></a><a name=\"_Toc42774212\"></a><a name=\"_Toc31271019\"></a><a name=\"_Toc30670090\"></a><!-- [if !supportLists]--><span lang=\"EN-AU\">1.<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\">Validity and Document Management</span></h2>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">This document is valid from the date of its approval and will be reviewed on an annual basis. The current working copy will be identified as such, and any superseded documents will be archived and maintained for a period of five years.</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\"> <span lang=\"EN-AU\" style=\"font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: \'Times New Roman\'; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-AU; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; layout-grid-mode: line;\">New versions will be identified with a versioning number. Full integers will denote a major document version, and a decimal number will indicate minor amendments or edits.</span></span></p>',	'<table style=\"text-align: justify;\" cellspacing=\"0\" cellpadding=\"0\" align=\"left\">\r\n<tbody>\r\n<tr>\r\n<td style=\"padding: 0cm 9pt;\" align=\"left\" valign=\"top\">\r\n<p class=\"Copyright\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</span></p>\r\n<p class=\"Copyright\"><span style=\"font-family: Calibri, sans-serif; text-align: justify;\">Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</span></p>\r\n<h2><a name=\"_Toc108180595\"></a><span lang=\"EN-AU\">1.1.<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\">CODE OF CONDUCT POLICY</span></h2>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">At FNQH Pathology (\"the Company\") we require that all of our employees conduct themselves according to the highest standards of ethics, integrity, and behaviour when dealing with our clients, colleagues and other stakeholders.&nbsp; This includes, but is not necessarily limited to, full compliance with all legal obligations imposed by statute or any other source of law.</span></p>\r\n<p><span lang=\"EN-AU\" style=\"font-size: 11pt; font-family: \'Calibri Light\', sans-serif;\">This Code establishes the standards of behaviour that must be met by all employees. Where these standards are not met, appropriate disciplinary action will be taken. In cases where the breach involves serious misconduct, this may result in summary dismissal. In cases where a breach of the policy involves a breach of any law, then the relevant government authorities or the police may be notified.</span></p>\r\n<p>&nbsp;</p>\r\n<h3><a name=\"_Toc108180596\"></a><span lang=\"EN-AU\">1.1.1.<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\">OPERATION</span></h3>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">The purpose of this policy is to make it clear what the Company expects from employees, and employees are required to be familiar with and comply with the terms of this policy at all times.&nbsp;&nbsp;Failure to do so may result in disciplinary action, including potentially termination of employment.</span></p>\r\n<p class=\"MsoNormal\"><span style=\"font-size: 11pt;\">In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual.</span></p>\r\n<p class=\"MsoNormal\"><span style=\"font-size: 11pt;\">The terms and conditions of employment that are intended to be contractual out in an employee&rsquo;s written employment contract.</span></p>\r\n<p class=\"MsoNormal\"><span style=\"font-size: 11pt;\">The Company may unilaterally introduce, vary, remove or replace this policy at any time.</span></p>\r\n<h3><a name=\"_Toc108180597\"></a><span lang=\"EN-AU\">1.1.2.<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\">STANDARDS OF CONDUCT</span></h3>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">The standards expected of employees include:</span></p>\r\n<p>&nbsp;</p>\r\n<p class=\"MsoListParagraphCxSpFirst\" style=\"text-indent: -18pt; text-align: justify;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">Compliance with all Company and workplace policies, procedures, rules, regulations and contracts;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">Compliance with all laws;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">Compliance with all reasonable and lawful instructions given by or on behalf of the Company;</span></p>\r\n<p style=\"text-align: justify;\">&nbsp;</p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-indent: -18pt; text-align: justify;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">Devotion of the employee&rsquo;s entire time, attention and skill during normal working hours and at other times as reasonably necessary for the employee to perform their duties;</span></p>\r\n<p style=\"text-align: justify;\">&nbsp;</p>\r\n<p class=\"MsoListParagraphCxSpFirst\" style=\"text-indent: -18pt; text-align: justify;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To be honest and fair in dealings with customers, clients, co-workers, Company management and the general public, and to treat them with courtesy and respect;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To be faithful and diligent, and actively pursue the Company&rsquo;s best interests at all times;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To work in a safe and compliant manner, and to observe all workplace health and safety rules and responsibilities;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">Refraining from any discriminatory, bullying or harassing behaviour toward customers, clients, co-workers, Company management and the general public;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To not make any statements to the media about the Company&rsquo;s business, unless expressly authorised to do so by the Company;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To not make any statements about the Company on social media, or any other public platform, that may harm the Company&rsquo;s reputation;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To not, in connection with the employee&rsquo;s employment, accept any financial or other benefit from any entity other than the Company &ndash; unless acceptance of such benefit is in accordance with the Company&rsquo;s other workplace policies or is otherwise disclosed to the Company and expressly permitted by the Company;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">Dependent on terms of the employment contract to determine if you are permitted to engage in any employment or provide any services, thus seeking verification and/or company consent.</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">Dependent on terms of employment to not engage in any employment or provide any services to a supplier or competitor of the Company, except with the Company&rsquo;s prior written consent;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">Immediately disclosing any potential, perceived or actual conflict of interest (whether direct or indirect) that may give rise to a conflict with the performance of the employee&rsquo;s obligations to the Company, or the Company&rsquo;s business, confidential information or reputational interests.&nbsp;&nbsp;The Company may direct employees to take action to eliminate or reduce any such conflict, and employees must comply with such directions;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To not engage in conduct, whether during or after work hours, that in the opinion of the Company causes damage or potential damage to the Company&rsquo;s property or reputation;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To not use, or come to work while affected by use of prohibited drugs or alcohol;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To not discriminate on the basis of personal characteristics including (but not limited to) sex, race, disability, pregnancy, age, marital status or sexual orientation;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To ensure and maintain punctuality;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To respect the Company&rsquo;s property;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To dress in an appropriate manner and to ensure that appearance is presentable, clean, neat and tidy (including but not limited to wearing any uniform that is required of you by the Company);</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To not use Company internet to access and/or download sexually explicit material or other offensive material;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt; text-align: justify;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To not use Company email to send sexually explicit or&nbsp;&nbsp;suggestive material, or other offensive or harassing material;</span></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-indent: -18pt; text-align: justify;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To maintain both during employment and after termination of employment with the Company, the confidentiality of any confidential information, records or other materials acquired during the course of employment;</span></p>\r\n<p class=\"MsoListParagraphCxSpFirst\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">At all times, behave in a way that upholds the Company&rsquo;s core values and the integrity and good reputation of the Company;</span></p>\r\n<p>&nbsp;</p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-indent: -18pt; text-align: justify;\">&nbsp;</p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">Reporting any conduct of other workplace participants which is in breach of any of the above, or potentially in breach of any of the above, without delay</span><span lang=\"EN-AU\">.</span></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-indent: -18pt;\">&nbsp;</p>\r\n<h3><a name=\"_Toc108180598\"></a><span lang=\"EN-AU\">1.1.3.<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\">OTHER POLICIES</span></h3>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">Employees are encouraged to read this policy in conjunction with other relevant Company policies, including:</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">Workplace Anti-Bullying &amp; Anti-Harassment Policy;</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\"><span lang=\"EN-AU\" style=\"font-size: 11pt; font-family: \'Calibri Light\', sans-serif;\">&nbsp; Equal Employment Opportunity and Anti-Discrimination Policy</span></span></p>\r\n<h2 style=\"margin-left: 18pt; text-indent: -18pt;\"><a name=\"_Toc108180599\"></a><a name=\"_Toc43193955\"></a><span lang=\"EN-AU\">1.<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;</span></span><span lang=\"EN-AU\">Managing Records kept on the basis of this document</span></h2>\r\n<p class=\"MsoNormal\">&nbsp;</p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">All records supporting this policy shall be kept in the FNQH Pathology document management system in the location, or system based, indicated in the procedure document. Any additional or deleted records shall be kept account of in the FNQH Pathology logging system such that any future enquiry will be able to clearly identify when the changes occurred, who made them, what these changes were and how the changes were approved.</span></p>\r\n<h2 style=\"margin-left: 18pt; text-indent: -18pt;\"><a name=\"_Toc108180600\"></a><a name=\"_Toc43193956\"></a><a name=\"_Toc42774212\"></a><a name=\"_Toc31271019\"></a><a name=\"_Toc30670090\"></a><span lang=\"EN-AU\">1.<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;</span></span><span lang=\"EN-AU\">Validity and Document Management</span></h2>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">This document is valid from the date of its approval and will be reviewed on an annual basis. The current working copy will be identified as such, and any superseded documents will be archived and maintained for a period of five years.</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\"><span lang=\"EN-AU\" style=\"font-size: 11pt; font-family: \'Calibri Light\', sans-serif;\">New versions will be identified with a versioning number. Full integers will denote a major document version, and a decimal number will indicate minor amendments or edits.</span></span></p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>',	'FNQH Pathology - Digital first, better patient outcomes',	1,	'FNQH-POL-AD080722 [INTERNAL]',	'',	1,	1,	451,	'2022-09-17 09:32:00'),
(38,	'FNQH-POL-AD080722 ',	'Code of Conducts',	452,	4,	8,	'2021-10-17',	'2021-10-17',	1,	1,	'Perth',	1,	12,	'2022-10-17',	'2022-11-17',	'Glenn Makowski',	'<div style=\"mso-element: frame; mso-element-frame-hspace: 9.0pt; mso-element-wrap: around; mso-element-anchor-vertical: paragraph; mso-element-anchor-horizontal: column; mso-element-top: 8.95pt; mso-height-rule: exactly;\">\r\n<table cellspacing=\"0\" cellpadding=\"0\" align=\"left\">\r\n<tbody>\r\n<tr>\r\n<td style=\"padding: 0cm 9.0pt 0cm 9.0pt;\" align=\"left\" valign=\"top\">\r\n<p class=\"Copyright\" style=\"mso-element: frame; mso-element-frame-hspace: 9.0pt; mso-element-wrap: around; mso-element-anchor-vertical: paragraph; mso-element-anchor-horizontal: column; mso-element-top: 8.95pt; mso-height-rule: exactly;\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Calibri Light\'; mso-bidi-theme-font: major-latin;\">This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</span></p>\r\n<p class=\"Copyright\" style=\"mso-element: frame; mso-element-frame-hspace: 9.0pt; mso-element-wrap: around; mso-element-anchor-vertical: paragraph; mso-element-anchor-horizontal: column; mso-element-top: 8.95pt; mso-height-rule: exactly;\"><span style=\"font-family: Calibri, sans-serif;\">Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</span></p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n</div>',	'<p class=\"MsoToc1\"><!-- [if supportFields]><span lang=EN-AU><span\r\nstyle=\'mso-element:field-begin\'></span><span\r\nstyle=\'mso-spacerun:yes\'></span>TOC \\o \"1-3\" \\h \\z \\u <span\r\nstyle=\'mso-element:field-separator\'></span></span><![endif]--><span lang=\"EN-AU\"><span class=\"MsoHyperlink\"><a href=\"file:///C:/Users/Aditya/Downloads/FNQH%20Pathology%20Code%20of%20Conduct%20INTERNAL%20V1.0.docx#_Toc108180592\">About This Document<span style=\"color: windowtext; display: none; text-decoration-line: none;\"> </span><!-- [if supportFields]><span\r\nstyle=\'color:windowtext;display:none;mso-hide:screen;text-decoration:none;\r\ntext-underline:none\'><span style=\'mso-element:field-begin\'></span></span><span\r\nstyle=\'color:windowtext;display:none;mso-hide:screen;text-decoration:none;\r\ntext-underline:none\'> PAGEREF _Toc108180592 \\h </span><span style=\'color:windowtext;\r\ndisplay:none;mso-hide:screen;text-decoration:none;text-underline:none\'><span\r\nstyle=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; text-decoration-line: none;\">2</span><span style=\"color: windowtext; display: none; text-decoration-line: none;\"><!-- [if gte mso 9]><xml>\r\n <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300038003100380030003500390032000000</w:data>\r\n</xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\ndisplay:none;mso-hide:screen;text-decoration:none;text-underline:none\'><span\r\nstyle=\'mso-element:field-end\'></span></span><![endif]--></a></span></span></p>\r\n<p class=\"MsoToc2\"><span class=\"MsoHyperlink\"><span lang=\"EN-AU\"><a href=\"file:///C:/Users/Aditya/Downloads/FNQH%20Pathology%20Code%20of%20Conduct%20INTERNAL%20V1.0.docx#_Toc108180593\">Document Control<span style=\"color: windowtext; display: none; text-decoration-line: none;\"> </span><!-- [if supportFields]><span\r\nstyle=\'color:windowtext;display:none;mso-hide:screen;mso-bidi-font-style:normal;\r\ntext-decoration:none;text-underline:none\'><span style=\'mso-element:field-begin\'></span></span><span\r\nstyle=\'color:windowtext;display:none;mso-hide:screen;mso-bidi-font-style:normal;\r\ntext-decoration:none;text-underline:none\'> PAGEREF _Toc108180593 \\h </span><span\r\nstyle=\'color:windowtext;display:none;mso-hide:screen;mso-bidi-font-style:normal;\r\ntext-decoration:none;text-underline:none\'><span style=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; text-decoration-line: none;\">2</span><span style=\"color: windowtext; display: none; text-decoration-line: none;\"><!-- [if gte mso 9]><xml>\r\n <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300038003100380030003500390033000000</w:data>\r\n</xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\ndisplay:none;mso-hide:screen;mso-bidi-font-style:normal;text-decoration:none;\r\ntext-underline:none\'><span style=\'mso-element:field-end\'></span></span><![endif]--></a></span></span></p>\r\n<p class=\"MsoToc2\"><span class=\"MsoHyperlink\"><span lang=\"EN-AU\"><a href=\"file:///C:/Users/Aditya/Downloads/FNQH%20Pathology%20Code%20of%20Conduct%20INTERNAL%20V1.0.docx#_Toc108180594\">Document History<span style=\"color: windowtext; display: none; text-decoration-line: none;\">. </span><!-- [if supportFields]><span\r\nstyle=\'color:windowtext;display:none;mso-hide:screen;mso-bidi-font-style:normal;\r\ntext-decoration:none;text-underline:none\'><span style=\'mso-element:field-begin\'></span></span><span\r\nstyle=\'color:windowtext;display:none;mso-hide:screen;mso-bidi-font-style:normal;\r\ntext-decoration:none;text-underline:none\'> PAGEREF _Toc108180594 \\h </span><span\r\nstyle=\'color:windowtext;display:none;mso-hide:screen;mso-bidi-font-style:normal;\r\ntext-decoration:none;text-underline:none\'><span style=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; text-decoration-line: none;\">2</span><span style=\"color: windowtext; display: none; text-decoration-line: none;\"><!-- [if gte mso 9]><xml>\r\n <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300038003100380030003500390034000000</w:data>\r\n</xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\ndisplay:none;mso-hide:screen;mso-bidi-font-style:normal;text-decoration:none;\r\ntext-underline:none\'><span style=\'mso-element:field-end\'></span></span><![endif]--></a></span></span></p>\r\n<p class=\"MsoToc2\"><span class=\"MsoHyperlink\"><span lang=\"EN-AU\"><a href=\"file:///C:/Users/Aditya/Downloads/FNQH%20Pathology%20Code%20of%20Conduct%20INTERNAL%20V1.0.docx#_Toc108180595\">1.1.<span lang=\"EN-GB\" style=\"font-family: Calibri, sans-serif; color: windowtext; text-decoration-line: none;\">&nbsp;&nbsp;&nbsp;&nbsp; </span>CODE OF CONDUCT POLICY<span style=\"color: windowtext; display: none; text-decoration-line: none;\">.. </span><!-- [if supportFields]><span\r\nstyle=\'color:windowtext;display:none;mso-hide:screen;layout-grid-mode:both;\r\ntext-decoration:none;text-underline:none\'><span style=\'mso-element:field-begin\'></span></span><span\r\nstyle=\'color:windowtext;display:none;mso-hide:screen;layout-grid-mode:both;\r\ntext-decoration:none;text-underline:none\'> PAGEREF _Toc108180595 \\h </span><span\r\nstyle=\'color:windowtext;display:none;mso-hide:screen;layout-grid-mode:both;\r\ntext-decoration:none;text-underline:none\'><span style=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; text-decoration-line: none;\">4</span><span style=\"color: windowtext; display: none; text-decoration-line: none;\"><!-- [if gte mso 9]><xml>\r\n <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300038003100380030003500390035000000</w:data>\r\n</xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\ndisplay:none;mso-hide:screen;layout-grid-mode:both;text-decoration:none;\r\ntext-underline:none\'><span style=\'mso-element:field-end\'></span></span><![endif]--></a></span></span></p>\r\n<p class=\"MsoToc3\"><span class=\"MsoHyperlink\"><span lang=\"EN-AU\"><a href=\"file:///C:/Users/Aditya/Downloads/FNQH%20Pathology%20Code%20of%20Conduct%20INTERNAL%20V1.0.docx#_Toc108180596\">1.1.1.<span lang=\"EN-GB\" style=\"font-family: Calibri, sans-serif; color: windowtext; text-decoration-line: none;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>OPERATION<span style=\"color: windowtext; display: none; text-decoration-line: none;\">.. </span><!-- [if supportFields]><span\r\nstyle=\'color:windowtext;display:none;mso-hide:screen;text-decoration:none;\r\ntext-underline:none\'><span style=\'mso-element:field-begin\'></span></span><span\r\nstyle=\'color:windowtext;display:none;mso-hide:screen;text-decoration:none;\r\ntext-underline:none\'> PAGEREF _Toc108180596 \\h </span><span style=\'color:windowtext;\r\ndisplay:none;mso-hide:screen;text-decoration:none;text-underline:none\'><span\r\nstyle=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; text-decoration-line: none;\">4</span><span style=\"color: windowtext; display: none; text-decoration-line: none;\"><!-- [if gte mso 9]><xml>\r\n <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300038003100380030003500390036000000</w:data>\r\n</xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\ndisplay:none;mso-hide:screen;text-decoration:none;text-underline:none\'><span\r\nstyle=\'mso-element:field-end\'></span></span><![endif]--></a></span></span></p>\r\n<p class=\"MsoToc3\"><span class=\"MsoHyperlink\"><span lang=\"EN-AU\"><a href=\"file:///C:/Users/Aditya/Downloads/FNQH%20Pathology%20Code%20of%20Conduct%20INTERNAL%20V1.0.docx#_Toc108180597\">1.1.2.<span lang=\"EN-GB\" style=\"font-family: Calibri, sans-serif; color: windowtext; text-decoration-line: none;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>STANDARDS OF CONDUCT<span style=\"color: windowtext; display: none; text-decoration-line: none;\">. </span><!-- [if supportFields]><span\r\nstyle=\'color:windowtext;display:none;mso-hide:screen;text-decoration:none;\r\ntext-underline:none\'><span style=\'mso-element:field-begin\'></span></span><span\r\nstyle=\'color:windowtext;display:none;mso-hide:screen;text-decoration:none;\r\ntext-underline:none\'> PAGEREF _Toc108180597 \\h </span><span style=\'color:windowtext;\r\ndisplay:none;mso-hide:screen;text-decoration:none;text-underline:none\'><span\r\nstyle=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; text-decoration-line: none;\">4</span><span style=\"color: windowtext; display: none; text-decoration-line: none;\"><!-- [if gte mso 9]><xml>\r\n <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300038003100380030003500390037000000</w:data>\r\n</xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\ndisplay:none;mso-hide:screen;text-decoration:none;text-underline:none\'><span\r\nstyle=\'mso-element:field-end\'></span></span><![endif]--></a></span></span></p>\r\n<p class=\"MsoToc3\"><span class=\"MsoHyperlink\"><span lang=\"EN-AU\"><a href=\"file:///C:/Users/Aditya/Downloads/FNQH%20Pathology%20Code%20of%20Conduct%20INTERNAL%20V1.0.docx#_Toc108180598\">1.1.3.<span lang=\"EN-GB\" style=\"font-family: Calibri, sans-serif; color: windowtext; text-decoration-line: none;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>OTHER POLICIES<span style=\"color: windowtext; display: none; text-decoration-line: none;\">. </span><!-- [if supportFields]><span\r\nstyle=\'color:windowtext;display:none;mso-hide:screen;text-decoration:none;\r\ntext-underline:none\'><span style=\'mso-element:field-begin\'></span></span><span\r\nstyle=\'color:windowtext;display:none;mso-hide:screen;text-decoration:none;\r\ntext-underline:none\'> PAGEREF _Toc108180598 \\h </span><span style=\'color:windowtext;\r\ndisplay:none;mso-hide:screen;text-decoration:none;text-underline:none\'><span\r\nstyle=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; text-decoration-line: none;\">6</span><span style=\"color: windowtext; display: none; text-decoration-line: none;\"><!-- [if gte mso 9]><xml>\r\n <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300038003100380030003500390038000000</w:data>\r\n</xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\ndisplay:none;mso-hide:screen;text-decoration:none;text-underline:none\'><span\r\nstyle=\'mso-element:field-end\'></span></span><![endif]--></a></span></span></p>\r\n<p class=\"MsoToc2\"><span class=\"MsoHyperlink\"><span lang=\"EN-AU\"><a href=\"file:///C:/Users/Aditya/Downloads/FNQH%20Pathology%20Code%20of%20Conduct%20INTERNAL%20V1.0.docx#_Toc108180599\">2.<span lang=\"EN-GB\" style=\"font-family: Calibri, sans-serif; color: windowtext; text-decoration-line: none;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Managing Records kept on the basis of this document<span style=\"color: windowtext; display: none; text-decoration-line: none;\"> </span><!-- [if supportFields]><span\r\nstyle=\'color:windowtext;display:none;mso-hide:screen;text-decoration:none;\r\ntext-underline:none\'><span style=\'mso-element:field-begin\'></span></span><span\r\nstyle=\'color:windowtext;display:none;mso-hide:screen;text-decoration:none;\r\ntext-underline:none\'> PAGEREF _Toc108180599 \\h </span><span style=\'color:windowtext;\r\ndisplay:none;mso-hide:screen;text-decoration:none;text-underline:none\'><span\r\nstyle=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; text-decoration-line: none;\">6</span><span style=\"color: windowtext; display: none; text-decoration-line: none;\"><!-- [if gte mso 9]><xml>\r\n <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300038003100380030003500390039000000</w:data>\r\n</xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\ndisplay:none;mso-hide:screen;text-decoration:none;text-underline:none\'><span\r\nstyle=\'mso-element:field-end\'></span></span><![endif]--></a></span></span></p>\r\n<p><!-- [if supportFields]><b><span lang=EN-AU style=\'font-size:11.0pt;mso-bidi-font-size:\r\n10.0pt;font-family:\"Calibri Light\",sans-serif;mso-ascii-theme-font:major-latin;\r\nmso-fareast-font-family:\"Times New Roman\";mso-hansi-theme-font:major-latin;\r\nmso-bidi-theme-font:major-latin;mso-ansi-language:EN-AU;mso-fareast-language:\r\nEN-US;mso-bidi-language:AR-SA;layout-grid-mode:line;mso-no-proof:yes\'><span\r\nstyle=\'mso-element:field-end\'></span></span></b><![endif]--></p>\r\n<p class=\"MsoToc2\" style=\"tab-stops: 44.0pt right dotted 453.35pt;\"><span class=\"MsoHyperlink\"><span lang=\"EN-AU\" style=\"mso-no-proof: yes;\"><a href=\"file:///C:/Users/Aditya/Downloads/FNQH%20Pathology%20Code%20of%20Conduct%20INTERNAL%20V1.0.docx#_Toc108180600\">3.<span lang=\"EN-GB\" style=\"mso-bidi-font-size: 11.0pt; font-family: \'Calibri\',sans-serif; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: \'Times New Roman\'; mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: \'Times New Roman\'; mso-bidi-theme-font: minor-bidi; color: windowtext; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-font-weight: normal; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Validity and Document Management</a></span></span></p>\r\n<h2><a name=\"_Toc108180595\"></a><!-- [if !supportLists]--><span lang=\"EN-AU\">1.1.<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\">CODE OF CONDUCT POLICY</span></h2>\r\n<p class=\"MsoNormal\" style=\"line-height: 115%;\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">At FNQH Pathology (\"the Company\") we require that all of our employees conduct themselves according to the highest standards of ethics, integrity, and behaviour when dealing with our clients, colleagues and other stakeholders.&nbsp; This includes, but is not necessarily limited to, full compliance with all legal obligations imposed by statute or any other source of law.</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">This Code establishes the standards of behaviour that must be met by all employees. Where these standards are not met, appropriate disciplinary action will be taken. In cases where the breach involves serious misconduct, this may result in summary dismissal. In cases where a breach of the policy involves a breach of any law, then the relevant government authorities or the police may be notified.</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<h3><a name=\"_Toc108180596\"></a><!-- [if !supportLists]--><span lang=\"EN-AU\">1.1.1.<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\">OPERATION</span></h3>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">The purpose of this policy is to make it clear what the Company expects from employees, and employees are required to be familiar with and comply with the terms of this policy at all times.&nbsp; Failure to do so may result in disciplinary action, including potentially termination of employment.</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual. </span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">The terms and conditions of employment that are intended to be contractual out in an employee&rsquo;s written employment contract.</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">The Company may unilaterally introduce, vary, remove or replace this policy at any time.</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<h3><a name=\"_Toc108180597\"></a><!-- [if !supportLists]--><span lang=\"EN-AU\">1.1.2.<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\">STANDARDS OF CONDUCT</span></h3>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">The standards expected of employees include:</span></p>\r\n<p class=\"MsoListParagraphCxSpFirst\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo2;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Compliance with all Company and workplace policies, procedures, rules, regulations and contracts;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo2;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Compliance with all laws;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo2;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Compliance with all reasonable and lawful instructions given by or on behalf of the Company;</span></p>\r\n<p class=\"MsoToc2\">&nbsp;</p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo2;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Devotion of the employee&rsquo;s entire time, attention and skill during normal working hours and at other times as reasonably necessary for the employee to perform their duties;</span></p>\r\n<p class=\"MsoListParagraphCxSpFirst\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To be honest and fair in dealings with customers, clients, co-workers, Company management and the general public, and to treat them with courtesy and respect;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To be faithful and diligent, and actively pursue the Company&rsquo;s best interests at all times;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To work in a safe and compliant manner, and to observe all workplace health and safety rules and responsibilities;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Refraining from any discriminatory, bullying or harassing behaviour toward customers, clients, co-workers, Company management and the general public;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To not make any statements to the media about the Company&rsquo;s business, unless expressly authorised to do so by the Company;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To not make any statements about the Company on social media, or any other public platform, that may harm the Company&rsquo;s reputation;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To not, in connection with the employee&rsquo;s employment, accept any financial or other benefit from any entity other than the Company &ndash; unless acceptance of such benefit is in accordance with the Company&rsquo;s other workplace policies or is otherwise disclosed to the Company and expressly permitted by the Company;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Dependent on terms of the employment contract to determine if you are permitted to engage in any employment or provide any services, thus seeking verification and/or company consent. </span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Dependent on terms of employment to not engage in any employment or provide any services to a supplier or competitor of the Company, except with the Company&rsquo;s prior written consent;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Immediately disclosing any potential, perceived or actual conflict of interest (whether direct or indirect) that may give rise to a conflict with the performance of the employee&rsquo;s obligations to the Company, or the Company&rsquo;s business, confidential information or reputational interests.&nbsp; The Company may direct employees to take action to eliminate or reduce any such conflict, and employees must comply with such directions;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To not engage in conduct, whether during or after work hours, that in the opinion of the Company causes damage or potential damage to the Company&rsquo;s property or reputation;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To not use, or come to work while affected by use of prohibited drugs or alcohol;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To not discriminate on the basis of personal characteristics including (but not limited to) sex, race, disability, pregnancy, age, marital status or sexual orientation;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To ensure and maintain punctuality;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To respect the Company&rsquo;s property;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To dress in an appropriate manner and to ensure that appearance is presentable, clean, neat and tidy (including but not limited to wearing any uniform that is required of you by the Company);</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To not use Company internet to access and/or download sexually explicit material or other offensive material;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To not use Company email to send sexually explicit or&nbsp; suggestive material, or other offensive or harassing material;</span></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo2;\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\"> </span></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">To maintain both during employment and after termination of employment with the Company, the confidentiality of any confidential information, records or other materials acquired during the course of employment;</span></p>\r\n<p class=\"MsoListParagraphCxSpFirst\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo2;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">At all times, behave in a way that upholds the Company&rsquo;s core values and the integrity and good reputation of the Company;</span></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo2;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Reporting any conduct of other workplace participants which is in breach of any of the above, or potentially in breach of any of the above, without delay</span><span lang=\"EN-AU\">.</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<h3><a name=\"_Toc108180598\"></a><!-- [if !supportLists]--><span lang=\"EN-AU\">1.1.1.<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\">OTHER POLICIES</span></h3>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">Employees are encouraged to read this policy in conjunction with other relevant Company policies, including:</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<p class=\"MsoListParagraphCxSpFirst\" style=\"text-indent: -18.0pt; mso-list: l1 level1 lfo3;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Workplace Anti-Bullying &amp; Anti-Harassment Policy;</span></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-indent: -18.0pt; mso-list: l1 level1 lfo3;\"><!-- [if !supportLists]--><span lang=\"EN-AU\" style=\"font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\">Equal Employment Opportunity and Anti-Discrimination Policy.</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span><a name=\"_Toc108180599\"></a><a name=\"_Toc43193955\"></a><!-- [if !supportLists]--><span lang=\"EN-AU\">2.<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\">Managing Records kept on the basis of this document</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">All records supporting this policy shall be kept in the FNQH Pathology document management system in the location, or system based, indicated in the procedure document. Any additional or deleted records shall be kept account of in the FNQH Pathology logging system such that any future enquiry will be able to clearly identify when the changes occurred, who made them, what these changes were and how the changes were approved.</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<h2 style=\"margin-left: 18.0pt; text-indent: -18.0pt; mso-list: l2 level1 lfo1;\"><a name=\"_Toc108180600\"></a><a name=\"_Toc43193956\"></a><a name=\"_Toc42774212\"></a><a name=\"_Toc31271019\"></a><a name=\"_Toc30670090\"></a><!-- [if !supportLists]--><span lang=\"EN-AU\">3.<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp; </span></span><!--[endif]--><span lang=\"EN-AU\">Validity and Document Management</span></h2>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">This document is valid from the date of its approval and will be reviewed on an annual basis. The current working copy will be identified as such, and any superseded documents will be archived and maintained for a period of five years.</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin;\"> <span lang=\"EN-AU\" style=\"font-size: 11pt;\">New versions will be identified with a versioning number. Full integers will denote a major document version, and a decimal number will indicate minor amendments or edits.</span></span></p>\r\n<p class=\"MsoToc2\" style=\"tab-stops: 44.0pt right dotted 453.35pt;\">&nbsp;</p>\r\n<p class=\"MsoToc2\" style=\"tab-stops: 44.0pt right dotted 453.35pt;\">&nbsp;</p>\r\n<p class=\"MsoToc2\" style=\"tab-stops: 44.0pt right dotted 453.35pt;\"><span class=\"MsoHyperlink\"><span lang=\"EN-AU\" style=\"mso-no-proof: yes;\"><a href=\"file:///C:/Users/Aditya/Downloads/FNQH%20Pathology%20Code%20of%20Conduct%20INTERNAL%20V1.0.docx#_Toc108180600\"><span style=\"color: windowtext; display: none; mso-hide: screen; text-decoration: none; text-underline: none;\"><span style=\"mso-tab-count: 1 dotted;\"> </span></span><!-- [if supportFields]><span\r\nstyle=\'color:windowtext;display:none;mso-hide:screen;text-decoration:none;\r\ntext-underline:none\'><span style=\'mso-element:field-begin\'></span></span><span\r\nstyle=\'color:windowtext;display:none;mso-hide:screen;text-decoration:none;\r\ntext-underline:none\'> PAGEREF _Toc108180600 \\h </span><span style=\'color:windowtext;\r\ndisplay:none;mso-hide:screen;text-decoration:none;text-underline:none\'><span\r\nstyle=\'mso-element:field-separator\'></span></span><![endif]--><span style=\"color: windowtext; display: none; mso-hide: screen; text-decoration: none; text-underline: none;\">6</span><span style=\"color: windowtext; display: none; mso-hide: screen; text-decoration: none; text-underline: none;\"><!-- [if gte mso 9]><xml>\r\n <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F0054006F0063003100300038003100380030003600300030000000</w:data>\r\n</xml><![endif]--></span><!-- [if supportFields]><span style=\'color:windowtext;\r\ndisplay:none;mso-hide:screen;text-decoration:none;text-underline:none\'><span\r\nstyle=\'mso-element:field-end\'></span></span><![endif]--></a></span></span></p>',	'<table cellspacing=\"0\" cellpadding=\"0\" align=\"left\">\r\n<tbody>\r\n<tr>\r\n<td style=\"padding: 0cm 9pt;\" align=\"left\" valign=\"top\">\r\n<p class=\"Copyright\"><span lang=\"EN-AU\" style=\"font-family: Calibri, sans-serif;\">This publication has been prepared and written by FNQH Pathology and is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act, no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission from the document controller. Product or company names are trademarks or registered trademarks of their respective holders.</span></p>\r\n<p class=\"Copyright\"><span style=\"font-family: Calibri, sans-serif;\">Note for non-FNQH Pathology readers: The contents of this publication are subject to incident without notice. All efforts have been made to ensure the accuracy of this publication. Notwithstanding, FNQH Pathology does not assume responsibility for any errors nor for any consequences arising from any errors in this publication.</span></p>\r\n<p class=\"MsoToc1\"><span lang=\"EN-AU\"><span class=\"MsoHyperlink\"><a href=\"file:///C:/Users/Aditya/Downloads/FNQH%20Pathology%20Code%20of%20Conduct%20INTERNAL%20V1.0.docx#_Toc108180592\">About This Document</a></span></span></p>\r\n<p class=\"MsoToc2\"><span class=\"MsoHyperlink\"><span lang=\"EN-AU\"><a href=\"file:///C:/Users/Aditya/Downloads/FNQH%20Pathology%20Code%20of%20Conduct%20INTERNAL%20V1.0.docx#_Toc108180593\">Document Control</a></span></span></p>\r\n<p class=\"MsoToc2\"><span class=\"MsoHyperlink\"><span lang=\"EN-AU\"><a href=\"file:///C:/Users/Aditya/Downloads/FNQH%20Pathology%20Code%20of%20Conduct%20INTERNAL%20V1.0.docx#_Toc108180594\">Document History</a></span></span></p>\r\n<p class=\"MsoToc2\"><span class=\"MsoHyperlink\"><span lang=\"EN-AU\"><a href=\"file:///C:/Users/Aditya/Downloads/FNQH%20Pathology%20Code%20of%20Conduct%20INTERNAL%20V1.0.docx#_Toc108180595\">1.1.<span lang=\"EN-GB\" style=\"font-family: Calibri, sans-serif; color: windowtext; text-decoration-line: none;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>CODE OF CONDUCT POLICY</a></span></span></p>\r\n<p class=\"MsoToc3\"><span class=\"MsoHyperlink\"><span lang=\"EN-AU\"><a href=\"file:///C:/Users/Aditya/Downloads/FNQH%20Pathology%20Code%20of%20Conduct%20INTERNAL%20V1.0.docx#_Toc108180596\">1.1.1.<span lang=\"EN-GB\" style=\"font-family: Calibri, sans-serif; color: windowtext; text-decoration-line: none;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>OPERATION</a></span></span></p>\r\n<p class=\"MsoToc3\"><span class=\"MsoHyperlink\"><span lang=\"EN-AU\"><a href=\"file:///C:/Users/Aditya/Downloads/FNQH%20Pathology%20Code%20of%20Conduct%20INTERNAL%20V1.0.docx#_Toc108180597\">1.1.2.<span lang=\"EN-GB\" style=\"font-family: Calibri, sans-serif; color: windowtext; text-decoration-line: none;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>STANDARDS OF CONDUCT</a></span></span></p>\r\n<p class=\"MsoToc3\"><span class=\"MsoHyperlink\"><span lang=\"EN-AU\"><a href=\"file:///C:/Users/Aditya/Downloads/FNQH%20Pathology%20Code%20of%20Conduct%20INTERNAL%20V1.0.docx#_Toc108180598\">1.1.3.<span lang=\"EN-GB\" style=\"font-family: Calibri, sans-serif; color: windowtext; text-decoration-line: none;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>OTHER POLICIES</a></span></span></p>\r\n<p class=\"MsoToc2\"><span class=\"MsoHyperlink\"><span lang=\"EN-AU\"><a href=\"file:///C:/Users/Aditya/Downloads/FNQH%20Pathology%20Code%20of%20Conduct%20INTERNAL%20V1.0.docx#_Toc108180599\">2.<span lang=\"EN-GB\" style=\"font-family: Calibri, sans-serif; color: windowtext; text-decoration-line: none;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>Managing Records kept on the basis of this document</a></span></span></p>\r\n<p>&nbsp;</p>\r\n<p class=\"MsoToc2\"><span class=\"MsoHyperlink\"><span lang=\"EN-AU\"><a href=\"file:///C:/Users/Aditya/Downloads/FNQH%20Pathology%20Code%20of%20Conduct%20INTERNAL%20V1.0.docx#_Toc108180600\">3.<span lang=\"EN-GB\" style=\"font-family: Calibri, sans-serif; color: windowtext; text-decoration-line: none;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>Validity and Document Management</a></span></span></p>\r\n<h2><a name=\"_Toc108180595\"></a><span lang=\"EN-AU\">1.1.<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\">CODE OF CONDUCT POLICY</span></h2>\r\n<p class=\"MsoNormal\" style=\"line-height: 20.7px;\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">At FNQH Pathology (\"the Company\") we require that all of our employees conduct themselves according to the highest standards of ethics, integrity, and behaviour when dealing with our clients, colleagues and other stakeholders.&nbsp;&nbsp;This includes, but is not necessarily limited to, full compliance with all legal obligations imposed by statute or any other source of law.</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">This Code establishes the standards of behaviour that must be met by all employees. Where these standards are not met, appropriate disciplinary action will be taken. In cases where the breach involves serious misconduct, this may result in summary dismissal. In cases where a breach of the policy involves a breach of any law, then the relevant government authorities or the police may be notified.</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<h3><a name=\"_Toc108180596\"></a><span lang=\"EN-AU\">1.1.1.<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\">OPERATION</span></h3>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">The purpose of this policy is to make it clear what the Company expects from employees, and employees are required to be familiar with and comply with the terms of this policy at all times.&nbsp;&nbsp;Failure to do so may result in disciplinary action, including potentially termination of employment.</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">In so far as this policy imposes any obligations on the Company, those obligations are not contractual and do not give rise to any contractual rights. To the extent that this policy describes benefits and entitlements for employees, they are discretionary in nature and are also not intended to be contractual.</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">The terms and conditions of employment that are intended to be contractual out in an employee&rsquo;s written employment contract.</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">The Company may unilaterally introduce, vary, remove or replace this policy at any time.</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<h3><a name=\"_Toc108180597\"></a><span lang=\"EN-AU\">1.1.2.<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\">STANDARDS OF CONDUCT</span></h3>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">The standards expected of employees include:</span></p>\r\n<p class=\"MsoListParagraphCxSpFirst\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">Compliance with all Company and workplace policies, procedures, rules, regulations and contracts;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">Compliance with all laws;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">Compliance with all reasonable and lawful instructions given by or on behalf of the Company;</span></p>\r\n<p class=\"MsoToc2\">&nbsp;</p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">Devotion of the employee&rsquo;s entire time, attention and skill during normal working hours and at other times as reasonably necessary for the employee to perform their duties;</span></p>\r\n<p class=\"MsoListParagraphCxSpFirst\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To be honest and fair in dealings with customers, clients, co-workers, Company management and the general public, and to treat them with courtesy and respect;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To be faithful and diligent, and actively pursue the Company&rsquo;s best interests at all times;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To work in a safe and compliant manner, and to observe all workplace health and safety rules and responsibilities;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">Refraining from any discriminatory, bullying or harassing behaviour toward customers, clients, co-workers, Company management and the general public;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To not make any statements to the media about the Company&rsquo;s business, unless expressly authorised to do so by the Company;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To not make any statements about the Company on social media, or any other public platform, that may harm the Company&rsquo;s reputation;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To not, in connection with the employee&rsquo;s employment, accept any financial or other benefit from any entity other than the Company &ndash; unless acceptance of such benefit is in accordance with the Company&rsquo;s other workplace policies or is otherwise disclosed to the Company and expressly permitted by the Company;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">Dependent on terms of the employment contract to determine if you are permitted to engage in any employment or provide any services, thus seeking verification and/or company consent.</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">Dependent on terms of employment to not engage in any employment or provide any services to a supplier or competitor of the Company, except with the Company&rsquo;s prior written consent;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">Immediately disclosing any potential, perceived or actual conflict of interest (whether direct or indirect) that may give rise to a conflict with the performance of the employee&rsquo;s obligations to the Company, or the Company&rsquo;s business, confidential information or reputational interests.&nbsp;&nbsp;The Company may direct employees to take action to eliminate or reduce any such conflict, and employees must comply with such directions;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To not engage in conduct, whether during or after work hours, that in the opinion of the Company causes damage or potential damage to the Company&rsquo;s property or reputation;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To not use, or come to work while affected by use of prohibited drugs or alcohol;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To not discriminate on the basis of personal characteristics including (but not limited to) sex, race, disability, pregnancy, age, marital status or sexual orientation;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To ensure and maintain punctuality;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To respect the Company&rsquo;s property;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To dress in an appropriate manner and to ensure that appearance is presentable, clean, neat and tidy (including but not limited to wearing any uniform that is required of you by the Company);</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To not use Company internet to access and/or download sexually explicit material or other offensive material;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To not use Company email to send sexually explicit or&nbsp;&nbsp;suggestive material, or other offensive or harassing material;</span></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-indent: -18pt;\">&nbsp;</p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">To maintain both during employment and after termination of employment with the Company, the confidentiality of any confidential information, records or other materials acquired during the course of employment;</span></p>\r\n<p class=\"MsoListParagraphCxSpFirst\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">At all times, behave in a way that upholds the Company&rsquo;s core values and the integrity and good reputation of the Company;</span></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">Reporting any conduct of other workplace participants which is in breach of any of the above, or potentially in breach of any of the above, without delay</span><span lang=\"EN-AU\">.</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<h3><a name=\"_Toc108180598\"></a><span lang=\"EN-AU\">1.1.1.<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\">OTHER POLICIES</span></h3>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">Employees are encouraged to read this policy in conjunction with other relevant Company policies, including:</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<p class=\"MsoListParagraphCxSpFirst\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">Workplace Anti-Bullying &amp; Anti-Harassment Policy;</span></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: Symbol;\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\">Equal Employment Opportunity and Anti-Discrimination Policy.</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span><a name=\"_Toc108180599\"></a><a name=\"_Toc43193955\"></a><span lang=\"EN-AU\">2.<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;</span></span><span lang=\"EN-AU\">Managing Records kept on the basis of this document</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">All records supporting this policy shall be kept in the FNQH Pathology document management system in the location, or system based, indicated in the procedure document. Any additional or deleted records shall be kept account of in the FNQH Pathology logging system such that any future enquiry will be able to clearly identify when the changes occurred, who made them, what these changes were and how the changes were approved.</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<h2 style=\"margin-left: 18pt; text-indent: -18pt;\"><a name=\"_Toc108180600\"></a><a name=\"_Toc43193956\"></a><a name=\"_Toc42774212\"></a><a name=\"_Toc31271019\"></a><a name=\"_Toc30670090\"></a><span lang=\"EN-AU\">3.<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \'Times New Roman\';\">&nbsp;&nbsp;</span></span><span lang=\"EN-AU\">Validity and Document Management</span></h2>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">This document is valid from the date of its approval and will be reviewed on an annual basis. The current working copy will be identified as such, and any superseded documents will be archived and maintained for a period of five years.</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-AU\">&nbsp;</span></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-indent: -18pt;\"><span lang=\"EN-AU\" style=\"font-family: \'Calibri Light\', sans-serif;\"><span lang=\"EN-AU\" style=\"font-size: 11pt;\">New versions will be identified with a versioning number. Full integers will denote a major document version, and a decimal number will indicate minor amendments or edits.</span></span></p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>',	'FNQH Pathology - Digital first, better patient outcomes',	1,	'FNQH-POL-AD080722 [INTERNAL]',	'',	0,	1,	452,	'2022-09-17 11:48:47');



DROP TABLE IF EXISTS `document_category`;
CREATE TABLE `document_category` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `name` varchar(100) NOT NULL,
  `short_name` varchar(20) NOT NULL,
  `created_by` int(11) NOT NULL,
  `created_at` datetime NOT NULL DEFAULT current_timestamp(),
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=15 DEFAULT CHARSET=utf8mb3;

INSERT INTO `document_category` (`id`, `name`, `short_name`, `created_by`, `created_at`) VALUES
(4, 'Forms & Templates',  'F',  0,  '2022-08-17 16:32:48'),
(10,  'Risk Management',  '', 453,  '2022-09-07 15:05:37'),
(12,  'Standard Operating Procedure (SOP)', '', 453,  '2022-09-09 01:44:26'),
(14,  'Policy (POL)', '', 453,  '2022-09-09 01:44:54');




DROP TABLE IF EXISTS `risk_register`;
CREATE TABLE `risk_register` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `project_name` varchar(100) NOT NULL,
  `project_manager_id` int(11) NOT NULL,
  `last_reviewed` date NOT NULL,
  `risk_register_category_id` int(11) NOT NULL,
  `risk_register_subcategy_id` int(11) NOT NULL,
  `source_of_business_risk_id` int(11) NOT NULL,
  `date_raised` date NOT NULL,
  `risk_description` text NOT NULL,
  `likelihood_id` int(11) NOT NULL COMMENT ' ',
  `Impact_id` int(11) NOT NULL,
  `severity_id` int(11) NOT NULL,
  `mitigating_actions` varchar(100) NOT NULL,
  `owner_id` int(11) NOT NULL,
  `status` tinyint(2) NOT NULL COMMENT '1=open ,2 = closed',
  `date_closed` date NOT NULL,
  `inherent_risk` int(5) NOT NULL,
  `controls_id` int(11) NOT NULL,
  `residual_risk` varchar(100) NOT NULL,
  `velocity_id` int(11) NOT NULL,
  `risk_threshold` int(11) NOT NULL,
  `business_areas` varchar(200) NOT NULL,
  `risk_ref` varchar(255) DEFAULT NULL,
  `risk_source` varchar(255) DEFAULT NULL,
  `current_controls` text DEFAULT NULL,
  `risk_cons` varchar(255) DEFAULT NULL,
  `likely` varchar(255) DEFAULT NULL,
  `risk_score` int(11) DEFAULT NULL,
  `risk_level` varchar(2) DEFAULT NULL,
  `action_plan_progress` text DEFAULT NULL,
  `risk_cost` varchar(255) DEFAULT NULL,
  `risk_owner` varchar(255) DEFAULT NULL,
  `register_date` varchar(255) DEFAULT NULL,
  `created_by` int(11) NOT NULL,
  `created_at` datetime NOT NULL DEFAULT current_timestamp(),
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=8 DEFAULT CHARSET=utf8mb3;

INSERT INTO `risk_register` (`id`, `project_name`, `project_manager_id`, `last_reviewed`, `risk_register_category_id`, `risk_register_subcategy_id`, `source_of_business_risk_id`, `date_raised`, `risk_description`, `likelihood_id`, `Impact_id`, `severity_id`, `mitigating_actions`, `owner_id`, `status`, `date_closed`, `inherent_risk`, `controls_id`, `residual_risk`, `velocity_id`, `risk_threshold`, `business_areas`, `risk_ref`, `risk_source`, `current_controls`, `risk_cons`, `likely`, `risk_score`, `risk_level`, `action_plan_progress`, `risk_cost`, `risk_owner`, `register_date`, `created_by`, `created_at`) VALUES
(5, 'test', 455,  '0000-00-00', 1,  1,  0,  '2022-08-30', '                                                Risk Description                                            ', 2,  1,  1,  'Mitigating Actions', 284,  1,  '2022-08-29', 0,  0,  '', 0,  0,  '', '', '', '', '', '', 0,  'E',  '', '', '', '', 284,  '2022-08-29 13:17:25'),
(6, 'test project uuuu',  452,  '0000-00-00', 1,  1,  0,  '2022-08-31', 'Risk Description', 1,  1,  1,  'Mitigating Actions', 452,  1,  '2022-08-31', 0,  0,  '', 0,  0,  '', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 452,  '2022-08-31 14:40:04'),
(7, 'Test', 452,  '0000-00-00', 1,  1,  0,  '2022-09-19', 'test', 1,  1,  1,  'NA', 452,  1,  '2022-09-21', 0,  0,  '', 0,  0,  '', '', 'Test', '', '', '', 0,  'E',  '', '', '', '2022-09-19', 452,  '2022-09-19 17:08:31');



DROP TABLE IF EXISTS `document_share`;
CREATE TABLE `document_share` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `from_user_id` int(11) NOT NULL,
  `to_user_id` int(11) NOT NULL,
  `document_id` int(11) NOT NULL,
  `view_permission` tinyint(2) NOT NULL,
  `delete_permission` tinyint(2) NOT NULL,
  `download_permission` tinyint(2) NOT NULL,
  `edit_permission` tinyint(2) NOT NULL,
  `description` text NOT NULL,
  `revision_status` tinyint(2) NOT NULL COMMENT '1 = rejcted , 2 = approved',
  `created_by` int(11) NOT NULL,
  `created_at` datetime NOT NULL DEFAULT current_timestamp(),
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=41 DEFAULT CHARSET=utf8mb3;

INSERT INTO `document_share` (`id`, `from_user_id`, `to_user_id`, `document_id`, `view_permission`, `delete_permission`, `download_permission`, `edit_permission`, `description`, `revision_status`, `created_by`, `created_at`) VALUES
(25,  284,  284,  5,  1,  0,  0,  0,  'adadafaf', 0,  284,  '2022-08-27 12:13:57'),
(26,  284,  401,  5,  1,  0,  0,  0,  'adadafaf', 0,  284,  '2022-08-27 12:13:57'),
(27,  284,  401,  1,  1,  0,  0,  0,  'test document assign', 0,  284,  '2022-09-05 06:31:13'),
(28,  284,  451,  1,  1,  1,  0,  0,  'test document assign', 0,  284,  '2022-09-05 06:40:56'),
(29,  284,  452,  1,  1,  1,  1,  1,  '', 2,  284,  '2022-09-05 07:36:44'),
(30,  452,  456,  3,  1,  1,  1,  1,  'test sbhare',  2,  452,  '2022-09-06 09:32:31'),
(31,  452,  454,  3,  1,  1,  1,  1,  'Demo Testing', 2,  452,  '2022-09-06 09:42:41'),
(32,  453,  460,  5,  1,  0,  0,  0,  '', 0,  453,  '2022-09-08 10:01:12'),
(33,  284,  452,  14, 1,  1,  1,  1,  'test document assign', 2,  284,  '2022-09-08 13:00:14'),
(34,  284,  452,  14, 1,  1,  1,  1,  'test document assign', 2,  284,  '2022-09-09 16:24:15'),
(35,  453,  455,  11, 1,  0,  0,  0,  '', 0,  453,  '2022-09-12 08:11:16'),
(39,  451,  284,  37, 1,  0,  1,  0,  '', 0,  451,  '2022-09-17 09:37:28'),
(40,  452,  453,  38, 1,  1,  1,  1,  'Please check it out',  0,  452,  '2022-09-17 11:52:57');





DROP TABLE IF EXISTS `risk_register_likelihood`;
CREATE TABLE `risk_register_likelihood` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `name` varchar(100) NOT NULL,
  `created_by` int(11) NOT NULL,
  `created_at` datetime NOT NULL DEFAULT current_timestamp(),
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=4 DEFAULT CHARSET=utf8mb3;

INSERT INTO `risk_register_likelihood` (`id`, `name`, `created_by`, `created_at`) VALUES
(1, 'Possible', 0,  '2022-08-26 16:59:38'),
(2, 'Likely', 0,  '2022-08-26 16:59:38'),
(3, 'Almost Certain', 0,  '2022-08-26 16:59:38');



DROP TABLE IF EXISTS `risk_register_impact`;
CREATE TABLE `risk_register_impact` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `name` varchar(100) NOT NULL,
  `created_by` int(11) NOT NULL,
  `created_at` datetime NOT NULL DEFAULT current_timestamp(),
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=3 DEFAULT CHARSET=utf8mb3;

INSERT INTO `risk_register_impact` (`id`, `name`, `created_by`, `created_at`) VALUES
(1, 'Extreme',  0,  '2022-08-26 17:05:07'),
(2, 'Major',  0,  '2022-08-26 17:05:07');



DROP TABLE IF EXISTS `risk_register_severity`;
CREATE TABLE `risk_register_severity` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `name` varchar(100) NOT NULL,
  `created_by` int(11) NOT NULL,
  `created_at` datetime NOT NULL DEFAULT current_timestamp(),
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=4 DEFAULT CHARSET=utf8mb3;

INSERT INTO `risk_register_severity` (`id`, `name`, `created_by`, `created_at`) VALUES
(1, 'test a', 0,  '2022-08-26 17:13:16'),
(2, 'test b', 0,  '2022-08-26 17:13:16');



DROP TABLE IF EXISTS `risk_comment`;
CREATE TABLE `risk_comment` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `risk_id` int(11) NOT NULL,
  `user_id` int(11) NOT NULL,
  `comment` text NOT NULL,
  `severty` varchar(255) DEFAULT NULL,
  `next_revision_date` varchar(255) DEFAULT NULL,
  `created_at` timestamp NULL DEFAULT current_timestamp(),
  PRIMARY KEY (`id`)
) ENGINE=MyISAM AUTO_INCREMENT=4 DEFAULT CHARSET=latin1;

INSERT INTO `risk_comment` (`id`, `risk_id`, `user_id`, `comment`, `severty`, `next_revision_date`, `created_at`) VALUES
(1, 5,  452,  'New Comment',  '2',  '2022-09-21', '2022-09-19 04:56:55'),
(2, 5,  452,  'New Comment 2 ', '2',  '2022-09-29', '2022-09-19 04:58:04'),
(3, 5,  452,  'New Comment 3',  '1',  '2022-09-22', '2022-09-19 08:28:36');




DROP TABLE IF EXISTS `risk_register_category`;
CREATE TABLE `risk_register_category` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `name` varchar(100) NOT NULL,
  `created_by` int(11) NOT NULL,
  `created_at` datetime NOT NULL DEFAULT current_timestamp(),
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=4 DEFAULT CHARSET=utf8mb3;

INSERT INTO `risk_register_category` (`id`, `name`, `created_by`, `created_at`) VALUES
(1, 'PRA',  0,  '2022-08-26 16:43:10'),
(2, 'BRA',  0,  '2022-08-26 16:43:10');




DROP TABLE IF EXISTS `risk_register_sub_category`;
CREATE TABLE `risk_register_sub_category` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `risk_register_category_id` int(11) NOT NULL,
  `name` varchar(100) NOT NULL,
  `created_by` int(11) NOT NULL,
  `created_at` datetime NOT NULL DEFAULT current_timestamp(),
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=5 DEFAULT CHARSET=utf8mb3;

INSERT INTO `risk_register_sub_category` (`id`, `risk_register_category_id`, `name`, `created_by`, `created_at`) VALUES
(1, 1,  'Process',  0,  '2022-08-26 16:44:41'),
(2, 1,  'Hazards',  0,  '2022-08-26 16:44:41'),
(3, 2,  'Business', 0,  '2022-08-26 16:44:41');



DROP TABLE IF EXISTS `document_issue_to`;
CREATE TABLE `document_issue_to` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `name` varchar(100) NOT NULL,
  `created_by` int(11) NOT NULL,
  `created_at` datetime NOT NULL DEFAULT current_timestamp(),
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=8 DEFAULT CHARSET=utf8mb3;

INSERT INTO `document_issue_to` (`id`, `name`, `created_by`, `created_at`) VALUES
(1, 'Consultants(C)', 0,  '2022-08-18 09:12:36'),
(2, 'Scientific (S)', 0,  '2022-08-18 09:12:36'),
(3, 'MLA(M)', 0,  '2022-08-18 09:12:36'),
(4, 'All staff (AS)', 0,  '2022-08-18 09:12:36'),
(5, 'Admin (A)',  0,  '2022-08-18 09:12:36'),
(6, 'Not Applicable(NA)', 0,  '2022-08-18 09:12:36'),
(7, 'Specify',  0,  '2022-08-18 09:12:36');



DROP TABLE IF EXISTS `document_subcategory`;
CREATE TABLE `document_subcategory` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `category_id` int(11) NOT NULL,
  `name` varchar(100) NOT NULL,
  `created_by` int(11) NOT NULL,
  `created_at` datetime NOT NULL DEFAULT current_timestamp(),
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=13 DEFAULT CHARSET=utf8mb3;

INSERT INTO `document_subcategory` (`id`, `category_id`, `name`, `created_by`, `created_at`) VALUES
(1, 1,  'test', 0,  '2022-08-18 17:34:04'),
(2, 2,  'test', 0,  '2022-08-18 17:34:04'),
(3, 3,  'test', 0,  '2022-08-18 17:34:04'),
(4, 4,  'test', 0,  '2022-08-18 17:34:04'),
(7, 10, 'testing update', 284,  '2022-09-08 09:29:17'),
(8, 14, 'Human Resources (HR)', 453,  '2022-09-09 01:47:05'),
(9, 12, 'Risk Management',  453,  '2022-09-09 01:48:53'),
(10,  14, 'Risk Management',  453,  '2022-09-09 01:49:06'),
(11,  14, 'Human Resources (HR)', 453,  '2022-09-09 01:49:21'),
(12,  12, 'Manual', 453,  '2022-09-09 01:50:01');



DROP TABLE IF EXISTS `document_viewers_history`;
CREATE TABLE `document_viewers_history` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `viewer_user_id` int(11) NOT NULL,
  `document_id` int(11) NOT NULL,
  `created_by` int(11) NOT NULL,
  `created_at` datetime NOT NULL DEFAULT current_timestamp(),
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=46 DEFAULT CHARSET=utf8mb3;

INSERT INTO `document_viewers_history` (`id`, `viewer_user_id`, `document_id`, `created_by`, `created_at`) VALUES
(1, 284,  5,  284,  '2022-08-25 14:36:27'),
(2, 401,  5,  401,  '2022-08-26 06:12:18'),
(3, 284,  5,  284,  '2022-08-26 07:38:22'),
(4, 284,  5,  284,  '2022-08-27 12:14:15'),
(5, 452,  1,  452,  '2022-09-06 12:00:48'),
(6, 452,  1,  452,  '2022-09-06 12:08:34'),
(7, 452,  1,  452,  '2022-09-06 12:21:35'),
(8, 452,  3,  452,  '2022-09-06 12:21:47'),
(9, 452,  3,  452,  '2022-09-06 12:44:01'),
(11,  284,  15, 284,  '2022-09-08 08:48:56'),
(12,  453,  1,  453,  '2022-09-08 08:59:36'),
(13,  284,  14, 284,  '2022-09-08 09:24:03'),
(14,  284,  14, 284,  '2022-09-08 09:24:45'),
(15,  284,  14, 284,  '2022-09-08 09:25:35'),
(16,  452,  14, 452,  '2022-09-08 12:01:06'),
(17,  452,  14, 452,  '2022-09-08 12:01:13'),
(18,  452,  14, 452,  '2022-09-08 13:01:40'),
(19,  452,  14, 452,  '2022-09-08 12:01:41'),
(20,  460,  12, 460,  '2022-09-08 15:19:42'),
(21,  460,  14, 460,  '2022-09-09 02:40:30'),
(22,  284,  13, 284,  '2022-09-09 09:55:22'),
(23,  284,  3,  284,  '2022-09-09 09:57:33'),
(24,  284,  14, 284,  '2022-09-09 11:10:34'),
(25,  284,  14, 284,  '2022-09-09 11:35:19'),
(26,  452,  1,  452,  '2022-09-09 15:25:11'),
(27,  452,  14, 452,  '2022-09-09 15:25:21'),
(28,  455,  11, 455,  '2022-09-12 07:13:23'),
(29,  460,  14, 460,  '2022-09-12 07:59:09'),
(30,  460,  11, 460,  '2022-09-12 08:00:12'),
(31,  460,  11, 460,  '2022-09-12 08:04:03'),
(33,  453,  16, 453,  '2022-09-15 19:52:17'),
(34,  453,  16, 453,  '2022-09-15 19:54:19'),
(35,  453,  17, 453,  '2022-09-15 19:59:11'),
(36,  453,  18, 453,  '2022-09-15 20:10:50'),
(37,  453,  24, 453,  '2022-09-15 22:28:36'),
(38,  453,  25, 453,  '2022-09-16 10:09:41'),
(39,  453,  26, 453,  '2022-09-16 10:20:38'),
(40,  453,  27, 453,  '2022-09-16 10:29:48'),
(41,  453,  32, 453,  '2022-09-16 11:20:52'),
(42,  451,  37, 451,  '2022-09-17 08:32:16'),
(43,  451,  37, 451,  '2022-09-17 08:35:32'),
(44,  452,  38, 452,  '2022-09-17 10:48:58'),
(45,  452,  38, 452,  '2022-09-17 11:29:12');
